# num of genes	num of total genes	Log of odds ratio	P-value	Adjusted p-value	GO term ID	GO term name	GO type
12	12	2.32129956088	-	4.04e-09	GO:0035635	entry of bacterium into host cell	BP
7	7	2.32129956088	-	1.28e-05	GO:2001171	positive regulation of ATP biosynthetic process	BP
7	7	2.32129956088	-	1.28e-05	GO:0032873	negative regulation of stress-activated MAPK cascade	BP
6	6	2.32129956088	-	6.39e-05	GO:2000323	negative regulation of glucocorticoid receptor signaling pathway	BP
3	3	2.32129956088	-	8.00e-03	GO:1902661	positive regulation of glucose mediated signaling pathway	BP
3	3	2.32129956088	-	8.00e-03	GO:0090261	positive regulation of inclusion body assembly	BP
3	3	2.32129956088	-	8.00e-03	GO:0035793	positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway	BP
3	3	2.32129956088	-	8.00e-03	GO:1904030	negative regulation of cyclin-dependent protein kinase activity	BP
3	3	2.32129956088	-	8.00e-03	GO:0014005	microglia development	BP
3	3	2.32129956088	-	8.00e-03	GO:0001827	inner cell mass cell fate commitment	BP
3	3	2.32129956088	-	8.00e-03	GO:0072277	metanephric glomerular capillary formation	BP
3	3	2.32129956088	-	8.00e-03	GO:1902803	regulation of synaptic vesicle transport	BP
3	3	2.32129956088	-	8.00e-03	GO:2000074	regulation of type B pancreatic cell development	BP
3	3	2.32129956088	-	8.00e-03	GO:0048807	female genitalia morphogenesis	BP
3	3	2.32129956088	-	8.00e-03	GO:2000619	negative regulation of histone H4-K16 acetylation	BP
3	3	2.32129956088	-	8.00e-03	GO:0022898	regulation of transmembrane transporter activity	BP
3	3	2.32129956088	-	8.00e-03	GO:1902263	apoptotic process involved in embryonic digit morphogenesis	BP
3	3	2.32129956088	-	8.00e-03	GO:0045069	regulation of viral genome replication	BP
3	3	2.32129956088	-	8.00e-03	GO:0050801	ion homeostasis	BP
3	3	2.32129956088	-	8.00e-03	GO:0070141	response to UV-A	BP
3	3	2.32129956088	-	8.00e-03	GO:0002366	leukocyte activation involved in immune response	BP
3	3	2.32129956088	-	8.00e-03	GO:1902306	negative regulation of sodium ion transmembrane transport	BP
3	3	2.32129956088	-	8.00e-03	GO:0006549	isoleucine metabolic process	BP
3	3	2.32129956088	-	8.00e-03	GO:0000255	allantoin metabolic process	BP
3	3	2.32129956088	-	8.00e-03	GO:0003157	endocardium development	BP
3	3	2.32129956088	-	8.00e-03	GO:0070433	negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway	BP
3	3	2.32129956088	-	8.00e-03	GO:0019724	B cell mediated immunity	BP
3	3	2.32129956088	-	8.00e-03	GO:1990535	neuron projection maintenance	BP
3	3	2.32129956088	-	8.00e-03	GO:0045218	zonula adherens maintenance	BP
3	3	2.32129956088	-	8.00e-03	GO:0061614	pri-miRNA transcription from RNA polymerase II promoter	BP
3	3	2.32129956088	-	8.00e-03	GO:1902951	negative regulation of dendritic spine maintenance	BP
3	3	2.32129956088	-	8.00e-03	GO:0035973	aggrephagy	BP
3	3	2.32129956088	-	8.00e-03	GO:0001922	B-1 B cell homeostasis	BP
3	3	2.32129956088	-	8.00e-03	GO:2001170	negative regulation of ATP biosynthetic process	BP
3	3	2.32129956088	-	8.00e-03	GO:0002902	regulation of B cell apoptotic process	BP
3	3	2.32129956088	-	8.00e-03	GO:0021781	glial cell fate commitment	BP
3	3	2.32129956088	-	8.00e-03	GO:1990785	response to water-immersion restraint stress	BP
3	3	2.32129956088	-	8.00e-03	GO:2000111	positive regulation of macrophage apoptotic process	BP
3	3	2.32129956088	-	8.00e-03	GO:0060168	positive regulation of adenosine receptor signaling pathway	BP
3	3	2.32129956088	-	8.00e-03	GO:0051707	response to other organism	BP
3	3	2.32129956088	-	8.00e-03	GO:0060368	regulation of Fc receptor mediated stimulatory signaling pathway	BP
3	3	2.32129956088	-	8.00e-03	GO:2000974	negative regulation of pro-B cell differentiation	BP
3	3	2.32129956088	-	8.00e-03	GO:2000973	regulation of pro-B cell differentiation	BP
3	3	2.32129956088	-	8.00e-03	GO:1902174	positive regulation of keratinocyte apoptotic process	BP
3	3	2.32129956088	-	8.00e-03	GO:0007176	regulation of epidermal growth factor-activated receptor activity	BP
3	3	2.32129956088	-	8.00e-03	GO:0070424	regulation of nucleotide-binding oligomerization domain containing signaling pathway	BP
3	3	2.32129956088	-	8.00e-03	GO:0061198	fungiform papilla formation	BP
3	3	2.32129956088	-	8.00e-03	GO:2000058	regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process	BP
3	3	2.32129956088	-	8.00e-03	GO:0090258	negative regulation of mitochondrial fission	BP
3	3	2.32129956088	-	8.00e-03	GO:0009648	photoperiodism	BP
3	3	2.32129956088	-	8.00e-03	GO:2000630	positive regulation of miRNA metabolic process	BP
3	3	2.32129956088	-	8.00e-03	GO:0060154	cellular process regulating host cell cycle in response to virus	BP
3	3	2.32129956088	-	8.00e-03	GO:0019065	receptor-mediated endocytosis of virus by host cell	BP
3	3	2.32129956088	-	8.00e-03	GO:0038145	macrophage colony-stimulating factor signaling pathway	BP
3	3	2.32129956088	-	8.00e-03	GO:0021697	cerebellar cortex formation	BP
3	3	2.32129956088	-	8.00e-03	GO:0043366	beta selection	BP
3	3	2.32129956088	-	8.00e-03	GO:0031281	positive regulation of cyclase activity	BP
3	3	2.32129956088	-	8.00e-03	GO:0018076	N-terminal peptidyl-lysine acetylation	BP
3	3	2.32129956088	-	8.00e-03	GO:2000687	negative regulation of rubidium ion transmembrane transporter activity	BP
3	3	2.32129956088	-	8.00e-03	GO:0002277	myeloid dendritic cell activation involved in immune response	BP
7	7	2.32129956088	-	1.28e-05	GO:0004679	AMP-activated protein kinase activity	MF
3	3	2.32129956088	-	8.00e-03	GO:0004992	platelet activating factor receptor activity	MF
3	3	2.32129956088	-	8.00e-03	GO:0050816	phosphothreonine residue binding	MF
3	3	2.32129956088	-	8.00e-03	GO:0045309	protein phosphorylated amino acid binding	MF
3	3	2.32129956088	-	8.00e-03	GO:0032139	dinucleotide insertion or deletion binding	MF
3	3	2.32129956088	-	8.00e-03	GO:0032137	guanine/thymine mispair binding	MF
3	3	2.32129956088	-	8.00e-03	GO:0070644	vitamin D response element binding	MF
3	3	2.32129956088	-	8.00e-03	GO:0097472	cyclin-dependent protein kinase activity	MF
3	3	2.32129956088	-	8.00e-03	GO:0016314	phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity	MF
3	3	2.32129956088	-	8.00e-03	GO:0043120	tumor necrosis factor binding	MF
3	3	2.32129956088	-	8.00e-03	GO:0043398	HLH domain binding	MF
3	3	2.32129956088	-	8.00e-03	GO:0004711	ribosomal protein S6 kinase activity	MF
3	3	2.32129956088	-	8.00e-03	GO:0008426	protein kinase C inhibitor activity	MF
3	3	2.32129956088	-	8.00e-03	GO:0032142	single guanine insertion binding	MF
11	11	2.32129956088	-	2.03e-08	GO:0060968	regulation of gene silencing	BP
5	5	2.32129956088	-	3.20e-04	GO:0046578	regulation of Ras protein signal transduction	BP
5	5	2.32129956088	-	3.20e-04	GO:1900015	regulation of cytokine production involved in inflammatory response	BP
5	5	2.32129956088	-	3.20e-04	GO:0071681	cellular response to indole-3-methanol	BP
5	5	2.32129956088	-	3.20e-04	GO:0042501	serine phosphorylation of STAT protein	BP
4	4	2.32129956088	-	1.60e-03	GO:0030578	PML body organization	BP
4	4	2.32129956088	-	1.60e-03	GO:0035791	platelet-derived growth factor receptor-beta signaling pathway	BP
4	4	2.32129956088	-	1.60e-03	GO:0007091	metaphase/anaphase transition of mitotic cell cycle	BP
4	4	2.32129956088	-	1.60e-03	GO:0030043	actin filament fragmentation	BP
4	4	2.32129956088	-	1.60e-03	GO:1903377	negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway	BP
4	4	2.32129956088	-	1.60e-03	GO:0038127	ERBB signaling pathway	BP
4	4	2.32129956088	-	1.60e-03	GO:0043570	maintenance of DNA repeat elements	BP
4	4	2.32129956088	-	1.60e-03	GO:0090170	regulation of Golgi inheritance	BP
4	4	2.32129956088	-	1.60e-03	GO:1902916	positive regulation of protein polyubiquitination	BP
4	4	2.32129956088	-	1.60e-03	GO:0003266	regulation of secondary heart field cardioblast proliferation	BP
4	4	2.32129956088	-	1.60e-03	GO:0010822	positive regulation of mitochondrion organization	BP
4	4	2.32129956088	-	1.60e-03	GO:0051098	regulation of binding	BP
4	4	2.32129956088	-	1.60e-03	GO:1904637	cellular response to ionomycin	BP
4	4	2.32129956088	-	1.60e-03	GO:0090559	regulation of membrane permeability	BP
4	4	2.32129956088	-	1.60e-03	GO:0021943	formation of radial glial scaffolds	BP
4	4	2.32129956088	-	1.60e-03	GO:1903936	cellular response to sodium arsenite	BP
4	4	2.32129956088	-	1.60e-03	GO:1902751	positive regulation of cell cycle G2/M phase transition	BP
4	4	2.32129956088	-	1.60e-03	GO:0045619	regulation of lymphocyte differentiation	BP
2	2	2.32129956088	-	4.00e-02	GO:0032431	activation of phospholipase A2 activity	BP
2	2	2.32129956088	-	4.00e-02	GO:0016198	axon choice point recognition	BP
2	2	2.32129956088	-	4.00e-02	GO:0070178	D-serine metabolic process	BP
2	2	2.32129956088	-	4.00e-02	GO:0061325	cell proliferation involved in outflow tract morphogenesis	BP
2	2	2.32129956088	-	4.00e-02	GO:0017055	negative regulation of RNA polymerase II transcriptional preinitiation complex assembly	BP
2	2	2.32129956088	-	4.00e-02	GO:0019285	glycine betaine biosynthetic process from choline	BP
2	2	2.32129956088	-	4.00e-02	GO:0030832	regulation of actin filament length	BP
2	2	2.32129956088	-	4.00e-02	GO:0030834	regulation of actin filament depolymerization	BP
2	2	2.32129956088	-	4.00e-02	GO:1904528	positive regulation of microtubule binding	BP
2	2	2.32129956088	-	4.00e-02	GO:0099563	modification of synaptic structure	BP
2	2	2.32129956088	-	4.00e-02	GO:0008050	female courtship behavior	BP
2	2	2.32129956088	-	4.00e-02	GO:0048320	axial mesoderm formation	BP
2	2	2.32129956088	-	4.00e-02	GO:0060341	regulation of cellular localization	BP
2	2	2.32129956088	-	4.00e-02	GO:0001865	NK T cell differentiation	BP
2	2	2.32129956088	-	4.00e-02	GO:0001869	negative regulation of complement activation, lectin pathway	BP
2	2	2.32129956088	-	4.00e-02	GO:0060667	branch elongation involved in salivary gland morphogenesis	BP
2	2	2.32129956088	-	4.00e-02	GO:0060661	submandibular salivary gland formation	BP
2	2	2.32129956088	-	4.00e-02	GO:0001672	regulation of chromatin assembly or disassembly	BP
2	2	2.32129956088	-	4.00e-02	GO:0071226	cellular response to molecule of fungal origin	BP
2	2	2.32129956088	-	4.00e-02	GO:0071221	cellular response to bacterial lipopeptide	BP
2	2	2.32129956088	-	4.00e-02	GO:0034344	regulation of type III interferon production	BP
2	2	2.32129956088	-	4.00e-02	GO:0046732	active induction of host immune response by virus	BP
2	2	2.32129956088	-	4.00e-02	GO:0042732	D-xylose metabolic process	BP
2	2	2.32129956088	-	4.00e-02	GO:0097498	endothelial tube lumen extension	BP
2	2	2.32129956088	-	4.00e-02	GO:1905664	regulation of calcium ion import across plasma membrane	BP
2	2	2.32129956088	-	4.00e-02	GO:0060595	fibroblast growth factor receptor signaling pathway involved in mammary gland specification	BP
2	2	2.32129956088	-	4.00e-02	GO:0002032	desensitization of G-protein coupled receptor protein signaling pathway by arrestin	BP
2	2	2.32129956088	-	4.00e-02	GO:1905426	positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation	BP
2	2	2.32129956088	-	4.00e-02	GO:0014040	positive regulation of Schwann cell differentiation	BP
2	2	2.32129956088	-	4.00e-02	GO:0032071	regulation of endodeoxyribonuclease activity	BP
2	2	2.32129956088	-	4.00e-02	GO:0019249	lactate biosynthetic process	BP
2	2	2.32129956088	-	4.00e-02	GO:0098868	bone growth	BP
2	2	2.32129956088	-	4.00e-02	GO:0061857	endoplasmic reticulum stress-induced pre-emptive quality control	BP
2	2	2.32129956088	-	4.00e-02	GO:0035507	regulation of myosin-light-chain-phosphatase activity	BP
2	2	2.32129956088	-	4.00e-02	GO:0061032	visceral serous pericardium development	BP
2	2	2.32129956088	-	4.00e-02	GO:0009785	blue light signaling pathway	BP
2	2	2.32129956088	-	4.00e-02	GO:1902530	positive regulation of protein linear polyubiquitination	BP
2	2	2.32129956088	-	4.00e-02	GO:0010652	positive regulation of cell communication by chemical coupling	BP
2	2	2.32129956088	-	4.00e-02	GO:0036353	histone H2A-K119 monoubiquitination	BP
2	2	2.32129956088	-	4.00e-02	GO:2000077	negative regulation of type B pancreatic cell development	BP
2	2	2.32129956088	-	4.00e-02	GO:0050922	negative regulation of chemotaxis	BP
2	2	2.32129956088	-	4.00e-02	GO:0070489	T cell aggregation	BP
2	2	2.32129956088	-	4.00e-02	GO:0046166	glyceraldehyde-3-phosphate biosynthetic process	BP
2	2	2.32129956088	-	4.00e-02	GO:0060512	prostate gland morphogenesis	BP
2	2	2.32129956088	-	4.00e-02	GO:1902746	regulation of lens fiber cell differentiation	BP
2	2	2.32129956088	-	4.00e-02	GO:2000402	negative regulation of lymphocyte migration	BP
2	2	2.32129956088	-	4.00e-02	GO:0032959	inositol trisphosphate biosynthetic process	BP
2	2	2.32129956088	-	4.00e-02	GO:0097695	establishment of macromolecular complex localization to telomere	BP
2	2	2.32129956088	-	4.00e-02	GO:0097694	establishment of RNA localization to telomere	BP
2	2	2.32129956088	-	4.00e-02	GO:0023035	CD40 signaling pathway	BP
2	2	2.32129956088	-	4.00e-02	GO:0035377	transepithelial water transport	BP
2	2	2.32129956088	-	4.00e-02	GO:0042534	regulation of tumor necrosis factor biosynthetic process	BP
2	2	2.32129956088	-	4.00e-02	GO:0097107	postsynaptic density assembly	BP
2	2	2.32129956088	-	4.00e-02	GO:0071306	cellular response to vitamin E	BP
2	2	2.32129956088	-	4.00e-02	GO:0051650	establishment of vesicle localization	BP
2	2	2.32129956088	-	4.00e-02	GO:0032916	positive regulation of transforming growth factor beta3 production	BP
2	2	2.32129956088	-	4.00e-02	GO:0045066	regulatory T cell differentiation	BP
2	2	2.32129956088	-	4.00e-02	GO:2000324	positive regulation of glucocorticoid receptor signaling pathway	BP
2	2	2.32129956088	-	4.00e-02	GO:0010725	regulation of primitive erythrocyte differentiation	BP
2	2	2.32129956088	-	4.00e-02	GO:0001914	regulation of T cell mediated cytotoxicity	BP
2	2	2.32129956088	-	4.00e-02	GO:0034391	regulation of smooth muscle cell apoptotic process	BP
2	2	2.32129956088	-	4.00e-02	GO:0060139	positive regulation of apoptotic process by virus	BP
2	2	2.32129956088	-	4.00e-02	GO:0002327	immature B cell differentiation	BP
2	2	2.32129956088	-	4.00e-02	GO:0032425	positive regulation of mismatch repair	BP
2	2	2.32129956088	-	4.00e-02	GO:0071174	mitotic spindle checkpoint	BP
2	2	2.32129956088	-	4.00e-02	GO:0010934	macrophage cytokine production	BP
2	2	2.32129956088	-	4.00e-02	GO:0033277	abortive mitotic cell cycle	BP
2	2	2.32129956088	-	4.00e-02	GO:1905366	negative regulation of intralumenal vesicle formation	BP
2	2	2.32129956088	-	4.00e-02	GO:0072604	interleukin-6 secretion	BP
2	2	2.32129956088	-	4.00e-02	GO:0019049	evasion or tolerance of host defenses by virus	BP
2	2	2.32129956088	-	4.00e-02	GO:0090218	positive regulation of lipid kinase activity	BP
2	2	2.32129956088	-	4.00e-02	GO:1903038	negative regulation of leukocyte cell-cell adhesion	BP
2	2	2.32129956088	-	4.00e-02	GO:1903033	positive regulation of microtubule plus-end binding	BP
2	2	2.32129956088	-	4.00e-02	GO:0007057	spindle assembly involved in female meiosis I	BP
2	2	2.32129956088	-	4.00e-02	GO:1903758	negative regulation of transcription from RNA polymerase II promoter by histone modification	BP
2	2	2.32129956088	-	4.00e-02	GO:0044334	canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition	BP
2	2	2.32129956088	-	4.00e-02	GO:0071460	cellular response to cell-matrix adhesion	BP
2	2	2.32129956088	-	4.00e-02	GO:0061741	chaperone-mediated protein transport involved in chaperone-mediated autophagy	BP
2	2	2.32129956088	-	4.00e-02	GO:0032817	regulation of natural killer cell proliferation	BP
2	2	2.32129956088	-	4.00e-02	GO:0035747	natural killer cell chemotaxis	BP
2	2	2.32129956088	-	4.00e-02	GO:1904049	negative regulation of spontaneous neurotransmitter secretion	BP
2	2	2.32129956088	-	4.00e-02	GO:1903894	regulation of IRE1-mediated unfolded protein response	BP
2	2	2.32129956088	-	4.00e-02	GO:0048145	regulation of fibroblast proliferation	BP
2	2	2.32129956088	-	4.00e-02	GO:1901558	response to metformin	BP
2	2	2.32129956088	-	4.00e-02	GO:0090737	telomere maintenance via telomere trimming	BP
2	2	2.32129956088	-	4.00e-02	GO:0070352	positive regulation of white fat cell proliferation	BP
2	2	2.32129956088	-	4.00e-02	GO:0060632	regulation of microtubule-based movement	BP
2	2	2.32129956088	-	4.00e-02	GO:0010255	glucose mediated signaling pathway	BP
2	2	2.32129956088	-	4.00e-02	GO:1903384	negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway	BP
2	2	2.32129956088	-	4.00e-02	GO:1902524	positive regulation of protein K48-linked ubiquitination	BP
2	2	2.32129956088	-	4.00e-02	GO:0072738	cellular response to diamide	BP
2	2	2.32129956088	-	4.00e-02	GO:0021589	cerebellum structural organization	BP
2	2	2.32129956088	-	4.00e-02	GO:0060545	positive regulation of necroptotic process	BP
2	2	2.32129956088	-	4.00e-02	GO:0033032	regulation of myeloid cell apoptotic process	BP
2	2	2.32129956088	-	4.00e-02	GO:0060988	lipid tube assembly	BP
2	2	2.32129956088	-	4.00e-02	GO:0036493	positive regulation of translation in response to endoplasmic reticulum stress	BP
2	2	2.32129956088	-	4.00e-02	GO:0032615	interleukin-12 production	BP
2	2	2.32129956088	-	4.00e-02	GO:0055025	positive regulation of cardiac muscle tissue development	BP
2	2	2.32129956088	-	4.00e-02	GO:0070254	mucus secretion	BP
2	2	2.32129956088	-	4.00e-02	GO:0071338	positive regulation of hair follicle cell proliferation	BP
2	2	2.32129956088	-	4.00e-02	GO:0035407	histone H3-T11 phosphorylation	BP
2	2	2.32129956088	-	4.00e-02	GO:0035408	histone H3-T6 phosphorylation	BP
2	2	2.32129956088	-	4.00e-02	GO:0061308	cardiac neural crest cell development involved in heart development	BP
2	2	2.32129956088	-	4.00e-02	GO:0003156	regulation of animal organ formation	BP
2	2	2.32129956088	-	4.00e-02	GO:0031959	mineralocorticoid receptor signaling pathway	BP
2	2	2.32129956088	-	4.00e-02	GO:0072156	distal tubule morphogenesis	BP
2	2	2.32129956088	-	4.00e-02	GO:1903923	positive regulation of protein processing in phagocytic vesicle	BP
2	2	2.32129956088	-	4.00e-02	GO:0090035	positive regulation of chaperone-mediated protein complex assembly	BP
2	2	2.32129956088	-	4.00e-02	GO:0019050	suppression by virus of host apoptotic process	BP
2	2	2.32129956088	-	4.00e-02	GO:0038179	neurotrophin signaling pathway	BP
2	2	2.32129956088	-	4.00e-02	GO:0005986	sucrose biosynthetic process	BP
2	2	2.32129956088	-	4.00e-02	GO:2000397	positive regulation of ubiquitin-dependent endocytosis	BP
2	2	2.32129956088	-	4.00e-02	GO:0060915	mesenchymal cell differentiation involved in lung development	BP
2	2	2.32129956088	-	4.00e-02	GO:2000978	negative regulation of forebrain neuron differentiation	BP
2	2	2.32129956088	-	4.00e-02	GO:1904017	cellular response to Thyroglobulin triiodothyronine	BP
2	2	2.32129956088	-	4.00e-02	GO:0010643	cell communication by chemical coupling	BP
2	2	2.32129956088	-	4.00e-02	GO:0035802	adrenal cortex formation	BP
2	2	2.32129956088	-	4.00e-02	GO:0048340	paraxial mesoderm morphogenesis	BP
2	2	2.32129956088	-	4.00e-02	GO:1904884	positive regulation of telomerase catalytic core complex assembly	BP
2	2	2.32129956088	-	4.00e-02	GO:1990051	activation of protein kinase C activity	BP
2	2	2.32129956088	-	4.00e-02	GO:0002866	positive regulation of acute inflammatory response to antigenic stimulus	BP
2	2	2.32129956088	-	4.00e-02	GO:1904424	regulation of GTP binding	BP
2	2	2.32129956088	-	4.00e-02	GO:0039528	cytoplasmic pattern recognition receptor signaling pathway in response to virus	BP
2	2	2.32129956088	-	4.00e-02	GO:0003057	regulation of the force of heart contraction by chemical signal	BP
2	2	2.32129956088	-	4.00e-02	GO:0050906	detection of stimulus involved in sensory perception	BP
2	2	2.32129956088	-	4.00e-02	GO:1902499	positive regulation of protein autoubiquitination	BP
2	2	2.32129956088	-	4.00e-02	GO:0006808	regulation of nitrogen utilization	BP
2	2	2.32129956088	-	4.00e-02	GO:1905448	positive regulation of mitochondrial ATP synthesis coupled electron transport	BP
2	2	2.32129956088	-	4.00e-02	GO:1900110	negative regulation of histone H3-K9 dimethylation	BP
2	2	2.32129956088	-	4.00e-02	GO:0036337	Fas signaling pathway	BP
2	2	2.32129956088	-	4.00e-02	GO:1902728	positive regulation of growth factor dependent skeletal muscle satellite cell proliferation	BP
2	2	2.32129956088	-	4.00e-02	GO:0007070	negative regulation of transcription from RNA polymerase II promoter during mitotic cell cycle	BP
2	2	2.32129956088	-	4.00e-02	GO:0033003	regulation of mast cell activation	BP
2	2	2.32129956088	-	4.00e-02	GO:0097324	melanocyte migration	BP
2	2	2.32129956088	-	4.00e-02	GO:0002268	follicular dendritic cell differentiation	BP
2	2	2.32129956088	-	4.00e-02	GO:0038188	cholecystokinin signaling pathway	BP
2	2	2.32129956088	-	4.00e-02	GO:0060390	regulation of SMAD protein import into nucleus	BP
2	2	2.32129956088	-	4.00e-02	GO:1902943	positive regulation of voltage-gated chloride channel activity	BP
2	2	2.32129956088	-	4.00e-02	GO:0060251	regulation of glial cell proliferation	BP
2	2	2.32129956088	-	4.00e-02	GO:1902202	regulation of hepatocyte growth factor receptor signaling pathway	BP
2	2	2.32129956088	-	4.00e-02	GO:0000720	pyrimidine dimer repair by nucleotide-excision repair	BP
2	2	2.32129956088	-	4.00e-02	GO:2000349	negative regulation of CD40 signaling pathway	BP
2	2	2.32129956088	-	4.00e-02	GO:1903526	negative regulation of membrane tubulation	BP
2	2	2.32129956088	-	4.00e-02	GO:0086098	angiotensin-activated signaling pathway involved in heart process	BP
2	2	2.32129956088	-	4.00e-02	GO:0050794	regulation of cellular process	BP
2	2	2.32129956088	-	4.00e-02	GO:0046666	retinal cell programmed cell death	BP
2	2	2.32129956088	-	4.00e-02	GO:0021514	ventral spinal cord interneuron differentiation	BP
2	2	2.32129956088	-	4.00e-02	GO:0071322	cellular response to carbohydrate stimulus	BP
2	2	2.32129956088	-	4.00e-02	GO:0042412	taurine biosynthetic process	BP
2	2	2.32129956088	-	4.00e-02	GO:0035607	fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development	BP
2	2	2.32129956088	-	4.00e-02	GO:0014733	regulation of skeletal muscle adaptation	BP
2	2	2.32129956088	-	4.00e-02	GO:0006925	inflammatory cell apoptotic process	BP
2	2	2.32129956088	-	4.00e-02	GO:0043970	histone H3-K9 acetylation	BP
2	2	2.32129956088	-	4.00e-02	GO:0032878	regulation of establishment or maintenance of cell polarity	BP
2	2	2.32129956088	-	4.00e-02	GO:0038109	Kit signaling pathway	BP
2	2	2.32129956088	-	4.00e-02	GO:0010512	negative regulation of phosphatidylinositol biosynthetic process	BP
2	2	2.32129956088	-	4.00e-02	GO:0003160	endocardium morphogenesis	BP
2	2	2.32129956088	-	4.00e-02	GO:0043006	activation of phospholipase A2 activity by calcium-mediated signaling	BP
2	2	2.32129956088	-	4.00e-02	GO:0072368	regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter	BP
2	2	2.32129956088	-	4.00e-02	GO:0072369	regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter	BP
2	2	2.32129956088	-	4.00e-02	GO:0005997	xylulose metabolic process	BP
2	2	2.32129956088	-	4.00e-02	GO:0010559	regulation of glycoprotein biosynthetic process	BP
2	2	2.32129956088	-	4.00e-02	GO:0014013	regulation of gliogenesis	BP
2	2	2.32129956088	-	4.00e-02	GO:1902958	positive regulation of mitochondrial electron transport, NADH to ubiquinone	BP
2	2	2.32129956088	-	4.00e-02	GO:0031247	actin rod assembly	BP
2	2	2.32129956088	-	4.00e-02	GO:0048378	regulation of lateral mesodermal cell fate specification	BP
2	2	2.32129956088	-	4.00e-02	GO:0060615	mammary gland bud formation	BP
2	2	2.32129956088	-	4.00e-02	GO:0035026	leading edge cell differentiation	BP
2	2	2.32129956088	-	4.00e-02	GO:1905477	positive regulation of protein localization to membrane	BP
2	2	2.32129956088	-	4.00e-02	GO:0035854	eosinophil fate commitment	BP
2	2	2.32129956088	-	4.00e-02	GO:0043555	regulation of translation in response to stress	BP
2	2	2.32129956088	-	4.00e-02	GO:2000681	negative regulation of rubidium ion transport	BP
2	2	2.32129956088	-	4.00e-02	GO:0070375	ERK5 cascade	BP
2	2	2.32129956088	-	4.00e-02	GO:0035728	response to hepatocyte growth factor	BP
2	2	2.32129956088	-	4.00e-02	GO:0042745	circadian sleep/wake cycle	BP
2	2	2.32129956088	-	4.00e-02	GO:0072134	nephrogenic mesenchyme morphogenesis	BP
2	2	2.32129956088	-	4.00e-02	GO:0003365	establishment of cell polarity involved in ameboidal cell migration	BP
2	2	2.32129956088	-	4.00e-02	GO:1990426	mitotic recombination-dependent replication fork processing	BP
2	2	2.32129956088	-	4.00e-02	GO:0019858	cytosine metabolic process	BP
2	2	2.32129956088	-	4.00e-02	GO:0009631	cold acclimation	BP
2	2	2.32129956088	-	4.00e-02	GO:0002752	cell surface pattern recognition receptor signaling pathway	BP
2	2	2.32129956088	-	4.00e-02	GO:0000710	meiotic mismatch repair	BP
2	2	2.32129956088	-	4.00e-02	GO:0021897	forebrain astrocyte development	BP
2	2	2.32129956088	-	4.00e-02	GO:0039692	single stranded viral RNA replication via double stranded DNA intermediate	BP
2	2	2.32129956088	-	4.00e-02	GO:0010966	regulation of phosphate transport	BP
2	2	2.32129956088	-	4.00e-02	GO:0060529	squamous basal epithelial stem cell differentiation involved in prostate gland acinus development	BP
2	2	2.32129956088	-	4.00e-02	GO:1990911	response to psychosocial stress	BP
1	1	2.32129956088	-	2.00e-01	GO:0090340	positive regulation of secretion of lysosomal enzymes	BP
1	1	2.32129956088	-	2.00e-01	GO:0060268	negative regulation of respiratory burst	BP
1	1	2.32129956088	-	2.00e-01	GO:0006591	ornithine metabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0099641	anterograde axonal protein transport	BP
1	1	2.32129956088	-	2.00e-01	GO:1902215	negative regulation of interleukin-4-mediated signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:0010752	regulation of cGMP-mediated signaling	BP
1	1	2.32129956088	-	2.00e-01	GO:0010758	regulation of macrophage chemotaxis	BP
1	1	2.32129956088	-	2.00e-01	GO:0090343	positive regulation of cell aging	BP
1	1	2.32129956088	-	2.00e-01	GO:1903538	regulation of meiotic cell cycle process involved in oocyte maturation	BP
1	1	2.32129956088	-	2.00e-01	GO:0039650	suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0010905	negative regulation of UDP-glucose catabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0002333	transitional one stage B cell differentiation	BP
1	1	2.32129956088	-	2.00e-01	GO:2000104	negative regulation of DNA-dependent DNA replication	BP
1	1	2.32129956088	-	2.00e-01	GO:0050812	regulation of acyl-CoA biosynthetic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0046671	negative regulation of retinal cell programmed cell death	BP
1	1	2.32129956088	-	2.00e-01	GO:1905580	positive regulation of ERBB3 signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:1902583	multi-organism intracellular transport	BP
1	1	2.32129956088	-	2.00e-01	GO:0007344	pronuclear fusion	BP
1	1	2.32129956088	-	2.00e-01	GO:0071352	cellular response to interleukin-2	BP
1	1	2.32129956088	-	2.00e-01	GO:0071351	cellular response to interleukin-18	BP
1	1	2.32129956088	-	2.00e-01	GO:2000646	positive regulation of receptor catabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:1904722	positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response	BP
1	1	2.32129956088	-	2.00e-01	GO:1902396	protein localization to bicellular tight junction	BP
1	1	2.32129956088	-	2.00e-01	GO:0021814	cell motility involved in cerebral cortex radial glia guided migration	BP
1	1	2.32129956088	-	2.00e-01	GO:0021813	cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration	BP
1	1	2.32129956088	-	2.00e-01	GO:0051232	meiotic spindle elongation	BP
1	1	2.32129956088	-	2.00e-01	GO:0046824	positive regulation of nucleocytoplasmic transport	BP
1	1	2.32129956088	-	2.00e-01	GO:0061326	renal tubule development	BP
1	1	2.32129956088	-	2.00e-01	GO:0061324	canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation	BP
1	1	2.32129956088	-	2.00e-01	GO:1903286	regulation of potassium ion import	BP
1	1	2.32129956088	-	2.00e-01	GO:1903285	positive regulation of hydrogen peroxide catabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:1903284	positive regulation of glutathione peroxidase activity	BP
1	1	2.32129956088	-	2.00e-01	GO:1904568	cellular response to wortmannin	BP
1	1	2.32129956088	-	2.00e-01	GO:0097291	renal phosphate ion absorption	BP
1	1	2.32129956088	-	2.00e-01	GO:0060496	mesenchymal-epithelial cell signaling involved in lung development	BP
1	1	2.32129956088	-	2.00e-01	GO:0002371	dendritic cell cytokine production	BP
1	1	2.32129956088	-	2.00e-01	GO:0001777	T cell homeostatic proliferation	BP
1	1	2.32129956088	-	2.00e-01	GO:2000850	negative regulation of glucocorticoid secretion	BP
1	1	2.32129956088	-	2.00e-01	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:0046587	positive regulation of calcium-dependent cell-cell adhesion	BP
1	1	2.32129956088	-	2.00e-01	GO:0046633	alpha-beta T cell proliferation	BP
1	1	2.32129956088	-	2.00e-01	GO:0046631	alpha-beta T cell activation	BP
1	1	2.32129956088	-	2.00e-01	GO:2001136	negative regulation of endocytic recycling	BP
1	1	2.32129956088	-	2.00e-01	GO:0030167	proteoglycan catabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:2001229	negative regulation of response to gamma radiation	BP
1	1	2.32129956088	-	2.00e-01	GO:1904764	chaperone-mediated autophagy translocation complex disassembly	BP
1	1	2.32129956088	-	2.00e-01	GO:0086055	Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling	BP
1	1	2.32129956088	-	2.00e-01	GO:0086054	bundle of His cell to Purkinje myocyte communication by electrical coupling	BP
1	1	2.32129956088	-	2.00e-01	GO:0086052	membrane repolarization during SA node cell action potential	BP
1	1	2.32129956088	-	2.00e-01	GO:0086050	membrane repolarization during bundle of His cell action potential	BP
1	1	2.32129956088	-	2.00e-01	GO:0034670	chemotaxis to arachidonic acid	BP
1	1	2.32129956088	-	2.00e-01	GO:1903007	positive regulation of Lys63-specific deubiquitinase activity	BP
1	1	2.32129956088	-	2.00e-01	GO:0045917	positive regulation of complement activation	BP
1	1	2.32129956088	-	2.00e-01	GO:0000053	argininosuccinate metabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0003294	atrial ventricular junction remodeling	BP
1	1	2.32129956088	-	2.00e-01	GO:0010522	regulation of calcium ion transport into cytosol	BP
1	1	2.32129956088	-	2.00e-01	GO:0035790	platelet-derived growth factor receptor-alpha signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:0001980	regulation of systemic arterial blood pressure by ischemic conditions	BP
1	1	2.32129956088	-	2.00e-01	GO:0021852	pyramidal neuron migration	BP
1	1	2.32129956088	-	2.00e-01	GO:0071268	homocysteine biosynthetic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0003171	atrioventricular valve development	BP
1	1	2.32129956088	-	2.00e-01	GO:0003174	mitral valve development	BP
1	1	2.32129956088	-	2.00e-01	GO:0097254	renal tubular secretion	BP
1	1	2.32129956088	-	2.00e-01	GO:0061365	positive regulation of triglyceride lipase activity	BP
1	1	2.32129956088	-	2.00e-01	GO:0061360	optic chiasma development	BP
1	1	2.32129956088	-	2.00e-01	GO:1903249	negative regulation of citrulline biosynthetic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0061582	intestinal epithelial cell migration	BP
1	1	2.32129956088	-	2.00e-01	GO:1905355	spine apparatus assembly	BP
1	1	2.32129956088	-	2.00e-01	GO:0046544	development of secondary male sexual characteristics	BP
1	1	2.32129956088	-	2.00e-01	GO:1905305	negative regulation of cardiac myofibril assembly	BP
1	1	2.32129956088	-	2.00e-01	GO:0035229	positive regulation of glutamate-cysteine ligase activity	BP
1	1	2.32129956088	-	2.00e-01	GO:1903904	negative regulation of establishment of T cell polarity	BP
1	1	2.32129956088	-	2.00e-01	GO:1903906	regulation of plasma membrane raft polarization	BP
1	1	2.32129956088	-	2.00e-01	GO:1903903	regulation of establishment of T cell polarity	BP
1	1	2.32129956088	-	2.00e-01	GO:1903909	regulation of receptor clustering	BP
1	1	2.32129956088	-	2.00e-01	GO:0045898	regulation of RNA polymerase II transcriptional preinitiation complex assembly	BP
1	1	2.32129956088	-	2.00e-01	GO:0038154	interleukin-11-mediated signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:0070447	positive regulation of oligodendrocyte progenitor proliferation	BP
1	1	2.32129956088	-	2.00e-01	GO:0043244	regulation of protein complex disassembly	BP
1	1	2.32129956088	-	2.00e-01	GO:0034635	glutathione transport	BP
1	1	2.32129956088	-	2.00e-01	GO:0034633	retinol transport	BP
1	1	2.32129956088	-	2.00e-01	GO:0098906	regulation of Purkinje myocyte action potential	BP
1	1	2.32129956088	-	2.00e-01	GO:0098902	regulation of membrane depolarization during action potential	BP
1	1	2.32129956088	-	2.00e-01	GO:0031662	positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle	BP
1	1	2.32129956088	-	2.00e-01	GO:0003284	septum primum development	BP
1	1	2.32129956088	-	2.00e-01	GO:0032361	pyridoxal phosphate catabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	BP
1	1	2.32129956088	-	2.00e-01	GO:1904206	positive regulation of skeletal muscle hypertrophy	BP
1	1	2.32129956088	-	2.00e-01	GO:0035750	protein localization to myelin sheath abaxonal region	BP
1	1	2.32129956088	-	2.00e-01	GO:2000814	positive regulation of barbed-end actin filament capping	BP
1	1	2.32129956088	-	2.00e-01	GO:0033182	regulation of histone ubiquitination	BP
1	1	2.32129956088	-	2.00e-01	GO:0033184	positive regulation of histone ubiquitination	BP
1	1	2.32129956088	-	2.00e-01	GO:0072235	metanephric distal tubule development	BP
1	1	2.32129956088	-	2.00e-01	GO:0072230	metanephric proximal straight tubule development	BP
1	1	2.32129956088	-	2.00e-01	GO:0072232	metanephric proximal convoluted tubule segment 2 development	BP
1	1	2.32129956088	-	2.00e-01	GO:0031058	positive regulation of histone modification	BP
1	1	2.32129956088	-	2.00e-01	GO:0022607	cellular component assembly	BP
1	1	2.32129956088	-	2.00e-01	GO:0010021	amylopectin biosynthetic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0032773	positive regulation of monophenol monooxygenase activity	BP
1	1	2.32129956088	-	2.00e-01	GO:0043610	regulation of carbohydrate utilization	BP
1	1	2.32129956088	-	2.00e-01	GO:0043618	regulation of transcription from RNA polymerase II promoter in response to stress	BP
1	1	2.32129956088	-	2.00e-01	GO:0071228	cellular response to tumor cell	BP
1	1	2.32129956088	-	2.00e-01	GO:0003136	negative regulation of heart induction by canonical Wnt signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:0003138	primary heart field specification	BP
1	1	2.32129956088	-	2.00e-01	GO:1904075	positive regulation of trophectodermal cell proliferation	BP
1	1	2.32129956088	-	2.00e-01	GO:0034346	positive regulation of type III interferon production	BP
1	1	2.32129956088	-	2.00e-01	GO:0002663	positive regulation of B cell tolerance induction	BP
1	1	2.32129956088	-	2.00e-01	GO:1903205	regulation of hydrogen peroxide-induced cell death	BP
1	1	2.32129956088	-	2.00e-01	GO:1903200	positive regulation of L-dopa decarboxylase activity	BP
1	1	2.32129956088	-	2.00e-01	GO:1902847	regulation of neuronal signal transduction	BP
1	1	2.32129956088	-	2.00e-01	GO:1905317	inferior endocardial cushion morphogenesis	BP
1	1	2.32129956088	-	2.00e-01	GO:1905314	semi-lunar valve development	BP
1	1	2.32129956088	-	2.00e-01	GO:1905313	transforming growth factor beta receptor signaling pathway involved in heart development	BP
1	1	2.32129956088	-	2.00e-01	GO:0071418	cellular response to amine stimulus	BP
1	1	2.32129956088	-	2.00e-01	GO:2000764	positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis	BP
1	1	2.32129956088	-	2.00e-01	GO:2000761	positive regulation of N-terminal peptidyl-lysine acetylation	BP
1	1	2.32129956088	-	2.00e-01	GO:2000763	positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0061736	engulfment of target by autophagosome	BP
1	1	2.32129956088	-	2.00e-01	GO:1903944	negative regulation of hepatocyte apoptotic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0044819	mitotic G1/S transition checkpoint	BP
1	1	2.32129956088	-	2.00e-01	GO:0093001	glycolysis from storage polysaccharide through glucose-1-phosphate	BP
1	1	2.32129956088	-	2.00e-01	GO:1903626	positive regulation of DNA catabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0002840	regulation of T cell mediated immune response to tumor cell	BP
1	1	2.32129956088	-	2.00e-01	GO:0002842	positive regulation of T cell mediated immune response to tumor cell	BP
1	1	2.32129956088	-	2.00e-01	GO:0070346	positive regulation of fat cell proliferation	BP
1	1	2.32129956088	-	2.00e-01	GO:0071691	cardiac muscle thin filament assembly	BP
1	1	2.32129956088	-	2.00e-01	GO:0021686	cerebellar granular layer maturation	BP
1	1	2.32129956088	-	2.00e-01	GO:0021682	nerve maturation	BP
1	1	2.32129956088	-	2.00e-01	GO:0035711	T-helper 1 cell activation	BP
1	1	2.32129956088	-	2.00e-01	GO:1903434	negative regulation of constitutive secretory pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:0060598	dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis	BP
1	1	2.32129956088	-	2.00e-01	GO:0060620	regulation of cholesterol import	BP
1	1	2.32129956088	-	2.00e-01	GO:1905875	negative regulation of postsynaptic density organization	BP
1	1	2.32129956088	-	2.00e-01	GO:1905872	negative regulation of protein localization to cell leading edge	BP
1	1	2.32129956088	-	2.00e-01	GO:1905873	positive regulation of protein localization to cell leading edge	BP
1	1	2.32129956088	-	2.00e-01	GO:0070640	vitamin D3 metabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:2000486	negative regulation of glutamine transport	BP
1	1	2.32129956088	-	2.00e-01	GO:0032738	positive regulation of interleukin-15 production	BP
1	1	2.32129956088	-	2.00e-01	GO:0032730	positive regulation of interleukin-1 alpha production	BP
1	1	2.32129956088	-	2.00e-01	GO:0002625	regulation of T cell antigen processing and presentation	BP
1	1	2.32129956088	-	2.00e-01	GO:0035037	sperm entry	BP
1	1	2.32129956088	-	2.00e-01	GO:0043379	memory T cell differentiation	BP
1	1	2.32129956088	-	2.00e-01	GO:0060456	positive regulation of digestive system process	BP
1	1	2.32129956088	-	2.00e-01	GO:0043371	negative regulation of CD4-positive, alpha-beta T cell differentiation	BP
1	1	2.32129956088	-	2.00e-01	GO:0043375	CD8-positive, alpha-beta T cell lineage commitment	BP
1	1	2.32129956088	-	2.00e-01	GO:0043376	regulation of CD8-positive, alpha-beta T cell differentiation	BP
1	1	2.32129956088	-	2.00e-01	GO:0006014	D-ribose metabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:1905469	negative regulation of clathrin-coated pit assembly	BP
1	1	2.32129956088	-	2.00e-01	GO:0042774	plasma membrane ATP synthesis coupled electron transport	BP
1	1	2.32129956088	-	2.00e-01	GO:0042772	DNA damage response, signal transduction resulting in transcription	BP
1	1	2.32129956088	-	2.00e-01	GO:0090648	response to environmental enrichment	BP
1	1	2.32129956088	-	2.00e-01	GO:2001107	negative regulation of Rho guanyl-nucleotide exchange factor activity	BP
1	1	2.32129956088	-	2.00e-01	GO:0032072	regulation of restriction endodeoxyribonuclease activity	BP
1	1	2.32129956088	-	2.00e-01	GO:0032076	negative regulation of deoxyribonuclease activity	BP
1	1	2.32129956088	-	2.00e-01	GO:0032077	positive regulation of deoxyribonuclease activity	BP
1	1	2.32129956088	-	2.00e-01	GO:1904404	response to formaldehyde	BP
1	1	2.32129956088	-	2.00e-01	GO:1900235	negative regulation of Kit signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:0045818	negative regulation of glycogen catabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0090096	positive regulation of metanephric cap mesenchymal cell proliferation	BP
1	1	2.32129956088	-	2.00e-01	GO:0006463	steroid hormone receptor complex assembly	BP
1	1	2.32129956088	-	2.00e-01	GO:1904544	positive regulation of free ubiquitin chain polymerization	BP
1	1	2.32129956088	-	2.00e-01	GO:0060817	inactivation of paternal X chromosome	BP
1	1	2.32129956088	-	2.00e-01	GO:1901622	positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning	BP
1	1	2.32129956088	-	2.00e-01	GO:0035508	positive regulation of myosin-light-chain-phosphatase activity	BP
1	1	2.32129956088	-	2.00e-01	GO:0006780	uroporphyrinogen III biosynthetic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0000097	sulfur amino acid biosynthetic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0048640	negative regulation of developmental growth	BP
1	1	2.32129956088	-	2.00e-01	GO:0120072	positive regulation of pyloric antrum smooth muscle contraction	BP
1	1	2.32129956088	-	2.00e-01	GO:0060552	positive regulation of fructose 1,6-bisphosphate metabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0060550	positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity	BP
1	1	2.32129956088	-	2.00e-01	GO:0060558	regulation of calcidiol 1-monooxygenase activity	BP
1	1	2.32129956088	-	2.00e-01	GO:1904828	positive regulation of hydrogen sulfide biosynthetic process	BP
1	1	2.32129956088	-	2.00e-01	GO:1905162	regulation of phagosome maturation	BP
1	1	2.32129956088	-	2.00e-01	GO:0007014	actin ubiquitination	BP
1	1	2.32129956088	-	2.00e-01	GO:0032990	cell part morphogenesis	BP
1	1	2.32129956088	-	2.00e-01	GO:0033028	myeloid cell apoptotic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0006055	CMP-N-acetylneuraminate biosynthetic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0072141	renal interstitial fibroblast development	BP
1	1	2.32129956088	-	2.00e-01	GO:0100002	negative regulation of protein kinase activity by protein phosphorylation	BP
1	1	2.32129956088	-	2.00e-01	GO:2000597	positive regulation of optic nerve formation	BP
1	1	2.32129956088	-	2.00e-01	GO:0046327	glycerol biosynthetic process from pyruvate	BP
1	1	2.32129956088	-	2.00e-01	GO:1904213	negative regulation of iodide transmembrane transport	BP
1	1	2.32129956088	-	2.00e-01	GO:1990774	tumor necrosis factor secretion	BP
1	1	2.32129956088	-	2.00e-01	GO:0000117	regulation of transcription involved in G2/M transition of mitotic cell cycle	BP
1	1	2.32129956088	-	2.00e-01	GO:1901666	positive regulation of NAD+ ADP-ribosyltransferase activity	BP
1	1	2.32129956088	-	2.00e-01	GO:1901660	calcium ion export	BP
1	1	2.32129956088	-	2.00e-01	GO:0072576	liver morphogenesis	BP
1	1	2.32129956088	-	2.00e-01	GO:1900133	regulation of renin secretion into blood stream	BP
1	1	2.32129956088	-	2.00e-01	GO:0048685	negative regulation of collateral sprouting of intact axon in response to injury	BP
1	1	2.32129956088	-	2.00e-01	GO:1904397	negative regulation of neuromuscular junction development	BP
1	1	2.32129956088	-	2.00e-01	GO:1904792	positive regulation of shelterin complex assembly	BP
1	1	2.32129956088	-	2.00e-01	GO:1904793	regulation of euchromatin binding	BP
1	1	2.32129956088	-	2.00e-01	GO:0071071	regulation of phospholipid biosynthetic process	BP
1	1	2.32129956088	-	2.00e-01	GO:1902748	positive regulation of lens fiber cell differentiation	BP
1	1	2.32129956088	-	2.00e-01	GO:1904651	positive regulation of fat cell apoptotic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0097698	telomere maintenance via base-excision repair	BP
1	1	2.32129956088	-	2.00e-01	GO:0097343	ripoptosome assembly	BP
1	1	2.32129956088	-	2.00e-01	GO:1902228	positive regulation of macrophage colony-stimulating factor signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:1902220	positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress	BP
1	1	2.32129956088	-	2.00e-01	GO:0021881	Wnt-activated signaling pathway involved in forebrain neuron fate commitment	BP
1	1	2.32129956088	-	2.00e-01	GO:0021888	hypothalamus gonadotrophin-releasing hormone neuron development	BP
1	1	2.32129956088	-	2.00e-01	GO:0051249	regulation of lymphocyte activation	BP
1	1	2.32129956088	-	2.00e-01	GO:0010768	negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage	BP
1	1	2.32129956088	-	2.00e-01	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	BP
1	1	2.32129956088	-	2.00e-01	GO:1904515	positive regulation of TORC2 signaling	BP
1	1	2.32129956088	-	2.00e-01	GO:0010481	epidermal cell division	BP
1	1	2.32129956088	-	2.00e-01	GO:2000176	positive regulation of pro-T cell differentiation	BP
1	1	2.32129956088	-	2.00e-01	GO:2000173	negative regulation of branching morphogenesis of a nerve	BP
1	1	2.32129956088	-	2.00e-01	GO:2000828	regulation of parathyroid hormone secretion	BP
1	1	2.32129956088	-	2.00e-01	GO:0097101	blood vessel endothelial cell fate specification	BP
1	1	2.32129956088	-	2.00e-01	GO:0051796	negative regulation of timing of catagen	BP
1	1	2.32129956088	-	2.00e-01	GO:0060709	glycogen cell differentiation involved in embryonic placenta development	BP
1	1	2.32129956088	-	2.00e-01	GO:1903376	regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:0007634	optokinetic behavior	BP
1	1	2.32129956088	-	2.00e-01	GO:0099607	lateral attachment of mitotic spindle microtubules to kinetochore	BP
1	1	2.32129956088	-	2.00e-01	GO:1905000	regulation of membrane repolarization during atrial cardiac muscle cell action potential	BP
1	1	2.32129956088	-	2.00e-01	GO:0034972	histone H3-R26 methylation	BP
1	1	2.32129956088	-	2.00e-01	GO:0071301	cellular response to vitamin B1	BP
1	1	2.32129956088	-	2.00e-01	GO:0006117	acetaldehyde metabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0090128	regulation of synapse maturation	BP
1	1	2.32129956088	-	2.00e-01	GO:0098736	negative regulation of the force of heart contraction	BP
1	1	2.32129956088	-	2.00e-01	GO:0003270	Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation	BP
1	1	2.32129956088	-	2.00e-01	GO:0070179	D-serine biosynthetic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0006582	melanin metabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0006585	dopamine biosynthetic process from tyrosine	BP
1	1	2.32129956088	-	2.00e-01	GO:0006638	neutral lipid metabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0030472	mitotic spindle organization in nucleus	BP
1	1	2.32129956088	-	2.00e-01	GO:1990442	intrinsic apoptotic signaling pathway in response to nitrosative stress	BP
1	1	2.32129956088	-	2.00e-01	GO:0035624	receptor transactivation	BP
1	1	2.32129956088	-	2.00e-01	GO:0050674	urothelial cell proliferation	BP
1	1	2.32129956088	-	2.00e-01	GO:0050677	positive regulation of urothelial cell proliferation	BP
1	1	2.32129956088	-	2.00e-01	GO:0001743	optic placode formation	BP
1	1	2.32129956088	-	2.00e-01	GO:0032423	regulation of mismatch repair	BP
1	1	2.32129956088	-	2.00e-01	GO:2000793	cell proliferation involved in heart valve development	BP
1	1	2.32129956088	-	2.00e-01	GO:0034148	negative regulation of toll-like receptor 5 signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:0010933	positive regulation of macrophage tolerance induction	BP
1	1	2.32129956088	-	2.00e-01	GO:1902068	regulation of sphingolipid mediated signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:0036399	TCR signalosome assembly	BP
1	1	2.32129956088	-	2.00e-01	GO:1905045	negative regulation of Schwann cell proliferation involved in axon regeneration	BP
1	1	2.32129956088	-	2.00e-01	GO:0019089	transmission of virus	BP
1	1	2.32129956088	-	2.00e-01	GO:2000655	negative regulation of cellular response to testosterone stimulus	BP
1	1	2.32129956088	-	2.00e-01	GO:2000657	negative regulation of apolipoprotein binding	BP
1	1	2.32129956088	-	2.00e-01	GO:1904716	positive regulation of chaperone-mediated autophagy	BP
1	1	2.32129956088	-	2.00e-01	GO:0038129	ERBB3 signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:1903073	negative regulation of death-inducing signaling complex assembly	BP
1	1	2.32129956088	-	2.00e-01	GO:0046295	glycolate biosynthetic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0048291	isotype switching to IgG isotypes	BP
1	1	2.32129956088	-	2.00e-01	GO:0014896	muscle hypertrophy	BP
1	1	2.32129956088	-	2.00e-01	GO:0043402	glucocorticoid mediated signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:0070572	positive regulation of neuron projection regeneration	BP
1	1	2.32129956088	-	2.00e-01	GO:2000514	regulation of CD4-positive, alpha-beta T cell activation	BP
1	1	2.32129956088	-	2.00e-01	GO:0002540	leukotriene production involved in inflammatory response	BP
1	1	2.32129956088	-	2.00e-01	GO:0032667	regulation of interleukin-23 production	BP
1	1	2.32129956088	-	2.00e-01	GO:0071629	ubiquitin-dependent catabolism of misfolded proteins by cytoplasm-associated proteasome	BP
1	1	2.32129956088	-	2.00e-01	GO:1905716	negative regulation of cornification	BP
1	1	2.32129956088	-	2.00e-01	GO:0072431	signal transduction involved in mitotic G1 DNA damage checkpoint	BP
1	1	2.32129956088	-	2.00e-01	GO:2000591	positive regulation of metanephric mesenchymal cell migration	BP
1	1	2.32129956088	-	2.00e-01	GO:1904591	positive regulation of protein import	BP
1	1	2.32129956088	-	2.00e-01	GO:1904597	negative regulation of connective tissue replacement involved in inflammatory response wound healing	BP
1	1	2.32129956088	-	2.00e-01	GO:1990402	embryonic liver development	BP
1	1	2.32129956088	-	2.00e-01	GO:0060178	regulation of exocyst localization	BP
1	1	2.32129956088	-	2.00e-01	GO:0002363	alpha-beta T cell lineage commitment	BP
1	1	2.32129956088	-	2.00e-01	GO:0002368	B cell cytokine production	BP
1	1	2.32129956088	-	2.00e-01	GO:0036211	protein modification process	BP
1	1	2.32129956088	-	2.00e-01	GO:0099551	trans-synaptic signaling by neuropeptide, modulating synaptic transmission	BP
1	1	2.32129956088	-	2.00e-01	GO:0099557	trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission	BP
1	1	2.32129956088	-	2.00e-01	GO:0052565	response to defense-related host nitric oxide production	BP
1	1	2.32129956088	-	2.00e-01	GO:0045358	negative regulation of interferon-beta biosynthetic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0000435	positive regulation of transcription from RNA polymerase II promoter by galactose	BP
1	1	2.32129956088	-	2.00e-01	GO:0030826	regulation of cGMP biosynthetic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0044089	positive regulation of cellular component biogenesis	BP
1	1	2.32129956088	-	2.00e-01	GO:1990349	gap junction-mediated intercellular transport	BP
1	1	2.32129956088	-	2.00e-01	GO:0072308	negative regulation of metanephric nephron tubule epithelial cell differentiation	BP
1	1	2.32129956088	-	2.00e-01	GO:0019043	establishment of viral latency	BP
1	1	2.32129956088	-	2.00e-01	GO:0038168	epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade	BP
1	1	2.32129956088	-	2.00e-01	GO:0051585	negative regulation of dopamine uptake involved in synaptic transmission	BP
1	1	2.32129956088	-	2.00e-01	GO:2000081	positive regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation	BP
1	1	2.32129956088	-	2.00e-01	GO:0034477	U6 snRNA 3'-end processing	BP
1	1	2.32129956088	-	2.00e-01	GO:0002502	peptide antigen assembly with MHC class I protein complex	BP
1	1	2.32129956088	-	2.00e-01	GO:1904914	negative regulation of establishment of macromolecular complex localization to telomere	BP
1	1	2.32129956088	-	2.00e-01	GO:0010533	regulation of activation of Janus kinase activity	BP
1	1	2.32129956088	-	2.00e-01	GO:1904911	negative regulation of establishment of RNA localization to telomere	BP
1	1	2.32129956088	-	2.00e-01	GO:0035789	metanephric mesenchymal cell migration	BP
1	1	2.32129956088	-	2.00e-01	GO:0035437	maintenance of protein localization in endoplasmic reticulum	BP
1	1	2.32129956088	-	2.00e-01	GO:0061106	negative regulation of stomach neuroendocrine cell differentiation	BP
1	1	2.32129956088	-	2.00e-01	GO:1903755	positive regulation of SUMO transferase activity	BP
1	1	2.32129956088	-	2.00e-01	GO:0051171	regulation of nitrogen compound metabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0044330	canonical Wnt signaling pathway involved in positive regulation of wound healing	BP
1	1	2.32129956088	-	2.00e-01	GO:0051282	regulation of sequestering of calcium ion	BP
1	1	2.32129956088	-	2.00e-01	GO:0001998	angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure	BP
1	1	2.32129956088	-	2.00e-01	GO:1901189	positive regulation of ephrin receptor signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:1901186	positive regulation of ERBB signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:1901187	regulation of ephrin receptor signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:0070104	negative regulation of interleukin-6-mediated signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:0070105	positive regulation of interleukin-6-mediated signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:0071275	cellular response to aluminum ion	BP
1	1	2.32129956088	-	2.00e-01	GO:0003108	negative regulation of the force of heart contraction by chemical signal	BP
1	1	2.32129956088	-	2.00e-01	GO:0061373	mammillary axonal complex development	BP
1	1	2.32129956088	-	2.00e-01	GO:0009992	cellular water homeostasis	BP
1	1	2.32129956088	-	2.00e-01	GO:0014038	regulation of Schwann cell differentiation	BP
1	1	2.32129956088	-	2.00e-01	GO:1903919	negative regulation of actin filament severing	BP
1	1	2.32129956088	-	2.00e-01	GO:1903911	positive regulation of receptor clustering	BP
1	1	2.32129956088	-	2.00e-01	GO:0043060	meiotic metaphase I plate congression	BP
1	1	2.32129956088	-	2.00e-01	GO:0043062	extracellular structure organization	BP
1	1	2.32129956088	-	2.00e-01	GO:0046680	response to DDT	BP
1	1	2.32129956088	-	2.00e-01	GO:0072340	cellular lactam catabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0048352	paraxial mesoderm structural organization	BP
1	1	2.32129956088	-	2.00e-01	GO:1904588	cellular response to glycoprotein	BP
1	1	2.32129956088	-	2.00e-01	GO:0032814	regulation of natural killer cell activation	BP
1	1	2.32129956088	-	2.00e-01	GO:1990029	vasomotion	BP
1	1	2.32129956088	-	2.00e-01	GO:0035744	T-helper 1 cell cytokine production	BP
1	1	2.32129956088	-	2.00e-01	GO:0072220	metanephric descending thin limb development	BP
1	1	2.32129956088	-	2.00e-01	GO:1902443	negative regulation of ripoptosome assembly involved in necroptotic process	BP
1	1	2.32129956088	-	2.00e-01	GO:1905799	regulation of intraciliary retrograde transport	BP
1	1	2.32129956088	-	2.00e-01	GO:1904045	cellular response to aldosterone	BP
1	1	2.32129956088	-	2.00e-01	GO:0046725	negative regulation by virus of viral protein levels in host cell	BP
1	1	2.32129956088	-	2.00e-01	GO:0002676	regulation of chronic inflammatory response	BP
1	1	2.32129956088	-	2.00e-01	GO:1903897	regulation of PERK-mediated unfolded protein response	BP
1	1	2.32129956088	-	2.00e-01	GO:1903891	regulation of ATF6-mediated unfolded protein response	BP
1	1	2.32129956088	-	2.00e-01	GO:0060283	negative regulation of oocyte development	BP
1	1	2.32129956088	-	2.00e-01	GO:1902850	microtubule cytoskeleton organization involved in mitosis	BP
1	1	2.32129956088	-	2.00e-01	GO:1902855	regulation of non-motile cilium assembly	BP
1	1	2.32129956088	-	2.00e-01	GO:2000753	positive regulation of glucosylceramide catabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:2000755	positive regulation of sphingomyelin catabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0046534	positive regulation of photoreceptor cell differentiation	BP
1	1	2.32129956088	-	2.00e-01	GO:0086103	G-protein coupled receptor signaling pathway involved in heart process	BP
1	1	2.32129956088	-	2.00e-01	GO:1904586	cellular response to putrescine	BP
1	1	2.32129956088	-	2.00e-01	GO:0072302	negative regulation of metanephric glomerular mesangial cell proliferation	BP
1	1	2.32129956088	-	2.00e-01	GO:0061885	positive regulation of mini excitatory postsynaptic potential	BP
1	1	2.32129956088	-	2.00e-01	GO:0051511	negative regulation of unidimensional cell growth	BP
1	1	2.32129956088	-	2.00e-01	GO:0060823	canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation	BP
1	1	2.32129956088	-	2.00e-01	GO:0001009	transcription from RNA polymerase III type 2 promoter	BP
1	1	2.32129956088	-	2.00e-01	GO:0048611	embryonic ectodermal digestive tract development	BP
1	1	2.32129956088	-	2.00e-01	GO:0003065	positive regulation of heart rate by epinephrine	BP
1	1	2.32129956088	-	2.00e-01	GO:0072262	metanephric glomerular mesangial cell proliferation involved in metanephros development	BP
1	1	2.32129956088	-	2.00e-01	GO:0060587	regulation of lipoprotein lipid oxidation	BP
1	1	2.32129956088	-	2.00e-01	GO:0061181	regulation of chondrocyte development	BP
1	1	2.32129956088	-	2.00e-01	GO:0002001	renin secretion into blood stream	BP
1	1	2.32129956088	-	2.00e-01	GO:0036088	D-serine catabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:1905289	regulation of CAMKK-AMPK signaling cascade	BP
1	1	2.32129956088	-	2.00e-01	GO:1905285	fibrous ring of heart morphogenesis	BP
1	1	2.32129956088	-	2.00e-01	GO:0019391	glucuronoside catabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0051456	attachment of spindle microtubules to kinetochore involved in meiotic sister chromatid segregation	BP
1	1	2.32129956088	-	2.00e-01	GO:0002637	regulation of immunoglobulin production	BP
1	1	2.32129956088	-	2.00e-01	GO:1903852	positive regulation of cristae formation	BP
1	1	2.32129956088	-	2.00e-01	GO:0061519	macrophage homeostasis	BP
1	1	2.32129956088	-	2.00e-01	GO:0052182	modification by host of symbiont morphology or physiology via secreted substance	BP
1	1	2.32129956088	-	2.00e-01	GO:0090676	calcium ion transmembrane transport via low voltage-gated calcium channel	BP
1	1	2.32129956088	-	2.00e-01	GO:0038002	endocrine signaling	BP
1	1	2.32129956088	-	2.00e-01	GO:0035872	nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:1904414	positive regulation of cardiac ventricle development	BP
1	1	2.32129956088	-	2.00e-01	GO:1900243	negative regulation of synaptic vesicle endocytosis	BP
1	1	2.32129956088	-	2.00e-01	GO:0060035	notochord cell development	BP
1	1	2.32129956088	-	2.00e-01	GO:0097501	stress response to metal ion	BP
1	1	2.32129956088	-	2.00e-01	GO:0090086	negative regulation of protein deubiquitination	BP
1	1	2.32129956088	-	2.00e-01	GO:0090085	regulation of protein deubiquitination	BP
1	1	2.32129956088	-	2.00e-01	GO:0061847	response to cholecystokinin	BP
1	1	2.32129956088	-	2.00e-01	GO:0061185	negative regulation of dermatome development	BP
1	1	2.32129956088	-	2.00e-01	GO:0016137	glycoside metabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:1901389	negative regulation of transforming growth factor beta activation	BP
1	1	2.32129956088	-	2.00e-01	GO:1904353	regulation of telomere capping	BP
1	1	2.32129956088	-	2.00e-01	GO:0061026	cardiac muscle tissue regeneration	BP
1	1	2.32129956088	-	2.00e-01	GO:1903387	positive regulation of homophilic cell adhesion	BP
1	1	2.32129956088	-	2.00e-01	GO:1902380	positive regulation of endoribonuclease activity	BP
1	1	2.32129956088	-	2.00e-01	GO:0036323	vascular endothelial growth factor receptor-1 signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:0001543	ovarian follicle rupture	BP
1	1	2.32129956088	-	2.00e-01	GO:0003025	regulation of systemic arterial blood pressure by baroreceptor feedback	BP
1	1	2.32129956088	-	2.00e-01	GO:0034213	quinolinate catabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:1903465	positive regulation of mitotic cell cycle DNA replication	BP
1	1	2.32129956088	-	2.00e-01	GO:1903464	negative regulation of mitotic cell cycle DNA replication	BP
1	1	2.32129956088	-	2.00e-01	GO:0042488	positive regulation of odontogenesis of dentin-containing tooth	BP
1	1	2.32129956088	-	2.00e-01	GO:1905171	positive regulation of protein localization to phagocytic vesicle	BP
1	1	2.32129956088	-	2.00e-01	GO:2000452	regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation	BP
1	1	2.32129956088	-	2.00e-01	GO:2000454	positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation	BP
1	1	2.32129956088	-	2.00e-01	GO:1905281	positive regulation of retrograde transport, endosome to Golgi	BP
1	1	2.32129956088	-	2.00e-01	GO:0061550	cranial ganglion development	BP
1	1	2.32129956088	-	2.00e-01	GO:0090329	regulation of DNA-dependent DNA replication	BP
1	1	2.32129956088	-	2.00e-01	GO:0060981	cell migration involved in coronary angiogenesis	BP
1	1	2.32129956088	-	2.00e-01	GO:0046318	negative regulation of glucosylceramide biosynthetic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0048753	pigment granule organization	BP
1	1	2.32129956088	-	2.00e-01	GO:0070926	regulation of ATP:ADP antiporter activity	BP
1	1	2.32129956088	-	2.00e-01	GO:0031441	negative regulation of mRNA 3'-end processing	BP
1	1	2.32129956088	-	2.00e-01	GO:0019481	L-alanine catabolic process, by transamination	BP
1	1	2.32129956088	-	2.00e-01	GO:0051595	response to methylglyoxal	BP
1	1	2.32129956088	-	2.00e-01	GO:0021933	radial glia guided migration of cerebellar granule cell	BP
1	1	2.32129956088	-	2.00e-01	GO:1904317	cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine	BP
1	1	2.32129956088	-	2.00e-01	GO:0010948	negative regulation of cell cycle process	BP
1	1	2.32129956088	-	2.00e-01	GO:0060735	regulation of eIF2 alpha phosphorylation by dsRNA	BP
1	1	2.32129956088	-	2.00e-01	GO:0051838	cytolysis by host of symbiont cells	BP
1	1	2.32129956088	-	2.00e-01	GO:2001286	regulation of caveolin-mediated endocytosis	BP
1	1	2.32129956088	-	2.00e-01	GO:0048691	positive regulation of axon extension involved in regeneration	BP
1	1	2.32129956088	-	2.00e-01	GO:1905031	regulation of membrane repolarization during cardiac muscle cell action potential	BP
1	1	2.32129956088	-	2.00e-01	GO:1905035	negative regulation of antifungal innate immune response	BP
1	1	2.32129956088	-	2.00e-01	GO:0033320	UDP-D-xylose biosynthetic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0021543	pallium development	BP
1	1	2.32129956088	-	2.00e-01	GO:0021541	ammon gyrus development	BP
1	1	2.32129956088	-	2.00e-01	GO:0051622	negative regulation of norepinephrine uptake	BP
1	1	2.32129956088	-	2.00e-01	GO:1904876	negative regulation of DNA ligase activity	BP
1	1	2.32129956088	-	2.00e-01	GO:0070845	polyubiquitinated misfolded protein transport	BP
1	1	2.32129956088	-	2.00e-01	GO:0070846	Hsp90 deacetylation	BP
1	1	2.32129956088	-	2.00e-01	GO:1905208	negative regulation of cardiocyte differentiation	BP
1	1	2.32129956088	-	2.00e-01	GO:0085032	modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade	BP
1	1	2.32129956088	-	2.00e-01	GO:0032960	regulation of inositol trisphosphate biosynthetic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0090367	negative regulation of mRNA modification	BP
1	1	2.32129956088	-	2.00e-01	GO:1902233	negative regulation of positive thymic T cell selection	BP
1	1	2.32129956088	-	2.00e-01	GO:2000351	regulation of endothelial cell apoptotic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0051257	meiotic spindle midzone assembly	BP
1	1	2.32129956088	-	2.00e-01	GO:0001928	regulation of exocyst assembly	BP
1	1	2.32129956088	-	2.00e-01	GO:0061383	trabecula morphogenesis	BP
1	1	2.32129956088	-	2.00e-01	GO:0003409	optic cup structural organization	BP
1	1	2.32129956088	-	2.00e-01	GO:0001710	mesodermal cell fate commitment	BP
1	1	2.32129956088	-	2.00e-01	GO:0052066	entry of symbiont into host cell by promotion of host phagocytosis	BP
1	1	2.32129956088	-	2.00e-01	GO:2000830	positive regulation of parathyroid hormone secretion	BP
1	1	2.32129956088	-	2.00e-01	GO:1900163	positive regulation of phospholipid scramblase activity	BP
1	1	2.32129956088	-	2.00e-01	GO:0050787	detoxification of mercury ion	BP
1	1	2.32129956088	-	2.00e-01	GO:0046657	folic acid catabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0043921	modulation by host of viral transcription	BP
1	1	2.32129956088	-	2.00e-01	GO:0051665	membrane raft localization	BP
1	1	2.32129956088	-	2.00e-01	GO:0009817	defense response to fungus, incompatible interaction	BP
1	1	2.32129956088	-	2.00e-01	GO:0006106	fumarate metabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0090282	positive regulation of transcription involved in G2/M transition of mitotic cell cycle	BP
1	1	2.32129956088	-	2.00e-01	GO:1902910	positive regulation of melanosome transport	BP
1	1	2.32129956088	-	2.00e-01	GO:0032928	regulation of superoxide anion generation	BP
1	1	2.32129956088	-	2.00e-01	GO:0016999	antibiotic metabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0032652	regulation of interleukin-1 production	BP
1	1	2.32129956088	-	2.00e-01	GO:0043380	regulation of memory T cell differentiation	BP
1	1	2.32129956088	-	2.00e-01	GO:1903189	glyoxal metabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0021830	interneuron migration from the subpallium to the cortex	BP
1	1	2.32129956088	-	2.00e-01	GO:0060901	regulation of hair cycle by canonical Wnt signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:0060904	regulation of protein folding in endoplasmic reticulum	BP
1	1	2.32129956088	-	2.00e-01	GO:2000317	negative regulation of T-helper 17 type immune response	BP
1	1	2.32129956088	-	2.00e-01	GO:0006343	establishment of chromatin silencing	BP
1	1	2.32129956088	-	2.00e-01	GO:1903514	release of sequestered calcium ion into cytosol by endoplasmic reticulum	BP
1	1	2.32129956088	-	2.00e-01	GO:0060127	prolactin secreting cell differentiation	BP
1	1	2.32129956088	-	2.00e-01	GO:2001031	positive regulation of cellular glucuronidation	BP
1	1	2.32129956088	-	2.00e-01	GO:0032415	regulation of sodium:proton antiporter activity	BP
1	1	2.32129956088	-	2.00e-01	GO:0032412	regulation of ion transmembrane transporter activity	BP
1	1	2.32129956088	-	2.00e-01	GO:0046016	positive regulation of transcription by glucose	BP
1	1	2.32129956088	-	2.00e-01	GO:1901340	negative regulation of store-operated calcium channel activity	BP
1	1	2.32129956088	-	2.00e-01	GO:2000784	positive regulation of establishment of cell polarity regulating cell shape	BP
1	1	2.32129956088	-	2.00e-01	GO:0071166	ribonucleoprotein complex localization	BP
1	1	2.32129956088	-	2.00e-01	GO:1904391	response to ciliary neurotrophic factor	BP
1	1	2.32129956088	-	2.00e-01	GO:1902073	positive regulation of hypoxia-inducible factor-1alpha signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:1900085	negative regulation of peptidyl-tyrosine autophosphorylation	BP
1	1	2.32129956088	-	2.00e-01	GO:0045933	positive regulation of muscle contraction	BP
1	1	2.32129956088	-	2.00e-01	GO:0045932	negative regulation of muscle contraction	BP
1	1	2.32129956088	-	2.00e-01	GO:0045938	positive regulation of circadian sleep/wake cycle, sleep	BP
1	1	2.32129956088	-	2.00e-01	GO:0035409	histone H3-Y41 phosphorylation	BP
1	1	2.32129956088	-	2.00e-01	GO:0042247	establishment of planar polarity of follicular epithelium	BP
1	1	2.32129956088	-	2.00e-01	GO:1905895	negative regulation of cellular response to tunicamycin	BP
1	1	2.32129956088	-	2.00e-01	GO:1905892	negative regulation of cellular response to thapsigargin	BP
1	1	2.32129956088	-	2.00e-01	GO:0021874	Wnt signaling pathway involved in forebrain neuroblast division	BP
1	1	2.32129956088	-	2.00e-01	GO:0072428	signal transduction involved in intra-S DNA damage checkpoint	BP
1	1	2.32129956088	-	2.00e-01	GO:0097275	cellular ammonia homeostasis	BP
1	1	2.32129956088	-	2.00e-01	GO:0097274	urea homeostasis	BP
1	1	2.32129956088	-	2.00e-01	GO:0097277	cellular urea homeostasis	BP
1	1	2.32129956088	-	2.00e-01	GO:0097276	cellular creatinine homeostasis	BP
1	1	2.32129956088	-	2.00e-01	GO:1904589	regulation of protein import	BP
1	1	2.32129956088	-	2.00e-01	GO:0007499	ectoderm and mesoderm interaction	BP
1	1	2.32129956088	-	2.00e-01	GO:0100057	regulation of phenotypic switching by transcription from RNA polymerase II promoter	BP
1	1	2.32129956088	-	2.00e-01	GO:1903926	cellular response to bisphenol A	BP
1	1	2.32129956088	-	2.00e-01	GO:0043012	regulation of fusion of sperm to egg plasma membrane	BP
1	1	2.32129956088	-	2.00e-01	GO:0042659	regulation of cell fate specification	BP
1	1	2.32129956088	-	2.00e-01	GO:0032848	negative regulation of cellular pH reduction	BP
1	1	2.32129956088	-	2.00e-01	GO:0019056	modulation by virus of host transcription	BP
1	1	2.32129956088	-	2.00e-01	GO:1904743	negative regulation of telomeric DNA binding	BP
1	1	2.32129956088	-	2.00e-01	GO:1902998	positive regulation of neurofibrillary tangle assembly	BP
1	1	2.32129956088	-	2.00e-01	GO:0045977	positive regulation of mitotic cell cycle, embryonic	BP
1	1	2.32129956088	-	2.00e-01	GO:1903028	positive regulation of opsonization	BP
1	1	2.32129956088	-	2.00e-01	GO:0009181	purine ribonucleoside diphosphate catabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0098968	neurotransmitter receptor transport postsynaptic membrane to endosome	BP
1	1	2.32129956088	-	2.00e-01	GO:0071245	cellular response to carbon monoxide	BP
1	1	2.32129956088	-	2.00e-01	GO:2000097	regulation of smooth muscle cell-matrix adhesion	BP
1	1	2.32129956088	-	2.00e-01	GO:0070586	cell-cell adhesion involved in gastrulation	BP
1	1	2.32129956088	-	2.00e-01	GO:0001840	neural plate development	BP
1	1	2.32129956088	-	2.00e-01	GO:1904268	positive regulation of Schwann cell chemotaxis	BP
1	1	2.32129956088	-	2.00e-01	GO:0033168	conversion of ds siRNA to ss siRNA involved in RNA interference	BP
1	1	2.32129956088	-	2.00e-01	GO:0061115	lung proximal/distal axis specification	BP
1	1	2.32129956088	-	2.00e-01	GO:0072219	metanephric cortical collecting duct development	BP
1	1	2.32129956088	-	2.00e-01	GO:0072214	metanephric cortex development	BP
1	1	2.32129956088	-	2.00e-01	GO:1903760	regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization	BP
1	1	2.32129956088	-	2.00e-01	GO:1903764	regulation of potassium ion export across plasma membrane	BP
1	1	2.32129956088	-	2.00e-01	GO:0044329	canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion	BP
1	1	2.32129956088	-	2.00e-01	GO:0044328	canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration	BP
1	1	2.32129956088	-	2.00e-01	GO:0007284	spermatogonial cell division	BP
1	1	2.32129956088	-	2.00e-01	GO:0055130	D-alanine catabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0071247	cellular response to chromate	BP
1	1	2.32129956088	-	2.00e-01	GO:2000977	regulation of forebrain neuron differentiation	BP
1	1	2.32129956088	-	2.00e-01	GO:0060876	semicircular canal formation	BP
1	1	2.32129956088	-	2.00e-01	GO:0060436	bronchiole morphogenesis	BP
1	1	2.32129956088	-	2.00e-01	GO:1902178	fibroblast growth factor receptor apoptotic signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:0002812	biosynthetic process of antibacterial peptides active against Gram-negative bacteria	BP
1	1	2.32129956088	-	2.00e-01	GO:1905337	positive regulation of aggrephagy	BP
1	1	2.32129956088	-	2.00e-01	GO:0001544	initiation of primordial ovarian follicle growth	BP
1	1	2.32129956088	-	2.00e-01	GO:0061753	substrate localization to autophagosome	BP
1	1	2.32129956088	-	2.00e-01	GO:0052213	interaction with symbiont via secreted substance involved in symbiotic interaction	BP
1	1	2.32129956088	-	2.00e-01	GO:0031275	regulation of lateral pseudopodium assembly	BP
1	1	2.32129956088	-	2.00e-01	GO:0098597	observational learning	BP
1	1	2.32129956088	-	2.00e-01	GO:0032803	regulation of low-density lipoprotein particle receptor catabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0060879	semicircular canal fusion	BP
1	1	2.32129956088	-	2.00e-01	GO:0003185	sinoatrial valve morphogenesis	BP
1	1	2.32129956088	-	2.00e-01	GO:0060872	semicircular canal development	BP
1	1	2.32129956088	-	2.00e-01	GO:0035564	regulation of kidney size	BP
1	1	2.32129956088	-	2.00e-01	GO:0002863	positive regulation of inflammatory response to antigenic stimulus	BP
1	1	2.32129956088	-	2.00e-01	GO:1904197	positive regulation of granulosa cell proliferation	BP
1	1	2.32129956088	-	2.00e-01	GO:1904193	negative regulation of cholangiocyte apoptotic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0003096	renal sodium ion transport	BP
1	1	2.32129956088	-	2.00e-01	GO:1904227	negative regulation of glycogen synthase activity, transferring glucose-1-phosphate	BP
1	1	2.32129956088	-	2.00e-01	GO:0060601	lateral sprouting from an epithelium	BP
1	1	2.32129956088	-	2.00e-01	GO:0070662	mast cell proliferation	BP
1	1	2.32129956088	-	2.00e-01	GO:0070664	negative regulation of leukocyte proliferation	BP
1	1	2.32129956088	-	2.00e-01	GO:0070667	negative regulation of mast cell proliferation	BP
1	1	2.32129956088	-	2.00e-01	GO:1904056	positive regulation of cholangiocyte proliferation	BP
1	1	2.32129956088	-	2.00e-01	GO:0051463	negative regulation of cortisol secretion	BP
1	1	2.32129956088	-	2.00e-01	GO:0071206	establishment of protein localization to juxtaparanode region of axon	BP
1	1	2.32129956088	-	2.00e-01	GO:1903886	positive regulation of chemokine (C-C motif) ligand 20 production	BP
1	1	2.32129956088	-	2.00e-01	GO:1903883	positive regulation of interleukin-17-mediated signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:0060479	lung cell differentiation	BP
1	1	2.32129956088	-	2.00e-01	GO:0090625	mRNA cleavage involved in gene silencing by siRNA	BP
1	1	2.32129956088	-	2.00e-01	GO:0007174	epidermal growth factor catabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:1901563	response to camptothecin	BP
1	1	2.32129956088	-	2.00e-01	GO:0000999	RNA polymerase III type 1 promoter transcriptional preinitiation complex assembly	BP
1	1	2.32129956088	-	2.00e-01	GO:0045870	positive regulation of single stranded viral RNA replication via double stranded DNA intermediate	BP
1	1	2.32129956088	-	2.00e-01	GO:1904887	Wnt signalosome assembly	BP
1	1	2.32129956088	-	2.00e-01	GO:0097531	mast cell migration	BP
1	1	2.32129956088	-	2.00e-01	GO:0045128	negative regulation of reciprocal meiotic recombination	BP
1	1	2.32129956088	-	2.00e-01	GO:0040032	post-embryonic body morphogenesis	BP
1	1	2.32129956088	-	2.00e-01	GO:0070429	negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:1901976	regulation of cell cycle checkpoint	BP
1	1	2.32129956088	-	2.00e-01	GO:0030264	nuclear fragmentation involved in apoptotic nuclear change	BP
1	1	2.32129956088	-	2.00e-01	GO:0010635	regulation of mitochondrial fusion	BP
1	1	2.32129956088	-	2.00e-01	GO:0036372	opsin transport	BP
1	1	2.32129956088	-	2.00e-01	GO:0031056	regulation of histone modification	BP
1	1	2.32129956088	-	2.00e-01	GO:0035732	nitric oxide storage	BP
1	1	2.32129956088	-	2.00e-01	GO:0035733	hepatic stellate cell activation	BP
1	1	2.32129956088	-	2.00e-01	GO:0031034	myosin filament assembly	BP
1	1	2.32129956088	-	2.00e-01	GO:0048852	diencephalon morphogenesis	BP
1	1	2.32129956088	-	2.00e-01	GO:1903452	positive regulation of G1 to G0 transition	BP
1	1	2.32129956088	-	2.00e-01	GO:0070194	synaptonemal complex disassembly	BP
1	1	2.32129956088	-	2.00e-01	GO:0007037	vacuolar phosphate transport	BP
1	1	2.32129956088	-	2.00e-01	GO:0003311	pancreatic D cell differentiation	BP
1	1	2.32129956088	-	2.00e-01	GO:2000981	negative regulation of inner ear receptor cell differentiation	BP
1	1	2.32129956088	-	2.00e-01	GO:2000191	regulation of fatty acid transport	BP
1	1	2.32129956088	-	2.00e-01	GO:0051541	elastin metabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0019101	female somatic sex determination	BP
1	1	2.32129956088	-	2.00e-01	GO:0019102	male somatic sex determination	BP
1	1	2.32129956088	-	2.00e-01	GO:2000227	negative regulation of pancreatic A cell differentiation	BP
1	1	2.32129956088	-	2.00e-01	GO:0042321	negative regulation of circadian sleep/wake cycle, sleep	BP
1	1	2.32129956088	-	2.00e-01	GO:1903644	regulation of chaperone-mediated protein folding	BP
1	1	2.32129956088	-	2.00e-01	GO:0060768	regulation of epithelial cell proliferation involved in prostate gland development	BP
1	1	2.32129956088	-	2.00e-01	GO:0036333	hepatocyte homeostasis	BP
1	1	2.32129956088	-	2.00e-01	GO:2000050	regulation of non-canonical Wnt signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:0060578	superior vena cava morphogenesis	BP
1	1	2.32129956088	-	2.00e-01	GO:0002761	regulation of myeloid leukocyte differentiation	BP
1	1	2.32129956088	-	2.00e-01	GO:1904800	negative regulation of neuron remodeling	BP
1	1	2.32129956088	-	2.00e-01	GO:0036526	peptidyl-cysteine deglycation	BP
1	1	2.32129956088	-	2.00e-01	GO:0036527	peptidyl-arginine deglycation	BP
1	1	2.32129956088	-	2.00e-01	GO:0036528	peptidyl-lysine deglycation	BP
1	1	2.32129956088	-	2.00e-01	GO:0036529	protein deglycation, glyoxal removal	BP
1	1	2.32129956088	-	2.00e-01	GO:0060683	regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling	BP
1	1	2.32129956088	-	2.00e-01	GO:0048239	negative regulation of DNA recombination at telomere	BP
1	1	2.32129956088	-	2.00e-01	GO:0071538	SH2 domain-mediated complex assembly	BP
1	1	2.32129956088	-	2.00e-01	GO:2000425	regulation of apoptotic cell clearance	BP
1	1	2.32129956088	-	2.00e-01	GO:0016479	negative regulation of transcription from RNA polymerase I promoter	BP
1	1	2.32129956088	-	2.00e-01	GO:0043315	positive regulation of neutrophil degranulation	BP
1	1	2.32129956088	-	2.00e-01	GO:1904631	response to glucoside	BP
1	1	2.32129956088	-	2.00e-01	GO:1904635	positive regulation of glomerular visceral epithelial cell apoptotic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0097326	melanocyte adhesion	BP
1	1	2.32129956088	-	2.00e-01	GO:0035934	corticosterone secretion	BP
1	1	2.32129956088	-	2.00e-01	GO:0007440	foregut morphogenesis	BP
1	1	2.32129956088	-	2.00e-01	GO:0018323	enzyme active site formation via L-cysteine sulfinic acid	BP
1	1	2.32129956088	-	2.00e-01	GO:0051582	positive regulation of neurotransmitter uptake	BP
1	1	2.32129956088	-	2.00e-01	GO:0061682	seminal vesicle morphogenesis	BP
1	1	2.32129956088	-	2.00e-01	GO:1904303	positive regulation of maternal process involved in parturition	BP
1	1	2.32129956088	-	2.00e-01	GO:1904300	positive regulation of transcytosis	BP
1	1	2.32129956088	-	2.00e-01	GO:1903689	regulation of wound healing, spreading of epidermal cells	BP
1	1	2.32129956088	-	2.00e-01	GO:2001145	negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity	BP
1	1	2.32129956088	-	2.00e-01	GO:1905689	positive regulation of diacylglycerol kinase activity	BP
1	1	2.32129956088	-	2.00e-01	GO:0002721	regulation of B cell cytokine production	BP
1	1	2.32129956088	-	2.00e-01	GO:1904843	cellular response to nitroglycerin	BP
1	1	2.32129956088	-	2.00e-01	GO:0043299	leukocyte degranulation	BP
1	1	2.32129956088	-	2.00e-01	GO:0045980	negative regulation of nucleotide metabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:1902947	regulation of tau-protein kinase activity	BP
1	1	2.32129956088	-	2.00e-01	GO:0090104	pancreatic epsilon cell differentiation	BP
1	1	2.32129956088	-	2.00e-01	GO:0090108	positive regulation of high-density lipoprotein particle assembly	BP
1	1	2.32129956088	-	2.00e-01	GO:0014870	response to muscle inactivity	BP
1	1	2.32129956088	-	2.00e-01	GO:0044111	development involved in symbiotic interaction	BP
1	1	2.32129956088	-	2.00e-01	GO:0032976	release of matrix enzymes from mitochondria	BP
1	1	2.32129956088	-	2.00e-01	GO:0003252	negative regulation of cell proliferation involved in heart valve morphogenesis	BP
1	1	2.32129956088	-	2.00e-01	GO:0003251	positive regulation of cell proliferation involved in heart valve morphogenesis	BP
1	1	2.32129956088	-	2.00e-01	GO:0035967	cellular response to topologically incorrect protein	BP
1	1	2.32129956088	-	2.00e-01	GO:0032606	type I interferon production	BP
1	1	2.32129956088	-	2.00e-01	GO:0034763	negative regulation of transmembrane transport	BP
1	1	2.32129956088	-	2.00e-01	GO:1902206	negative regulation of interleukin-2-mediated signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:1902203	negative regulation of hepatocyte growth factor receptor signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:0023057	negative regulation of signaling	BP
1	1	2.32129956088	-	2.00e-01	GO:0042214	terpene metabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0010743	regulation of macrophage derived foam cell differentiation	BP
1	1	2.32129956088	-	2.00e-01	GO:1904530	negative regulation of actin filament binding	BP
1	1	2.32129956088	-	2.00e-01	GO:1904531	positive regulation of actin filament binding	BP
1	1	2.32129956088	-	2.00e-01	GO:0061395	positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance	BP
1	1	2.32129956088	-	2.00e-01	GO:0061394	regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance	BP
1	1	2.32129956088	-	2.00e-01	GO:0060699	regulation of endoribonuclease activity	BP
1	1	2.32129956088	-	2.00e-01	GO:0009396	folic acid-containing compound biosynthetic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0007403	glial cell fate determination	BP
1	1	2.32129956088	-	2.00e-01	GO:2000118	regulation of sodium-dependent phosphate transport	BP
1	1	2.32129956088	-	2.00e-01	GO:2000119	negative regulation of sodium-dependent phosphate transport	BP
1	1	2.32129956088	-	2.00e-01	GO:0016189	synaptic vesicle to endosome fusion	BP
1	1	2.32129956088	-	2.00e-01	GO:0072255	metanephric glomerular mesangial cell development	BP
1	1	2.32129956088	-	2.00e-01	GO:2000808	negative regulation of synaptic vesicle clustering	BP
1	1	2.32129956088	-	2.00e-01	GO:2000802	positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation	BP
1	1	2.32129956088	-	2.00e-01	GO:0050793	regulation of developmental process	BP
1	1	2.32129956088	-	2.00e-01	GO:0046668	regulation of retinal cell programmed cell death	BP
1	1	2.32129956088	-	2.00e-01	GO:0034127	regulation of MyD88-independent toll-like receptor signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:1905062	positive regulation of cardioblast proliferation	BP
1	1	2.32129956088	-	2.00e-01	GO:0021515	cell differentiation in spinal cord	BP
1	1	2.32129956088	-	2.00e-01	GO:2000639	negative regulation of SREBP signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:1990117	B cell receptor apoptotic signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:0061408	positive regulation of transcription from RNA polymerase II promoter in response to heat stress	BP
1	1	2.32129956088	-	2.00e-01	GO:0061400	positive regulation of transcription from RNA polymerase II promoter in response to calcium ion	BP
1	1	2.32129956088	-	2.00e-01	GO:1903055	positive regulation of extracellular matrix organization	BP
1	1	2.32129956088	-	2.00e-01	GO:1902904	negative regulation of supramolecular fiber organization	BP
1	1	2.32129956088	-	2.00e-01	GO:1902903	regulation of supramolecular fiber organization	BP
1	1	2.32129956088	-	2.00e-01	GO:1905273	positive regulation of proton-transporting ATP synthase activity, rotational mechanism	BP
1	1	2.32129956088	-	2.00e-01	GO:1905274	regulation of modification of postsynaptic actin cytoskeleton	BP
1	1	2.32129956088	-	2.00e-01	GO:0099040	ceramide translocation	BP
1	1	2.32129956088	-	2.00e-01	GO:0003213	cardiac right atrium morphogenesis	BP
1	1	2.32129956088	-	2.00e-01	GO:0070512	positive regulation of histone H4-K20 methylation	BP
1	1	2.32129956088	-	2.00e-01	GO:0001100	negative regulation of exit from mitosis	BP
1	1	2.32129956088	-	2.00e-01	GO:1903197	positive regulation of L-dopa biosynthetic process	BP
1	1	2.32129956088	-	2.00e-01	GO:1901297	positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment	BP
1	1	2.32129956088	-	2.00e-01	GO:0001971	negative regulation of activation of membrane attack complex	BP
1	1	2.32129956088	-	2.00e-01	GO:0035604	fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow	BP
1	1	2.32129956088	-	2.00e-01	GO:0035602	fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow	BP
1	1	2.32129956088	-	2.00e-01	GO:0035603	fibroblast growth factor receptor signaling pathway involved in hemopoiesis	BP
1	1	2.32129956088	-	2.00e-01	GO:1990859	cellular response to endothelin	BP
1	1	2.32129956088	-	2.00e-01	GO:0060481	lobar bronchus epithelium development	BP
1	1	2.32129956088	-	2.00e-01	GO:1901355	response to rapamycin	BP
1	1	2.32129956088	-	2.00e-01	GO:0052501	positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction	BP
1	1	2.32129956088	-	2.00e-01	GO:1901350	cell-cell signaling involved in cell-cell junction organization	BP
1	1	2.32129956088	-	2.00e-01	GO:0072666	establishment of protein localization to vacuole	BP
1	1	2.32129956088	-	2.00e-01	GO:1900402	regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter	BP
1	1	2.32129956088	-	2.00e-01	GO:1904389	rod bipolar cell differentiation	BP
1	1	2.32129956088	-	2.00e-01	GO:0050865	regulation of cell activation	BP
1	1	2.32129956088	-	2.00e-01	GO:0002152	bile acid conjugation	BP
1	1	2.32129956088	-	2.00e-01	GO:0051884	regulation of timing of anagen	BP
1	1	2.32129956088	-	2.00e-01	GO:0036404	conversion of ds siRNA to ss siRNA	BP
1	1	2.32129956088	-	2.00e-01	GO:2001239	regulation of extrinsic apoptotic signaling pathway in absence of ligand	BP
1	1	2.32129956088	-	2.00e-01	GO:0043973	histone H3-K4 acetylation	BP
1	1	2.32129956088	-	2.00e-01	GO:0048087	positive regulation of developmental pigmentation	BP
1	1	2.32129956088	-	2.00e-01	GO:0019061	uncoating of virus	BP
1	1	2.32129956088	-	2.00e-01	GO:0071362	cellular response to ether	BP
1	1	2.32129956088	-	2.00e-01	GO:1901725	regulation of histone deacetylase activity	BP
1	1	2.32129956088	-	2.00e-01	GO:1901723	negative regulation of cell proliferation involved in kidney development	BP
1	1	2.32129956088	-	2.00e-01	GO:1904772	response to tetrachloromethane	BP
1	1	2.32129956088	-	2.00e-01	GO:0086044	atrial cardiac muscle cell to AV node cell communication by electrical coupling	BP
1	1	2.32129956088	-	2.00e-01	GO:2000536	negative regulation of entry of bacterium into host cell	BP
1	1	2.32129956088	-	2.00e-01	GO:2000533	negative regulation of renal albumin absorption	BP
1	1	2.32129956088	-	2.00e-01	GO:0010517	regulation of phospholipase activity	BP
1	1	2.32129956088	-	2.00e-01	GO:0097090	presynaptic membrane organization	BP
1	1	2.32129956088	-	2.00e-01	GO:1903489	positive regulation of lactation	BP
1	1	2.32129956088	-	2.00e-01	GO:1903488	negative regulation of lactation	BP
1	1	2.32129956088	-	2.00e-01	GO:0043969	histone H2B acetylation	BP
1	1	2.32129956088	-	2.00e-01	GO:1905774	regulation of DNA helicase activity	BP
1	1	2.32129956088	-	2.00e-01	GO:1905776	positive regulation of DNA helicase activity	BP
1	1	2.32129956088	-	2.00e-01	GO:0046814	coreceptor-mediated virion attachment to host cell	BP
1	1	2.32129956088	-	2.00e-01	GO:0071839	apoptotic process in bone marrow	BP
1	1	2.32129956088	-	2.00e-01	GO:1901258	positive regulation of macrophage colony-stimulating factor production	BP
1	1	2.32129956088	-	2.00e-01	GO:1904025	positive regulation of glucose catabolic process to lactate via pyruvate	BP
1	1	2.32129956088	-	2.00e-01	GO:0035644	phosphoanandamide dephosphorylation	BP
1	1	2.32129956088	-	2.00e-01	GO:0002695	negative regulation of leukocyte activation	BP
1	1	2.32129956088	-	2.00e-01	GO:0072434	signal transduction involved in mitotic G2 DNA damage checkpoint	BP
1	1	2.32129956088	-	2.00e-01	GO:0052547	regulation of peptidase activity	BP
1	1	2.32129956088	-	2.00e-01	GO:2000739	regulation of mesenchymal stem cell differentiation	BP
1	1	2.32129956088	-	2.00e-01	GO:0071441	negative regulation of histone H3-K14 acetylation	BP
1	1	2.32129956088	-	2.00e-01	GO:1901863	positive regulation of muscle tissue development	BP
1	1	2.32129956088	-	2.00e-01	GO:1904924	negative regulation of mitophagy in response to mitochondrial depolarization	BP
1	1	2.32129956088	-	2.00e-01	GO:0061767	negative regulation of lung blood pressure	BP
1	1	2.32129956088	-	2.00e-01	GO:0043000	Golgi to plasma membrane CFTR protein transport	BP
1	1	2.32129956088	-	2.00e-01	GO:0010990	regulation of SMAD protein complex assembly	BP
1	1	2.32129956088	-	2.00e-01	GO:0048337	positive regulation of mesodermal cell fate specification	BP
1	1	2.32129956088	-	2.00e-01	GO:0072362	regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter	BP
1	1	2.32129956088	-	2.00e-01	GO:0072363	regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter	BP
1	1	2.32129956088	-	2.00e-01	GO:0035665	TIRAP-dependent toll-like receptor 4 signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:0072366	regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter	BP
1	1	2.32129956088	-	2.00e-01	GO:0072365	regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter	BP
1	1	2.32129956088	-	2.00e-01	GO:1990401	embryonic lung development	BP
1	1	2.32129956088	-	2.00e-01	GO:2001273	regulation of glucose import in response to insulin stimulus	BP
1	1	2.32129956088	-	2.00e-01	GO:0090025	regulation of monocyte chemotaxis	BP
1	1	2.32129956088	-	2.00e-01	GO:0044843	cell cycle G1/S phase transition	BP
1	1	2.32129956088	-	2.00e-01	GO:0072040	negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis	BP
1	1	2.32129956088	-	2.00e-01	GO:0090237	regulation of arachidonic acid secretion	BP
1	1	2.32129956088	-	2.00e-01	GO:1902988	neurofibrillary tangle assembly	BP
1	1	2.32129956088	-	2.00e-01	GO:0005998	xylulose catabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0006713	glucocorticoid catabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0098974	postsynaptic actin cytoskeleton organization	BP
1	1	2.32129956088	-	2.00e-01	GO:0045081	negative regulation of interleukin-10 biosynthetic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0045083	negative regulation of interleukin-12 biosynthetic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0002066	columnar/cuboidal epithelial cell development	BP
1	1	2.32129956088	-	2.00e-01	GO:0010034	response to acetate	BP
1	1	2.32129956088	-	2.00e-01	GO:1902425	positive regulation of attachment of mitotic spindle microtubules to kinetochore	BP
1	1	2.32129956088	-	2.00e-01	GO:0036060	slit diaphragm assembly	BP
1	1	2.32129956088	-	2.00e-01	GO:0032769	negative regulation of monooxygenase activity	BP
1	1	2.32129956088	-	2.00e-01	GO:0071873	response to norepinephrine	BP
1	1	2.32129956088	-	2.00e-01	GO:0008655	pyrimidine-containing compound salvage	BP
1	1	2.32129956088	-	2.00e-01	GO:0071250	cellular response to nitrite	BP
1	1	2.32129956088	-	2.00e-01	GO:0071258	cellular response to gravity	BP
1	1	2.32129956088	-	2.00e-01	GO:0060405	regulation of penile erection	BP
1	1	2.32129956088	-	2.00e-01	GO:0060400	negative regulation of growth hormone receptor signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:0002651	positive regulation of tolerance induction to self antigen	BP
1	1	2.32129956088	-	2.00e-01	GO:1902161	positive regulation of cyclic nucleotide-gated ion channel activity	BP
1	1	2.32129956088	-	2.00e-01	GO:1902165	regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	BP
1	1	2.32129956088	-	2.00e-01	GO:0014010	Schwann cell proliferation	BP
1	1	2.32129956088	-	2.00e-01	GO:2000775	histone H3-S10 phosphorylation involved in chromosome condensation	BP
1	1	2.32129956088	-	2.00e-01	GO:0045685	regulation of glial cell differentiation	BP
1	1	2.32129956088	-	2.00e-01	GO:0061724	lipophagy	BP
1	1	2.32129956088	-	2.00e-01	GO:1903978	regulation of microglial cell activation	BP
1	1	2.32129956088	-	2.00e-01	GO:1902511	negative regulation of apoptotic DNA fragmentation	BP
1	1	2.32129956088	-	2.00e-01	GO:0032298	positive regulation of DNA-dependent DNA replication initiation	BP
1	1	2.32129956088	-	2.00e-01	GO:1990828	hepatocyte dedifferentiation	BP
1	1	2.32129956088	-	2.00e-01	GO:0051695	actin filament uncapping	BP
1	1	2.32129956088	-	2.00e-01	GO:0021998	neural plate mediolateral regionalization	BP
1	1	2.32129956088	-	2.00e-01	GO:0060844	arterial endothelial cell fate commitment	BP
1	1	2.32129956088	-	2.00e-01	GO:0060843	venous endothelial cell differentiation	BP
1	1	2.32129956088	-	2.00e-01	GO:0098930	axonal transport	BP
1	1	2.32129956088	-	2.00e-01	GO:1903632	positive regulation of aminoacyl-tRNA ligase activity	BP
1	1	2.32129956088	-	2.00e-01	GO:1905672	negative regulation of lysosome organization	BP
1	1	2.32129956088	-	2.00e-01	GO:0032350	regulation of hormone metabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0019742	pentacyclic triterpenoid metabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0001835	blastocyst hatching	BP
1	1	2.32129956088	-	2.00e-01	GO:0045713	low-density lipoprotein particle receptor biosynthetic process	BP
1	1	2.32129956088	-	2.00e-01	GO:1904238	pericyte cell differentiation	BP
1	1	2.32129956088	-	2.00e-01	GO:1904237	positive regulation of substrate-dependent cell migration, cell attachment to substrate	BP
1	1	2.32129956088	-	2.00e-01	GO:1903408	positive regulation of sodium:potassium-exchanging ATPase activity	BP
1	1	2.32129956088	-	2.00e-01	GO:0097017	renal protein absorption	BP
1	1	2.32129956088	-	2.00e-01	GO:0035491	positive regulation of leukotriene production involved in inflammatory response	BP
1	1	2.32129956088	-	2.00e-01	GO:0060611	mammary gland fat development	BP
1	1	2.32129956088	-	2.00e-01	GO:0000173	inactivation of MAPK activity involved in osmosensory signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:0046898	response to cycloheximide	BP
1	1	2.32129956088	-	2.00e-01	GO:0019510	S-adenosylhomocysteine catabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0071211	protein targeting to vacuole involved in autophagy	BP
1	1	2.32129956088	-	2.00e-01	GO:0072389	flavin adenine dinucleotide catabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0072386	plus-end-directed organelle transport along microtubule	BP
1	1	2.32129956088	-	2.00e-01	GO:0042703	menstruation	BP
1	1	2.32129956088	-	2.00e-01	GO:1900142	negative regulation of oligodendrocyte apoptotic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0010070	zygote asymmetric cell division	BP
1	1	2.32129956088	-	2.00e-01	GO:0070981	L-asparagine biosynthetic process	BP
1	1	2.32129956088	-	2.00e-01	GO:2000277	positive regulation of oxidative phosphorylation uncoupler activity	BP
1	1	2.32129956088	-	2.00e-01	GO:0051531	NFAT protein import into nucleus	BP
1	1	2.32129956088	-	2.00e-01	GO:0060806	negative regulation of cell differentiation involved in embryonic placenta development	BP
1	1	2.32129956088	-	2.00e-01	GO:1904373	response to kainic acid	BP
1	1	2.32129956088	-	2.00e-01	GO:0061043	regulation of vascular wound healing	BP
1	1	2.32129956088	-	2.00e-01	GO:0061040	female gonad morphogenesis	BP
1	1	2.32129956088	-	2.00e-01	GO:1903676	positive regulation of cap-dependent translational initiation	BP
1	1	2.32129956088	-	2.00e-01	GO:1903673	mitotic cleavage furrow formation	BP
1	1	2.32129956088	-	2.00e-01	GO:0007538	primary sex determination	BP
1	1	2.32129956088	-	2.00e-01	GO:1904141	positive regulation of microglial cell migration	BP
1	1	2.32129956088	-	2.00e-01	GO:0070377	negative regulation of ERK5 cascade	BP
1	1	2.32129956088	-	2.00e-01	GO:1905843	regulation of cellular response to gamma radiation	BP
1	1	2.32129956088	-	2.00e-01	GO:0048241	epinephrine transport	BP
1	1	2.32129956088	-	2.00e-01	GO:1905154	negative regulation of membrane invagination	BP
1	1	2.32129956088	-	2.00e-01	GO:1900383	regulation of synaptic plasticity by receptor localization to synapse	BP
1	1	2.32129956088	-	2.00e-01	GO:1904604	negative regulation of advanced glycation end-product receptor activity	BP
1	1	2.32129956088	-	2.00e-01	GO:0061535	glutamate secretion, neurotransmission	BP
1	1	2.32129956088	-	2.00e-01	GO:0061534	gamma-aminobutyric acid secretion, neurotransmission	BP
1	1	2.32129956088	-	2.00e-01	GO:0006046	N-acetylglucosamine catabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:1903126	negative regulation of centriole-centriole cohesion	BP
1	1	2.32129956088	-	2.00e-01	GO:1903125	negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation	BP
1	1	2.32129956088	-	2.00e-01	GO:0014048	regulation of glutamate secretion	BP
1	1	2.32129956088	-	2.00e-01	GO:0043519	regulation of myosin II filament organization	BP
1	1	2.32129956088	-	2.00e-01	GO:0060014	granulosa cell differentiation	BP
1	1	2.32129956088	-	2.00e-01	GO:0060010	Sertoli cell fate commitment	BP
1	1	2.32129956088	-	2.00e-01	GO:0090219	negative regulation of lipid kinase activity	BP
1	1	2.32129956088	-	2.00e-01	GO:0045175	basal protein localization	BP
1	1	2.32129956088	-	2.00e-01	GO:0070946	neutrophil mediated killing of gram-positive bacterium	BP
1	1	2.32129956088	-	2.00e-01	GO:0070947	neutrophil mediated killing of fungus	BP
1	1	2.32129956088	-	2.00e-01	GO:2000184	positive regulation of progesterone biosynthetic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0021919	BMP signaling pathway involved in spinal cord dorsal/ventral patterning	BP
1	1	2.32129956088	-	2.00e-01	GO:0070235	regulation of activation-induced cell death of T cells	BP
1	1	2.32129956088	-	2.00e-01	GO:2000230	negative regulation of pancreatic stellate cell proliferation	BP
1	1	2.32129956088	-	2.00e-01	GO:1901675	negative regulation of histone H3-K27 acetylation	BP
1	1	2.32129956088	-	2.00e-01	GO:1900100	positive regulation of plasma cell differentiation	BP
1	1	2.32129956088	-	2.00e-01	GO:1900102	negative regulation of endoplasmic reticulum unfolded protein response	BP
1	1	2.32129956088	-	2.00e-01	GO:0002344	B cell affinity maturation	BP
1	1	2.32129956088	-	2.00e-01	GO:0060751	branch elongation involved in mammary gland duct branching	BP
1	1	2.32129956088	-	2.00e-01	GO:0050760	negative regulation of thymidylate synthase biosynthetic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0002236	detection of misfolded protein	BP
1	1	2.32129956088	-	2.00e-01	GO:0046958	nonassociative learning	BP
1	1	2.32129956088	-	2.00e-01	GO:2001113	negative regulation of cellular response to hepatocyte growth factor stimulus	BP
1	1	2.32129956088	-	2.00e-01	GO:1902618	cellular response to fluoride	BP
1	1	2.32129956088	-	2.00e-01	GO:0006991	response to sterol depletion	BP
1	1	2.32129956088	-	2.00e-01	GO:1904501	positive regulation of chromatin-mediated maintenance of transcription	BP
1	1	2.32129956088	-	2.00e-01	GO:0032535	regulation of cellular component size	BP
1	1	2.32129956088	-	2.00e-01	GO:0002758	innate immune response-activating signal transduction	BP
1	1	2.32129956088	-	2.00e-01	GO:0075521	microtubule-dependent intracellular transport of viral material towards nucleus	BP
1	1	2.32129956088	-	2.00e-01	GO:0036531	glutathione deglycation	BP
1	1	2.32129956088	-	2.00e-01	GO:0036530	protein deglycation, methylglyoxal removal	BP
1	1	2.32129956088	-	2.00e-01	GO:0060694	regulation of cholesterol transporter activity	BP
1	1	2.32129956088	-	2.00e-01	GO:0060696	regulation of phospholipid catabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0060691	epithelial cell maturation involved in salivary gland development	BP
1	1	2.32129956088	-	2.00e-01	GO:0003336	corneocyte desquamation	BP
1	1	2.32129956088	-	2.00e-01	GO:0098761	cellular response to interleukin-7	BP
1	1	2.32129956088	-	2.00e-01	GO:0085018	maintenance of symbiont-containing vacuole by host	BP
1	1	2.32129956088	-	2.00e-01	GO:0014820	tonic smooth muscle contraction	BP
1	1	2.32129956088	-	2.00e-01	GO:0044140	negative regulation of growth of symbiont on or near host surface	BP
1	1	2.32129956088	-	2.00e-01	GO:0007063	regulation of sister chromatid cohesion	BP
1	1	2.32129956088	-	2.00e-01	GO:0071295	cellular response to vitamin	BP
1	1	2.32129956088	-	2.00e-01	GO:0071298	cellular response to L-ascorbic acid	BP
1	1	2.32129956088	-	2.00e-01	GO:1903839	positive regulation of mRNA 3'-UTR binding	BP
1	1	2.32129956088	-	2.00e-01	GO:0046782	regulation of viral transcription	BP
1	1	2.32129956088	-	2.00e-01	GO:1903168	positive regulation of pyrroline-5-carboxylate reductase activity	BP
1	1	2.32129956088	-	2.00e-01	GO:0010232	vascular transport	BP
1	1	2.32129956088	-	2.00e-01	GO:1903178	positive regulation of tyrosine 3-monooxygenase activity	BP
1	1	2.32129956088	-	2.00e-01	GO:1901860	positive regulation of mitochondrial DNA metabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:2000374	regulation of oxygen metabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0021763	subthalamic nucleus development	BP
1	1	2.32129956088	-	2.00e-01	GO:1903573	negative regulation of response to endoplasmic reticulum stress	BP
1	1	2.32129956088	-	2.00e-01	GO:0044268	multicellular organismal protein metabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0036119	response to platelet-derived growth factor	BP
1	1	2.32129956088	-	2.00e-01	GO:0052047	interaction with other organism via secreted substance involved in symbiotic interaction	BP
1	1	2.32129956088	-	2.00e-01	GO:0097117	guanylate kinase-associated protein clustering	BP
1	1	2.32129956088	-	2.00e-01	GO:1900148	negative regulation of Schwann cell migration	BP
1	1	2.32129956088	-	2.00e-01	GO:0009441	glycolate metabolic process	BP
1	1	2.32129956088	-	2.00e-01	GO:0036471	cellular response to glyoxal	BP
1	1	2.32129956088	-	2.00e-01	GO:0002270	plasmacytoid dendritic cell activation	BP
1	1	2.32129956088	-	2.00e-01	GO:1902548	negative regulation of cellular response to vascular endothelial growth factor stimulus	BP
1	1	2.32129956088	-	2.00e-01	GO:1902544	regulation of DNA N-glycosylase activity	BP
1	1	2.32129956088	-	2.00e-01	GO:0072750	cellular response to leptomycin B	BP
1	1	2.32129956088	-	2.00e-01	GO:0021564	vagus nerve development	BP
1	1	2.32129956088	-	2.00e-01	GO:0021563	glossopharyngeal nerve development	BP
1	1	2.32129956088	-	2.00e-01	GO:0007388	posterior compartment specification	BP
1	1	2.32129956088	-	2.00e-01	GO:0007387	anterior compartment pattern formation	BP
1	1	2.32129956088	-	2.00e-01	GO:0035105	sterol regulatory element binding protein import into nucleus	BP
1	1	2.32129956088	-	2.00e-01	GO:1904850	negative regulation of establishment of protein localization to telomere	BP
1	1	2.32129956088	-	2.00e-01	GO:0060520	activation of prostate induction by androgen receptor signaling pathway	BP
1	1	2.32129956088	-	2.00e-01	GO:0045992	negative regulation of embryonic development	BP
1	1	2.32129956088	-	2.00e-01	GO:0045990	carbon catabolite regulation of transcription	BP
1	1	2.32129956088	-	2.00e-01	GO:0060383	positive regulation of DNA strand elongation	BP
1	1	2.32129956088	-	2.00e-01	GO:1905229	cellular response to thyrotropin-releasing hormone	BP
1	1	2.32129956088	-	2.00e-01	GO:1905223	epicardium morphogenesis	BP
1	1	2.32129956088	-	2.00e-01	GO:0014866	skeletal myofibril assembly	BP
1	1	2.32129956088	-	2.00e-01	GO:0032637	interleukin-8 production	BP
1	1	2.32129956088	-	2.00e-01	GO:0032633	interleukin-4 production	BP
9	9	2.32129956088	-	5.09e-07	GO:0004716	signal transducer, downstream of receptor, with protein tyrosine kinase activity	MF
5	5	2.32129956088	-	3.20e-04	GO:0030235	nitric-oxide synthase regulator activity	MF
4	4	2.32129956088	-	1.60e-03	GO:0050815	phosphoserine residue binding	MF
4	4	2.32129956088	-	1.60e-03	GO:0070851	growth factor receptor binding	MF
4	4	2.32129956088	-	1.60e-03	GO:0051425	PTB domain binding	MF
4	4	2.32129956088	-	1.60e-03	GO:0043125	ErbB-3 class receptor binding	MF
4	4	2.32129956088	-	1.60e-03	GO:0043121	neurotrophin binding	MF
2	2	2.32129956088	-	4.00e-02	GO:0031755	Edg-2 lysophosphatidic acid receptor binding	MF
2	2	2.32129956088	-	4.00e-02	GO:0030366	molybdopterin synthase activity	MF
2	2	2.32129956088	-	4.00e-02	GO:0004951	cholecystokinin receptor activity	MF
2	2	2.32129956088	-	4.00e-02	GO:0038052	RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding	MF
2	2	2.32129956088	-	4.00e-02	GO:0051990	(R)-2-hydroxyglutarate dehydrogenase activity	MF
2	2	2.32129956088	-	4.00e-02	GO:0047322	[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity	MF
2	2	2.32129956088	-	4.00e-02	GO:0050436	microfibril binding	MF
2	2	2.32129956088	-	4.00e-02	GO:0071074	eukaryotic initiation factor eIF2 binding	MF
2	2	2.32129956088	-	4.00e-02	GO:0098770	FBXO family protein binding	MF
2	2	2.32129956088	-	4.00e-02	GO:0000701	purine-specific mismatch base pair DNA N-glycosylase activity	MF
2	2	2.32129956088	-	4.00e-02	GO:0032427	GBD domain binding	MF
2	2	2.32129956088	-	4.00e-02	GO:0032143	single thymine insertion binding	MF
2	2	2.32129956088	-	4.00e-02	GO:0008269	JAK pathway signal transduction adaptor activity	MF
2	2	2.32129956088	-	4.00e-02	GO:0005011	macrophage colony-stimulating factor receptor activity	MF
2	2	2.32129956088	-	4.00e-02	GO:0005019	platelet-derived growth factor beta-receptor activity	MF
2	2	2.32129956088	-	4.00e-02	GO:0032181	dinucleotide repeat insertion binding	MF
2	2	2.32129956088	-	4.00e-02	GO:0034212	peptide N-acetyltransferase activity	MF
2	2	2.32129956088	-	4.00e-02	GO:0001025	RNA polymerase III transcription factor binding	MF
2	2	2.32129956088	-	4.00e-02	GO:0000406	double-strand/single-strand DNA junction binding	MF
2	2	2.32129956088	-	4.00e-02	GO:0042610	CD8 receptor binding	MF
2	2	2.32129956088	-	4.00e-02	GO:0086075	gap junction channel activity involved in cardiac conduction electrical coupling	MF
2	2	2.32129956088	-	4.00e-02	GO:0035402	histone kinase activity (H3-T11 specific)	MF
2	2	2.32129956088	-	4.00e-02	GO:0035403	histone kinase activity (H3-T6 specific)	MF
2	2	2.32129956088	-	4.00e-02	GO:0061752	telomeric repeat-containing RNA binding	MF
2	2	2.32129956088	-	4.00e-02	GO:0034988	Fc-gamma receptor I complex binding	MF
2	2	2.32129956088	-	4.00e-02	GO:0031701	angiotensin receptor binding	MF
2	2	2.32129956088	-	4.00e-02	GO:0001225	RNA polymerase II transcription coactivator binding	MF
2	2	2.32129956088	-	4.00e-02	GO:0005048	signal sequence binding	MF
2	2	2.32129956088	-	4.00e-02	GO:0098847	sequence-specific single stranded DNA binding	MF
2	2	2.32129956088	-	4.00e-02	GO:0010465	nerve growth factor receptor activity	MF
2	2	2.32129956088	-	4.00e-02	GO:0042132	fructose 1,6-bisphosphate 1-phosphatase activity	MF
2	2	2.32129956088	-	4.00e-02	GO:0009882	blue light photoreceptor activity	MF
2	2	2.32129956088	-	4.00e-02	GO:0005163	nerve growth factor receptor binding	MF
2	2	2.32129956088	-	4.00e-02	GO:0031762	follicle-stimulating hormone receptor binding	MF
2	2	2.32129956088	-	4.00e-02	GO:0097199	cysteine-type endopeptidase activity involved in apoptotic signaling pathway	MF
2	2	2.32129956088	-	4.00e-02	GO:0008160	protein tyrosine phosphatase activator activity	MF
2	2	2.32129956088	-	4.00e-02	GO:0051800	phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity	MF
2	2	2.32129956088	-	4.00e-02	GO:0050405	[acetyl-CoA carboxylase] kinase activity	MF
2	2	2.32129956088	-	4.00e-02	GO:0031691	alpha-1A adrenergic receptor binding	MF
1	1	2.32129956088	-	2.00e-01	GO:1990450	linear polyubiquitin binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0004856	xylulokinase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0004853	uroporphyrinogen decarboxylase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0004852	uroporphyrinogen-III synthase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0001626	nociceptin receptor activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0008545	JUN kinase kinase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0045340	mercury ion binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0031544	peptidyl-proline 3-dioxygenase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0004588	orotate phosphoribosyltransferase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0004586	ornithine decarboxylase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0035226	glutamate-cysteine ligase catalytic subunit binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0061770	translation elongation factor binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0034632	retinol transporter activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0016248	channel inhibitor activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0047801	L-cysteine:2-oxoglutarate aminotransferase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0004043	L-aminoadipate-semialdehyde dehydrogenase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0038051	glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0015439	heme-transporting ATPase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0032138	single base insertion or deletion binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0001011	transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting	MF
1	1	2.32129956088	-	2.00e-01	GO:0004648	O-phospho-L-serine:2-oxoglutarate aminotransferase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0005020	stem cell factor receptor activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0050115	myosin-light-chain-phosphatase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0035033	histone deacetylase regulator activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0004508	steroid 17-alpha-monooxygenase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0005252	open rectifier potassium channel activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0046904	calcium oxalate binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0008434	calcitriol receptor activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0004334	fumarylacetoacetase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0004333	fumarate hydratase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0042924	neuromedin U binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0042922	neuromedin U receptor binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0047453	ATP-dependent NAD(P)H-hydrate dehydratase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0052817	very long chain acyl-CoA hydrolase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0052816	long-chain acyl-CoA hydrolase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0036317	tyrosyl-RNA phosphodiesterase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0004941	beta2-adrenergic receptor activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0047305	(R)-3-amino-2-methylpropionate-pyruvate transaminase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0070856	myosin VI light chain binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0008802	betaine-aldehyde dehydrogenase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0004639	phosphoribosylaminoimidazolesuccinocarboxamide synthase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0004638	phosphoribosylaminoimidazole carboxylase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0052855	ADP-dependent NAD(P)H-hydrate dehydratase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0070260	5'-tyrosyl-DNA phosphodiesterase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0060703	deoxyribonuclease inhibitor activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0004676	3-phosphoinositide-dependent protein kinase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0018114	threonine racemase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:1990444	F-box domain binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0017024	myosin I binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0061663	NEDD8 ligase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0002135	CTP binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0008962	phosphatidylglycerophosphatase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0086063	voltage-gated sodium channel activity involved in SA node cell action potential	MF
1	1	2.32129956088	-	2.00e-01	GO:0086060	voltage-gated sodium channel activity involved in AV node cell action potential	MF
1	1	2.32129956088	-	2.00e-01	GO:0086061	voltage-gated sodium channel activity involved in bundle of His cell action potential	MF
1	1	2.32129956088	-	2.00e-01	GO:0061609	fructose-1-phosphate aldolase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0052835	inositol-3,4,6-trisphosphate 1-kinase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:1904599	advanced glycation end-product binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0031962	mineralocorticoid receptor binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0060175	brain-derived neurotrophic factor-activated receptor activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	MF
1	1	2.32129956088	-	2.00e-01	GO:1901707	leptomycin B binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0001087	transcription factor activity, TFIIB-class binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0001850	complement component C3a binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0030379	neurotensin receptor activity, non-G-protein coupled	MF
1	1	2.32129956088	-	2.00e-01	GO:0030378	serine racemase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0030372	high molecular weight B cell growth factor receptor binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0030377	urokinase plasminogen activator receptor activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0004900	erythropoietin receptor activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0004013	adenosylhomocysteinase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0036004	GAF domain binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0047016	cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0051908	double-stranded DNA 5'-3' exodeoxyribonuclease activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0005199	structural constituent of cell wall	MF
1	1	2.32129956088	-	2.00e-01	GO:0000250	lanosterol synthase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0005017	platelet-derived growth factor-activated receptor activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0004055	argininosuccinate synthase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0004051	arachidonate 5-lipoxygenase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0004059	aralkylamine N-acetyltransferase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0038049	transcription factor activity, ligand-activated RNA polymerase II transcription factor binding	MF
1	1	2.32129956088	-	2.00e-01	GO:1904455	ubiquitin-specific protease activity involved in negative regulation of ERAD pathway	MF
1	1	2.32129956088	-	2.00e-01	GO:0033676	double-stranded DNA-dependent ATPase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0001005	transcription factor activity, RNA polymerase III type 1 promoter sequence-specific binding, TFIIIB recruiting	MF
1	1	2.32129956088	-	2.00e-01	GO:0030272	5-formyltetrahydrofolate cyclo-ligase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0035538	carbohydrate response element binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0050462	N-acetylneuraminate synthase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0036326	VEGF-A-activated receptor activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0036327	VEGF-B-activated receptor activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0008448	N-acetylglucosamine-6-phosphate deacetylase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0034211	GTP-dependent protein kinase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0050429	calcium-dependent phospholipase C activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0047444	N-acylneuraminate-9-phosphate synthase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0047442	17-alpha-hydroxyprogesterone aldolase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0030899	calcium-dependent ATPase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0031859	platelet activating factor receptor binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0031851	kappa-type opioid receptor binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0015929	hexosaminidase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0004363	glutathione synthase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0052725	inositol-1,3,4-trisphosphate 6-kinase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0052726	inositol-1,3,4-trisphosphate 5-kinase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0008817	cob(I)yrinic acid a,c-diamide adenosyltransferase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0008812	choline dehydrogenase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0030616	transforming growth factor beta receptor, common-partner cytoplasmic mediator activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0102390	mycophenolic acid acyl-glucuronide esterase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0061656	SUMO conjugating enzyme activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0051916	granulocyte colony-stimulating factor binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0043739	G/U mismatch-specific uracil-DNA glycosylase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0031812	P2Y1 nucleotide receptor binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0050780	dopamine receptor binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0036458	hepatocyte growth factor binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0033867	Fas-activated serine/threonine kinase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0003884	D-amino-acid oxidase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0005133	interferon-gamma receptor binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0001133	RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0004643	phosphoribosylaminoimidazolecarboxamide formyltransferase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0034545	fumarylpyruvate hydrolase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:1904399	heparan sulfate binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0086079	gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling	MF
1	1	2.32129956088	-	2.00e-01	GO:0086078	gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling	MF
1	1	2.32129956088	-	2.00e-01	GO:0086076	gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling	MF
1	1	2.32129956088	-	2.00e-01	GO:0099038	ceramide-translocating ATPase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0035401	histone kinase activity (H3-Y41 specific)	MF
1	1	2.32129956088	-	2.00e-01	GO:0071820	N-box binding	MF
1	1	2.32129956088	-	2.00e-01	GO:1990439	MAP kinase serine/threonine phosphatase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0031896	V2 vasopressin receptor binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0030554	adenyl nucleotide binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0001846	opsonin binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0003937	IMP cyclohydrolase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0030184	nitric oxide transmembrane transporter activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0005018	platelet-derived growth factor alpha-receptor activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0038024	cargo receptor activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0000016	lactase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0004728	signal transducer, downstream of receptor, with protein tyrosine phosphatase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0019970	interleukin-11 binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0070320	inward rectifier potassium channel inhibitor activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0052666	tRNA (cytosine-2'-O-)-methyltransferase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0017174	glycine N-methyltransferase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0017172	cysteine dioxygenase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0005009	insulin-activated receptor activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0005008	hepatocyte growth factor-activated receptor activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0090624	endoribonuclease activity, cleaving miRNA-paired mRNA	MF
1	1	2.32129956088	-	2.00e-01	GO:0000990	transcription factor activity, core RNA polymerase binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0009020	tRNA (guanosine-2'-O-)-methyltransferase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0008995	ribonuclease E activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0004883	glucocorticoid receptor activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0004955	prostaglandin receptor activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0035730	S-nitrosoglutathione binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0035731	dinitrosyl-iron complex binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0051427	hormone receptor binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0031370	eukaryotic initiation factor 4G binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0005527	macrolide binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0060001	minus-end directed microfilament motor activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0070975	FHA domain binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0070974	POU domain binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0070976	TIR domain binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0030226	apolipoprotein receptor activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0036332	placental growth factor-activated receptor activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0070012	oligopeptidase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0042131	thiamine phosphate phosphatase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0047325	inositol tetrakisphosphate 1-kinase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0036524	protein deglycase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0086087	voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization	MF
1	1	2.32129956088	-	2.00e-01	GO:0042497	triacyl lipopeptide binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0015126	canalicular bile acid transmembrane transporter activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0030412	formimidoyltetrahydrofolate cyclodeaminase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0052830	inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0052831	inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0004807	triose-phosphate isomerase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0031687	A2A adenosine receptor binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0036487	nitric-oxide synthase inhibitor activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0032561	guanyl ribonucleotide binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0050038	L-xylulose reductase (NADP+) activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0038186	lithocholic acid receptor activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0016430	tRNA (adenine-N6-)-methyltransferase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0001727	lipid kinase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0036143	kringle domain binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0018773	acetylpyruvate hydrolase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0008721	D-serine ammonia-lyase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0048040	UDP-glucuronate decarboxylase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0016964	alpha-2 macroglobulin receptor activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0043423	3-phosphoinositide-dependent protein kinase binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0035605	peptidyl-cysteine S-nitrosylase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0017045	corticotropin-releasing hormone activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0008554	sodium-exporting ATPase activity, phosphorylative mechanism	MF
1	1	2.32129956088	-	2.00e-01	GO:0002153	steroid receptor RNA activator RNA binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0044377	RNA polymerase II core promoter proximal region sequence-specific DNA binding, bending	MF
1	1	2.32129956088	-	2.00e-01	GO:0004751	ribose-5-phosphate isomerase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0070551	endoribonuclease activity, cleaving siRNA-paired mRNA	MF
1	1	2.32129956088	-	2.00e-01	GO:0004921	interleukin-11 receptor activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0046817	chemokine receptor antagonist activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0010858	calcium-dependent protein kinase regulator activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0010857	calcium-dependent protein kinase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0102773	dihydroceramide kinase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0004590	orotidine-5'-phosphate decarboxylase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0004595	pantetheine-phosphate adenylyltransferase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0050379	UDP-glucuronate 5'-epimerase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0031741	type B gastrin/cholecystokinin receptor binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0098973	structural constituent of postsynaptic actin cytoskeleton	MF
1	1	2.32129956088	-	2.00e-01	GO:0070773	protein-N-terminal glutamine amidohydrolase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0015054	gastrin receptor activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0031249	denatured protein binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0001069	regulatory region RNA binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0047621	acylpyruvate hydrolase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0005030	neurotrophin receptor activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0003860	3-hydroxyisobutyryl-CoA hydrolase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0004511	tyrosine 3-monooxygenase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:1902121	lithocholic acid binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0015091	ferric iron transmembrane transporter activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0005260	intracellular ATPase-gated chloride channel activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0038021	leptin receptor activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0047464	heparosan-N-sulfate-glucuronate 5-epimerase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0017082	mineralocorticoid receptor activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0086090	voltage-gated potassium channel activity involved in SA node cell action potential repolarization	MF
1	1	2.32129956088	-	2.00e-01	GO:0008127	quercetin 2,3-dioxygenase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:1990955	G-rich single-stranded DNA binding	MF
1	1	2.32129956088	-	2.00e-01	GO:0030407	formimidoyltransferase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0030409	glutamate formimidoyltransferase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0052825	inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0047963	glycine N-choloyltransferase activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0036470	tyrosine 3-monooxygenase activator activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0036478	L-dopa decarboxylase activator activity	MF
1	1	2.32129956088	-	2.00e-01	GO:0036479	peroxidase inhibitor activity	MF
1	1	2.32129956088	-	2.00e-01	GO:1902098	calcitriol binding	MF
12	13	2.20582234346	-	4.28e-08	GO:0060334	regulation of interferon-gamma-mediated signaling pathway	BP
11	12	2.19576867879	-	1.99e-07	GO:0097284	hepatocyte apoptotic process	BP
21	23	2.1900550276	-	3.31e-13	GO:0051439	regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle	BP
10	11	2.18379603713	-	9.14e-07	GO:0060544	regulation of necroptotic process	BP
10	11	2.18379603713	-	9.14e-07	GO:0043560	insulin receptor substrate binding	MF
10	11	2.18379603713	-	9.14e-07	GO:0070411	I-SMAD binding	MF
28	31	2.17445817255	-	5.78e-17	GO:0042059	negative regulation of epidermal growth factor receptor signaling pathway	BP
42	47	2.15902813198	-	2.60e-26	GO:0038083	peptidyl-tyrosine autophosphorylation	BP
8	9	2.15137455944	-	1.89e-05	GO:0030071	regulation of mitotic metaphase/anaphase transition	BP
8	9	2.15137455944	-	1.89e-05	GO:0010863	positive regulation of phospholipase C activity	BP
31	35	2.14621285432	-	4.24e-18	GO:0001784	phosphotyrosine residue binding	MF
7	8	2.12865448294	-	1.28e-05	GO:0060020	Bergmann glial cell differentiation	BP
7	8	2.12865448294	-	8.43e-05	GO:2000587	negative regulation of platelet-derived growth factor receptor-beta signaling pathway	BP
7	8	2.12865448294	-	8.43e-05	GO:0007172	signal complex assembly	BP
7	8	2.12865448294	-	8.43e-05	GO:0060396	growth hormone receptor signaling pathway	BP
7	8	2.12865448294	-	8.43e-05	GO:0032872	regulation of stress-activated MAPK cascade	BP
7	8	2.12865448294	-	8.43e-05	GO:1990000	amyloid fibril formation	BP
14	16	2.12865448294	-	1.96e-09	GO:0005159	insulin-like growth factor receptor binding	MF
6	7	2.09890713954	-	3.71e-04	GO:0046826	negative regulation of protein export from nucleus	BP
6	7	2.09890713954	-	3.71e-04	GO:0051988	regulation of attachment of spindle microtubules to kinetochore	BP
6	7	2.09890713954	-	3.71e-04	GO:2000601	positive regulation of Arp2/3 complex-mediated actin nucleation	BP
11	13	2.08029146137	-	1.99e-07	GO:2001241	positive regulation of extrinsic apoptotic signaling pathway in absence of ligand	BP
32	38	2.07337204743	-	9.45e-19	GO:0038128	ERBB2 signaling pathway	BP
5	6	2.05826515504	-	3.20e-04	GO:0030579	ubiquitin-dependent SMAD protein catabolic process	BP
5	6	2.05826515504	-	1.60e-03	GO:0038202	TORC1 signaling	BP
5	6	2.05826515504	-	1.60e-03	GO:0060789	hair follicle placode formation	BP
5	6	2.05826515504	-	1.60e-03	GO:1903799	negative regulation of production of miRNAs involved in gene silencing by miRNA	BP
5	6	2.05826515504	-	1.60e-03	GO:0036289	peptidyl-serine autophosphorylation	BP
5	6	2.05826515504	-	1.60e-03	GO:0033210	leptin-mediated signaling pathway	BP
5	6	2.05826515504	-	1.60e-03	GO:0007182	common-partner SMAD protein phosphorylation	BP
5	6	2.05826515504	-	1.60e-03	GO:0035020	regulation of Rac protein signal transduction	BP
5	6	2.05826515504	-	1.60e-03	GO:0060440	trachea formation	BP
5	6	2.05826515504	-	1.60e-03	GO:0097527	necroptotic signaling pathway	BP
5	6	2.05826515504	-	1.60e-03	GO:0005168	neurotrophin TRKA receptor binding	MF
5	6	2.05826515504	-	1.60e-03	GO:0010997	anaphase-promoting complex binding	MF
12	15	1.99937146599	-	9.99e-07	GO:0005123	death receptor binding	MF
4	5	1.99937146599	-	1.60e-03	GO:1900180	regulation of protein localization to nucleus	BP
4	5	1.99937146599	-	1.60e-03	GO:0060509	Type I pneumocyte differentiation	BP
4	5	1.99937146599	-	1.60e-03	GO:0002318	myeloid progenitor cell differentiation	BP
4	5	1.99937146599	-	6.72e-03	GO:0010715	regulation of extracellular matrix disassembly	BP
4	5	1.99937146599	-	6.72e-03	GO:0034134	toll-like receptor 2 signaling pathway	BP
4	5	1.99937146599	-	6.72e-03	GO:0070345	negative regulation of fat cell proliferation	BP
4	5	1.99937146599	-	6.72e-03	GO:0042306	regulation of protein import into nucleus	BP
4	5	1.99937146599	-	6.72e-03	GO:0050882	voluntary musculoskeletal movement	BP
4	5	1.99937146599	-	6.72e-03	GO:0048639	positive regulation of developmental growth	BP
4	5	1.99937146599	-	6.72e-03	GO:0050847	progesterone receptor signaling pathway	BP
4	5	1.99937146599	-	6.72e-03	GO:0040020	regulation of meiotic nuclear division	BP
4	5	1.99937146599	-	6.72e-03	GO:0019530	taurine metabolic process	BP
4	5	1.99937146599	-	6.72e-03	GO:0002634	regulation of germinal center formation	BP
4	5	1.99937146599	-	6.72e-03	GO:0055062	phosphate ion homeostasis	BP
4	5	1.99937146599	-	6.72e-03	GO:0051534	negative regulation of NFAT protein import into nucleus	BP
4	5	1.99937146599	-	6.72e-03	GO:0070842	aggresome assembly	BP
4	5	1.99937146599	-	6.72e-03	GO:0090240	positive regulation of histone H4 acetylation	BP
4	5	1.99937146599	-	6.72e-03	GO:0002821	positive regulation of adaptive immune response	BP
4	5	1.99937146599	-	6.72e-03	GO:1904885	beta-catenin destruction complex assembly	BP
4	5	1.99937146599	-	6.72e-03	GO:0051220	cytoplasmic sequestering of protein	BP
4	5	1.99937146599	-	6.72e-03	GO:0034121	regulation of toll-like receptor signaling pathway	BP
4	5	1.99937146599	-	6.72e-03	GO:0021861	forebrain radial glial cell differentiation	BP
4	5	1.99937146599	-	6.72e-03	GO:0003161	cardiac conduction system development	BP
16	20	1.99937146599	-	1.35e-08	GO:0043548	phosphatidylinositol 3-kinase binding	MF
8	10	1.99937146599	-	7.76e-05	GO:0045295	gamma-catenin binding	MF
4	5	1.99937146599	-	1.60e-03	GO:0005007	fibroblast growth factor-activated receptor activity	MF
4	5	1.99937146599	-	6.72e-03	GO:0044388	small protein activating enzyme binding	MF
4	5	1.99937146599	-	6.72e-03	GO:0031802	type 5 metabotropic glutamate receptor binding	MF
4	5	1.99937146599	-	6.72e-03	GO:0035004	phosphatidylinositol 3-kinase activity	MF
4	5	1.99937146599	-	6.72e-03	GO:0030618	transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity	MF
4	5	1.99937146599	-	6.72e-03	GO:0043426	MRF binding	MF
4	5	1.99937146599	-	6.72e-03	GO:0032407	MutSalpha complex binding	MF
4	5	1.99937146599	-	6.72e-03	GO:0032405	MutLalpha complex binding	MF
4	5	1.99937146599	-	6.72e-03	GO:0030284	estrogen receptor activity	MF
15	19	1.98026264304	-	5.43e-08	GO:0070064	proline-rich region binding	MF
7	9	1.95872948149	-	3.13e-04	GO:0010944	negative regulation of transcription by competitive promoter binding	BP
7	9	1.95872948149	-	3.13e-04	GO:0033762	response to glucagon	BP
17	22	1.94933078349	-	1.18e-08	GO:0035257	nuclear hormone receptor binding	MF
10	13	1.94278793762	-	1.59e-05	GO:0097296	activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway	BP
24	32	1.9062620616	-	3.03e-11	GO:0010803	regulation of tumor necrosis factor-mediated signaling pathway	BP
18	24	1.9062620616	-	9.73e-09	GO:0051403	stress-activated MAPK cascade	BP
12	16	1.9062620616	-	3.26e-06	GO:0006978	DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator	BP
6	8	1.9062620616	-	3.71e-04	GO:1901017	negative regulation of potassium ion transmembrane transporter activity	BP
6	8	1.9062620616	-	3.71e-04	GO:0007183	SMAD protein complex assembly	BP
6	8	1.9062620616	-	1.23e-03	GO:0071550	death-inducing signaling complex assembly	BP
6	8	1.9062620616	-	1.23e-03	GO:0048762	mesenchymal cell differentiation	BP
6	8	1.9062620616	-	1.23e-03	GO:0034629	cellular protein complex localization	BP
6	8	1.9062620616	-	1.23e-03	GO:0006975	DNA damage induced protein phosphorylation	BP
6	8	1.9062620616	-	1.23e-03	GO:1903265	positive regulation of tumor necrosis factor-mediated signaling pathway	BP
6	8	1.9062620616	-	1.23e-03	GO:0010544	negative regulation of platelet activation	BP
6	8	1.9062620616	-	1.23e-03	GO:0043297	apical junction assembly	BP
3	4	1.9062620616	-	8.00e-03	GO:1903243	negative regulation of cardiac muscle hypertrophy in response to stress	BP
3	4	1.9062620616	-	8.00e-03	GO:0048608	reproductive structure development	BP
3	4	1.9062620616	-	8.00e-03	GO:0071466	cellular response to xenobiotic stimulus	BP
3	4	1.9062620616	-	8.00e-03	GO:0070317	negative regulation of G0 to G1 transition	BP
3	4	1.9062620616	-	8.00e-03	GO:2000757	negative regulation of peptidyl-lysine acetylation	BP
3	4	1.9062620616	-	8.00e-03	GO:2000048	negative regulation of cell-cell adhesion mediated by cadherin	BP
3	4	1.9062620616	-	8.00e-03	GO:0033031	positive regulation of neutrophil apoptotic process	BP
3	4	1.9062620616	-	8.00e-03	GO:1902177	positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway	BP
3	4	1.9062620616	-	8.00e-03	GO:1904058	positive regulation of sensory perception of pain	BP
3	4	1.9062620616	-	8.00e-03	GO:0043549	regulation of kinase activity	BP
3	4	1.9062620616	-	8.00e-03	GO:1900127	positive regulation of hyaluronan biosynthetic process	BP
3	4	1.9062620616	-	2.72e-02	GO:0090400	stress-induced premature senescence	BP
3	4	1.9062620616	-	2.72e-02	GO:0071801	regulation of podosome assembly	BP
3	4	1.9062620616	-	2.72e-02	GO:0038110	interleukin-2-mediated signaling pathway	BP
3	4	1.9062620616	-	2.72e-02	GO:0097411	hypoxia-inducible factor-1alpha signaling pathway	BP
3	4	1.9062620616	-	2.72e-02	GO:0032925	regulation of activin receptor signaling pathway	BP
3	4	1.9062620616	-	2.72e-02	GO:0016240	autophagosome membrane docking	BP
3	4	1.9062620616	-	2.72e-02	GO:0060665	regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling	BP
3	4	1.9062620616	-	2.72e-02	GO:1901203	positive regulation of extracellular matrix assembly	BP
3	4	1.9062620616	-	2.72e-02	GO:1902115	regulation of organelle assembly	BP
3	4	1.9062620616	-	2.72e-02	GO:0014042	positive regulation of neuron maturation	BP
3	4	1.9062620616	-	2.72e-02	GO:0042345	regulation of NF-kappaB import into nucleus	BP
3	4	1.9062620616	-	2.72e-02	GO:0032507	maintenance of protein location in cell	BP
3	4	1.9062620616	-	2.72e-02	GO:0097300	programmed necrotic cell death	BP
3	4	1.9062620616	-	2.72e-02	GO:0045415	negative regulation of interleukin-8 biosynthetic process	BP
3	4	1.9062620616	-	2.72e-02	GO:0098779	positive regulation of mitophagy in response to mitochondrial depolarization	BP
3	4	1.9062620616	-	2.72e-02	GO:1903829	positive regulation of cellular protein localization	BP
3	4	1.9062620616	-	2.72e-02	GO:0090312	positive regulation of protein deacetylation	BP
3	4	1.9062620616	-	2.72e-02	GO:2001168	positive regulation of histone H2B ubiquitination	BP
3	4	1.9062620616	-	2.72e-02	GO:0002328	pro-B cell differentiation	BP
3	4	1.9062620616	-	2.72e-02	GO:0002326	B cell lineage commitment	BP
3	4	1.9062620616	-	2.72e-02	GO:0060336	negative regulation of interferon-gamma-mediated signaling pathway	BP
3	4	1.9062620616	-	2.72e-02	GO:0007258	JUN phosphorylation	BP
3	4	1.9062620616	-	2.72e-02	GO:0035087	siRNA loading onto RISC involved in RNA interference	BP
3	4	1.9062620616	-	2.72e-02	GO:0003104	positive regulation of glomerular filtration	BP
3	4	1.9062620616	-	2.72e-02	GO:2000491	positive regulation of hepatic stellate cell activation	BP
3	4	1.9062620616	-	2.72e-02	GO:0018393	internal peptidyl-lysine acetylation	BP
3	4	1.9062620616	-	2.72e-02	GO:1990182	exosomal secretion	BP
3	4	1.9062620616	-	2.72e-02	GO:0016447	somatic recombination of immunoglobulin gene segments	BP
3	4	1.9062620616	-	2.72e-02	GO:0090324	negative regulation of oxidative phosphorylation	BP
3	4	1.9062620616	-	2.72e-02	GO:0051599	response to hydrostatic pressure	BP
3	4	1.9062620616	-	2.72e-02	GO:0051835	positive regulation of synapse structural plasticity	BP
3	4	1.9062620616	-	2.72e-02	GO:0030950	establishment or maintenance of actin cytoskeleton polarity	BP
3	4	1.9062620616	-	2.72e-02	GO:1904781	positive regulation of protein localization to centrosome	BP
3	4	1.9062620616	-	2.72e-02	GO:0051660	establishment of centrosome localization	BP
3	4	1.9062620616	-	2.72e-02	GO:0061419	positive regulation of transcription from RNA polymerase II promoter in response to hypoxia	BP
3	4	1.9062620616	-	2.72e-02	GO:0070885	negative regulation of calcineurin-NFAT signaling cascade	BP
3	4	1.9062620616	-	2.72e-02	GO:0051048	negative regulation of secretion	BP
3	4	1.9062620616	-	2.72e-02	GO:0070294	renal sodium ion absorption	BP
3	4	1.9062620616	-	2.72e-02	GO:0046449	creatinine metabolic process	BP
3	4	1.9062620616	-	2.72e-02	GO:0035404	histone-serine phosphorylation	BP
3	4	1.9062620616	-	2.72e-02	GO:0005981	regulation of glycogen catabolic process	BP
3	4	1.9062620616	-	2.72e-02	GO:0060430	lung saccule development	BP
3	4	1.9062620616	-	2.72e-02	GO:0003186	tricuspid valve morphogenesis	BP
3	4	1.9062620616	-	2.72e-02	GO:0006573	valine metabolic process	BP
3	4	1.9062620616	-	2.72e-02	GO:0002051	osteoblast fate commitment	BP
3	4	1.9062620616	-	2.72e-02	GO:1902459	positive regulation of stem cell population maintenance	BP
3	4	1.9062620616	-	2.72e-02	GO:0042490	mechanoreceptor differentiation	BP
3	4	1.9062620616	-	2.72e-02	GO:0033686	positive regulation of luteinizing hormone secretion	BP
3	4	1.9062620616	-	2.72e-02	GO:0010957	negative regulation of vitamin D biosynthetic process	BP
3	4	1.9062620616	-	2.72e-02	GO:0014878	response to electrical stimulus involved in regulation of muscle adaptation	BP
3	4	1.9062620616	-	2.72e-02	GO:0003253	cardiac neural crest cell migration involved in outflow tract morphogenesis	BP
3	4	1.9062620616	-	2.72e-02	GO:0097167	circadian regulation of translation	BP
3	4	1.9062620616	-	2.72e-02	GO:0045472	response to ether	BP
3	4	1.9062620616	-	2.72e-02	GO:0032648	regulation of interferon-beta production	BP
3	4	1.9062620616	-	2.72e-02	GO:2001236	regulation of extrinsic apoptotic signaling pathway	BP
3	4	1.9062620616	-	2.72e-02	GO:0006924	activation-induced cell death of T cells	BP
3	4	1.9062620616	-	2.72e-02	GO:0090063	positive regulation of microtubule nucleation	BP
3	4	1.9062620616	-	2.72e-02	GO:0038108	negative regulation of appetite by leptin-mediated signaling pathway	BP
3	4	1.9062620616	-	2.72e-02	GO:0033158	regulation of protein import into nucleus, translocation	BP
3	4	1.9062620616	-	2.72e-02	GO:1901985	positive regulation of protein acetylation	BP
3	4	1.9062620616	-	2.72e-02	GO:0097201	negative regulation of transcription from RNA polymerase II promoter in response to stress	BP
3	4	1.9062620616	-	2.72e-02	GO:1904431	positive regulation of t-circle formation	BP
3	4	1.9062620616	-	2.72e-02	GO:1990869	cellular response to chemokine	BP
3	4	1.9062620616	-	2.72e-02	GO:1990086	lens fiber cell apoptotic process	BP
3	4	1.9062620616	-	2.72e-02	GO:0038028	insulin receptor signaling pathway via phosphatidylinositol 3-kinase	BP
3	4	1.9062620616	-	2.72e-02	GO:0006990	positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response	BP
3	4	1.9062620616	-	2.72e-02	GO:0097350	neutrophil clearance	BP
3	4	1.9062620616	-	2.72e-02	GO:0021955	central nervous system neuron axonogenesis	BP
3	4	1.9062620616	-	2.72e-02	GO:0032909	regulation of transforming growth factor beta2 production	BP
6	8	1.9062620616	-	1.23e-03	GO:0070878	primary miRNA binding	MF
3	4	1.9062620616	-	8.00e-03	GO:0005176	ErbB-2 class receptor binding	MF
3	4	1.9062620616	-	2.72e-02	GO:0048408	epidermal growth factor binding	MF
3	4	1.9062620616	-	2.72e-02	GO:0035173	histone kinase activity	MF
3	4	1.9062620616	-	2.72e-02	GO:0038085	vascular endothelial growth factor binding	MF
3	4	1.9062620616	-	2.72e-02	GO:0035877	death effector domain binding	MF
3	4	1.9062620616	-	2.72e-02	GO:0034617	tetrahydrobiopterin binding	MF
3	4	1.9062620616	-	2.72e-02	GO:0045159	myosin II binding	MF
3	4	1.9062620616	-	2.72e-02	GO:0004698	calcium-dependent protein kinase C activity	MF
3	4	1.9062620616	-	2.72e-02	GO:0061575	cyclin-dependent protein serine/threonine kinase activator activity	MF
3	4	1.9062620616	-	2.72e-02	GO:0051022	Rho GDP-dissociation inhibitor binding	MF
3	4	1.9062620616	-	2.72e-02	GO:0031698	beta-2 adrenergic receptor binding	MF
15	20	1.9062620616	-	1.77e-07	GO:1902895	positive regulation of pri-miRNA transcription from RNA polymerase II promoter	BP
20	27	1.8883401536	-	2.05e-09	GO:0045931	positive regulation of mitotic cell cycle	BP
11	15	1.87384058391	-	1.24e-05	GO:0031929	TOR signaling	BP
11	15	1.87384058391	-	1.24e-05	GO:0048011	neurotrophin TRK receptor signaling pathway	BP
8	11	1.86186794224	-	7.76e-05	GO:0045792	negative regulation of cell size	BP
8	11	1.86186794224	-	2.34e-04	GO:0033628	regulation of cell adhesion mediated by integrin	BP
8	11	1.86186794224	-	2.34e-04	GO:0043276	anoikis	BP
8	11	1.86186794224	-	2.34e-04	GO:0090136	epithelial cell-cell adhesion	BP
8	11	1.86186794224	-	2.34e-04	GO:0045667	regulation of osteoblast differentiation	BP
8	11	1.86186794224	-	2.34e-04	GO:0004707	MAP kinase activity	MF
8	11	1.86186794224	-	2.34e-04	GO:0031996	thioesterase binding	MF
21	29	1.85563598853	-	5.41e-10	GO:0043552	positive regulation of phosphatidylinositol 3-kinase activity	BP
21	29	1.85563598853	-	1.59e-09	GO:1900740	positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway	BP
46	64	1.84486151693	-	4.68e-20	GO:0019903	protein phosphatase binding	MF
5	7	1.83587273371	-	1.60e-03	GO:2000650	negative regulation of sodium ion transmembrane transporter activity	BP
5	7	1.83587273371	-	1.60e-03	GO:1903077	negative regulation of protein localization to plasma membrane	BP
5	7	1.83587273371	-	1.60e-03	GO:0043620	regulation of DNA-templated transcription in response to stress	BP
5	7	1.83587273371	-	1.60e-03	GO:0060449	bud elongation involved in lung branching	BP
5	7	1.83587273371	-	4.67e-03	GO:2000641	regulation of early endosome to late endosome transport	BP
5	7	1.83587273371	-	4.67e-03	GO:0071499	cellular response to laminar fluid shear stress	BP
5	7	1.83587273371	-	4.67e-03	GO:0099565	chemical synaptic transmission, postsynaptic	BP
5	7	1.83587273371	-	4.67e-03	GO:0001783	B cell apoptotic process	BP
5	7	1.83587273371	-	4.67e-03	GO:0042921	glucocorticoid receptor signaling pathway	BP
5	7	1.83587273371	-	4.67e-03	GO:2000171	negative regulation of dendrite development	BP
5	7	1.83587273371	-	4.67e-03	GO:0043405	regulation of MAP kinase activity	BP
5	7	1.83587273371	-	4.67e-03	GO:1903896	positive regulation of IRE1-mediated unfolded protein response	BP
5	7	1.83587273371	-	4.67e-03	GO:2000347	positive regulation of hepatocyte proliferation	BP
5	7	1.83587273371	-	4.67e-03	GO:0010742	macrophage derived foam cell differentiation	BP
5	7	1.83587273371	-	4.67e-03	GO:0044351	macropinocytosis	BP
5	7	1.83587273371	-	4.67e-03	GO:0031659	positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle	BP
5	7	1.83587273371	-	4.67e-03	GO:0050764	regulation of phagocytosis	BP
5	7	1.83587273371	-	4.67e-03	GO:2000144	positive regulation of DNA-templated transcription, initiation	BP
20	28	1.83587273371	-	5.81e-09	GO:0046875	ephrin receptor binding	MF
20	28	1.83587273371	-	5.81e-09	GO:0004714	transmembrane receptor protein tyrosine kinase activity	MF
10	14	1.83587273371	-	4.57e-05	GO:0031434	mitogen-activated protein kinase kinase binding	MF
5	7	1.83587273371	-	1.60e-03	GO:0035005	1-phosphatidylinositol-4-phosphate 3-kinase activity	MF
5	7	1.83587273371	-	4.67e-03	GO:0019209	kinase activator activity	MF
5	7	1.83587273371	-	4.67e-03	GO:0009931	calcium-dependent protein serine/threonine kinase activity	MF
22	31	1.82653486913	-	1.41e-10	GO:0005158	insulin receptor binding	MF
17	24	1.82379990141	-	1.03e-07	GO:0070423	nucleotide-binding oligomerization domain containing signaling pathway	BP
36	51	1.81879922035	-	3.11e-16	GO:0004715	non-membrane spanning protein tyrosine kinase activity	MF
19	27	1.81433957216	-	7.65e-09	GO:0035329	hippo signaling	BP
7	10	1.80672638805	-	3.13e-04	GO:0042532	negative regulation of tyrosine phosphorylation of STAT protein	BP
7	10	1.80672638805	-	3.13e-04	GO:0048715	negative regulation of oligodendrocyte differentiation	BP
7	10	1.80672638805	-	8.63e-04	GO:0031571	mitotic G1 DNA damage checkpoint	BP
7	10	1.80672638805	-	8.63e-04	GO:1902237	positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway	BP
7	10	1.80672638805	-	8.63e-04	GO:0044320	cellular response to leptin stimulus	BP
7	10	1.80672638805	-	8.63e-04	GO:0016572	histone phosphorylation	BP
7	10	1.80672638805	-	8.63e-04	GO:0048156	tau protein binding	MF
7	10	1.80672638805	-	8.63e-04	GO:0033558	protein deacetylase activity	MF
9	13	1.79078484418	-	1.65e-04	GO:1904668	positive regulation of ubiquitin protein ligase activity	BP
9	13	1.79078484418	-	1.65e-04	GO:2000573	positive regulation of DNA biosynthetic process	BP
11	16	1.78073117951	-	1.24e-05	GO:0071732	cellular response to nitric oxide	BP
11	16	1.78073117951	-	3.23e-05	GO:0046328	regulation of JNK cascade	BP
11	16	1.78073117951	-	3.23e-05	GO:0031396	regulation of protein ubiquitination	BP
11	16	1.78073117951	-	4.03e-06	GO:0019789	SUMO transferase activity	MF
11	16	1.78073117951	-	3.23e-05	GO:0005001	transmembrane receptor protein tyrosine phosphatase activity	MF
13	19	1.77381176558	-	2.49e-06	GO:0046827	positive regulation of protein export from nucleus	BP
13	19	1.77381176558	-	2.49e-06	GO:0043153	entrainment of circadian clock by photoperiod	BP
39	57	1.77381176558	-	1.57e-16	GO:0005070	SH3/SH2 adaptor activity	MF
17	25	1.76490621235	-	1.03e-07	GO:0071889	14-3-3 protein binding	MF
27	40	1.75425896815	-	1.71e-12	GO:0071902	positive regulation of protein serine/threonine kinase activity	BP
20	30	1.73633706016	-	1.52e-08	GO:0046627	negative regulation of insulin receptor signaling pathway	BP
10	15	1.73633706016	-	4.57e-05	GO:0043162	ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway	BP
8	12	1.73633706016	-	5.79e-04	GO:0043149	stress fiber assembly	BP
8	12	1.73633706016	-	5.79e-04	GO:0090656	t-circle formation	BP
6	9	1.73633706016	-	1.23e-03	GO:0036500	ATF6-mediated unfolded protein response	BP
6	9	1.73633706016	-	1.23e-03	GO:1990314	cellular response to insulin-like growth factor stimulus	BP
6	9	1.73633706016	-	1.23e-03	GO:0090073	positive regulation of protein homodimerization activity	BP
6	9	1.73633706016	-	1.23e-03	GO:0042754	negative regulation of circadian rhythm	BP
6	9	1.73633706016	-	1.23e-03	GO:0032835	glomerulus development	BP
4	6	1.73633706016	-	1.60e-03	GO:0045910	negative regulation of DNA recombination	BP
4	6	1.73633706016	-	1.60e-03	GO:0007144	female meiosis I	BP
6	9	1.73633706016	-	3.06e-03	GO:0051146	striated muscle cell differentiation	BP
6	9	1.73633706016	-	3.06e-03	GO:1903827	regulation of cellular protein localization	BP
6	9	1.73633706016	-	3.06e-03	GO:0043589	skin morphogenesis	BP
6	9	1.73633706016	-	3.06e-03	GO:0034333	adherens junction assembly	BP
6	9	1.73633706016	-	3.06e-03	GO:0043497	regulation of protein heterodimerization activity	BP
4	6	1.73633706016	-	6.72e-03	GO:0071287	cellular response to manganese ion	BP
4	6	1.73633706016	-	6.72e-03	GO:1904385	cellular response to angiotensin	BP
4	6	1.73633706016	-	1.70e-02	GO:0046825	regulation of protein export from nucleus	BP
4	6	1.73633706016	-	1.70e-02	GO:2001014	regulation of skeletal muscle cell differentiation	BP
4	6	1.73633706016	-	1.70e-02	GO:0000423	mitophagy	BP
4	6	1.73633706016	-	1.70e-02	GO:0051101	regulation of DNA binding	BP
4	6	1.73633706016	-	1.70e-02	GO:1900744	regulation of p38MAPK cascade	BP
4	6	1.73633706016	-	1.70e-02	GO:0090166	Golgi disassembly	BP
4	6	1.73633706016	-	1.70e-02	GO:0036003	positive regulation of transcription from RNA polymerase II promoter in response to stress	BP
4	6	1.73633706016	-	1.70e-02	GO:0034620	cellular response to unfolded protein	BP
4	6	1.73633706016	-	1.70e-02	GO:0032025	response to cobalt ion	BP
4	6	1.73633706016	-	1.70e-02	GO:0051702	interaction with symbiont	BP
4	6	1.73633706016	-	1.70e-02	GO:0001844	protein insertion into mitochondrial membrane involved in apoptotic signaling pathway	BP
4	6	1.73633706016	-	1.70e-02	GO:0071476	cellular hypotonic response	BP
4	6	1.73633706016	-	1.70e-02	GO:0035897	proteolysis in other organism	BP
4	6	1.73633706016	-	1.70e-02	GO:1901222	regulation of NIK/NF-kappaB signaling	BP
4	6	1.73633706016	-	1.70e-02	GO:0048668	collateral sprouting	BP
4	6	1.73633706016	-	1.70e-02	GO:0051096	positive regulation of helicase activity	BP
4	6	1.73633706016	-	1.70e-02	GO:0051444	negative regulation of ubiquitin-protein transferase activity	BP
2	3	1.73633706016	-	4.00e-02	GO:0042668	auditory receptor cell fate determination	BP
2	3	1.73633706016	-	4.00e-02	GO:0070561	vitamin D receptor signaling pathway	BP
2	3	1.73633706016	-	4.00e-02	GO:1990418	response to insulin-like growth factor stimulus	BP
2	3	1.73633706016	-	4.00e-02	GO:0048732	gland development	BP
2	3	1.73633706016	-	4.00e-02	GO:2000381	negative regulation of mesoderm development	BP
2	3	1.73633706016	-	4.00e-02	GO:0001828	inner cell mass cellular morphogenesis	BP
2	3	1.73633706016	-	4.00e-02	GO:0002803	positive regulation of antibacterial peptide production	BP
2	3	1.73633706016	-	4.00e-02	GO:0010482	regulation of epidermal cell division	BP
2	3	1.73633706016	-	4.00e-02	GO:0060916	mesenchymal cell proliferation involved in lung development	BP
2	3	1.73633706016	-	4.00e-02	GO:0072050	S-shaped body morphogenesis	BP
2	3	1.73633706016	-	4.00e-02	GO:0021847	ventricular zone neuroblast division	BP
2	3	1.73633706016	-	4.00e-02	GO:1990542	mitochondrial transmembrane transport	BP
2	3	1.73633706016	-	4.00e-02	GO:0010956	negative regulation of calcidiol 1-monooxygenase activity	BP
2	3	1.73633706016	-	4.00e-02	GO:0002679	respiratory burst involved in defense response	BP
2	3	1.73633706016	-	4.00e-02	GO:0072044	collecting duct development	BP
2	3	1.73633706016	-	4.00e-02	GO:0001547	antral ovarian follicle growth	BP
2	3	1.73633706016	-	4.00e-02	GO:0010980	positive regulation of vitamin D 24-hydroxylase activity	BP
2	3	1.73633706016	-	4.00e-02	GO:0021544	subpallium development	BP
2	3	1.73633706016	-	4.00e-02	GO:0034502	protein localization to chromosome	BP
2	3	1.73633706016	-	4.00e-02	GO:0010909	positive regulation of heparan sulfate proteoglycan biosynthetic process	BP
2	3	1.73633706016	-	4.00e-02	GO:0021502	neural fold elevation formation	BP
2	3	1.73633706016	-	4.00e-02	GO:0051668	localization within membrane	BP
2	3	1.73633706016	-	4.00e-02	GO:0032929	negative regulation of superoxide anion generation	BP
2	3	1.73633706016	-	4.00e-02	GO:0033326	cerebrospinal fluid secretion	BP
2	3	1.73633706016	-	4.00e-02	GO:1900042	positive regulation of interleukin-2 secretion	BP
2	3	1.73633706016	-	4.00e-02	GO:0060769	positive regulation of epithelial cell proliferation involved in prostate gland development	BP
2	3	1.73633706016	-	4.00e-02	GO:0023016	signal transduction by trans-phosphorylation	BP
2	3	1.73633706016	-	4.00e-02	GO:0034766	negative regulation of ion transmembrane transport	BP
2	3	1.73633706016	-	4.00e-02	GO:1904383	response to sodium phosphate	BP
2	3	1.73633706016	-	4.00e-02	GO:0072049	comma-shaped body morphogenesis	BP
2	3	1.73633706016	-	4.00e-02	GO:1903215	negative regulation of protein targeting to mitochondrion	BP
2	3	1.73633706016	-	4.00e-02	GO:0071930	negative regulation of transcription involved in G1/S transition of mitotic cell cycle	BP
2	3	1.73633706016	-	4.00e-02	GO:0043369	CD4-positive or CD8-positive, alpha-beta T cell lineage commitment	BP
2	3	1.73633706016	-	4.00e-02	GO:0072133	metanephric mesenchyme morphogenesis	BP
2	3	1.73633706016	-	4.00e-02	GO:0072136	metanephric mesenchymal cell proliferation involved in metanephros development	BP
2	3	1.73633706016	-	4.00e-02	GO:1904339	negative regulation of dopaminergic neuron differentiation	BP
2	3	1.73633706016	-	4.00e-02	GO:0007060	male meiosis chromosome segregation	BP
2	3	1.73633706016	-	4.00e-02	GO:0071314	cellular response to cocaine	BP
2	3	1.73633706016	-	4.00e-02	GO:0060523	prostate epithelial cord elongation	BP
2	3	1.73633706016	-	1.04e-01	GO:1903984	positive regulation of TRAIL-activated apoptotic signaling pathway	BP
2	3	1.73633706016	-	1.04e-01	GO:0043415	positive regulation of skeletal muscle tissue regeneration	BP
2	3	1.73633706016	-	1.04e-01	GO:0002553	histamine secretion by mast cell	BP
2	3	1.73633706016	-	1.04e-01	GO:0072125	negative regulation of glomerular mesangial cell proliferation	BP
2	3	1.73633706016	-	1.04e-01	GO:0044346	fibroblast apoptotic process	BP
2	3	1.73633706016	-	1.04e-01	GO:0006499	N-terminal protein myristoylation	BP
2	3	1.73633706016	-	1.04e-01	GO:0001773	myeloid dendritic cell activation	BP
2	3	1.73633706016	-	1.04e-01	GO:1903003	positive regulation of protein deubiquitination	BP
2	3	1.73633706016	-	1.04e-01	GO:0002513	tolerance induction to self antigen	BP
2	3	1.73633706016	-	1.04e-01	GO:0033144	negative regulation of intracellular steroid hormone receptor signaling pathway	BP
2	3	1.73633706016	-	1.04e-01	GO:0031937	positive regulation of chromatin silencing	BP
2	3	1.73633706016	-	1.04e-01	GO:1900451	positive regulation of glutamate receptor signaling pathway	BP
2	3	1.73633706016	-	1.04e-01	GO:0038091	positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway	BP
2	3	1.73633706016	-	1.04e-01	GO:0046985	positive regulation of hemoglobin biosynthetic process	BP
2	3	1.73633706016	-	1.04e-01	GO:0031587	positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity	BP
2	3	1.73633706016	-	1.04e-01	GO:1903208	negative regulation of hydrogen peroxide-induced neuron death	BP
2	3	1.73633706016	-	1.04e-01	GO:0060453	regulation of gastric acid secretion	BP
2	3	1.73633706016	-	1.04e-01	GO:1902512	positive regulation of apoptotic DNA fragmentation	BP
2	3	1.73633706016	-	1.04e-01	GO:0033590	response to cobalamin	BP
2	3	1.73633706016	-	1.04e-01	GO:0097720	calcineurin-mediated signaling	BP
2	3	1.73633706016	-	1.04e-01	GO:0030241	skeletal muscle myosin thick filament assembly	BP
2	3	1.73633706016	-	1.04e-01	GO:0070602	regulation of centromeric sister chromatid cohesion	BP
2	3	1.73633706016	-	1.04e-01	GO:0055098	response to low-density lipoprotein particle stimulus	BP
2	3	1.73633706016	-	1.04e-01	GO:1901897	regulation of relaxation of cardiac muscle	BP
2	3	1.73633706016	-	1.04e-01	GO:0060745	mammary gland branching involved in pregnancy	BP
2	3	1.73633706016	-	1.04e-01	GO:0060748	tertiary branching involved in mammary gland duct morphogenesis	BP
2	3	1.73633706016	-	1.04e-01	GO:0048936	peripheral nervous system neuron axonogenesis	BP
2	3	1.73633706016	-	1.04e-01	GO:0051612	negative regulation of serotonin uptake	BP
2	3	1.73633706016	-	1.04e-01	GO:0022028	tangential migration from the subventricular zone to the olfactory bulb	BP
2	3	1.73633706016	-	1.04e-01	GO:2000366	positive regulation of STAT protein import into nucleus	BP
2	3	1.73633706016	-	1.04e-01	GO:0021885	forebrain cell migration	BP
2	3	1.73633706016	-	1.04e-01	GO:0010766	negative regulation of sodium ion transport	BP
2	3	1.73633706016	-	1.04e-01	GO:0071899	negative regulation of estrogen receptor binding	BP
2	3	1.73633706016	-	1.04e-01	GO:1903542	negative regulation of exosomal secretion	BP
2	3	1.73633706016	-	1.04e-01	GO:2000172	regulation of branching morphogenesis of a nerve	BP
2	3	1.73633706016	-	1.04e-01	GO:0045604	regulation of epidermal cell differentiation	BP
2	3	1.73633706016	-	1.04e-01	GO:0045608	negative regulation of auditory receptor cell differentiation	BP
2	3	1.73633706016	-	1.04e-01	GO:0072539	T-helper 17 cell differentiation	BP
2	3	1.73633706016	-	1.04e-01	GO:0036462	TRAIL-activated apoptotic signaling pathway	BP
2	3	1.73633706016	-	1.04e-01	GO:0006114	glycerol biosynthetic process	BP
2	3	1.73633706016	-	1.04e-01	GO:1902268	negative regulation of polyamine transmembrane transport	BP
2	3	1.73633706016	-	1.04e-01	GO:0055070	copper ion homeostasis	BP
2	3	1.73633706016	-	1.04e-01	GO:0006354	DNA-templated transcription, elongation	BP
2	3	1.73633706016	-	1.04e-01	GO:0071173	spindle assembly checkpoint	BP
2	3	1.73633706016	-	1.04e-01	GO:0034140	negative regulation of toll-like receptor 3 signaling pathway	BP
2	3	1.73633706016	-	1.04e-01	GO:0050803	regulation of synapse structure or activity	BP
2	3	1.73633706016	-	1.04e-01	GO:0007352	zygotic specification of dorsal/ventral axis	BP
2	3	1.73633706016	-	1.04e-01	GO:0045925	positive regulation of female receptivity	BP
2	3	1.73633706016	-	1.04e-01	GO:0048294	negative regulation of isotype switching to IgE isotypes	BP
2	3	1.73633706016	-	1.04e-01	GO:0035984	cellular response to trichostatin A	BP
2	3	1.73633706016	-	1.04e-01	GO:0010871	negative regulation of receptor biosynthetic process	BP
2	3	1.73633706016	-	1.04e-01	GO:0050849	negative regulation of calcium-mediated signaling	BP
2	3	1.73633706016	-	1.04e-01	GO:0072300	positive regulation of metanephric glomerulus development	BP
2	3	1.73633706016	-	1.04e-01	GO:0090043	regulation of tubulin deacetylation	BP
2	3	1.73633706016	-	1.04e-01	GO:0038162	erythropoietin-mediated signaling pathway	BP
2	3	1.73633706016	-	1.04e-01	GO:0060379	cardiac muscle cell myoblast differentiation	BP
2	3	1.73633706016	-	1.04e-01	GO:0060374	mast cell differentiation	BP
2	3	1.73633706016	-	1.04e-01	GO:0060370	susceptibility to T cell mediated cytotoxicity	BP
2	3	1.73633706016	-	1.04e-01	GO:0051365	cellular response to potassium ion starvation	BP
2	3	1.73633706016	-	1.04e-01	GO:0051280	negative regulation of release of sequestered calcium ion into cytosol	BP
2	3	1.73633706016	-	1.04e-01	GO:1903238	positive regulation of leukocyte tethering or rolling	BP
2	3	1.73633706016	-	1.04e-01	GO:0061740	protein targeting to lysosome involved in chaperone-mediated autophagy	BP
2	3	1.73633706016	-	1.04e-01	GO:0098912	membrane depolarization during atrial cardiac muscle cell action potential	BP
2	3	1.73633706016	-	1.04e-01	GO:1901026	ripoptosome assembly involved in necroptotic process	BP
2	3	1.73633706016	-	1.04e-01	GO:0060672	epithelial cell morphogenesis involved in placental branching	BP
2	3	1.73633706016	-	1.04e-01	GO:1902856	negative regulation of non-motile cilium assembly	BP
2	3	1.73633706016	-	1.04e-01	GO:0019218	regulation of steroid metabolic process	BP
2	3	1.73633706016	-	1.04e-01	GO:0070434	positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway	BP
2	3	1.73633706016	-	1.04e-01	GO:0039530	MDA-5 signaling pathway	BP
2	3	1.73633706016	-	1.04e-01	GO:0039535	regulation of RIG-I signaling pathway	BP
2	3	1.73633706016	-	1.04e-01	GO:0097039	protein linear polyubiquitination	BP
2	3	1.73633706016	-	1.04e-01	GO:1903421	regulation of synaptic vesicle recycling	BP
2	3	1.73633706016	-	1.04e-01	GO:0002638	negative regulation of immunoglobulin production	BP
2	3	1.73633706016	-	1.04e-01	GO:0009912	auditory receptor cell fate commitment	BP
2	3	1.73633706016	-	1.04e-01	GO:1902523	positive regulation of protein K63-linked ubiquitination	BP
2	3	1.73633706016	-	1.04e-01	GO:0003256	regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation	BP
2	3	1.73633706016	-	1.04e-01	GO:0045217	cell-cell junction maintenance	BP
2	3	1.73633706016	-	1.04e-01	GO:0003340	negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis	BP
2	3	1.73633706016	-	1.04e-01	GO:1903378	positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway	BP
2	3	1.73633706016	-	1.04e-01	GO:1900126	negative regulation of hyaluronan biosynthetic process	BP
2	3	1.73633706016	-	1.04e-01	GO:1904783	positive regulation of NMDA glutamate receptor activity	BP
2	3	1.73633706016	-	1.04e-01	GO:1902952	positive regulation of dendritic spine maintenance	BP
2	3	1.73633706016	-	1.04e-01	GO:0071500	cellular response to nitrosative stress	BP
2	3	1.73633706016	-	1.04e-01	GO:0032613	interleukin-10 production	BP
2	3	1.73633706016	-	1.04e-01	GO:1902108	regulation of mitochondrial membrane permeability involved in apoptotic process	BP
2	3	1.73633706016	-	1.04e-01	GO:0060242	contact inhibition	BP
2	3	1.73633706016	-	1.04e-01	GO:1902897	regulation of postsynaptic density protein 95 clustering	BP
2	3	1.73633706016	-	1.04e-01	GO:0051250	negative regulation of lymphocyte activation	BP
2	3	1.73633706016	-	1.04e-01	GO:0021747	cochlear nucleus development	BP
2	3	1.73633706016	-	1.04e-01	GO:0030423	targeting of mRNA for destruction involved in RNA interference	BP
2	3	1.73633706016	-	1.04e-01	GO:1903551	regulation of extracellular exosome assembly	BP
2	3	1.73633706016	-	1.04e-01	GO:0051788	response to misfolded protein	BP
2	3	1.73633706016	-	1.04e-01	GO:0002904	positive regulation of B cell apoptotic process	BP
2	3	1.73633706016	-	1.04e-01	GO:0072017	distal tubule development	BP
2	3	1.73633706016	-	1.04e-01	GO:0090135	actin filament branching	BP
2	3	1.73633706016	-	1.04e-01	GO:0099074	mitochondrion to lysosome transport	BP
2	3	1.73633706016	-	1.04e-01	GO:0003190	atrioventricular valve formation	BP
2	3	1.73633706016	-	1.04e-01	GO:0000189	MAPK import into nucleus	BP
2	3	1.73633706016	-	1.04e-01	GO:2000669	negative regulation of dendritic cell apoptotic process	BP
2	3	1.73633706016	-	1.04e-01	GO:1903721	positive regulation of I-kappaB phosphorylation	BP
2	3	1.73633706016	-	1.04e-01	GO:0061309	cardiac neural crest cell development involved in outflow tract morphogenesis	BP
2	3	1.73633706016	-	1.04e-01	GO:2001242	regulation of intrinsic apoptotic signaling pathway	BP
2	3	1.73633706016	-	1.04e-01	GO:0019932	second-messenger-mediated signaling	BP
2	3	1.73633706016	-	1.04e-01	GO:0046013	regulation of T cell homeostatic proliferation	BP
2	3	1.73633706016	-	1.04e-01	GO:0034465	response to carbon monoxide	BP
2	3	1.73633706016	-	1.04e-01	GO:0060437	lung growth	BP
2	3	1.73633706016	-	1.04e-01	GO:0033363	secretory granule organization	BP
2	3	1.73633706016	-	1.04e-01	GO:0000819	sister chromatid segregation	BP
2	3	1.73633706016	-	1.04e-01	GO:0048625	myoblast fate commitment	BP
2	3	1.73633706016	-	1.04e-01	GO:0070093	negative regulation of glucagon secretion	BP
2	3	1.73633706016	-	1.04e-01	GO:0003093	regulation of glomerular filtration	BP
2	3	1.73633706016	-	1.04e-01	GO:0033602	negative regulation of dopamine secretion	BP
2	3	1.73633706016	-	1.04e-01	GO:0050904	diapedesis	BP
2	3	1.73633706016	-	1.04e-01	GO:0097049	motor neuron apoptotic process	BP
2	3	1.73633706016	-	1.04e-01	GO:2000466	negative regulation of glycogen (starch) synthase activity	BP
2	3	1.73633706016	-	1.04e-01	GO:0032053	ciliary basal body organization	BP
2	3	1.73633706016	-	1.04e-01	GO:0003310	pancreatic A cell differentiation	BP
2	3	1.73633706016	-	1.04e-01	GO:2000195	negative regulation of female gonad development	BP
2	3	1.73633706016	-	1.04e-01	GO:0051097	negative regulation of helicase activity	BP
2	3	1.73633706016	-	1.04e-01	GO:0071733	transcriptional activation by promoter-enhancer looping	BP
2	3	1.73633706016	-	1.04e-01	GO:1904117	cellular response to vasopressin	BP
2	3	1.73633706016	-	1.04e-01	GO:0002762	negative regulation of myeloid leukocyte differentiation	BP
2	3	1.73633706016	-	1.04e-01	GO:0045200	establishment of neuroblast polarity	BP
2	3	1.73633706016	-	1.04e-01	GO:0022007	convergent extension involved in neural plate elongation	BP
2	3	1.73633706016	-	1.04e-01	GO:0070168	negative regulation of biomineral tissue development	BP
2	3	1.73633706016	-	1.04e-01	GO:0060215	primitive hemopoiesis	BP
2	3	1.73633706016	-	1.04e-01	GO:0000915	actomyosin contractile ring assembly	BP
2	3	1.73633706016	-	1.04e-01	GO:0035359	negative regulation of peroxisome proliferator activated receptor signaling pathway	BP
2	3	1.73633706016	-	1.04e-01	GO:0033688	regulation of osteoblast proliferation	BP
2	3	1.73633706016	-	1.04e-01	GO:0002265	astrocyte activation involved in immune response	BP
2	3	1.73633706016	-	1.04e-01	GO:0060399	positive regulation of growth hormone receptor signaling pathway	BP
2	3	1.73633706016	-	1.04e-01	GO:1905232	cellular response to L-glutamate	BP
2	3	1.73633706016	-	1.04e-01	GO:2000345	regulation of hepatocyte proliferation	BP
2	3	1.73633706016	-	1.04e-01	GO:2000348	regulation of CD40 signaling pathway	BP
2	3	1.73633706016	-	1.04e-01	GO:1903527	positive regulation of membrane tubulation	BP
2	3	1.73633706016	-	1.04e-01	GO:2000116	regulation of cysteine-type endopeptidase activity	BP
2	3	1.73633706016	-	1.04e-01	GO:2001184	positive regulation of interleukin-12 secretion	BP
2	3	1.73633706016	-	1.04e-01	GO:1901299	negative regulation of hydrogen peroxide-mediated programmed cell death	BP
2	3	1.73633706016	-	1.04e-01	GO:0061684	chaperone-mediated autophagy	BP
2	3	1.73633706016	-	1.04e-01	GO:0097286	iron ion import	BP
2	3	1.73633706016	-	1.04e-01	GO:0060480	lung goblet cell differentiation	BP
2	3	1.73633706016	-	1.04e-01	GO:1900407	regulation of cellular response to oxidative stress	BP
2	3	1.73633706016	-	1.04e-01	GO:0051882	mitochondrial depolarization	BP
2	3	1.73633706016	-	1.04e-01	GO:0033152	immunoglobulin V(D)J recombination	BP
2	3	1.73633706016	-	1.04e-01	GO:0043009	chordate embryonic development	BP
2	3	1.73633706016	-	1.04e-01	GO:2001271	negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis	BP
2	3	1.73633706016	-	1.04e-01	GO:0090272	negative regulation of fibroblast growth factor production	BP
2	3	1.73633706016	-	1.04e-01	GO:0032310	prostaglandin secretion	BP
2	3	1.73633706016	-	1.04e-01	GO:0002520	immune system development	BP
2	3	1.73633706016	-	1.04e-01	GO:1903774	positive regulation of viral budding via host ESCRT complex	BP
2	3	1.73633706016	-	1.04e-01	GO:1903772	regulation of viral budding via host ESCRT complex	BP
2	3	1.73633706016	-	1.04e-01	GO:0046890	regulation of lipid biosynthetic process	BP
2	3	1.73633706016	-	1.04e-01	GO:0060058	positive regulation of apoptotic process involved in mammary gland involution	BP
2	3	1.73633706016	-	1.04e-01	GO:2000278	regulation of DNA biosynthetic process	BP
2	3	1.73633706016	-	1.04e-01	GO:0060800	regulation of cell differentiation involved in embryonic placenta development	BP
2	3	1.73633706016	-	1.04e-01	GO:1904378	maintenance of unfolded protein involved in ERAD pathway	BP
2	3	1.73633706016	-	1.04e-01	GO:0070370	cellular heat acclimation	BP
2	3	1.73633706016	-	1.04e-01	GO:0072282	metanephric nephron tubule morphogenesis	BP
2	3	1.73633706016	-	1.04e-01	GO:0045588	positive regulation of gamma-delta T cell differentiation	BP
2	3	1.73633706016	-	1.04e-01	GO:0070495	negative regulation of thrombin-activated receptor signaling pathway	BP
2	3	1.73633706016	-	1.04e-01	GO:0002232	leukocyte chemotaxis involved in inflammatory response	BP
2	3	1.73633706016	-	1.04e-01	GO:0051389	inactivation of MAPKK activity	BP
2	3	1.73633706016	-	1.04e-01	GO:0010664	negative regulation of striated muscle cell apoptotic process	BP
2	3	1.73633706016	-	1.04e-01	GO:0072717	cellular response to actinomycin D	BP
2	3	1.73633706016	-	1.04e-01	GO:1904645	response to amyloid-beta	BP
2	3	1.73633706016	-	1.04e-01	GO:1904640	response to methionine	BP
2	3	1.73633706016	-	1.04e-01	GO:2000370	positive regulation of clathrin-dependent endocytosis	BP
2	3	1.73633706016	-	1.04e-01	GO:0021769	orbitofrontal cortex development	BP
2	3	1.73633706016	-	1.04e-01	GO:0033563	dorsal/ventral axon guidance	BP
16	24	1.73633706016	-	8.95e-07	GO:0043425	bHLH transcription factor binding	MF
10	15	1.73633706016	-	1.13e-04	GO:0004697	protein kinase C activity	MF
8	12	1.73633706016	-	2.34e-04	GO:0050321	tau-protein kinase activity	MF
8	12	1.73633706016	-	5.79e-04	GO:0004861	cyclin-dependent protein serine/threonine kinase inhibitor activity	MF
8	12	1.73633706016	-	5.79e-04	GO:0043422	protein kinase B binding	MF
8	12	1.73633706016	-	5.79e-04	GO:0000989	transcription factor activity, transcription factor binding	MF
6	9	1.73633706016	-	3.06e-03	GO:0005522	profilin binding	MF
4	6	1.73633706016	-	6.72e-03	GO:0046935	1-phosphatidylinositol-3-kinase regulator activity	MF
4	6	1.73633706016	-	1.70e-02	GO:0019870	potassium channel inhibitor activity	MF
4	6	1.73633706016	-	1.70e-02	GO:0097371	MDM2/MDM4 family protein binding	MF
4	6	1.73633706016	-	1.70e-02	GO:0055131	C3HC4-type RING finger domain binding	MF
4	6	1.73633706016	-	1.70e-02	GO:0048273	mitogen-activated protein kinase p38 binding	MF
4	6	1.73633706016	-	1.70e-02	GO:0043559	insulin binding	MF
2	3	1.73633706016	-	4.00e-02	GO:0017077	oxidative phosphorylation uncoupler activity	MF
2	3	1.73633706016	-	4.00e-02	GO:0097677	STAT family protein binding	MF
2	3	1.73633706016	-	4.00e-02	GO:0051920	peroxiredoxin activity	MF
2	3	1.73633706016	-	4.00e-02	GO:1902936	phosphatidylinositol bisphosphate binding	MF
2	3	1.73633706016	-	1.04e-01	GO:0031752	D5 dopamine receptor binding	MF
2	3	1.73633706016	-	1.04e-01	GO:0001093	TFIIB-class transcription factor binding	MF
2	3	1.73633706016	-	1.04e-01	GO:0055100	adiponectin binding	MF
2	3	1.73633706016	-	1.04e-01	GO:0001156	TFIIIC-class transcription factor binding	MF
2	3	1.73633706016	-	1.04e-01	GO:0004705	JUN kinase activity	MF
2	3	1.73633706016	-	1.04e-01	GO:0019959	interleukin-8 binding	MF
2	3	1.73633706016	-	1.04e-01	GO:0019776	Atg8 ligase activity	MF
2	3	1.73633706016	-	1.04e-01	GO:0004332	fructose-bisphosphate aldolase activity	MF
2	3	1.73633706016	-	1.04e-01	GO:1903135	cupric ion binding	MF
2	3	1.73633706016	-	1.04e-01	GO:0022890	inorganic cation transmembrane transporter activity	MF
2	3	1.73633706016	-	1.04e-01	GO:0016618	hydroxypyruvate reductase activity	MF
2	3	1.73633706016	-	1.04e-01	GO:0030172	troponin C binding	MF
2	3	1.73633706016	-	1.04e-01	GO:0055106	ubiquitin-protein transferase regulator activity	MF
2	3	1.73633706016	-	1.04e-01	GO:0004060	arylamine N-acetyltransferase activity	MF
2	3	1.73633706016	-	1.04e-01	GO:0004911	interleukin-2 receptor activity	MF
2	3	1.73633706016	-	1.04e-01	GO:0008384	IkappaB kinase activity	MF
2	3	1.73633706016	-	1.04e-01	GO:0000404	heteroduplex DNA loop binding	MF
2	3	1.73633706016	-	1.04e-01	GO:0008073	ornithine decarboxylase inhibitor activity	MF
2	3	1.73633706016	-	1.04e-01	GO:0019976	interleukin-2 binding	MF
2	3	1.73633706016	-	1.04e-01	GO:0005111	type 2 fibroblast growth factor receptor binding	MF
2	3	1.73633706016	-	1.04e-01	GO:0004882	androgen receptor activity	MF
2	3	1.73633706016	-	1.04e-01	GO:0001030	RNA polymerase III type 1 promoter DNA binding	MF
2	3	1.73633706016	-	1.04e-01	GO:0001031	RNA polymerase III type 2 promoter DNA binding	MF
2	3	1.73633706016	-	1.04e-01	GO:0030267	glyoxylate reductase (NADP) activity	MF
2	3	1.73633706016	-	1.04e-01	GO:0008330	protein tyrosine/threonine phosphatase activity	MF
2	3	1.73633706016	-	1.04e-01	GO:0031720	haptoglobin binding	MF
2	3	1.73633706016	-	1.04e-01	GO:0004924	oncostatin-M receptor activity	MF
2	3	1.73633706016	-	1.04e-01	GO:0004699	calcium-independent protein kinase C activity	MF
2	3	1.73633706016	-	1.04e-01	GO:1905773	8-hydroxy-2'-deoxyguanosine DNA binding	MF
2	3	1.73633706016	-	1.04e-01	GO:0050692	DBD domain binding	MF
2	3	1.73633706016	-	1.04e-01	GO:0005220	inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity	MF
2	3	1.73633706016	-	1.04e-01	GO:0004517	nitric-oxide synthase activity	MF
2	3	1.73633706016	-	1.04e-01	GO:0031697	beta-1 adrenergic receptor binding	MF
2	3	1.73633706016	-	1.04e-01	GO:0031871	proteinase activated receptor binding	MF
2	3	1.73633706016	-	1.04e-01	GO:0031692	alpha-1B adrenergic receptor binding	MF
21	32	1.71361698366	-	2.55e-08	GO:0008625	extrinsic apoptotic signaling pathway via death domain receptors	BP
19	29	1.71124607919	-	1.25e-07	GO:0035666	TRIF-dependent toll-like receptor signaling pathway	BP
37	57	1.69786291234	-	5.57e-15	GO:0007173	epidermal growth factor receptor signaling pathway	BP
31	48	1.69053337054	-	1.61e-12	GO:0042752	regulation of circadian rhythm	BP
18	28	1.68386964026	-	7.45e-08	GO:0048008	platelet-derived growth factor receptor signaling pathway	BP
9	14	1.68386964026	-	6.19e-05	GO:1901185	negative regulation of ERBB signaling pathway	BP
9	14	1.68386964026	-	1.65e-04	GO:2000060	positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process	BP
9	14	1.68386964026	-	1.65e-04	GO:1903351	cellular response to dopamine	BP
9	14	1.68386964026	-	3.80e-04	GO:0042993	positive regulation of transcription factor import into nucleus	BP
9	14	1.68386964026	-	3.80e-04	GO:0048009	insulin-like growth factor receptor signaling pathway	BP
18	28	1.68386964026	-	4.13e-07	GO:0097718	disordered domain specific binding	MF
65	102	1.67124203193	-	1.55e-24	GO:0038111	interleukin-7-mediated signaling pathway	BP
7	11	1.6692228643	-	8.63e-04	GO:0032434	regulation of proteasomal ubiquitin-dependent protein catabolic process	BP
7	11	1.6692228643	-	8.63e-04	GO:0006476	protein deacetylation	BP
7	11	1.6692228643	-	8.63e-04	GO:0060445	branching involved in salivary gland morphogenesis	BP
7	11	1.6692228643	-	1.96e-03	GO:0061001	regulation of dendritic spine morphogenesis	BP
42	66	1.6692228643	-	2.53e-17	GO:0046934	phosphatidylinositol-4,5-bisphosphate 3-kinase activity	MF
14	22	1.6692228643	-	9.96e-06	GO:0004709	MAP kinase kinase kinase activity	MF
7	11	1.6692228643	-	1.96e-03	GO:0032041	NAD-dependent histone deacetylase activity (H3-K14 specific)	MF
45	71	1.6634055377	-	8.13e-16	GO:0048010	vascular endothelial growth factor receptor signaling pathway	BP
12	19	1.65833454816	-	4.93e-05	GO:1900182	positive regulation of protein localization to nucleus	BP
22	35	1.65144816257	-	3.79e-08	GO:0070491	repressing transcription factor binding	MF
30	48	1.64322765576	-	1.52e-10	GO:0043525	positive regulation of neuron apoptotic process	BP
25	40	1.64322765576	-	1.08e-09	GO:0071364	cellular response to epidermal growth factor stimulus	BP
15	24	1.64322765576	-	6.56e-06	GO:1901216	positive regulation of neuron death	BP
5	8	1.64322765576	-	1.60e-03	GO:0040016	embryonic cleavage	BP
5	8	1.64322765576	-	4.67e-03	GO:0005979	regulation of glycogen biosynthetic process	BP
5	8	1.64322765576	-	4.67e-03	GO:0001542	ovulation from ovarian follicle	BP
5	8	1.64322765576	-	4.67e-03	GO:0032691	negative regulation of interleukin-1 beta production	BP
5	8	1.64322765576	-	4.67e-03	GO:0071316	cellular response to nicotine	BP
5	8	1.64322765576	-	1.04e-02	GO:2000643	positive regulation of early endosome to late endosome transport	BP
5	8	1.64322765576	-	1.04e-02	GO:0070262	peptidyl-serine dephosphorylation	BP
5	8	1.64322765576	-	1.04e-02	GO:0048143	astrocyte activation	BP
5	8	1.64322765576	-	1.04e-02	GO:0033129	positive regulation of histone phosphorylation	BP
5	8	1.64322765576	-	1.04e-02	GO:1903800	positive regulation of production of miRNAs involved in gene silencing by miRNA	BP
5	8	1.64322765576	-	1.04e-02	GO:1901838	positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter	BP
5	8	1.64322765576	-	1.04e-02	GO:0014732	skeletal muscle atrophy	BP
10	16	1.64322765576	-	1.13e-04	GO:0031435	mitogen-activated protein kinase kinase kinase binding	MF
5	8	1.64322765576	-	1.04e-02	GO:0030983	mismatched DNA binding	MF
5	8	1.64322765576	-	1.04e-02	GO:0008432	JUN kinase binding	MF
5	8	1.64322765576	-	1.04e-02	GO:0008140	cAMP response element binding protein binding	MF
5	8	1.64322765576	-	1.04e-02	GO:0031386	protein tag	MF
5	8	1.64322765576	-	1.04e-02	GO:0004726	non-membrane spanning protein tyrosine phosphatase activity	MF
43	69	1.6390398588	-	3.90e-15	GO:0007265	Ras protein signal transduction	BP
23	37	1.63540815131	-	1.17e-08	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	BP
18	29	1.63324356719	-	2.82e-08	GO:2000145	regulation of cell motility	BP
13	21	1.62942185624	-	2.49e-06	GO:0043539	protein serine/threonine kinase activator activity	MF
16	26	1.62085984274	-	3.67e-07	GO:0045840	positive regulation of mitotic nuclear division	BP
16	26	1.62085984274	-	2.02e-06	GO:0071480	cellular response to gamma radiation	BP
8	13	1.62085984274	-	2.34e-04	GO:0061029	eyelid development in camera-type eye	BP
8	13	1.62085984274	-	2.34e-04	GO:0046628	positive regulation of insulin receptor signaling pathway	BP
8	13	1.62085984274	-	5.79e-04	GO:1900181	negative regulation of protein localization to nucleus	BP
8	13	1.62085984274	-	5.79e-04	GO:0071285	cellular response to lithium ion	BP
8	13	1.62085984274	-	1.24e-03	GO:0070306	lens fiber cell differentiation	BP
8	13	1.62085984274	-	1.24e-03	GO:0045197	establishment or maintenance of epithelial cell apical/basal polarity	BP
8	13	1.62085984274	-	1.24e-03	GO:0042176	regulation of protein catabolic process	BP
8	13	1.62085984274	-	1.24e-03	GO:0035259	glucocorticoid receptor binding	MF
11	18	1.61080617807	-	7.50e-05	GO:0009416	response to light stimulus	BP
42	69	1.60509252688	-	2.51e-15	GO:0018107	peptidyl-threonine phosphorylation	BP
14	23	1.60509252688	-	2.08e-05	GO:0000715	nucleotide-excision repair, DNA damage recognition	BP
17	28	1.60140748007	-	2.78e-06	GO:0070979	protein K11-linked ubiquitination	BP
20	33	1.59883353641	-	3.77e-07	GO:0097192	extrinsic apoptotic signaling pathway in absence of ligand	BP
26	43	1.59547452432	-	1.32e-10	GO:0016303	1-phosphatidylinositol-3-kinase activity	MF
53	88	1.5897883968	-	3.41e-18	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	BP
12	20	1.58433396671	-	1.01e-04	GO:0070932	histone H3 deacetylation	BP
9	15	1.58433396671	-	1.65e-04	GO:2000310	regulation of NMDA receptor activity	BP
9	15	1.58433396671	-	3.80e-04	GO:0043277	apoptotic cell clearance	BP
9	15	1.58433396671	-	3.80e-04	GO:0030330	DNA damage response, signal transduction by p53 class mediator	BP
9	15	1.58433396671	-	3.80e-04	GO:0060397	JAK-STAT cascade involved in growth hormone signaling pathway	BP
9	15	1.58433396671	-	3.80e-04	GO:0043254	regulation of protein complex assembly	BP
6	10	1.58433396671	-	3.06e-03	GO:0050855	regulation of B cell receptor signaling pathway	BP
6	10	1.58433396671	-	3.06e-03	GO:0090084	negative regulation of inclusion body assembly	BP
6	10	1.58433396671	-	3.06e-03	GO:1902894	negative regulation of pri-miRNA transcription from RNA polymerase II promoter	BP
6	10	1.58433396671	-	3.06e-03	GO:0060081	membrane hyperpolarization	BP
6	10	1.58433396671	-	3.06e-03	GO:0010469	regulation of receptor activity	BP
6	10	1.58433396671	-	6.36e-03	GO:0051918	negative regulation of fibrinolysis	BP
6	10	1.58433396671	-	6.36e-03	GO:0033235	positive regulation of protein sumoylation	BP
6	10	1.58433396671	-	6.36e-03	GO:0050678	regulation of epithelial cell proliferation	BP
6	10	1.58433396671	-	6.36e-03	GO:1904357	negative regulation of telomere maintenance via telomere lengthening	BP
6	10	1.58433396671	-	6.36e-03	GO:1901522	positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus	BP
3	5	1.58433396671	-	8.00e-03	GO:0038203	TORC2 signaling	BP
3	5	1.58433396671	-	2.72e-02	GO:0009299	mRNA transcription	BP
3	5	1.58433396671	-	2.72e-02	GO:0072162	metanephric mesenchymal cell differentiation	BP
3	5	1.58433396671	-	2.72e-02	GO:0060956	endocardial cell differentiation	BP
3	5	1.58433396671	-	2.72e-02	GO:0051754	meiotic sister chromatid cohesion, centromeric	BP
3	5	1.58433396671	-	2.72e-02	GO:0019217	regulation of fatty acid metabolic process	BP
3	5	1.58433396671	-	2.72e-02	GO:2000987	positive regulation of behavioral fear response	BP
3	5	1.58433396671	-	2.72e-02	GO:0072284	metanephric S-shaped body morphogenesis	BP
3	5	1.58433396671	-	2.72e-02	GO:0007406	negative regulation of neuroblast proliferation	BP
3	5	1.58433396671	-	2.72e-02	GO:0001302	replicative cell aging	BP
3	5	1.58433396671	-	2.72e-02	GO:0031914	negative regulation of synaptic plasticity	BP
3	5	1.58433396671	-	2.72e-02	GO:0010632	regulation of epithelial cell migration	BP
3	5	1.58433396671	-	2.72e-02	GO:0009597	detection of virus	BP
3	5	1.58433396671	-	2.72e-02	GO:0016101	diterpenoid metabolic process	BP
3	5	1.58433396671	-	2.72e-02	GO:0090650	cellular response to oxygen-glucose deprivation	BP
3	5	1.58433396671	-	2.72e-02	GO:0060019	radial glial cell differentiation	BP
3	5	1.58433396671	-	2.72e-02	GO:0070231	T cell apoptotic process	BP
3	5	1.58433396671	-	5.80e-02	GO:0072655	establishment of protein localization to mitochondrion	BP
3	5	1.58433396671	-	5.80e-02	GO:0002551	mast cell chemotaxis	BP
3	5	1.58433396671	-	5.80e-02	GO:0042634	regulation of hair cycle	BP
3	5	1.58433396671	-	5.80e-02	GO:0007262	STAT protein import into nucleus	BP
3	5	1.58433396671	-	5.80e-02	GO:0072378	blood coagulation, fibrin clot formation	BP
3	5	1.58433396671	-	5.80e-02	GO:2001268	negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway	BP
3	5	1.58433396671	-	5.80e-02	GO:0034349	glial cell apoptotic process	BP
3	5	1.58433396671	-	5.80e-02	GO:0061734	parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization	BP
3	5	1.58433396671	-	5.80e-02	GO:0060850	regulation of transcription involved in cell fate commitment	BP
3	5	1.58433396671	-	5.80e-02	GO:2000481	positive regulation of cAMP-dependent protein kinase activity	BP
3	5	1.58433396671	-	5.80e-02	GO:0051823	regulation of synapse structural plasticity	BP
3	5	1.58433396671	-	5.80e-02	GO:0090335	regulation of brown fat cell differentiation	BP
3	5	1.58433396671	-	5.80e-02	GO:0055012	ventricular cardiac muscle cell differentiation	BP
3	5	1.58433396671	-	5.80e-02	GO:1990441	negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress	BP
3	5	1.58433396671	-	5.80e-02	GO:1904714	regulation of chaperone-mediated autophagy	BP
3	5	1.58433396671	-	5.80e-02	GO:0048298	positive regulation of isotype switching to IgA isotypes	BP
3	5	1.58433396671	-	5.80e-02	GO:1903753	negative regulation of p38MAPK cascade	BP
3	5	1.58433396671	-	5.80e-02	GO:0042976	activation of Janus kinase activity	BP
3	5	1.58433396671	-	5.80e-02	GO:0008063	Toll signaling pathway	BP
3	5	1.58433396671	-	5.80e-02	GO:0098914	membrane repolarization during atrial cardiac muscle cell action potential	BP
3	5	1.58433396671	-	5.80e-02	GO:0022614	membrane to membrane docking	BP
3	5	1.58433396671	-	5.80e-02	GO:1903898	negative regulation of PERK-mediated unfolded protein response	BP
3	5	1.58433396671	-	5.80e-02	GO:0006896	Golgi to vacuole transport	BP
3	5	1.58433396671	-	5.80e-02	GO:0038001	paracrine signaling	BP
3	5	1.58433396671	-	5.80e-02	GO:0051081	nuclear envelope disassembly	BP
3	5	1.58433396671	-	5.80e-02	GO:0016202	regulation of striated muscle tissue development	BP
3	5	1.58433396671	-	5.80e-02	GO:0048755	branching morphogenesis of a nerve	BP
3	5	1.58433396671	-	5.80e-02	GO:0032232	negative regulation of actin filament bundle assembly	BP
3	5	1.58433396671	-	5.80e-02	GO:0071332	cellular response to fructose stimulus	BP
3	5	1.58433396671	-	5.80e-02	GO:0010543	regulation of platelet activation	BP
3	5	1.58433396671	-	5.80e-02	GO:0032410	negative regulation of transporter activity	BP
3	5	1.58433396671	-	5.80e-02	GO:0072584	caveolin-mediated endocytosis	BP
3	5	1.58433396671	-	5.80e-02	GO:0070242	thymocyte apoptotic process	BP
3	5	1.58433396671	-	5.80e-02	GO:0098780	response to mitochondrial depolarisation	BP
3	5	1.58433396671	-	5.80e-02	GO:0048170	positive regulation of long-term neuronal synaptic plasticity	BP
3	5	1.58433396671	-	5.80e-02	GO:0033081	regulation of T cell differentiation in thymus	BP
3	5	1.58433396671	-	5.80e-02	GO:2000467	positive regulation of glycogen (starch) synthase activity	BP
3	5	1.58433396671	-	5.80e-02	GO:0038033	positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway	BP
3	5	1.58433396671	-	5.80e-02	GO:0000303	response to superoxide	BP
3	5	1.58433396671	-	5.80e-02	GO:0060761	negative regulation of response to cytokine stimulus	BP
3	5	1.58433396671	-	5.80e-02	GO:0090330	regulation of platelet aggregation	BP
3	5	1.58433396671	-	5.80e-02	GO:0051583	dopamine uptake involved in synaptic transmission	BP
3	5	1.58433396671	-	5.80e-02	GO:0090188	negative regulation of pancreatic juice secretion	BP
3	5	1.58433396671	-	5.80e-02	GO:0070120	ciliary neurotrophic factor-mediated signaling pathway	BP
3	5	1.58433396671	-	5.80e-02	GO:0010994	free ubiquitin chain polymerization	BP
3	5	1.58433396671	-	5.80e-02	GO:0072201	negative regulation of mesenchymal cell proliferation	BP
3	5	1.58433396671	-	5.80e-02	GO:0043550	regulation of lipid kinase activity	BP
3	5	1.58433396671	-	5.80e-02	GO:0060052	neurofilament cytoskeleton organization	BP
3	5	1.58433396671	-	5.80e-02	GO:0035519	protein K29-linked ubiquitination	BP
3	5	1.58433396671	-	5.80e-02	GO:0010891	negative regulation of sequestering of triglyceride	BP
3	5	1.58433396671	-	5.80e-02	GO:0051573	negative regulation of histone H3-K9 methylation	BP
3	5	1.58433396671	-	5.80e-02	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	BP
9	15	1.58433396671	-	7.82e-04	GO:0004708	MAP kinase kinase activity	MF
6	10	1.58433396671	-	3.06e-03	GO:0036312	phosphatidylinositol 3-kinase regulatory subunit binding	MF
6	10	1.58433396671	-	6.36e-03	GO:0098505	G-rich strand telomeric DNA binding	MF
6	10	1.58433396671	-	6.36e-03	GO:0070016	armadillo repeat domain binding	MF
6	10	1.58433396671	-	6.36e-03	GO:0097200	cysteine-type endopeptidase activity involved in execution phase of apoptosis	MF
6	10	1.58433396671	-	6.36e-03	GO:0017166	vinculin binding	MF
6	10	1.58433396671	-	6.36e-03	GO:0042975	peroxisome proliferator activated receptor binding	MF
3	5	1.58433396671	-	2.72e-02	GO:0061665	SUMO ligase activity	MF
3	5	1.58433396671	-	2.72e-02	GO:0019871	sodium channel inhibitor activity	MF
3	5	1.58433396671	-	2.72e-02	GO:1990405	protein antigen binding	MF
3	5	1.58433396671	-	2.72e-02	GO:0051434	BH3 domain binding	MF
3	5	1.58433396671	-	5.80e-02	GO:0051373	FATZ binding	MF
3	5	1.58433396671	-	5.80e-02	GO:0003708	retinoic acid receptor activity	MF
3	5	1.58433396671	-	5.80e-02	GO:0035174	histone serine kinase activity	MF
3	5	1.58433396671	-	5.80e-02	GO:0070061	fructose binding	MF
3	5	1.58433396671	-	5.80e-02	GO:0005131	growth hormone receptor binding	MF
73	122	1.58038678219	-	2.54e-24	GO:0004713	protein tyrosine kinase activity	MF
25	42	1.57283832787	-	2.43e-09	GO:0008630	intrinsic apoptotic signaling pathway in response to DNA damage	BP
64	108	1.56641205871	-	1.78e-22	GO:0048015	phosphatidylinositol-mediated signaling	BP
13	22	1.56230766038	-	1.50e-05	GO:1904886	beta-catenin destruction complex disassembly	BP
13	22	1.56230766038	-	3.21e-05	GO:0010165	response to X-ray	BP
10	17	1.55576481451	-	1.13e-04	GO:0071375	cellular response to peptide hormone stimulus	BP
10	17	1.55576481451	-	2.46e-04	GO:2000249	regulation of actin cytoskeleton reorganization	BP
10	17	1.55576481451	-	2.46e-04	GO:1902041	regulation of extrinsic apoptotic signaling pathway via death domain receptors	BP
17	29	1.550781407	-	2.78e-06	GO:0030032	lamellipodium assembly	BP
17	29	1.550781407	-	5.47e-06	GO:0042771	intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	BP
48	82	1.54871005698	-	5.15e-17	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	BP
24	41	1.54871005698	-	3.58e-09	GO:0010718	positive regulation of epithelial to mesenchymal transition	BP
7	12	1.54369198221	-	8.63e-04	GO:0090399	replicative senescence	BP
7	12	1.54369198221	-	8.63e-04	GO:0060391	positive regulation of SMAD protein import into nucleus	BP
7	12	1.54369198221	-	1.96e-03	GO:0008154	actin polymerization or depolymerization	BP
7	12	1.54369198221	-	1.96e-03	GO:0032495	response to muramyl dipeptide	BP
7	12	1.54369198221	-	1.96e-03	GO:0060766	negative regulation of androgen receptor signaling pathway	BP
7	12	1.54369198221	-	3.90e-03	GO:0051457	maintenance of protein location in nucleus	BP
7	12	1.54369198221	-	3.90e-03	GO:0042994	cytoplasmic sequestering of transcription factor	BP
7	12	1.54369198221	-	3.90e-03	GO:0035970	peptidyl-threonine dephosphorylation	BP
7	12	1.54369198221	-	3.90e-03	GO:0034329	cell junction assembly	BP
7	12	1.54369198221	-	3.90e-03	GO:0046710	GDP metabolic process	BP
7	12	1.54369198221	-	3.90e-03	GO:0040007	growth	BP
7	12	1.54369198221	-	3.90e-03	GO:0048012	hepatocyte growth factor receptor signaling pathway	BP
7	12	1.54369198221	-	3.90e-03	GO:0045820	negative regulation of glycolytic process	BP
7	12	1.54369198221	-	3.90e-03	GO:0050765	negative regulation of phagocytosis	BP
7	12	1.54369198221	-	3.90e-03	GO:2000146	negative regulation of cell motility	BP
25	43	1.53889099595	-	4.21e-08	GO:0050681	androgen receptor binding	MF
11	19	1.53280366607	-	7.50e-05	GO:0042246	tissue regeneration	BP
11	19	1.53280366607	-	1.58e-04	GO:0048169	regulation of long-term neuronal synaptic plasticity	BP
11	19	1.53280366607	-	3.07e-04	GO:0031572	G2 DNA damage checkpoint	BP
15	26	1.52775043835	-	2.57e-05	GO:0043388	positive regulation of DNA binding	BP
38	66	1.52483295496	-	6.24e-13	GO:0014068	positive regulation of phosphatidylinositol 3-kinase signaling	BP
84	146	1.52379242478	-	4.98e-25	GO:0018105	peptidyl-serine phosphorylation	BP
95	166	1.51611573786	-	1.50e-26	GO:0046777	protein autophosphorylation	BP
20	35	1.51394463882	-	3.77e-07	GO:1902042	negative regulation of extrinsic apoptotic signaling pathway via death domain receptors	BP
12	21	1.51394463882	-	1.92e-04	GO:0043393	regulation of protein binding	BP
8	14	1.51394463882	-	5.79e-04	GO:1903078	positive regulation of protein localization to plasma membrane	BP
4	7	1.51394463882	-	1.60e-03	GO:0048680	positive regulation of axon regeneration	BP
8	14	1.51394463882	-	2.39e-03	GO:0042026	protein refolding	BP
8	14	1.51394463882	-	2.39e-03	GO:1902187	negative regulation of viral release from host cell	BP
8	14	1.51394463882	-	2.39e-03	GO:0043069	negative regulation of programmed cell death	BP
8	14	1.51394463882	-	2.39e-03	GO:0051492	regulation of stress fiber assembly	BP
8	14	1.51394463882	-	2.39e-03	GO:0031529	ruffle organization	BP
8	14	1.51394463882	-	2.39e-03	GO:0007175	negative regulation of epidermal growth factor-activated receptor activity	BP
8	14	1.51394463882	-	2.39e-03	GO:0032006	regulation of TOR signaling	BP
4	7	1.51394463882	-	6.72e-03	GO:0045577	regulation of B cell differentiation	BP
4	7	1.51394463882	-	6.72e-03	GO:0010518	positive regulation of phospholipase activity	BP
4	7	1.51394463882	-	6.72e-03	GO:0007530	sex determination	BP
4	7	1.51394463882	-	6.72e-03	GO:0003360	brainstem development	BP
4	7	1.51394463882	-	1.70e-02	GO:0045656	negative regulation of monocyte differentiation	BP
4	7	1.51394463882	-	1.70e-02	GO:0071455	cellular response to hyperoxia	BP
4	7	1.51394463882	-	1.70e-02	GO:0045722	positive regulation of gluconeogenesis	BP
4	7	1.51394463882	-	1.70e-02	GO:0060998	regulation of dendritic spine development	BP
4	7	1.51394463882	-	1.70e-02	GO:2000617	positive regulation of histone H3-K9 acetylation	BP
4	7	1.51394463882	-	1.70e-02	GO:0022612	gland morphogenesis	BP
4	7	1.51394463882	-	1.70e-02	GO:0030510	regulation of BMP signaling pathway	BP
4	7	1.51394463882	-	1.70e-02	GO:2001028	positive regulation of endothelial cell chemotaxis	BP
4	7	1.51394463882	-	1.70e-02	GO:0061298	retina vasculature development in camera-type eye	BP
4	7	1.51394463882	-	1.70e-02	GO:0043551	regulation of phosphatidylinositol 3-kinase activity	BP
4	7	1.51394463882	-	1.70e-02	GO:0060563	neuroepithelial cell differentiation	BP
4	7	1.51394463882	-	3.34e-02	GO:0032825	positive regulation of natural killer cell differentiation	BP
4	7	1.51394463882	-	3.34e-02	GO:2000483	negative regulation of interleukin-8 secretion	BP
4	7	1.51394463882	-	3.34e-02	GO:0060706	cell differentiation involved in embryonic placenta development	BP
4	7	1.51394463882	-	3.34e-02	GO:0019896	axonal transport of mitochondrion	BP
4	7	1.51394463882	-	3.34e-02	GO:0003183	mitral valve morphogenesis	BP
4	7	1.51394463882	-	3.34e-02	GO:0034141	positive regulation of toll-like receptor 3 signaling pathway	BP
4	7	1.51394463882	-	3.34e-02	GO:0010870	positive regulation of receptor biosynthetic process	BP
4	7	1.51394463882	-	3.34e-02	GO:0034351	negative regulation of glial cell apoptotic process	BP
4	7	1.51394463882	-	3.34e-02	GO:2000210	positive regulation of anoikis	BP
4	7	1.51394463882	-	3.34e-02	GO:0030388	fructose 1,6-bisphosphate metabolic process	BP
4	7	1.51394463882	-	3.34e-02	GO:0044321	response to leptin	BP
4	7	1.51394463882	-	3.34e-02	GO:1903599	positive regulation of autophagy of mitochondrion	BP
4	7	1.51394463882	-	3.34e-02	GO:0035520	monoubiquitinated protein deubiquitination	BP
4	7	1.51394463882	-	3.34e-02	GO:0060687	regulation of branching involved in prostate gland morphogenesis	BP
4	7	1.51394463882	-	3.34e-02	GO:0010918	positive regulation of mitochondrial membrane potential	BP
4	7	1.51394463882	-	3.34e-02	GO:0070417	cellular response to cold	BP
12	21	1.51394463882	-	1.92e-04	GO:0051019	mitogen-activated protein kinase binding	MF
8	14	1.51394463882	-	5.79e-04	GO:0000982	transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding	MF
4	7	1.51394463882	-	1.70e-02	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	MF
4	7	1.51394463882	-	1.70e-02	GO:0070324	thyroid hormone binding	MF
4	7	1.51394463882	-	1.70e-02	GO:0005004	GPI-linked ephrin receptor activity	MF
4	7	1.51394463882	-	3.34e-02	GO:0005021	vascular endothelial growth factor-activated receptor activity	MF
4	7	1.51394463882	-	3.34e-02	GO:0042609	CD4 receptor binding	MF
4	7	1.51394463882	-	3.34e-02	GO:0030274	LIM domain binding	MF
4	7	1.51394463882	-	3.34e-02	GO:0030346	protein phosphatase 2B binding	MF
4	7	1.51394463882	-	3.34e-02	GO:0019784	NEDD8-specific protease activity	MF
17	30	1.50187180652	-	2.78e-06	GO:0042177	negative regulation of protein catabolic process	BP
13	23	1.49817732296	-	1.20e-04	GO:0045736	negative regulation of cyclin-dependent protein serine/threonine kinase activity	BP
22	39	1.49532896065	-	1.58e-07	GO:0001102	RNA polymerase II activating transcription factor binding	MF
31	55	1.49413615774	-	1.55e-09	GO:0032922	circadian regulation of gene expression	BP
9	16	1.49122456232	-	7.82e-04	GO:2000811	negative regulation of anoikis	BP
9	16	1.49122456232	-	1.47e-03	GO:0045725	positive regulation of glycogen biosynthetic process	BP
23	41	1.48730951232	-	1.02e-07	GO:0045740	positive regulation of DNA replication	BP
23	41	1.48730951232	-	1.02e-07	GO:0043124	negative regulation of I-kappaB kinase/NF-kappaB signaling	BP
14	25	1.48479829316	-	7.54e-05	GO:0045742	positive regulation of epidermal growth factor receptor signaling pathway	BP
14	25	1.48479829316	-	4.06e-05	GO:0030332	cyclin binding	MF
19	34	1.48176423307	-	2.22e-06	GO:0097194	execution phase of apoptosis	BP
24	43	1.4799973069	-	7.87e-09	GO:0048538	thymus development	BP
34	61	1.47802506457	-	5.81e-11	GO:0009967	positive regulation of signal transduction	BP
34	61	1.47802506457	-	2.16e-10	GO:0031398	positive regulation of protein ubiquitination	BP
20	36	1.47330265432	-	1.41e-06	GO:0043407	negative regulation of MAP kinase activity	BP
15	27	1.47330265432	-	6.56e-06	GO:0046580	negative regulation of Ras protein signal transduction	BP
10	18	1.47330265432	-	4.91e-04	GO:0046579	positive regulation of Ras protein signal transduction	BP
5	9	1.47330265432	-	1.60e-03	GO:1900165	negative regulation of interleukin-6 secretion	BP
5	9	1.47330265432	-	4.67e-03	GO:0071374	cellular response to parathyroid hormone stimulus	BP
5	9	1.47330265432	-	1.04e-02	GO:0030836	positive regulation of actin filament depolymerization	BP
5	9	1.47330265432	-	1.04e-02	GO:0060068	vagina development	BP
5	9	1.47330265432	-	1.04e-02	GO:0032731	positive regulation of interleukin-1 beta production	BP
5	9	1.47330265432	-	1.04e-02	GO:0045591	positive regulation of regulatory T cell differentiation	BP
5	9	1.47330265432	-	1.04e-02	GO:0042473	outer ear morphogenesis	BP
5	9	1.47330265432	-	1.04e-02	GO:0051974	negative regulation of telomerase activity	BP
5	9	1.47330265432	-	1.04e-02	GO:0048660	regulation of smooth muscle cell proliferation	BP
5	9	1.47330265432	-	1.96e-02	GO:0008090	retrograde axonal transport	BP
5	9	1.47330265432	-	1.96e-02	GO:0034405	response to fluid shear stress	BP
5	9	1.47330265432	-	1.96e-02	GO:0008354	germ cell migration	BP
5	9	1.47330265432	-	1.96e-02	GO:0042304	regulation of fatty acid biosynthetic process	BP
5	9	1.47330265432	-	1.96e-02	GO:0006312	mitotic recombination	BP
5	9	1.47330265432	-	1.96e-02	GO:0043068	positive regulation of programmed cell death	BP
5	9	1.47330265432	-	1.96e-02	GO:0006000	fructose metabolic process	BP
5	9	1.47330265432	-	1.96e-02	GO:0061820	telomeric D-loop disassembly	BP
5	9	1.47330265432	-	1.96e-02	GO:0032000	positive regulation of fatty acid beta-oxidation	BP
5	9	1.47330265432	-	1.96e-02	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	BP
25	45	1.47330265432	-	1.09e-08	GO:0030971	receptor tyrosine kinase binding	MF
15	27	1.47330265432	-	4.72e-05	GO:0051721	protein phosphatase 2A binding	MF
5	9	1.47330265432	-	1.04e-02	GO:0046790	virion binding	MF
5	9	1.47330265432	-	1.96e-02	GO:0034713	type I transforming growth factor beta receptor binding	MF
5	9	1.47330265432	-	1.96e-02	GO:0017162	aryl hydrocarbon receptor binding	MF
16	29	1.46331856575	-	4.28e-06	GO:0001103	RNA polymerase II repressing transcription factor binding	MF
16	29	1.46331856575	-	1.63e-05	GO:0004712	protein serine/threonine/tyrosine kinase activity	MF
11	20	1.45880308463	-	1.58e-04	GO:0050771	negative regulation of axonogenesis	BP
11	20	1.45880308463	-	5.60e-04	GO:0008361	regulation of cell size	BP
34	62	1.45456609174	-	2.16e-10	GO:0006977	DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	BP
17	31	1.45456609174	-	2.78e-06	GO:0034614	cellular response to reactive oxygen species	BP
35	64	1.45058257782	-	2.07e-12	GO:0070373	negative regulation of ERK1 and ERK2 cascade	BP
6	11	1.44683044296	-	3.06e-03	GO:0070997	neuron death	BP
6	11	1.44683044296	-	3.06e-03	GO:0035414	negative regulation of catenin import into nucleus	BP
6	11	1.44683044296	-	3.06e-03	GO:0043666	regulation of phosphoprotein phosphatase activity	BP
6	11	1.44683044296	-	6.36e-03	GO:0001944	vasculature development	BP
6	11	1.44683044296	-	6.36e-03	GO:0055015	ventricular cardiac muscle cell development	BP
6	11	1.44683044296	-	6.36e-03	GO:1990440	positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress	BP
6	11	1.44683044296	-	6.36e-03	GO:0001952	regulation of cell-matrix adhesion	BP
6	11	1.44683044296	-	6.36e-03	GO:0006937	regulation of muscle contraction	BP
6	11	1.44683044296	-	6.36e-03	GO:0032930	positive regulation of superoxide anion generation	BP
6	11	1.44683044296	-	1.16e-02	GO:0051279	regulation of release of sequestered calcium ion into cytosol	BP
6	11	1.44683044296	-	1.16e-02	GO:0071803	positive regulation of podosome assembly	BP
6	11	1.44683044296	-	1.16e-02	GO:0032516	positive regulation of phosphoprotein phosphatase activity	BP
6	11	1.44683044296	-	1.16e-02	GO:0045637	regulation of myeloid cell differentiation	BP
6	11	1.44683044296	-	1.16e-02	GO:0048712	negative regulation of astrocyte differentiation	BP
6	11	1.44683044296	-	1.16e-02	GO:0033197	response to vitamin E	BP
6	11	1.44683044296	-	1.16e-02	GO:0032727	positive regulation of interferon-alpha production	BP
6	11	1.44683044296	-	1.16e-02	GO:0060444	branching involved in mammary gland duct morphogenesis	BP
12	22	1.44683044296	-	1.92e-04	GO:0004683	calmodulin-dependent protein kinase activity	MF
6	11	1.44683044296	-	6.36e-03	GO:0048407	platelet-derived growth factor binding	MF
6	11	1.44683044296	-	6.36e-03	GO:0005068	transmembrane receptor protein tyrosine kinase adaptor activity	MF
6	11	1.44683044296	-	6.36e-03	GO:0008349	MAP kinase kinase kinase kinase activity	MF
6	11	1.44683044296	-	1.16e-02	GO:0008093	cytoskeletal adaptor activity	MF
6	11	1.44683044296	-	1.16e-02	GO:0043522	leucine zipper domain binding	MF
18	33	1.44683044296	-	6.48e-06	GO:0043491	protein kinase B signaling	BP
13	24	1.4367767783	-	1.20e-04	GO:0048041	focal adhesion assembly	BP
13	24	1.4367767783	-	2.15e-04	GO:2001238	positive regulation of extrinsic apoptotic signaling pathway	BP
13	24	1.4367767783	-	2.15e-04	GO:0030295	protein kinase activator activity	MF
13	24	1.4367767783	-	2.15e-04	GO:0031593	polyubiquitin modification-dependent protein binding	MF
33	61	1.43495634267	-	1.16e-09	GO:0007249	I-kappaB kinase/NF-kappaB signaling	BP
27	50	1.43233087327	-	2.29e-09	GO:0036092	phosphatidylinositol-3-phosphate biosynthetic process	BP
21	39	1.42821476479	-	1.62e-06	GO:0030155	regulation of cell adhesion	BP
21	39	1.42821476479	-	2.86e-06	GO:0030522	intracellular receptor signaling pathway	BP
14	26	1.42821476479	-	7.54e-05	GO:0000732	strand displacement	BP
14	26	1.42821476479	-	1.33e-04	GO:0016239	positive regulation of macroautophagy	BP
7	13	1.42821476479	-	1.96e-03	GO:0050872	white fat cell differentiation	BP
7	13	1.42821476479	-	1.96e-03	GO:0048546	digestive tract morphogenesis	BP
7	13	1.42821476479	-	1.96e-03	GO:0055089	fatty acid homeostasis	BP
7	13	1.42821476479	-	6.99e-03	GO:0016242	negative regulation of macroautophagy	BP
7	13	1.42821476479	-	6.99e-03	GO:0002756	MyD88-independent toll-like receptor signaling pathway	BP
7	13	1.42821476479	-	6.99e-03	GO:0004385	guanylate kinase activity	MF
43	80	1.42563622069	-	7.87e-14	GO:0016301	kinase activity	MF
15	28	1.42083523443	-	6.56e-06	GO:0032148	activation of protein kinase B activity	BP
15	28	1.42083523443	-	2.57e-05	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	BP
31	58	1.41751487614	-	9.20e-09	GO:0045732	positive regulation of protein catabolic process	BP
16	30	1.41440896527	-	8.56e-06	GO:0007259	JAK-STAT cascade	BP
8	15	1.41440896527	-	2.39e-03	GO:2000251	positive regulation of actin cytoskeleton reorganization	BP
8	15	1.41440896527	-	2.39e-03	GO:0051412	response to corticosterone	BP
8	15	1.41440896527	-	2.39e-03	GO:0000729	DNA double-strand break processing	BP
8	15	1.41440896527	-	4.23e-03	GO:0060997	dendritic spine morphogenesis	BP
8	15	1.41440896527	-	4.23e-03	GO:0045190	isotype switching	BP
8	15	1.41440896527	-	4.23e-03	GO:2000679	positive regulation of transcription regulatory region DNA binding	BP
8	15	1.41440896527	-	2.39e-03	GO:0005161	platelet-derived growth factor receptor binding	MF
81	152	1.41322205032	-	3.40e-22	GO:0018108	peptidyl-tyrosine phosphorylation	BP
25	47	1.41056689897	-	4.43e-07	GO:0000186	activation of MAPKK activity	BP
25	47	1.41056689897	-	4.43e-07	GO:0034644	cellular response to UV	BP
17	32	1.40876240213	-	1.85e-05	GO:0002755	MyD88-dependent toll-like receptor signaling pathway	BP
27	51	1.40376172107	-	4.63e-09	GO:0048146	positive regulation of fibroblast proliferation	BP
18	34	1.40376172107	-	3.49e-06	GO:0031098	stress-activated protein kinase signaling cascade	BP
9	17	1.40376172107	-	3.80e-04	GO:1903506	regulation of nucleic acid-templated transcription	BP
9	17	1.40376172107	-	7.82e-04	GO:0001702	gastrulation with mouth forming second	BP
9	17	1.40376172107	-	1.47e-03	GO:0090201	negative regulation of release of cytochrome c from mitochondria	BP
28	53	1.40073402837	-	5.85e-09	GO:0048511	rhythmic process	BP
19	36	1.39930207288	-	4.09e-06	GO:0051402	neuron apoptotic process	BP
19	36	1.39930207288	-	1.25e-05	GO:0004879	RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding	MF
48	91	1.3984674214	-	6.55e-14	GO:0007179	transforming growth factor beta receptor signaling pathway	BP
10	19	1.39530014232	-	2.46e-04	GO:0010592	positive regulation of lamellipodium assembly	BP
10	19	1.39530014232	-	2.46e-04	GO:0030220	platelet formation	BP
10	19	1.39530014232	-	4.91e-04	GO:0014911	positive regulation of smooth muscle cell migration	BP
10	19	1.39530014232	-	4.91e-04	GO:0036120	cellular response to platelet-derived growth factor stimulus	BP
10	19	1.39530014232	-	9.07e-04	GO:0008157	protein phosphatase 1 binding	MF
21	40	1.39168888877	-	1.62e-06	GO:0031648	protein destabilization	BP
21	40	1.39168888877	-	1.62e-06	GO:0070527	platelet aggregation	BP
33	63	1.38841375674	-	1.16e-09	GO:0001933	negative regulation of protein phosphorylation	BP
11	21	1.38841375674	-	3.07e-04	GO:0043113	receptor clustering	BP
35	67	1.38449338736	-	1.46e-09	GO:0001047	core promoter binding	MF
12	23	1.38270010554	-	1.92e-04	GO:0048870	cell motility	BP
60	115	1.38270010554	-	1.35e-17	GO:0005088	Ras guanyl-nucleotide exchange factor activity	MF
24	46	1.38270010554	-	1.24e-07	GO:0046332	SMAD binding	MF
13	25	1.37788308924	-	6.41e-05	GO:0050772	positive regulation of axonogenesis	BP
13	25	1.37788308924	-	1.20e-04	GO:0030511	positive regulation of transforming growth factor beta receptor signaling pathway	BP
13	25	1.37788308924	-	1.50e-05	GO:0019838	growth factor binding	MF
14	27	1.37376698077	-	7.54e-05	GO:0040014	regulation of multicellular organism growth	BP
14	27	1.37376698077	-	4.06e-05	GO:0001106	RNA polymerase II transcription corepressor activity	MF
44	85	1.37134024338	-	1.34e-12	GO:0019900	kinase binding	MF
31	60	1.36860527566	-	9.20e-09	GO:0070301	cellular response to hydrogen peroxide	BP
16	31	1.36710325049	-	8.56e-06	GO:0014065	phosphatidylinositol 3-kinase signaling	BP
16	31	1.36710325049	-	2.95e-05	GO:0071276	cellular response to cadmium ion	BP
16	31	1.36710325049	-	5.16e-05	GO:0019058	viral life cycle	BP
17	33	1.36436828277	-	1.85e-05	GO:0005154	epidermal growth factor receptor binding	MF
18	35	1.36194154537	-	6.48e-06	GO:0051219	phosphoprotein binding	MF
39	76	1.3587742663	-	6.68e-10	GO:1900034	regulation of cellular response to heat	BP
41	80	1.35692347061	-	9.25e-11	GO:0007346	regulation of mitotic cell cycle	BP
23	45	1.3530084206	-	1.95e-07	GO:0030838	positive regulation of actin filament polymerization	BP
24	47	1.35167320992	-	1.98e-06	GO:0007254	JNK cascade	BP
96	188	1.35167320992	-	6.73e-24	GO:0004672	protein kinase activity	MF
40	80	1.32129956088	-	2.50e-10	GO:0033138	positive regulation of peptidyl-serine phosphorylation	BP
33	66	1.32129956088	-	1.80e-08	GO:0032147	activation of protein kinase activity	BP
19	38	1.32129956088	-	1.16e-06	GO:0045597	positive regulation of cell differentiation	BP
14	28	1.32129956088	-	4.06e-05	GO:0045595	regulation of cell differentiation	BP
16	32	1.32129956088	-	8.68e-05	GO:0006513	protein monoubiquitination	BP
13	26	1.32129956088	-	1.20e-04	GO:0070372	regulation of ERK1 and ERK2 cascade	BP
16	32	1.32129956088	-	1.42e-04	GO:0070911	global genome nucleotide-excision repair	BP
11	22	1.32129956088	-	1.58e-04	GO:0071157	negative regulation of cell cycle arrest	BP
15	30	1.32129956088	-	2.28e-04	GO:0070059	intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress	BP
14	28	1.32129956088	-	3.69e-04	GO:0010332	response to gamma radiation	BP
9	18	1.32129956088	-	3.80e-04	GO:0001556	oocyte maturation	BP
8	16	1.32129956088	-	5.79e-04	GO:0043409	negative regulation of MAPK cascade	BP
9	18	1.32129956088	-	7.82e-04	GO:1901214	regulation of neuron death	BP
7	14	1.32129956088	-	8.63e-04	GO:0031103	axon regeneration	BP
11	22	1.32129956088	-	9.64e-04	GO:2000378	negative regulation of reactive oxygen species metabolic process	BP
9	18	1.32129956088	-	1.47e-03	GO:0042789	mRNA transcription from RNA polymerase II promoter	BP
10	20	1.32129956088	-	1.57e-03	GO:0032465	regulation of cytokinesis	BP
7	14	1.32129956088	-	1.96e-03	GO:0022408	negative regulation of cell-cell adhesion	BP
9	18	1.32129956088	-	2.57e-03	GO:0050860	negative regulation of T cell receptor signaling pathway	BP
9	18	1.32129956088	-	2.57e-03	GO:0048854	brain morphogenesis	BP
7	14	1.32129956088	-	3.90e-03	GO:0060065	uterus development	BP
7	14	1.32129956088	-	3.90e-03	GO:0000712	resolution of meiotic recombination intermediates	BP
8	16	1.32129956088	-	4.23e-03	GO:0046037	GMP metabolic process	BP
8	16	1.32129956088	-	4.23e-03	GO:0060749	mammary gland alveolus development	BP
8	16	1.32129956088	-	4.23e-03	GO:0051131	chaperone-mediated protein complex assembly	BP
9	18	1.32129956088	-	4.24e-03	GO:0045821	positive regulation of glycolytic process	BP
5	10	1.32129956088	-	4.67e-03	GO:0048935	peripheral nervous system neuron development	BP
4	8	1.32129956088	-	6.72e-03	GO:0035865	cellular response to potassium ion	BP
8	16	1.32129956088	-	6.99e-03	GO:1900273	positive regulation of long-term synaptic potentiation	BP
8	16	1.32129956088	-	6.99e-03	GO:0001935	endothelial cell proliferation	BP
7	14	1.32129956088	-	6.99e-03	GO:0014912	negative regulation of smooth muscle cell migration	BP
7	14	1.32129956088	-	6.99e-03	GO:0040029	regulation of gene expression, epigenetic	BP
3	6	1.32129956088	-	8.00e-03	GO:1903202	negative regulation of oxidative stress-induced cell death	BP
5	10	1.32129956088	-	1.04e-02	GO:0043267	negative regulation of potassium ion transport	BP
7	14	1.32129956088	-	1.16e-02	GO:0008631	intrinsic apoptotic signaling pathway in response to oxidative stress	BP
6	12	1.32129956088	-	1.16e-02	GO:0045651	positive regulation of macrophage differentiation	BP
6	12	1.32129956088	-	1.16e-02	GO:0071498	cellular response to fluid shear stress	BP
6	12	1.32129956088	-	1.16e-02	GO:0030833	regulation of actin filament polymerization	BP
6	12	1.32129956088	-	1.16e-02	GO:0031669	cellular response to nutrient levels	BP
6	12	1.32129956088	-	1.16e-02	GO:0045060	negative thymic T cell selection	BP
6	12	1.32129956088	-	1.16e-02	GO:0008340	determination of adult lifespan	BP
6	12	1.32129956088	-	1.16e-02	GO:2000505	regulation of energy homeostasis	BP
6	12	1.32129956088	-	1.16e-02	GO:0014067	negative regulation of phosphatidylinositol 3-kinase signaling	BP
6	12	1.32129956088	-	1.16e-02	GO:0030212	hyaluronan metabolic process	BP
4	8	1.32129956088	-	1.70e-02	GO:1903427	negative regulation of reactive oxygen species biosynthetic process	BP
6	12	1.32129956088	-	1.94e-02	GO:0046902	regulation of mitochondrial membrane permeability	BP
6	12	1.32129956088	-	1.94e-02	GO:0055093	response to hyperoxia	BP
6	12	1.32129956088	-	1.94e-02	GO:0032897	negative regulation of viral transcription	BP
6	12	1.32129956088	-	1.94e-02	GO:0007252	I-kappaB phosphorylation	BP
6	12	1.32129956088	-	1.94e-02	GO:0033160	positive regulation of protein import into nucleus, translocation	BP
6	12	1.32129956088	-	1.94e-02	GO:0032801	receptor catabolic process	BP
6	12	1.32129956088	-	1.94e-02	GO:0036499	PERK-mediated unfolded protein response	BP
5	10	1.32129956088	-	1.96e-02	GO:0042770	signal transduction in response to DNA damage	BP
5	10	1.32129956088	-	1.96e-02	GO:0003334	keratinocyte development	BP
5	10	1.32129956088	-	1.96e-02	GO:0014894	response to denervation involved in regulation of muscle adaptation	BP
5	10	1.32129956088	-	1.96e-02	GO:0051901	positive regulation of mitochondrial depolarization	BP
5	10	1.32129956088	-	1.96e-02	GO:0007084	mitotic nuclear envelope reassembly	BP
5	10	1.32129956088	-	1.96e-02	GO:0033673	negative regulation of kinase activity	BP
5	10	1.32129956088	-	1.96e-02	GO:0061564	axon development	BP
5	10	1.32129956088	-	1.96e-02	GO:0010954	positive regulation of protein processing	BP
5	10	1.32129956088	-	1.96e-02	GO:0003214	cardiac left ventricle morphogenesis	BP
5	10	1.32129956088	-	1.96e-02	GO:0060484	lung-associated mesenchyme development	BP
5	10	1.32129956088	-	1.96e-02	GO:0045793	positive regulation of cell size	BP
3	6	1.32129956088	-	2.72e-02	GO:1990845	adaptive thermogenesis	BP
3	6	1.32129956088	-	2.72e-02	GO:0009913	epidermal cell differentiation	BP
3	6	1.32129956088	-	2.72e-02	GO:0035754	B cell chemotaxis	BP
3	6	1.32129956088	-	2.72e-02	GO:0071947	protein deubiquitination involved in ubiquitin-dependent protein catabolic process	BP
5	10	1.32129956088	-	3.28e-02	GO:0051272	positive regulation of cellular component movement	BP
5	10	1.32129956088	-	3.28e-02	GO:0001771	immunological synapse formation	BP
5	10	1.32129956088	-	3.28e-02	GO:0033148	positive regulation of intracellular estrogen receptor signaling pathway	BP
5	10	1.32129956088	-	3.28e-02	GO:0007016	cytoskeletal anchoring at plasma membrane	BP
5	10	1.32129956088	-	3.28e-02	GO:0051247	positive regulation of protein metabolic process	BP
5	10	1.32129956088	-	3.28e-02	GO:0090129	positive regulation of synapse maturation	BP
5	10	1.32129956088	-	3.28e-02	GO:0032464	positive regulation of protein homooligomerization	BP
5	10	1.32129956088	-	3.28e-02	GO:0060546	negative regulation of necroptotic process	BP
5	10	1.32129956088	-	3.28e-02	GO:0001759	organ induction	BP
5	10	1.32129956088	-	3.28e-02	GO:0048304	positive regulation of isotype switching to IgG isotypes	BP
5	10	1.32129956088	-	3.28e-02	GO:0007178	transmembrane receptor protein serine/threonine kinase signaling pathway	BP
5	10	1.32129956088	-	3.28e-02	GO:0000338	protein deneddylation	BP
4	8	1.32129956088	-	3.34e-02	GO:0055001	muscle cell development	BP
4	8	1.32129956088	-	3.34e-02	GO:0072075	metanephric mesenchyme development	BP
4	8	1.32129956088	-	3.34e-02	GO:0035265	organ growth	BP
4	8	1.32129956088	-	3.34e-02	GO:0098909	regulation of cardiac muscle cell action potential involved in regulation of contraction	BP
4	8	1.32129956088	-	3.34e-02	GO:0003139	secondary heart field specification	BP
4	8	1.32129956088	-	3.34e-02	GO:0045410	positive regulation of interleukin-6 biosynthetic process	BP
4	8	1.32129956088	-	3.34e-02	GO:0034393	positive regulation of smooth muscle cell apoptotic process	BP
4	8	1.32129956088	-	3.34e-02	GO:0070102	interleukin-6-mediated signaling pathway	BP
4	8	1.32129956088	-	3.34e-02	GO:0009651	response to salt stress	BP
4	8	1.32129956088	-	3.34e-02	GO:0007167	enzyme linked receptor protein signaling pathway	BP
4	8	1.32129956088	-	3.34e-02	GO:0045059	positive thymic T cell selection	BP
4	8	1.32129956088	-	3.34e-02	GO:1901380	negative regulation of potassium ion transmembrane transport	BP
4	8	1.32129956088	-	3.34e-02	GO:0035357	peroxisome proliferator activated receptor signaling pathway	BP
4	8	1.32129956088	-	3.34e-02	GO:0050869	negative regulation of B cell activation	BP
4	8	1.32129956088	-	3.34e-02	GO:0060059	embryonic retina morphogenesis in camera-type eye	BP
4	8	1.32129956088	-	3.34e-02	GO:0071394	cellular response to testosterone stimulus	BP
2	4	1.32129956088	-	4.00e-02	GO:0006662	glycerol ether metabolic process	BP
2	4	1.32129956088	-	4.00e-02	GO:0043697	cell dedifferentiation	BP
2	4	1.32129956088	-	4.00e-02	GO:0021575	hindbrain morphogenesis	BP
2	4	1.32129956088	-	4.00e-02	GO:0090403	oxidative stress-induced premature senescence	BP
2	4	1.32129956088	-	4.00e-02	GO:0006311	meiotic gene conversion	BP
2	4	1.32129956088	-	4.00e-02	GO:0072672	neutrophil extravasation	BP
2	4	1.32129956088	-	4.00e-02	GO:0010868	negative regulation of triglyceride biosynthetic process	BP
2	4	1.32129956088	-	4.00e-02	GO:0030323	respiratory tube development	BP
2	4	1.32129956088	-	4.00e-02	GO:0072126	positive regulation of glomerular mesangial cell proliferation	BP
2	4	1.32129956088	-	4.00e-02	GO:0006651	diacylglycerol biosynthetic process	BP
2	4	1.32129956088	-	4.00e-02	GO:0050994	regulation of lipid catabolic process	BP
4	8	1.32129956088	-	5.63e-02	GO:0033523	histone H2B ubiquitination	BP
4	8	1.32129956088	-	5.63e-02	GO:0070723	response to cholesterol	BP
4	8	1.32129956088	-	5.63e-02	GO:0070307	lens fiber cell development	BP
4	8	1.32129956088	-	5.63e-02	GO:0035148	tube formation	BP
4	8	1.32129956088	-	5.63e-02	GO:0033598	mammary gland epithelial cell proliferation	BP
4	8	1.32129956088	-	5.63e-02	GO:0010888	negative regulation of lipid storage	BP
4	8	1.32129956088	-	5.63e-02	GO:0072577	endothelial cell apoptotic process	BP
4	8	1.32129956088	-	5.63e-02	GO:0006987	activation of signaling protein activity involved in unfolded protein response	BP
4	8	1.32129956088	-	5.63e-02	GO:0002467	germinal center formation	BP
4	8	1.32129956088	-	5.63e-02	GO:0035372	protein localization to microtubule	BP
4	8	1.32129956088	-	5.63e-02	GO:2000177	regulation of neural precursor cell proliferation	BP
4	8	1.32129956088	-	5.63e-02	GO:0001955	blood vessel maturation	BP
4	8	1.32129956088	-	5.63e-02	GO:0035234	ectopic germ cell programmed cell death	BP
4	8	1.32129956088	-	5.63e-02	GO:0002674	negative regulation of acute inflammatory response	BP
4	8	1.32129956088	-	5.63e-02	GO:0002903	negative regulation of B cell apoptotic process	BP
4	8	1.32129956088	-	5.63e-02	GO:1900364	negative regulation of mRNA polyadenylation	BP
4	8	1.32129956088	-	5.63e-02	GO:0000075	cell cycle checkpoint	BP
4	8	1.32129956088	-	5.63e-02	GO:1900119	positive regulation of execution phase of apoptosis	BP
4	8	1.32129956088	-	5.63e-02	GO:0038180	nerve growth factor signaling pathway	BP
4	8	1.32129956088	-	5.63e-02	GO:0085020	protein K6-linked ubiquitination	BP
4	8	1.32129956088	-	5.63e-02	GO:0007184	SMAD protein import into nucleus	BP
4	8	1.32129956088	-	5.63e-02	GO:0021795	cerebral cortex cell migration	BP
4	8	1.32129956088	-	5.63e-02	GO:0051646	mitochondrion localization	BP
3	6	1.32129956088	-	5.80e-02	GO:0090344	negative regulation of cell aging	BP
3	6	1.32129956088	-	5.80e-02	GO:0006596	polyamine biosynthetic process	BP
3	6	1.32129956088	-	5.80e-02	GO:2001269	positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway	BP
3	6	1.32129956088	-	5.80e-02	GO:0010887	negative regulation of cholesterol storage	BP
3	6	1.32129956088	-	5.80e-02	GO:0002320	lymphoid progenitor cell differentiation	BP
3	6	1.32129956088	-	5.80e-02	GO:0048524	positive regulation of viral process	BP
3	6	1.32129956088	-	5.80e-02	GO:0060372	regulation of atrial cardiac muscle cell membrane repolarization	BP
3	6	1.32129956088	-	5.80e-02	GO:0046533	negative regulation of photoreceptor cell differentiation	BP
3	6	1.32129956088	-	5.80e-02	GO:0021984	adenohypophysis development	BP
3	6	1.32129956088	-	5.80e-02	GO:0010631	epithelial cell migration	BP
3	6	1.32129956088	-	5.80e-02	GO:0035315	hair cell differentiation	BP
3	6	1.32129956088	-	5.80e-02	GO:0060296	regulation of cilium beat frequency involved in ciliary motility	BP
3	6	1.32129956088	-	5.80e-02	GO:0009052	pentose-phosphate shunt, non-oxidative branch	BP
3	6	1.32129956088	-	5.80e-02	GO:0010594	regulation of endothelial cell migration	BP
3	6	1.32129956088	-	5.80e-02	GO:0060056	mammary gland involution	BP
3	6	1.32129956088	-	9.89e-02	GO:0051271	negative regulation of cellular component movement	BP
3	6	1.32129956088	-	9.89e-02	GO:0010756	positive regulation of plasminogen activation	BP
3	6	1.32129956088	-	9.89e-02	GO:0046632	alpha-beta T cell differentiation	BP
3	6	1.32129956088	-	9.89e-02	GO:0031584	activation of phospholipase D activity	BP
3	6	1.32129956088	-	9.89e-02	GO:0010792	DNA double-strand break processing involved in repair via single-strand annealing	BP
3	6	1.32129956088	-	9.89e-02	GO:0043619	regulation of transcription from RNA polymerase II promoter in response to oxidative stress	BP
3	6	1.32129956088	-	9.89e-02	GO:0014910	regulation of smooth muscle cell migration	BP
3	6	1.32129956088	-	9.89e-02	GO:0043567	regulation of insulin-like growth factor receptor signaling pathway	BP
3	6	1.32129956088	-	9.89e-02	GO:1900272	negative regulation of long-term synaptic potentiation	BP
3	6	1.32129956088	-	9.89e-02	GO:0046321	positive regulation of fatty acid oxidation	BP
3	6	1.32129956088	-	9.89e-02	GO:1904798	positive regulation of core promoter binding	BP
3	6	1.32129956088	-	9.89e-02	GO:0035900	response to isolation stress	BP
3	6	1.32129956088	-	9.89e-02	GO:1902065	response to L-glutamate	BP
3	6	1.32129956088	-	9.89e-02	GO:0072307	regulation of metanephric nephron tubule epithelial cell differentiation	BP
3	6	1.32129956088	-	9.89e-02	GO:0051902	negative regulation of mitochondrial depolarization	BP
3	6	1.32129956088	-	9.89e-02	GO:0045842	positive regulation of mitotic metaphase/anaphase transition	BP
3	6	1.32129956088	-	9.89e-02	GO:1904417	positive regulation of xenophagy	BP
3	6	1.32129956088	-	9.89e-02	GO:0017145	stem cell division	BP
3	6	1.32129956088	-	9.89e-02	GO:0042487	regulation of odontogenesis of dentin-containing tooth	BP
3	6	1.32129956088	-	9.89e-02	GO:0010216	maintenance of DNA methylation	BP
3	6	1.32129956088	-	9.89e-02	GO:0043535	regulation of blood vessel endothelial cell migration	BP
3	6	1.32129956088	-	9.89e-02	GO:0045639	positive regulation of myeloid cell differentiation	BP
3	6	1.32129956088	-	9.89e-02	GO:1903140	regulation of establishment of endothelial barrier	BP
3	6	1.32129956088	-	9.89e-02	GO:0006101	citrate metabolic process	BP
3	6	1.32129956088	-	9.89e-02	GO:0003158	endothelium development	BP
3	6	1.32129956088	-	9.89e-02	GO:0051353	positive regulation of oxidoreductase activity	BP
3	6	1.32129956088	-	9.89e-02	GO:0046755	viral budding	BP
3	6	1.32129956088	-	9.89e-02	GO:1901016	regulation of potassium ion transmembrane transporter activity	BP
3	6	1.32129956088	-	9.89e-02	GO:0046881	positive regulation of follicle-stimulating hormone secretion	BP
3	6	1.32129956088	-	9.89e-02	GO:0048667	cell morphogenesis involved in neuron differentiation	BP
3	6	1.32129956088	-	9.89e-02	GO:0032210	regulation of telomere maintenance via telomerase	BP
3	6	1.32129956088	-	9.89e-02	GO:1900113	negative regulation of histone H3-K9 trimethylation	BP
3	6	1.32129956088	-	9.89e-02	GO:0001553	luteinization	BP
3	6	1.32129956088	-	9.89e-02	GO:0060536	cartilage morphogenesis	BP
3	6	1.32129956088	-	9.89e-02	GO:0007185	transmembrane receptor protein tyrosine phosphatase signaling pathway	BP
3	6	1.32129956088	-	9.89e-02	GO:0071156	regulation of cell cycle arrest	BP
3	6	1.32129956088	-	9.89e-02	GO:0090279	regulation of calcium ion import	BP
3	6	1.32129956088	-	9.89e-02	GO:0034454	microtubule anchoring at centrosome	BP
3	6	1.32129956088	-	9.89e-02	GO:0007100	mitotic centrosome separation	BP
3	6	1.32129956088	-	9.89e-02	GO:0051346	negative regulation of hydrolase activity	BP
3	6	1.32129956088	-	9.89e-02	GO:0045084	positive regulation of interleukin-12 biosynthetic process	BP
3	6	1.32129956088	-	9.89e-02	GO:0010035	response to inorganic substance	BP
3	6	1.32129956088	-	9.89e-02	GO:0006282	regulation of DNA repair	BP
3	6	1.32129956088	-	9.89e-02	GO:0007044	cell-substrate junction assembly	BP
3	6	1.32129956088	-	9.89e-02	GO:0038066	p38MAPK cascade	BP
3	6	1.32129956088	-	9.89e-02	GO:0060561	apoptotic process involved in morphogenesis	BP
3	6	1.32129956088	-	9.89e-02	GO:0060527	prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis	BP
2	4	1.32129956088	-	1.04e-01	GO:0035616	histone H2B conserved C-terminal lysine deubiquitination	BP
2	4	1.32129956088	-	1.04e-01	GO:0045918	negative regulation of cytolysis	BP
2	4	1.32129956088	-	1.04e-01	GO:0060965	negative regulation of gene silencing by miRNA	BP
2	4	1.32129956088	-	1.04e-01	GO:1904037	positive regulation of epithelial cell apoptotic process	BP
2	4	1.32129956088	-	1.04e-01	GO:0009987	cellular process	BP
2	4	1.32129956088	-	1.04e-01	GO:2001056	positive regulation of cysteine-type endopeptidase activity	BP
2	4	1.32129956088	-	1.04e-01	GO:0048368	lateral mesoderm development	BP
2	4	1.32129956088	-	1.04e-01	GO:0032286	central nervous system myelin maintenance	BP
2	4	1.32129956088	-	1.04e-01	GO:1902806	regulation of cell cycle G1/S phase transition	BP
2	4	1.32129956088	-	1.04e-01	GO:0003338	metanephros morphogenesis	BP
2	4	1.32129956088	-	1.04e-01	GO:0060742	epithelial cell differentiation involved in prostate gland development	BP
2	4	1.32129956088	-	1.04e-01	GO:0060510	Type II pneumocyte differentiation	BP
2	4	1.32129956088	-	1.04e-01	GO:0003272	endocardial cushion formation	BP
2	4	1.32129956088	-	1.04e-01	GO:0051208	sequestering of calcium ion	BP
2	4	1.32129956088	-	1.04e-01	GO:0050672	negative regulation of lymphocyte proliferation	BP
2	4	1.32129956088	-	1.04e-01	GO:0045920	negative regulation of exocytosis	BP
2	4	1.32129956088	-	1.04e-01	GO:0071816	tail-anchored membrane protein insertion into ER membrane	BP
2	4	1.32129956088	-	1.04e-01	GO:0035088	establishment or maintenance of apical/basal cell polarity	BP
2	4	1.32129956088	-	1.04e-01	GO:0070857	regulation of bile acid biosynthetic process	BP
2	4	1.32129956088	-	1.04e-01	GO:0072606	interleukin-8 secretion	BP
2	4	1.32129956088	-	1.04e-01	GO:0034103	regulation of tissue remodeling	BP
2	4	1.32129956088	-	1.04e-01	GO:0034136	negative regulation of toll-like receptor 2 signaling pathway	BP
2	4	1.32129956088	-	1.04e-01	GO:0044331	cell-cell adhesion mediated by cadherin	BP
2	4	1.32129956088	-	1.04e-01	GO:0048808	male genitalia morphogenesis	BP
2	4	1.32129956088	-	1.04e-01	GO:0010644	cell communication by electrical coupling	BP
2	4	1.32129956088	-	1.04e-01	GO:0051873	killing by host of symbiont cells	BP
2	4	1.32129956088	-	1.04e-01	GO:0048550	negative regulation of pinocytosis	BP
2	4	1.32129956088	-	1.04e-01	GO:0021782	glial cell development	BP
2	4	1.32129956088	-	1.04e-01	GO:0048070	regulation of developmental pigmentation	BP
2	4	1.32129956088	-	1.04e-01	GO:0048133	male germ-line stem cell asymmetric division	BP
2	4	1.32129956088	-	1.04e-01	GO:1902175	regulation of oxidative stress-induced intrinsic apoptotic signaling pathway	BP
2	4	1.32129956088	-	1.04e-01	GO:1901525	negative regulation of mitophagy	BP
2	4	1.32129956088	-	1.04e-01	GO:0060043	regulation of cardiac muscle cell proliferation	BP
2	4	1.32129956088	-	1.04e-01	GO:0030641	regulation of cellular pH	BP
2	4	1.32129956088	-	1.04e-01	GO:0001880	Mullerian duct regression	BP
2	4	1.32129956088	-	1.04e-01	GO:1901097	negative regulation of autophagosome maturation	BP
2	4	1.32129956088	-	1.04e-01	GO:0060571	morphogenesis of an epithelial fold	BP
2	4	1.32129956088	-	1.04e-01	GO:0002768	immune response-regulating cell surface receptor signaling pathway	BP
2	4	1.32129956088	-	1.04e-01	GO:2001141	regulation of RNA biosynthetic process	BP
2	4	1.32129956088	-	1.04e-01	GO:0060393	regulation of pathway-restricted SMAD protein phosphorylation	BP
2	4	1.32129956088	-	1.04e-01	GO:0070212	protein poly-ADP-ribosylation	BP
2	4	1.32129956088	-	1.04e-01	GO:0030644	cellular chloride ion homeostasis	BP
2	4	1.32129956088	-	1.04e-01	GO:0051055	negative regulation of lipid biosynthetic process	BP
2	4	1.32129956088	-	1.04e-01	GO:0046596	regulation of viral entry into host cell	BP
2	4	1.32129956088	-	1.04e-01	GO:2000672	negative regulation of motor neuron apoptotic process	BP
2	4	1.32129956088	-	1.04e-01	GO:2001274	negative regulation of glucose import in response to insulin stimulus	BP
2	4	1.32129956088	-	1.04e-01	GO:2000021	regulation of ion homeostasis	BP
2	4	1.32129956088	-	1.04e-01	GO:0045759	negative regulation of action potential	BP
2	4	1.32129956088	-	1.04e-01	GO:0070945	neutrophil mediated killing of gram-negative bacterium	BP
2	4	1.32129956088	-	1.04e-01	GO:0070236	negative regulation of activation-induced cell death of T cells	BP
2	4	1.32129956088	-	1.04e-01	GO:0090309	positive regulation of methylation-dependent chromatin silencing	BP
2	4	1.32129956088	-	1.04e-01	GO:0016321	female meiosis chromosome segregation	BP
2	4	1.32129956088	-	1.04e-01	GO:0072757	cellular response to camptothecin	BP
2	4	1.32129956088	-	1.81e-01	GO:0002455	humoral immune response mediated by circulating immunoglobulin	BP
2	4	1.32129956088	-	1.81e-01	GO:0032439	endosome localization	BP
2	4	1.32129956088	-	1.81e-01	GO:0030835	negative regulation of actin filament depolymerization	BP
2	4	1.32129956088	-	1.81e-01	GO:0050859	negative regulation of B cell receptor signaling pathway	BP
2	4	1.32129956088	-	1.81e-01	GO:0044772	mitotic cell cycle phase transition	BP
2	4	1.32129956088	-	1.81e-01	GO:0043201	response to leucine	BP
2	4	1.32129956088	-	1.81e-01	GO:0035799	ureter maturation	BP
2	4	1.32129956088	-	1.81e-01	GO:0051147	regulation of muscle cell differentiation	BP
2	4	1.32129956088	-	1.81e-01	GO:0035655	interleukin-18-mediated signaling pathway	BP
2	4	1.32129956088	-	1.81e-01	GO:0070445	regulation of oligodendrocyte progenitor proliferation	BP
2	4	1.32129956088	-	1.81e-01	GO:0043242	negative regulation of protein complex disassembly	BP
2	4	1.32129956088	-	1.81e-01	GO:0016199	axon midline choice point recognition	BP
2	4	1.32129956088	-	1.81e-01	GO:0032369	negative regulation of lipid transport	BP
2	4	1.32129956088	-	1.81e-01	GO:0002074	extraocular skeletal muscle development	BP
2	4	1.32129956088	-	1.81e-01	GO:0051106	positive regulation of DNA ligation	BP
2	4	1.32129956088	-	1.81e-01	GO:0050689	negative regulation of defense response to virus by host	BP
2	4	1.32129956088	-	1.81e-01	GO:0008356	asymmetric cell division	BP
2	4	1.32129956088	-	1.81e-01	GO:0010883	regulation of lipid storage	BP
2	4	1.32129956088	-	1.81e-01	GO:0035549	positive regulation of interferon-beta secretion	BP
2	4	1.32129956088	-	1.81e-01	GO:0014044	Schwann cell development	BP
2	4	1.32129956088	-	1.81e-01	GO:0032079	positive regulation of endodeoxyribonuclease activity	BP
2	4	1.32129956088	-	1.81e-01	GO:1990966	ATP generation from poly-ADP-D-ribose	BP
2	4	1.32129956088	-	1.81e-01	GO:0032205	negative regulation of telomere maintenance	BP
2	4	1.32129956088	-	1.81e-01	GO:0070836	caveola assembly	BP
2	4	1.32129956088	-	1.81e-01	GO:0050881	musculoskeletal movement	BP
2	4	1.32129956088	-	1.81e-01	GO:0002248	connective tissue replacement involved in inflammatory response wound healing	BP
2	4	1.32129956088	-	1.81e-01	GO:0060513	prostatic bud formation	BP
2	4	1.32129956088	-	1.81e-01	GO:1902966	positive regulation of protein localization to early endosome	BP
2	4	1.32129956088	-	1.81e-01	GO:0071514	genetic imprinting	BP
2	4	1.32129956088	-	1.81e-01	GO:0060235	lens induction in camera-type eye	BP
2	4	1.32129956088	-	1.81e-01	GO:0048023	positive regulation of melanin biosynthetic process	BP
2	4	1.32129956088	-	1.81e-01	GO:0061428	negative regulation of transcription from RNA polymerase II promoter in response to hypoxia	BP
2	4	1.32129956088	-	1.81e-01	GO:2000320	negative regulation of T-helper 17 cell differentiation	BP
2	4	1.32129956088	-	1.81e-01	GO:0048633	positive regulation of skeletal muscle tissue growth	BP
2	4	1.32129956088	-	1.81e-01	GO:0035089	establishment of apical/basal cell polarity	BP
2	4	1.32129956088	-	1.81e-01	GO:0051712	positive regulation of killing of cells of other organism	BP
2	4	1.32129956088	-	1.81e-01	GO:0038165	oncostatin-M-mediated signaling pathway	BP
2	4	1.32129956088	-	1.81e-01	GO:0021631	optic nerve morphogenesis	BP
2	4	1.32129956088	-	1.81e-01	GO:0042271	susceptibility to natural killer cell mediated cytotoxicity	BP
2	4	1.32129956088	-	1.81e-01	GO:0007296	vitellogenesis	BP
2	4	1.32129956088	-	1.81e-01	GO:0042063	gliogenesis	BP
2	4	1.32129956088	-	1.81e-01	GO:0051900	regulation of mitochondrial depolarization	BP
2	4	1.32129956088	-	1.81e-01	GO:1905323	telomerase holoenzyme complex assembly	BP
2	4	1.32129956088	-	1.81e-01	GO:0051138	positive regulation of NK T cell differentiation	BP
2	4	1.32129956088	-	1.81e-01	GO:0051495	positive regulation of cytoskeleton organization	BP
2	4	1.32129956088	-	1.81e-01	GO:0007089	traversing start control point of mitotic cell cycle	BP
2	4	1.32129956088	-	1.81e-01	GO:1903899	positive regulation of PERK-mediated unfolded protein response	BP
2	4	1.32129956088	-	1.81e-01	GO:0007161	calcium-independent cell-matrix adhesion	BP
2	4	1.32129956088	-	1.81e-01	GO:0051450	myoblast proliferation	BP
2	4	1.32129956088	-	1.81e-01	GO:0030035	microspike assembly	BP
2	4	1.32129956088	-	1.81e-01	GO:0018394	peptidyl-lysine acetylation	BP
2	4	1.32129956088	-	1.81e-01	GO:1902527	positive regulation of protein monoubiquitination	BP
2	4	1.32129956088	-	1.81e-01	GO:0032510	endosome to lysosome transport via multivesicular body sorting pathway	BP
2	4	1.32129956088	-	1.81e-01	GO:0098815	modulation of excitatory postsynaptic potential	BP
2	4	1.32129956088	-	1.81e-01	GO:0070213	protein auto-ADP-ribosylation	BP
2	4	1.32129956088	-	1.81e-01	GO:1903347	negative regulation of bicellular tight junction assembly	BP
2	4	1.32129956088	-	1.81e-01	GO:0070849	response to epidermal growth factor	BP
2	4	1.32129956088	-	1.81e-01	GO:0042992	negative regulation of transcription factor import into nucleus	BP
2	4	1.32129956088	-	1.81e-01	GO:0048679	regulation of axon regeneration	BP
2	4	1.32129956088	-	1.81e-01	GO:1903553	positive regulation of extracellular exosome assembly	BP
2	4	1.32129956088	-	1.81e-01	GO:0048386	positive regulation of retinoic acid receptor signaling pathway	BP
2	4	1.32129956088	-	1.81e-01	GO:1901797	negative regulation of signal transduction by p53 class mediator	BP
2	4	1.32129956088	-	1.81e-01	GO:0072012	glomerulus vasculature development	BP
2	4	1.32129956088	-	1.81e-01	GO:1905244	regulation of modification of synaptic structure	BP
2	4	1.32129956088	-	1.81e-01	GO:0018126	protein hydroxylation	BP
2	4	1.32129956088	-	1.81e-01	GO:0006344	maintenance of chromatin silencing	BP
2	4	1.32129956088	-	1.81e-01	GO:2001033	negative regulation of double-strand break repair via nonhomologous end joining	BP
2	4	1.32129956088	-	1.81e-01	GO:0070293	renal absorption	BP
2	4	1.32129956088	-	1.81e-01	GO:2001200	positive regulation of dendritic cell differentiation	BP
2	4	1.32129956088	-	1.81e-01	GO:0031952	regulation of protein autophosphorylation	BP
2	4	1.32129956088	-	1.81e-01	GO:0060161	positive regulation of dopamine receptor signaling pathway	BP
2	4	1.32129956088	-	1.81e-01	GO:0046661	male sex differentiation	BP
2	4	1.32129956088	-	1.81e-01	GO:0032455	nerve growth factor processing	BP
2	4	1.32129956088	-	1.81e-01	GO:0045064	T-helper 2 cell differentiation	BP
2	4	1.32129956088	-	1.81e-01	GO:1900041	negative regulation of interleukin-2 secretion	BP
2	4	1.32129956088	-	1.81e-01	GO:0006534	cysteine metabolic process	BP
2	4	1.32129956088	-	1.81e-01	GO:0071866	negative regulation of apoptotic process in bone marrow	BP
2	4	1.32129956088	-	1.81e-01	GO:1990834	response to odorant	BP
2	4	1.32129956088	-	1.81e-01	GO:0006574	valine catabolic process	BP
2	4	1.32129956088	-	1.81e-01	GO:0033600	negative regulation of mammary gland epithelial cell proliferation	BP
2	4	1.32129956088	-	1.81e-01	GO:0035522	monoubiquitinated histone H2A deubiquitination	BP
2	4	1.32129956088	-	1.81e-01	GO:0031999	negative regulation of fatty acid beta-oxidation	BP
2	4	1.32129956088	-	1.81e-01	GO:0043353	enucleate erythrocyte differentiation	BP
2	4	1.32129956088	-	1.81e-01	GO:0000301	retrograde transport, vesicle recycling within Golgi	BP
2	4	1.32129956088	-	1.81e-01	GO:0060574	intestinal epithelial cell maturation	BP
2	4	1.32129956088	-	1.81e-01	GO:0014834	skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration	BP
2	4	1.32129956088	-	1.81e-01	GO:0032226	positive regulation of synaptic transmission, dopaminergic	BP
2	4	1.32129956088	-	1.81e-01	GO:0032488	Cdc42 protein signal transduction	BP
2	4	1.32129956088	-	1.81e-01	GO:0045629	negative regulation of T-helper 2 cell differentiation	BP
2	4	1.32129956088	-	1.81e-01	GO:0060534	trachea cartilage development	BP
2	4	1.32129956088	-	1.81e-01	GO:1902949	positive regulation of tau-protein kinase activity	BP
2	4	1.32129956088	-	1.81e-01	GO:0010748	negative regulation of plasma membrane long-chain fatty acid transport	BP
2	4	1.32129956088	-	1.81e-01	GO:0042089	cytokine biosynthetic process	BP
2	4	1.32129956088	-	1.81e-01	GO:0050798	activated T cell proliferation	BP
2	4	1.32129956088	-	1.81e-01	GO:2001181	positive regulation of interleukin-10 secretion	BP
2	4	1.32129956088	-	1.81e-01	GO:0048549	positive regulation of pinocytosis	BP
2	4	1.32129956088	-	1.81e-01	GO:0003219	cardiac right ventricle formation	BP
2	4	1.32129956088	-	1.81e-01	GO:0032640	tumor necrosis factor production	BP
2	4	1.32129956088	-	1.81e-01	GO:0032095	regulation of response to food	BP
2	4	1.32129956088	-	1.81e-01	GO:1903298	negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway	BP
2	4	1.32129956088	-	1.81e-01	GO:0060159	regulation of dopamine receptor signaling pathway	BP
2	4	1.32129956088	-	1.81e-01	GO:0034123	positive regulation of toll-like receptor signaling pathway	BP
2	4	1.32129956088	-	1.81e-01	GO:0002159	desmosome assembly	BP
2	4	1.32129956088	-	1.81e-01	GO:0045906	negative regulation of vasoconstriction	BP
2	4	1.32129956088	-	1.81e-01	GO:0048505	regulation of timing of cell differentiation	BP
2	4	1.32129956088	-	1.81e-01	GO:0001505	regulation of neurotransmitter levels	BP
2	4	1.32129956088	-	1.81e-01	GO:0061333	renal tubule morphogenesis	BP
2	4	1.32129956088	-	1.81e-01	GO:1901984	negative regulation of protein acetylation	BP
2	4	1.32129956088	-	1.81e-01	GO:0014904	myotube cell development	BP
2	4	1.32129956088	-	1.81e-01	GO:0033353	S-adenosylmethionine cycle	BP
2	4	1.32129956088	-	1.81e-01	GO:0045716	positive regulation of low-density lipoprotein particle receptor biosynthetic process	BP
2	4	1.32129956088	-	1.81e-01	GO:0043622	cortical microtubule organization	BP
2	4	1.32129956088	-	1.81e-01	GO:0035021	negative regulation of Rac protein signal transduction	BP
2	4	1.32129956088	-	1.81e-01	GO:0060442	branching involved in prostate gland morphogenesis	BP
2	4	1.32129956088	-	1.81e-01	GO:1902714	negative regulation of interferon-gamma secretion	BP
2	4	1.32129956088	-	1.81e-01	GO:0038026	reelin-mediated signaling pathway	BP
2	4	1.32129956088	-	1.81e-01	GO:0060011	Sertoli cell proliferation	BP
2	4	1.32129956088	-	1.81e-01	GO:0060750	epithelial cell proliferation involved in mammary gland duct elongation	BP
2	4	1.32129956088	-	1.81e-01	GO:0051387	negative regulation of neurotrophin TRK receptor signaling pathway	BP
2	4	1.32129956088	-	1.81e-01	GO:0051385	response to mineralocorticoid	BP
2	4	1.32129956088	-	1.81e-01	GO:0035910	ascending aorta morphogenesis	BP
2	4	1.32129956088	-	1.81e-01	GO:0097113	AMPA glutamate receptor clustering	BP
2	4	1.32129956088	-	1.81e-01	GO:0097118	neuroligin clustering involved in postsynaptic membrane assembly	BP
2	4	1.32129956088	-	1.81e-01	GO:0051645	Golgi localization	BP
2	4	1.32129956088	-	1.81e-01	GO:0060528	secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development	BP
2	4	1.32129956088	-	1.81e-01	GO:0010992	ubiquitin recycling	BP
1	2	1.32129956088	-	2.00e-01	GO:0072079	nephron tubule formation	BP
1	2	1.32129956088	-	2.00e-01	GO:0070564	positive regulation of vitamin D receptor signaling pathway	BP
1	2	1.32129956088	-	2.00e-01	GO:2001226	negative regulation of chloride transport	BP
1	2	1.32129956088	-	2.00e-01	GO:1904762	positive regulation of myofibroblast differentiation	BP
1	2	1.32129956088	-	2.00e-01	GO:0046031	ADP metabolic process	BP
1	2	1.32129956088	-	2.00e-01	GO:0043247	telomere maintenance in response to DNA damage	BP
1	2	1.32129956088	-	2.00e-01	GO:0042226	interleukin-6 biosynthetic process	BP
1	2	1.32129956088	-	2.00e-01	GO:0072239	metanephric glomerulus vasculature development	BP
1	2	1.32129956088	-	2.00e-01	GO:0002072	optic cup morphogenesis involved in camera-type eye development	BP
1	2	1.32129956088	-	2.00e-01	GO:1904695	positive regulation of vascular smooth muscle contraction	BP
1	2	1.32129956088	-	2.00e-01	GO:0097553	calcium ion transmembrane import into cytosol	BP
1	2	1.32129956088	-	2.00e-01	GO:0045720	negative regulation of integrin biosynthetic process	BP
1	2	1.32129956088	-	2.00e-01	GO:0044381	glucose import in response to insulin stimulus	BP
1	2	1.32129956088	-	2.00e-01	GO:0033594	response to hydroxyisoflavone	BP
1	2	1.32129956088	-	2.00e-01	GO:1903860	negative regulation of dendrite extension	BP
1	2	1.32129956088	-	2.00e-01	GO:0072573	tolerance induction to lipopolysaccharide	BP
1	2	1.32129956088	-	2.00e-01	GO:0019323	pentose catabolic process	BP
1	2	1.32129956088	-	2.00e-01	GO:1901857	positive regulation of cellular respiration	BP
1	2	1.32129956088	-	2.00e-01	GO:0021882	regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment	BP
1	2	1.32129956088	-	2.00e-01	GO:1903547	regulation of growth hormone activity	BP
1	2	1.32129956088	-	2.00e-01	GO:0036292	DNA rewinding	BP
1	2	1.32129956088	-	2.00e-01	GO:0045922	negative regulation of fatty acid metabolic process	BP
1	2	1.32129956088	-	2.00e-01	GO:0010872	regulation of cholesterol esterification	BP
1	2	1.32129956088	-	2.00e-01	GO:0046006	regulation of activated T cell proliferation	BP
1	2	1.32129956088	-	2.00e-01	GO:1904251	regulation of bile acid metabolic process	BP
1	2	1.32129956088	-	2.00e-01	GO:0021842	chemorepulsion involved in interneuron migration from the subpallium to the cortex	BP
1	2	1.32129956088	-	2.00e-01	GO:0070106	interleukin-27-mediated signaling pathway	BP
1	2	1.32129956088	-	2.00e-01	GO:0071464	cellular response to hydrostatic pressure	BP
1	2	1.32129956088	-	2.00e-01	GO:0009072	aromatic amino acid family metabolic process	BP
1	2	1.32129956088	-	2.00e-01	GO:0000390	spliceosomal complex disassembly	BP
1	2	1.32129956088	-	2.00e-01	GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	BP
1	2	1.32129956088	-	2.00e-01	GO:0060460	left lung morphogenesis	BP
1	2	1.32129956088	-	2.00e-01	GO:0002588	positive regulation of antigen processing and presentation of peptide antigen via MHC class II	BP
1	2	1.32129956088	-	2.00e-01	GO:0097035	regulation of membrane lipid distribution	BP
1	2	1.32129956088	-	2.00e-01	GO:0048840	otolith development	BP
1	2	1.32129956088	-	2.00e-01	GO:1905176	positive regulation of vascular smooth muscle cell dedifferentiation	BP
1	2	1.32129956088	-	2.00e-01	GO:2001287	negative regulation of caveolin-mediated endocytosis	BP
1	2	1.32129956088	-	2.00e-01	GO:0048697	positive regulation of collateral sprouting in absence of injury	BP
1	2	1.32129956088	-	2.00e-01	GO:0002739	regulation of cytokine secretion involved in immune response	BP
1	2	1.32129956088	-	2.00e-01	GO:0090134	cell migration involved in mesendoderm migration	BP
1	2	1.32129956088	-	2.00e-01	GO:1900365	positive regulation of mRNA polyadenylation	BP
1	2	1.32129956088	-	2.00e-01	GO:0060900	embryonic camera-type eye formation	BP
1	2	1.32129956088	-	2.00e-01	GO:0010730	negative regulation of hydrogen peroxide biosynthetic process	BP
1	2	1.32129956088	-	2.00e-01	GO:0051046	regulation of secretion	BP
1	2	1.32129956088	-	2.00e-01	GO:2001204	regulation of osteoclast development	BP
1	2	1.32129956088	-	2.00e-01	GO:1900082	negative regulation of arginine catabolic process	BP
1	2	1.32129956088	-	2.00e-01	GO:0002684	positive regulation of immune system process	BP
1	2	1.32129956088	-	2.00e-01	GO:0060369	positive regulation of Fc receptor mediated stimulatory signaling pathway	BP
1	2	1.32129956088	-	2.00e-01	GO:0045976	negative regulation of mitotic cell cycle, embryonic	BP
1	2	1.32129956088	-	2.00e-01	GO:0071241	cellular response to inorganic substance	BP
1	2	1.32129956088	-	2.00e-01	GO:0021623	oculomotor nerve formation	BP
1	2	1.32129956088	-	2.00e-01	GO:0072210	metanephric nephron development	BP
1	2	1.32129956088	-	2.00e-01	GO:0008078	mesodermal cell migration	BP
1	2	1.32129956088	-	2.00e-01	GO:0030187	melatonin biosynthetic process	BP
1	2	1.32129956088	-	2.00e-01	GO:0001808	negative regulation of type IV hypersensitivity	BP
1	2	1.32129956088	-	2.00e-01	GO:0003097	renal water transport	BP
1	2	1.32129956088	-	2.00e-01	GO:0015888	thiamine transport	BP
1	2	1.32129956088	-	2.00e-01	GO:2000866	positive regulation of estradiol secretion	BP
1	2	1.32129956088	-	2.00e-01	GO:0003050	regulation of systemic arterial blood pressure by atrial natriuretic peptide	BP
1	2	1.32129956088	-	2.00e-01	GO:0030222	eosinophil differentiation	BP
1	2	1.32129956088	-	2.00e-01	GO:0072554	blood vessel lumenization	BP
1	2	1.32129956088	-	2.00e-01	GO:0002228	natural killer cell mediated immunity	BP
1	2	1.32129956088	-	2.00e-01	GO:0001554	luteolysis	BP
1	2	1.32129956088	-	2.00e-01	GO:0032528	microvillus organization	BP
1	2	1.32129956088	-	2.00e-01	GO:0002769	natural killer cell inhibitory signaling pathway	BP
1	2	1.32129956088	-	2.00e-01	GO:0014835	myoblast differentiation involved in skeletal muscle regeneration	BP
1	2	1.32129956088	-	2.00e-01	GO:0033005	positive regulation of mast cell activation	BP
1	2	1.32129956088	-	2.00e-01	GO:1904639	cellular response to resveratrol	BP
1	2	1.32129956088	-	2.00e-01	GO:0072166	posterior mesonephric tubule development	BP
1	2	1.32129956088	-	2.00e-01	GO:1905408	negative regulation of creatine transmembrane transporter activity	BP
1	2	1.32129956088	-	2.00e-01	GO:0035358	regulation of peroxisome proliferator activated receptor signaling pathway	BP
1	2	1.32129956088	-	2.00e-01	GO:1904306	positive regulation of gastro-intestinal system smooth muscle contraction	BP
1	2	1.32129956088	-	2.00e-01	GO:0021551	central nervous system morphogenesis	BP
1	2	1.32129956088	-	2.00e-01	GO:0021557	oculomotor nerve development	BP
1	2	1.32129956088	-	2.00e-01	GO:0021558	trochlear nerve development	BP
1	2	1.32129956088	-	2.00e-01	GO:0002720	positive regulation of cytokine production involved in immune response	BP
1	2	1.32129956088	-	2.00e-01	GO:0034165	positive regulation of toll-like receptor 9 signaling pathway	BP
1	2	1.32129956088	-	2.00e-01	GO:1905069	allantois development	BP
1	2	1.32129956088	-	2.00e-01	GO:1903053	regulation of extracellular matrix organization	BP
1	2	1.32129956088	-	2.00e-01	GO:0010705	meiotic DNA double-strand break processing involved in reciprocal meiotic recombination	BP
1	2	1.32129956088	-	2.00e-01	GO:0042595	behavioral response to starvation	BP
1	2	1.32129956088	-	2.00e-01	GO:0051053	negative regulation of DNA metabolic process	BP
1	2	1.32129956088	-	2.00e-01	GO:0090276	regulation of peptide hormone secretion	BP
1	2	1.32129956088	-	2.00e-01	GO:0090187	positive regulation of pancreatic juice secretion	BP
1	2	1.32129956088	-	2.00e-01	GO:0010519	negative regulation of phospholipase activity	BP
1	2	1.32129956088	-	2.00e-01	GO:0097241	hematopoietic stem cell migration to bone marrow	BP
1	2	1.32129956088	-	2.00e-01	GO:1902613	negative regulation of anti-Mullerian hormone signaling pathway	BP
1	2	1.32129956088	-	2.00e-01	GO:0072208	metanephric smooth muscle tissue development	BP
1	2	1.32129956088	-	2.00e-01	GO:0006529	asparagine biosynthetic process	BP
1	2	1.32129956088	-	2.00e-01	GO:1903217	negative regulation of protein processing involved in protein targeting to mitochondrion	BP
1	2	1.32129956088	-	2.00e-01	GO:0008207	C21-steroid hormone metabolic process	BP
1	2	1.32129956088	-	2.00e-01	GO:1905206	positive regulation of hydrogen peroxide-induced cell death	BP
1	2	1.32129956088	-	2.00e-01	GO:0032370	positive regulation of lipid transport	BP
1	2	1.32129956088	-	2.00e-01	GO:0032290	peripheral nervous system myelin formation	BP
1	2	1.32129956088	-	2.00e-01	GO:0031658	negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle	BP
1	2	1.32129956088	-	2.00e-01	GO:0002879	positive regulation of acute inflammatory response to non-antigenic stimulus	BP
1	2	1.32129956088	-	2.00e-01	GO:0070086	ubiquitin-dependent endocytosis	BP
1	2	1.32129956088	-	2.00e-01	GO:0001831	trophectodermal cellular morphogenesis	BP
1	2	1.32129956088	-	2.00e-01	GO:0021692	cerebellar Purkinje cell layer morphogenesis	BP
1	2	1.32129956088	-	2.00e-01	GO:1902871	positive regulation of amacrine cell differentiation	BP
1	2	1.32129956088	-	2.00e-01	GO:0090657	telomeric loop disassembly	BP
1	2	1.32129956088	-	2.00e-01	GO:1900224	positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry	BP
1	2	1.32129956088	-	2.00e-01	GO:0051446	positive regulation of meiotic cell cycle	BP
1	2	1.32129956088	-	2.00e-01	GO:0010623	programmed cell death involved in cell development	BP
1	2	1.32129956088	-	2.00e-01	GO:0001562	response to protozoan	BP
1	2	1.32129956088	-	2.00e-01	GO:0035063	nuclear speck organization	BP
1	2	1.32129956088	-	2.00e-01	GO:0051386	regulation of neurotrophin TRK receptor signaling pathway	BP
1	2	1.32129956088	-	2.00e-01	GO:0097681	double-strand break repair via alternative nonhomologous end joining	BP
1	2	1.32129956088	-	2.00e-01	GO:0021893	cerebral cortex GABAergic interneuron fate commitment	BP
1	2	1.32129956088	-	2.00e-01	GO:2000143	negative regulation of DNA-templated transcription, initiation	BP
1	2	1.32129956088	-	2.00e-01	GO:0038195	urokinase plasminogen activator signaling pathway	BP
1	2	1.32129956088	-	2.00e-01	GO:0003241	growth involved in heart morphogenesis	BP
1	2	1.32129956088	-	3.60e-01	GO:0045076	regulation of interleukin-2 biosynthetic process	BP
1	2	1.32129956088	-	3.60e-01	GO:1903531	negative regulation of secretion by cell	BP
1	2	1.32129956088	-	3.60e-01	GO:0051284	positive regulation of sequestering of calcium ion	BP
1	2	1.32129956088	-	3.60e-01	GO:0045659	negative regulation of neutrophil differentiation	BP
1	2	1.32129956088	-	3.60e-01	GO:0045655	regulation of monocyte differentiation	BP
1	2	1.32129956088	-	3.60e-01	GO:0071109	superior temporal gyrus development	BP
1	2	1.32129956088	-	3.60e-01	GO:0097154	GABAergic neuron differentiation	BP
1	2	1.32129956088	-	3.60e-01	GO:0097156	fasciculation of motor neuron axon	BP
1	2	1.32129956088	-	3.60e-01	GO:1904956	regulation of midbrain dopaminergic neuron differentiation	BP
1	2	1.32129956088	-	3.60e-01	GO:1903044	protein localization to membrane raft	BP
1	2	1.32129956088	-	3.60e-01	GO:0070563	negative regulation of vitamin D receptor signaling pathway	BP
1	2	1.32129956088	-	3.60e-01	GO:0032675	regulation of interleukin-6 production	BP
1	2	1.32129956088	-	3.60e-01	GO:1990646	cellular response to prolactin	BP
1	2	1.32129956088	-	3.60e-01	GO:0033384	geranyl diphosphate biosynthetic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0031503	protein complex localization	BP
1	2	1.32129956088	-	3.60e-01	GO:0044340	canonical Wnt signaling pathway involved in regulation of cell proliferation	BP
1	2	1.32129956088	-	3.60e-01	GO:0010710	regulation of collagen catabolic process	BP
1	2	1.32129956088	-	3.60e-01	GO:1990414	replication-born double-strand break repair via sister chromatid exchange	BP
1	2	1.32129956088	-	3.60e-01	GO:0002378	immunoglobulin biosynthetic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0001776	leukocyte homeostasis	BP
1	2	1.32129956088	-	3.60e-01	GO:2000854	positive regulation of corticosterone secretion	BP
1	2	1.32129956088	-	3.60e-01	GO:0044565	dendritic cell proliferation	BP
1	2	1.32129956088	-	3.60e-01	GO:0071140	resolution of mitotic recombination intermediates	BP
1	2	1.32129956088	-	3.60e-01	GO:0046636	negative regulation of alpha-beta T cell activation	BP
1	2	1.32129956088	-	3.60e-01	GO:1904527	negative regulation of microtubule binding	BP
1	2	1.32129956088	-	3.60e-01	GO:0019075	virus maturation	BP
1	2	1.32129956088	-	3.60e-01	GO:0038112	interleukin-8-mediated signaling pathway	BP
1	2	1.32129956088	-	3.60e-01	GO:0086053	AV node cell to bundle of His cell communication by electrical coupling	BP
1	2	1.32129956088	-	3.60e-01	GO:1903006	positive regulation of protein K63-linked deubiquitination	BP
1	2	1.32129956088	-	3.60e-01	GO:0021855	hypothalamus cell migration	BP
1	2	1.32129956088	-	3.60e-01	GO:0014740	negative regulation of muscle hyperplasia	BP
1	2	1.32129956088	-	3.60e-01	GO:0097252	oligodendrocyte apoptotic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0051917	regulation of fibrinolysis	BP
1	2	1.32129956088	-	3.60e-01	GO:0036228	protein localization to nuclear inner membrane	BP
1	2	1.32129956088	-	3.60e-01	GO:0072182	regulation of nephron tubule epithelial cell differentiation	BP
1	2	1.32129956088	-	3.60e-01	GO:0071453	cellular response to oxygen levels	BP
1	2	1.32129956088	-	3.60e-01	GO:0046543	development of secondary female sexual characteristics	BP
1	2	1.32129956088	-	3.60e-01	GO:1904211	membrane protein proteolysis involved in retrograde protein transport, ER to cytosol	BP
1	2	1.32129956088	-	3.60e-01	GO:0043241	protein complex disassembly	BP
1	2	1.32129956088	-	3.60e-01	GO:0006525	arginine metabolic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0098905	regulation of bundle of His cell action potential	BP
1	2	1.32129956088	-	3.60e-01	GO:0098901	regulation of cardiac muscle cell action potential	BP
1	2	1.32129956088	-	3.60e-01	GO:0032368	regulation of lipid transport	BP
1	2	1.32129956088	-	3.60e-01	GO:0071657	positive regulation of granulocyte colony-stimulating factor production	BP
1	2	1.32129956088	-	3.60e-01	GO:0071650	negative regulation of chemokine (C-C motif) ligand 5 production	BP
1	2	1.32129956088	-	3.60e-01	GO:1905839	negative regulation of telomeric D-loop disassembly	BP
1	2	1.32129956088	-	3.60e-01	GO:0010796	regulation of multivesicular body size	BP
1	2	1.32129956088	-	3.60e-01	GO:0008627	intrinsic apoptotic signaling pathway in response to osmotic stress	BP
1	2	1.32129956088	-	3.60e-01	GO:1900186	negative regulation of clathrin-dependent endocytosis	BP
1	2	1.32129956088	-	3.60e-01	GO:0034342	response to type III interferon	BP
1	2	1.32129956088	-	3.60e-01	GO:0036269	swimming behavior	BP
1	2	1.32129956088	-	3.60e-01	GO:0014916	regulation of lung blood pressure	BP
1	2	1.32129956088	-	3.60e-01	GO:0071417	cellular response to organonitrogen compound	BP
1	2	1.32129956088	-	3.60e-01	GO:0045851	pH reduction	BP
1	2	1.32129956088	-	3.60e-01	GO:0044818	mitotic G2/M transition checkpoint	BP
1	2	1.32129956088	-	3.60e-01	GO:0040013	negative regulation of locomotion	BP
1	2	1.32129956088	-	3.60e-01	GO:1905663	positive regulation of telomerase RNA reverse transcriptase activity	BP
1	2	1.32129956088	-	3.60e-01	GO:1905665	positive regulation of calcium ion import across plasma membrane	BP
1	2	1.32129956088	-	3.60e-01	GO:0010611	regulation of cardiac muscle hypertrophy	BP
1	2	1.32129956088	-	3.60e-01	GO:0021681	cerebellar granular layer development	BP
1	2	1.32129956088	-	3.60e-01	GO:0045728	respiratory burst after phagocytosis	BP
1	2	1.32129956088	-	3.60e-01	GO:0060599	lateral sprouting involved in mammary gland duct morphogenesis	BP
1	2	1.32129956088	-	3.60e-01	GO:0051692	cellular oligosaccharide catabolic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0060629	regulation of homologous chromosome segregation	BP
1	2	1.32129956088	-	3.60e-01	GO:0060623	regulation of chromosome condensation	BP
1	2	1.32129956088	-	3.60e-01	GO:0060454	positive regulation of gastric acid secretion	BP
1	2	1.32129956088	-	3.60e-01	GO:0043370	regulation of CD4-positive, alpha-beta T cell differentiation	BP
1	2	1.32129956088	-	3.60e-01	GO:0014041	regulation of neuron maturation	BP
1	2	1.32129956088	-	3.60e-01	GO:0060025	regulation of synaptic activity	BP
1	2	1.32129956088	-	3.60e-01	GO:0045819	positive regulation of glycogen catabolic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0061035	regulation of cartilage development	BP
1	2	1.32129956088	-	3.60e-01	GO:0061033	secretion by lung epithelial cell involved in lung growth	BP
1	2	1.32129956088	-	3.60e-01	GO:0098989	NMDA selective glutamate receptor signaling pathway	BP
1	2	1.32129956088	-	3.60e-01	GO:0032509	endosome transport via multivesicular body sorting pathway	BP
1	2	1.32129956088	-	3.60e-01	GO:0071389	cellular response to mineralocorticoid stimulus	BP
1	2	1.32129956088	-	3.60e-01	GO:0060557	positive regulation of vitamin D biosynthetic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0050925	negative regulation of negative chemotaxis	BP
1	2	1.32129956088	-	3.60e-01	GO:0097069	cellular response to thyroxine stimulus	BP
1	2	1.32129956088	-	3.60e-01	GO:0048259	regulation of receptor-mediated endocytosis	BP
1	2	1.32129956088	-	3.60e-01	GO:1905167	positive regulation of lysosomal protein catabolic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0043335	protein unfolding	BP
1	2	1.32129956088	-	3.60e-01	GO:0043331	response to dsRNA	BP
1	2	1.32129956088	-	3.60e-01	GO:0055092	sterol homeostasis	BP
1	2	1.32129956088	-	3.60e-01	GO:1900275	negative regulation of phospholipase C activity	BP
1	2	1.32129956088	-	3.60e-01	GO:0006425	glutaminyl-tRNA aminoacylation	BP
1	2	1.32129956088	-	3.60e-01	GO:0006423	cysteinyl-tRNA aminoacylation	BP
1	2	1.32129956088	-	3.60e-01	GO:1990776	response to angiotensin	BP
1	2	1.32129956088	-	3.60e-01	GO:0003207	cardiac chamber formation	BP
1	2	1.32129956088	-	3.60e-01	GO:0044236	multicellular organism metabolic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0051563	smooth endoplasmic reticulum calcium ion homeostasis	BP
1	2	1.32129956088	-	3.60e-01	GO:0042496	detection of diacyl bacterial lipopeptide	BP
1	2	1.32129956088	-	3.60e-01	GO:0009438	methylglyoxal metabolic process	BP
1	2	1.32129956088	-	3.60e-01	GO:2001295	malonyl-CoA biosynthetic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0036315	cellular response to sterol	BP
1	2	1.32129956088	-	3.60e-01	GO:0048213	Golgi vesicle prefusion complex stabilization	BP
1	2	1.32129956088	-	3.60e-01	GO:0048210	Golgi vesicle fusion to target membrane	BP
1	2	1.32129956088	-	3.60e-01	GO:0090164	asymmetric Golgi ribbon formation	BP
1	2	1.32129956088	-	3.60e-01	GO:2000405	negative regulation of T cell migration	BP
1	2	1.32129956088	-	3.60e-01	GO:0032957	inositol trisphosphate metabolic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0006097	glyoxylate cycle	BP
1	2	1.32129956088	-	3.60e-01	GO:1902227	negative regulation of macrophage colony-stimulating factor signaling pathway	BP
1	2	1.32129956088	-	3.60e-01	GO:0055059	asymmetric neuroblast division	BP
1	2	1.32129956088	-	3.60e-01	GO:0018153	isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine	BP
1	2	1.32129956088	-	3.60e-01	GO:0010767	regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage	BP
1	2	1.32129956088	-	3.60e-01	GO:0035378	carbon dioxide transmembrane transport	BP
1	2	1.32129956088	-	3.60e-01	GO:0036294	cellular response to decreased oxygen levels	BP
1	2	1.32129956088	-	3.60e-01	GO:0031111	negative regulation of microtubule polymerization or depolymerization	BP
1	2	1.32129956088	-	3.60e-01	GO:0035585	calcium-mediated signaling using extracellular calcium source	BP
1	2	1.32129956088	-	3.60e-01	GO:0046642	negative regulation of alpha-beta T cell proliferation	BP
1	2	1.32129956088	-	3.60e-01	GO:0007638	mechanosensory behavior	BP
1	2	1.32129956088	-	3.60e-01	GO:0002283	neutrophil activation involved in immune response	BP
1	2	1.32129956088	-	3.60e-01	GO:0070075	tear secretion	BP
1	2	1.32129956088	-	3.60e-01	GO:2000615	regulation of histone H3-K9 acetylation	BP
1	2	1.32129956088	-	3.60e-01	GO:0072160	nephron tubule epithelial cell differentiation	BP
1	2	1.32129956088	-	3.60e-01	GO:0071307	cellular response to vitamin K	BP
1	2	1.32129956088	-	3.60e-01	GO:0051654	establishment of mitochondrion localization	BP
1	2	1.32129956088	-	3.60e-01	GO:0051656	establishment of organelle localization	BP
1	2	1.32129956088	-	3.60e-01	GO:0048563	post-embryonic animal organ morphogenesis	BP
1	2	1.32129956088	-	3.60e-01	GO:0086021	SA node cell to atrial cardiac muscle cell communication by electrical coupling	BP
1	2	1.32129956088	-	3.60e-01	GO:0006116	NADH oxidation	BP
1	2	1.32129956088	-	3.60e-01	GO:0090291	negative regulation of osteoclast proliferation	BP
1	2	1.32129956088	-	3.60e-01	GO:1905259	negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway	BP
1	2	1.32129956088	-	3.60e-01	GO:0032915	positive regulation of transforming growth factor beta2 production	BP
1	2	1.32129956088	-	3.60e-01	GO:0032912	negative regulation of transforming growth factor beta2 production	BP
1	2	1.32129956088	-	3.60e-01	GO:0032620	interleukin-17 production	BP
1	2	1.32129956088	-	3.60e-01	GO:0070535	histone H2A K63-linked ubiquitination	BP
1	2	1.32129956088	-	3.60e-01	GO:0031393	negative regulation of prostaglandin biosynthetic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0000294	nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay	BP
1	2	1.32129956088	-	3.60e-01	GO:0046877	regulation of saliva secretion	BP
1	2	1.32129956088	-	3.60e-01	GO:0001912	positive regulation of leukocyte mediated cytotoxicity	BP
1	2	1.32129956088	-	3.60e-01	GO:1905908	positive regulation of amyloid fibril formation	BP
1	2	1.32129956088	-	3.60e-01	GO:0032429	regulation of phospholipase A2 activity	BP
1	2	1.32129956088	-	3.60e-01	GO:1901374	acetate ester transport	BP
1	2	1.32129956088	-	3.60e-01	GO:1900424	regulation of defense response to bacterium	BP
1	2	1.32129956088	-	3.60e-01	GO:0030862	positive regulation of polarized epithelial cell differentiation	BP
1	2	1.32129956088	-	3.60e-01	GO:0046605	regulation of centrosome cycle	BP
1	2	1.32129956088	-	3.60e-01	GO:0046601	positive regulation of centriole replication	BP
1	2	1.32129956088	-	3.60e-01	GO:0048069	eye pigmentation	BP
1	2	1.32129956088	-	3.60e-01	GO:0021535	cell migration in hindbrain	BP
1	2	1.32129956088	-	3.60e-01	GO:0019087	transformation of host cell by virus	BP
1	2	1.32129956088	-	3.60e-01	GO:1901740	negative regulation of myoblast fusion	BP
1	2	1.32129956088	-	3.60e-01	GO:0086067	AV node cell to bundle of His cell communication	BP
1	2	1.32129956088	-	3.60e-01	GO:0014891	striated muscle atrophy	BP
1	2	1.32129956088	-	3.60e-01	GO:0071624	positive regulation of granulocyte chemotaxis	BP
1	2	1.32129956088	-	3.60e-01	GO:0061145	lung smooth muscle development	BP
1	2	1.32129956088	-	3.60e-01	GO:0045023	G0 to G1 transition	BP
1	2	1.32129956088	-	3.60e-01	GO:1905719	protein localization to perinuclear region of cytoplasm	BP
1	2	1.32129956088	-	3.60e-01	GO:0080135	regulation of cellular response to stress	BP
1	2	1.32129956088	-	3.60e-01	GO:0046831	regulation of RNA export from nucleus	BP
1	2	1.32129956088	-	3.60e-01	GO:0046833	positive regulation of RNA export from nucleus	BP
1	2	1.32129956088	-	3.60e-01	GO:0021801	cerebral cortex radial glia guided migration	BP
1	2	1.32129956088	-	3.60e-01	GO:0035669	TRAM-dependent toll-like receptor 4 signaling pathway	BP
1	2	1.32129956088	-	3.60e-01	GO:0003430	growth plate cartilage chondrocyte growth	BP
1	2	1.32129956088	-	3.60e-01	GO:0010874	regulation of cholesterol efflux	BP
1	2	1.32129956088	-	3.60e-01	GO:0051946	regulation of glutamate uptake involved in transmission of nerve impulse	BP
1	2	1.32129956088	-	3.60e-01	GO:0099553	trans-synaptic signaling by endocannabinoid, modulating synaptic transmission	BP
1	2	1.32129956088	-	3.60e-01	GO:0045355	negative regulation of interferon-alpha biosynthetic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0000430	regulation of transcription from RNA polymerase II promoter by glucose	BP
1	2	1.32129956088	-	3.60e-01	GO:0030822	positive regulation of cAMP catabolic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0030821	negative regulation of cAMP catabolic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0035279	mRNA cleavage involved in gene silencing by miRNA	BP
1	2	1.32129956088	-	3.60e-01	GO:1904908	negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric	BP
1	2	1.32129956088	-	3.60e-01	GO:0060073	micturition	BP
1	2	1.32129956088	-	3.60e-01	GO:0072305	negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis	BP
1	2	1.32129956088	-	3.60e-01	GO:1905552	positive regulation of protein localization to endoplasmic reticulum	BP
1	2	1.32129956088	-	3.60e-01	GO:0090042	tubulin deacetylation	BP
1	2	1.32129956088	-	3.60e-01	GO:0090045	positive regulation of deacetylase activity	BP
1	2	1.32129956088	-	3.60e-01	GO:0045963	negative regulation of dopamine metabolic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0021633	optic nerve structural organization	BP
1	2	1.32129956088	-	3.60e-01	GO:0035786	protein complex oligomerization	BP
1	2	1.32129956088	-	3.60e-01	GO:0061104	adrenal chromaffin cell differentiation	BP
1	2	1.32129956088	-	3.60e-01	GO:1990927	calcium ion regulated lysosome exocytosis	BP
1	2	1.32129956088	-	3.60e-01	GO:0032785	negative regulation of DNA-templated transcription, elongation	BP
1	2	1.32129956088	-	3.60e-01	GO:0021849	neuroblast division in subventricular zone	BP
1	2	1.32129956088	-	3.60e-01	GO:0070101	positive regulation of chemokine-mediated signaling pathway	BP
1	2	1.32129956088	-	3.60e-01	GO:0008615	pyridoxine biosynthetic process	BP
1	2	1.32129956088	-	3.60e-01	GO:2001045	negative regulation of integrin-mediated signaling pathway	BP
1	2	1.32129956088	-	3.60e-01	GO:0044869	negative regulation by host of viral exo-alpha-sialidase activity	BP
1	2	1.32129956088	-	3.60e-01	GO:0044860	protein localization to plasma membrane raft	BP
1	2	1.32129956088	-	3.60e-01	GO:2000594	positive regulation of metanephric DCT cell differentiation	BP
1	2	1.32129956088	-	3.60e-01	GO:0030997	regulation of centriole-centriole cohesion	BP
1	2	1.32129956088	-	3.60e-01	GO:0006542	glutamine biosynthetic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0060443	mammary gland morphogenesis	BP
1	2	1.32129956088	-	3.60e-01	GO:0032741	positive regulation of interleukin-18 production	BP
1	2	1.32129956088	-	3.60e-01	GO:0015847	putrescine transport	BP
1	2	1.32129956088	-	3.60e-01	GO:0002673	regulation of acute inflammatory response	BP
1	2	1.32129956088	-	3.60e-01	GO:0072422	signal transduction involved in DNA damage checkpoint	BP
1	2	1.32129956088	-	3.60e-01	GO:0060282	positive regulation of oocyte development	BP
1	2	1.32129956088	-	3.60e-01	GO:0071426	ribonucleoprotein complex export from nucleus	BP
1	2	1.32129956088	-	3.60e-01	GO:0038044	transforming growth factor-beta secretion	BP
1	2	1.32129956088	-	3.60e-01	GO:0061709	reticulophagy	BP
1	2	1.32129956088	-	3.60e-01	GO:1902532	negative regulation of intracellular signal transduction	BP
1	2	1.32129956088	-	3.60e-01	GO:0090260	negative regulation of retinal ganglion cell axon guidance	BP
1	2	1.32129956088	-	3.60e-01	GO:0036369	transcription factor catabolic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0002352	B cell negative selection	BP
1	2	1.32129956088	-	3.60e-01	GO:0072164	mesonephric tubule development	BP
1	2	1.32129956088	-	3.60e-01	GO:1905618	positive regulation of miRNA mediated inhibition of translation	BP
1	2	1.32129956088	-	3.60e-01	GO:0009756	carbohydrate mediated signaling	BP
1	2	1.32129956088	-	3.60e-01	GO:0007518	myoblast fate determination	BP
1	2	1.32129956088	-	3.60e-01	GO:0003062	regulation of heart rate by chemical signal	BP
1	2	1.32129956088	-	3.60e-01	GO:0003064	regulation of heart rate by hormone	BP
1	2	1.32129956088	-	3.60e-01	GO:1903422	negative regulation of synaptic vesicle recycling	BP
1	2	1.32129956088	-	3.60e-01	GO:0060538	skeletal muscle organ development	BP
1	2	1.32129956088	-	3.60e-01	GO:0032707	negative regulation of interleukin-23 production	BP
1	2	1.32129956088	-	3.60e-01	GO:0051458	corticotropin secretion	BP
1	2	1.32129956088	-	3.60e-01	GO:0061511	centriole elongation	BP
1	2	1.32129956088	-	3.60e-01	GO:0061518	microglial cell proliferation	BP
1	2	1.32129956088	-	3.60e-01	GO:1905451	positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis	BP
1	2	1.32129956088	-	3.60e-01	GO:0031345	negative regulation of cell projection organization	BP
1	2	1.32129956088	-	3.60e-01	GO:0060032	notochord regression	BP
1	2	1.32129956088	-	3.60e-01	GO:0071709	membrane assembly	BP
1	2	1.32129956088	-	3.60e-01	GO:0036324	vascular endothelial growth factor receptor-2 signaling pathway	BP
1	2	1.32129956088	-	3.60e-01	GO:2000041	negative regulation of planar cell polarity pathway involved in axis elongation	BP
1	2	1.32129956088	-	3.60e-01	GO:0032511	late endosome to vacuole transport via multivesicular body sorting pathway	BP
1	2	1.32129956088	-	3.60e-01	GO:0042109	lymphotoxin A biosynthetic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0009890	negative regulation of biosynthetic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0045136	development of secondary sexual characteristics	BP
1	2	1.32129956088	-	3.60e-01	GO:0045213	neurotransmitter receptor metabolic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0016441	posttranscriptional gene silencing	BP
1	2	1.32129956088	-	3.60e-01	GO:0090325	regulation of locomotion involved in locomotory behavior	BP
1	2	1.32129956088	-	3.60e-01	GO:0097332	response to antipsychotic drug	BP
1	2	1.32129956088	-	3.60e-01	GO:0002439	chronic inflammatory response to antigenic stimulus	BP
1	2	1.32129956088	-	3.60e-01	GO:0002431	Fc receptor mediated stimulatory signaling pathway	BP
1	2	1.32129956088	-	3.60e-01	GO:0031444	slow-twitch skeletal muscle fiber contraction	BP
1	2	1.32129956088	-	3.60e-01	GO:0032490	detection of molecule of bacterial origin	BP
1	2	1.32129956088	-	3.60e-01	GO:1904313	response to methamphetamine hydrochloride	BP
1	2	1.32129956088	-	3.60e-01	GO:0050748	negative regulation of lipoprotein metabolic process	BP
1	2	1.32129956088	-	3.60e-01	GO:2001288	positive regulation of caveolin-mediated endocytosis	BP
1	2	1.32129956088	-	3.60e-01	GO:0045401	positive regulation of interleukin-3 biosynthetic process	BP
1	2	1.32129956088	-	3.60e-01	GO:1990264	peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity	BP
1	2	1.32129956088	-	3.60e-01	GO:1904782	negative regulation of NMDA glutamate receptor activity	BP
1	2	1.32129956088	-	3.60e-01	GO:0002730	regulation of dendritic cell cytokine production	BP
1	2	1.32129956088	-	3.60e-01	GO:0060502	epithelial cell proliferation involved in lung morphogenesis	BP
1	2	1.32129956088	-	3.60e-01	GO:0048597	post-embryonic camera-type eye morphogenesis	BP
1	2	1.32129956088	-	3.60e-01	GO:1902957	negative regulation of mitochondrial electron transport, NADH to ubiquinone	BP
1	2	1.32129956088	-	3.60e-01	GO:0042991	transcription factor import into nucleus	BP
1	2	1.32129956088	-	3.60e-01	GO:0022037	metencephalon development	BP
1	2	1.32129956088	-	3.60e-01	GO:0014806	smooth muscle hyperplasia	BP
1	2	1.32129956088	-	3.60e-01	GO:0071506	cellular response to mycophenolic acid	BP
1	2	1.32129956088	-	3.60e-01	GO:1903147	negative regulation of autophagy of mitochondrion	BP
1	2	1.32129956088	-	3.60e-01	GO:0055026	negative regulation of cardiac muscle tissue development	BP
1	2	1.32129956088	-	3.60e-01	GO:0051252	regulation of RNA metabolic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0001927	exocyst assembly	BP
1	2	1.32129956088	-	3.60e-01	GO:0016340	calcium-dependent cell-matrix adhesion	BP
1	2	1.32129956088	-	3.60e-01	GO:0003404	optic vesicle morphogenesis	BP
1	2	1.32129956088	-	3.60e-01	GO:0048710	regulation of astrocyte differentiation	BP
1	2	1.32129956088	-	3.60e-01	GO:0070252	actin-mediated cell contraction	BP
1	2	1.32129956088	-	3.60e-01	GO:1900168	positive regulation of glial cell-derived neurotrophic factor secretion	BP
1	2	1.32129956088	-	3.60e-01	GO:0051877	pigment granule aggregation in cell center	BP
1	2	1.32129956088	-	3.60e-01	GO:2000627	positive regulation of miRNA catabolic process	BP
1	2	1.32129956088	-	3.60e-01	GO:2000620	positive regulation of histone H4-K16 acetylation	BP
1	2	1.32129956088	-	3.60e-01	GO:1990108	protein linear deubiquitination	BP
1	2	1.32129956088	-	3.60e-01	GO:0052314	phytoalexin metabolic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0098707	ferrous iron import across plasma membrane	BP
1	2	1.32129956088	-	3.60e-01	GO:0046098	guanine metabolic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0030382	sperm mitochondrion organization	BP
1	2	1.32129956088	-	3.60e-01	GO:0035441	cell migration involved in vasculogenesis	BP
1	2	1.32129956088	-	3.60e-01	GO:1903181	positive regulation of dopamine biosynthetic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0021836	chemorepulsion involved in postnatal olfactory bulb interneuron migration	BP
1	2	1.32129956088	-	3.60e-01	GO:0014728	regulation of the force of skeletal muscle contraction	BP
1	2	1.32129956088	-	3.60e-01	GO:0003193	pulmonary valve formation	BP
1	2	1.32129956088	-	3.60e-01	GO:0060125	negative regulation of growth hormone secretion	BP
1	2	1.32129956088	-	3.60e-01	GO:0060128	corticotropin hormone secreting cell differentiation	BP
1	2	1.32129956088	-	3.60e-01	GO:0002316	follicular B cell differentiation	BP
1	2	1.32129956088	-	3.60e-01	GO:2001038	regulation of cellular response to drug	BP
1	2	1.32129956088	-	3.60e-01	GO:0032416	negative regulation of sodium:proton antiporter activity	BP
1	2	1.32129956088	-	3.60e-01	GO:0071163	DNA replication preinitiation complex assembly	BP
1	2	1.32129956088	-	3.60e-01	GO:1904395	positive regulation of skeletal muscle acetylcholine-gated channel clustering	BP
1	2	1.32129956088	-	3.60e-01	GO:0046619	optic placode formation involved in camera-type eye formation	BP
1	2	1.32129956088	-	3.60e-01	GO:2001202	negative regulation of transforming growth factor-beta secretion	BP
1	2	1.32129956088	-	3.60e-01	GO:0090071	negative regulation of ribosome biogenesis	BP
1	2	1.32129956088	-	3.60e-01	GO:0035947	regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter	BP
1	2	1.32129956088	-	3.60e-01	GO:0090241	negative regulation of histone H4 acetylation	BP
1	2	1.32129956088	-	3.60e-01	GO:0072053	renal inner medulla development	BP
1	2	1.32129956088	-	3.60e-01	GO:0072054	renal outer medulla development	BP
1	2	1.32129956088	-	3.60e-01	GO:0001300	chronological cell aging	BP
1	2	1.32129956088	-	3.60e-01	GO:0003220	left ventricular cardiac muscle tissue morphogenesis	BP
1	2	1.32129956088	-	3.60e-01	GO:0014889	muscle atrophy	BP
1	2	1.32129956088	-	3.60e-01	GO:0014886	transition between slow and fast fiber	BP
1	2	1.32129956088	-	3.60e-01	GO:2000506	negative regulation of energy homeostasis	BP
1	2	1.32129956088	-	3.60e-01	GO:0001172	transcription, RNA-templated	BP
1	2	1.32129956088	-	3.60e-01	GO:0061153	trachea gland development	BP
1	2	1.32129956088	-	3.60e-01	GO:0021873	forebrain neuroblast division	BP
1	2	1.32129956088	-	3.60e-01	GO:0061302	smooth muscle cell-matrix adhesion	BP
1	2	1.32129956088	-	3.60e-01	GO:0044324	regulation of transcription involved in anterior/posterior axis specification	BP
1	2	1.32129956088	-	3.60e-01	GO:0002685	regulation of leukocyte migration	BP
1	2	1.32129956088	-	3.60e-01	GO:0002358	B cell homeostatic proliferation	BP
1	2	1.32129956088	-	3.60e-01	GO:0007497	posterior midgut development	BP
1	2	1.32129956088	-	3.60e-01	GO:2001076	positive regulation of metanephric ureteric bud development	BP
1	2	1.32129956088	-	3.60e-01	GO:1902992	negative regulation of amyloid precursor protein catabolic process	BP
1	2	1.32129956088	-	3.60e-01	GO:1903382	negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway	BP
1	2	1.32129956088	-	3.60e-01	GO:2000098	negative regulation of smooth muscle cell-matrix adhesion	BP
1	2	1.32129956088	-	3.60e-01	GO:0032305	positive regulation of icosanoid secretion	BP
1	2	1.32129956088	-	3.60e-01	GO:0071670	smooth muscle cell chemotaxis	BP
1	2	1.32129956088	-	3.60e-01	GO:0051299	centrosome separation	BP
1	2	1.32129956088	-	3.60e-01	GO:0032796	uropod organization	BP
1	2	1.32129956088	-	3.60e-01	GO:0010727	negative regulation of hydrogen peroxide metabolic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0060435	bronchiole development	BP
1	2	1.32129956088	-	3.60e-01	GO:0060434	bronchus morphogenesis	BP
1	2	1.32129956088	-	3.60e-01	GO:0002643	regulation of tolerance induction	BP
1	2	1.32129956088	-	3.60e-01	GO:1902170	cellular response to reactive nitrogen species	BP
1	2	1.32129956088	-	3.60e-01	GO:2000707	positive regulation of dense core granule biogenesis	BP
1	2	1.32129956088	-	3.60e-01	GO:0033364	mast cell secretory granule organization	BP
1	2	1.32129956088	-	3.60e-01	GO:1901529	positive regulation of anion channel activity	BP
1	2	1.32129956088	-	3.60e-01	GO:0048343	paraxial mesodermal cell fate commitment	BP
1	2	1.32129956088	-	3.60e-01	GO:0044871	negative regulation by host of viral glycoprotein metabolic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0009069	serine family amino acid metabolic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0035566	regulation of metanephros size	BP
1	2	1.32129956088	-	3.60e-01	GO:0001805	positive regulation of type III hypersensitivity	BP
1	2	1.32129956088	-	3.60e-01	GO:0051124	synaptic growth at neuromuscular junction	BP
1	2	1.32129956088	-	3.60e-01	GO:1904293	negative regulation of ERAD pathway	BP
1	2	1.32129956088	-	3.60e-01	GO:0070668	positive regulation of mast cell proliferation	BP
1	2	1.32129956088	-	3.60e-01	GO:1904059	regulation of locomotor rhythm	BP
1	2	1.32129956088	-	3.60e-01	GO:0014062	regulation of serotonin secretion	BP
1	2	1.32129956088	-	3.60e-01	GO:1900215	negative regulation of apoptotic process involved in metanephric collecting duct development	BP
1	2	1.32129956088	-	3.60e-01	GO:1900218	negative regulation of apoptotic process involved in metanephric nephron tubule development	BP
1	2	1.32129956088	-	3.60e-01	GO:0072318	clathrin coat disassembly	BP
1	2	1.32129956088	-	3.60e-01	GO:1904209	positive regulation of chemokine (C-C motif) ligand 2 secretion	BP
1	2	1.32129956088	-	3.60e-01	GO:0070427	nucleotide-binding oligomerization domain containing 1 signaling pathway	BP
1	2	1.32129956088	-	3.60e-01	GO:0048669	collateral sprouting in absence of injury	BP
1	2	1.32129956088	-	3.60e-01	GO:1905606	regulation of presynapse assembly	BP
1	2	1.32129956088	-	3.60e-01	GO:0007521	muscle cell fate determination	BP
1	2	1.32129956088	-	3.60e-01	GO:0007525	somatic muscle development	BP
1	2	1.32129956088	-	3.60e-01	GO:0071900	regulation of protein serine/threonine kinase activity	BP
1	2	1.32129956088	-	3.60e-01	GO:2000017	positive regulation of determination of dorsal identity	BP
1	2	1.32129956088	-	3.60e-01	GO:2000016	negative regulation of determination of dorsal identity	BP
1	2	1.32129956088	-	3.60e-01	GO:0046104	thymidine metabolic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0033043	regulation of organelle organization	BP
1	2	1.32129956088	-	3.60e-01	GO:1903849	positive regulation of aorta morphogenesis	BP
1	2	1.32129956088	-	3.60e-01	GO:1902823	negative regulation of late endosome to lysosome transport	BP
1	2	1.32129956088	-	3.60e-01	GO:1902824	positive regulation of late endosome to lysosome transport	BP
1	2	1.32129956088	-	3.60e-01	GO:0019265	glycine biosynthetic process, by transamination of glyoxylate	BP
1	2	1.32129956088	-	3.60e-01	GO:0043506	regulation of JUN kinase activity	BP
1	2	1.32129956088	-	3.60e-01	GO:0043503	skeletal muscle fiber adaptation	BP
1	2	1.32129956088	-	3.60e-01	GO:0061833	protein localization to tricellular tight junction	BP
1	2	1.32129956088	-	3.60e-01	GO:0045161	neuronal ion channel clustering	BP
1	2	1.32129956088	-	3.60e-01	GO:0070977	bone maturation	BP
1	2	1.32129956088	-	3.60e-01	GO:2000194	regulation of female gonad development	BP
1	2	1.32129956088	-	3.60e-01	GO:0051548	negative regulation of keratinocyte migration	BP
1	2	1.32129956088	-	3.60e-01	GO:0019100	male germ-line sex determination	BP
1	2	1.32129956088	-	3.60e-01	GO:0030221	basophil differentiation	BP
1	2	1.32129956088	-	3.60e-01	GO:0042322	negative regulation of circadian sleep/wake cycle, REM sleep	BP
1	2	1.32129956088	-	3.60e-01	GO:1903393	positive regulation of adherens junction organization	BP
1	2	1.32129956088	-	3.60e-01	GO:0050711	negative regulation of interleukin-1 secretion	BP
1	2	1.32129956088	-	3.60e-01	GO:0002192	IRES-dependent translational initiation of linear mRNA	BP
1	2	1.32129956088	-	3.60e-01	GO:0072709	cellular response to sorbitol	BP
1	2	1.32129956088	-	3.60e-01	GO:0021599	abducens nerve formation	BP
1	2	1.32129956088	-	3.60e-01	GO:0060577	pulmonary vein morphogenesis	BP
1	2	1.32129956088	-	3.60e-01	GO:0042495	detection of triacyl bacterial lipopeptide	BP
1	2	1.32129956088	-	3.60e-01	GO:1902722	positive regulation of prolactin secretion	BP
1	2	1.32129956088	-	3.60e-01	GO:0014839	myoblast migration involved in skeletal muscle regeneration	BP
1	2	1.32129956088	-	3.60e-01	GO:2000426	negative regulation of apoptotic cell clearance	BP
1	2	1.32129956088	-	3.60e-01	GO:0071283	cellular response to iron(III) ion	BP
1	2	1.32129956088	-	3.60e-01	GO:0033007	negative regulation of mast cell activation involved in immune response	BP
1	2	1.32129956088	-	3.60e-01	GO:0035922	foramen ovale closure	BP
1	2	1.32129956088	-	3.60e-01	GO:0043314	negative regulation of neutrophil degranulation	BP
1	2	1.32129956088	-	3.60e-01	GO:0043313	regulation of neutrophil degranulation	BP
1	2	1.32129956088	-	3.60e-01	GO:2000309	positive regulation of tumor necrosis factor (ligand) superfamily member 11 production	BP
1	2	1.32129956088	-	3.60e-01	GO:0006407	rRNA export from nucleus	BP
1	2	1.32129956088	-	3.60e-01	GO:1903566	positive regulation of protein localization to cilium	BP
1	2	1.32129956088	-	3.60e-01	GO:0009609	response to symbiotic bacterium	BP
1	2	1.32129956088	-	3.60e-01	GO:2000156	regulation of retrograde vesicle-mediated transport, Golgi to ER	BP
1	2	1.32129956088	-	3.60e-01	GO:2000157	negative regulation of ubiquitin-specific protease activity	BP
1	2	1.32129956088	-	3.60e-01	GO:2000158	positive regulation of ubiquitin-specific protease activity	BP
1	2	1.32129956088	-	3.60e-01	GO:0021940	positive regulation of cerebellar granule cell precursor proliferation	BP
1	2	1.32129956088	-	3.60e-01	GO:0021941	negative regulation of cerebellar granule cell precursor proliferation	BP
1	2	1.32129956088	-	3.60e-01	GO:0045624	positive regulation of T-helper cell differentiation	BP
1	2	1.32129956088	-	3.60e-01	GO:0031134	sister chromatid biorientation	BP
1	2	1.32129956088	-	3.60e-01	GO:0034243	regulation of transcription elongation from RNA polymerase II promoter	BP
1	2	1.32129956088	-	3.60e-01	GO:0038183	bile acid signaling pathway	BP
1	2	1.32129956088	-	3.60e-01	GO:1990791	dorsal root ganglion development	BP
1	2	1.32129956088	-	3.60e-01	GO:0060532	bronchus cartilage development	BP
1	2	1.32129956088	-	3.60e-01	GO:0048588	developmental cell growth	BP
1	2	1.32129956088	-	3.60e-01	GO:0045988	negative regulation of striated muscle contraction	BP
1	2	1.32129956088	-	3.60e-01	GO:1902766	skeletal muscle satellite cell migration	BP
1	2	1.32129956088	-	3.60e-01	GO:0032607	interferon-alpha production	BP
1	2	1.32129956088	-	3.60e-01	GO:1904674	positive regulation of somatic stem cell population maintenance	BP
1	2	1.32129956088	-	3.60e-01	GO:0045041	protein import into mitochondrial intermembrane space	BP
1	2	1.32129956088	-	3.60e-01	GO:2000342	negative regulation of chemokine (C-X-C motif) ligand 2 production	BP
1	2	1.32129956088	-	3.60e-01	GO:2000340	positive regulation of chemokine (C-X-C motif) ligand 1 production	BP
1	2	1.32129956088	-	3.60e-01	GO:0002448	mast cell mediated immunity	BP
1	2	1.32129956088	-	3.60e-01	GO:0061647	histone H3-K9 modification	BP
1	2	1.32129956088	-	3.60e-01	GO:0016185	synaptic vesicle budding from presynaptic endocytic zone membrane	BP
1	2	1.32129956088	-	3.60e-01	GO:1900195	positive regulation of oocyte maturation	BP
1	2	1.32129956088	-	3.60e-01	GO:1902595	regulation of DNA replication origin binding	BP
1	2	1.32129956088	-	3.60e-01	GO:0061402	positive regulation of transcription from RNA polymerase II promoter in response to acidic pH	BP
1	2	1.32129956088	-	3.60e-01	GO:0086003	cardiac muscle cell contraction	BP
1	2	1.32129956088	-	3.60e-01	GO:1903056	regulation of melanosome organization	BP
1	2	1.32129956088	-	3.60e-01	GO:0042418	epinephrine biosynthetic process	BP
1	2	1.32129956088	-	3.60e-01	GO:1905279	regulation of retrograde transport, endosome to Golgi	BP
1	2	1.32129956088	-	3.60e-01	GO:0046068	cGMP metabolic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0019883	antigen processing and presentation of endogenous antigen	BP
1	2	1.32129956088	-	3.60e-01	GO:0001976	neurological system process involved in regulation of systemic arterial blood pressure	BP
1	2	1.32129956088	-	3.60e-01	GO:0035606	peptidyl-cysteine S-trans-nitrosylation	BP
1	2	1.32129956088	-	3.60e-01	GO:0014736	negative regulation of muscle atrophy	BP
1	2	1.32129956088	-	3.60e-01	GO:0098886	modification of dendritic spine	BP
1	2	1.32129956088	-	3.60e-01	GO:0042590	antigen processing and presentation of exogenous peptide antigen via MHC class I	BP
1	2	1.32129956088	-	3.60e-01	GO:0060152	microtubule-based peroxisome localization	BP
1	2	1.32129956088	-	3.60e-01	GO:0002302	CD8-positive, alpha-beta T cell differentiation involved in immune response	BP
1	2	1.32129956088	-	3.60e-01	GO:0034124	regulation of MyD88-dependent toll-like receptor signaling pathway	BP
1	2	1.32129956088	-	3.60e-01	GO:0050867	positive regulation of cell activation	BP
1	2	1.32129956088	-	3.60e-01	GO:0010949	negative regulation of intestinal phytosterol absorption	BP
1	2	1.32129956088	-	3.60e-01	GO:0061441	renal artery morphogenesis	BP
1	2	1.32129956088	-	3.60e-01	GO:0086043	bundle of His cell action potential	BP
1	2	1.32129956088	-	3.60e-01	GO:1903016	negative regulation of exo-alpha-sialidase activity	BP
1	2	1.32129956088	-	3.60e-01	GO:1903019	negative regulation of glycoprotein metabolic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0036496	regulation of translational initiation by eIF2 alpha dephosphorylation	BP
1	2	1.32129956088	-	3.60e-01	GO:2000538	positive regulation of B cell chemotaxis	BP
1	2	1.32129956088	-	3.60e-01	GO:0033484	nitric oxide homeostasis	BP
1	2	1.32129956088	-	3.60e-01	GO:0032682	negative regulation of chemokine production	BP
1	2	1.32129956088	-	3.60e-01	GO:1990619	histone H3-K9 deacetylation	BP
1	2	1.32129956088	-	3.60e-01	GO:1902283	negative regulation of primary amine oxidase activity	BP
1	2	1.32129956088	-	3.60e-01	GO:1905778	negative regulation of exonuclease activity	BP
1	2	1.32129956088	-	3.60e-01	GO:1901253	negative regulation of intracellular transport of viral material	BP
1	2	1.32129956088	-	3.60e-01	GO:1901255	nucleotide-excision repair involved in interstrand cross-link repair	BP
1	2	1.32129956088	-	3.60e-01	GO:0003162	atrioventricular node development	BP
1	2	1.32129956088	-	3.60e-01	GO:0003169	coronary vein morphogenesis	BP
1	2	1.32129956088	-	3.60e-01	GO:1904021	negative regulation of G-protein coupled receptor internalization	BP
1	2	1.32129956088	-	3.60e-01	GO:0061317	canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment	BP
1	2	1.32129956088	-	3.60e-01	GO:0031943	regulation of glucocorticoid metabolic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0002692	negative regulation of cellular extravasation	BP
1	2	1.32129956088	-	3.60e-01	GO:0031204	posttranslational protein targeting to membrane, translocation	BP
1	2	1.32129956088	-	3.60e-01	GO:0032834	positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response	BP
1	2	1.32129956088	-	3.60e-01	GO:0005999	xylulose biosynthetic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0051343	positive regulation of cyclic-nucleotide phosphodiesterase activity	BP
1	2	1.32129956088	-	3.60e-01	GO:0002528	regulation of vascular permeability involved in acute inflammatory response	BP
1	2	1.32129956088	-	3.60e-01	GO:0002522	leukocyte migration involved in immune response	BP
1	2	1.32129956088	-	3.60e-01	GO:0045082	positive regulation of interleukin-10 biosynthetic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0018205	peptidyl-lysine modification	BP
1	2	1.32129956088	-	3.60e-01	GO:0032762	mast cell cytokine production	BP
1	2	1.32129956088	-	3.60e-01	GO:0032764	negative regulation of mast cell cytokine production	BP
1	2	1.32129956088	-	3.60e-01	GO:0071874	cellular response to norepinephrine stimulus	BP
1	2	1.32129956088	-	3.60e-01	GO:0071879	positive regulation of adrenergic receptor signaling pathway	BP
1	2	1.32129956088	-	3.60e-01	GO:0019550	glutamate catabolic process to aspartate	BP
1	2	1.32129956088	-	3.60e-01	GO:0019551	glutamate catabolic process to 2-oxoglutarate	BP
1	2	1.32129956088	-	3.60e-01	GO:0003127	detection of nodal flow	BP
1	2	1.32129956088	-	3.60e-01	GO:0045337	farnesyl diphosphate biosynthetic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0014908	myotube differentiation involved in skeletal muscle regeneration	BP
1	2	1.32129956088	-	3.60e-01	GO:0044062	regulation of excretion	BP
1	2	1.32129956088	-	3.60e-01	GO:2000779	regulation of double-strand break repair	BP
1	2	1.32129956088	-	3.60e-01	GO:2000777	positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia	BP
1	2	1.32129956088	-	3.60e-01	GO:0061723	glycophagy	BP
1	2	1.32129956088	-	3.60e-01	GO:1903438	positive regulation of mitotic cytokinetic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0039003	pronephric field specification	BP
1	2	1.32129956088	-	3.60e-01	GO:0097021	lymphocyte migration into lymphoid organs	BP
1	2	1.32129956088	-	3.60e-01	GO:0006286	base-excision repair, base-free sugar-phosphate removal	BP
1	2	1.32129956088	-	3.60e-01	GO:0006285	base-excision repair, AP site formation	BP
1	2	1.32129956088	-	3.60e-01	GO:1903094	negative regulation of protein K48-linked deubiquitination	BP
1	2	1.32129956088	-	3.60e-01	GO:0048638	regulation of developmental growth	BP
1	2	1.32129956088	-	3.60e-01	GO:0051303	establishment of chromosome localization	BP
1	2	1.32129956088	-	3.60e-01	GO:0001838	embryonic epithelial tube formation	BP
1	2	1.32129956088	-	3.60e-01	GO:0002029	desensitization of G-protein coupled receptor protein signaling pathway	BP
1	2	1.32129956088	-	3.60e-01	GO:0019516	lactate oxidation	BP
1	2	1.32129956088	-	3.60e-01	GO:0035022	positive regulation of Rac protein signal transduction	BP
1	2	1.32129956088	-	3.60e-01	GO:0014057	positive regulation of acetylcholine secretion, neurotransmission	BP
1	2	1.32129956088	-	3.60e-01	GO:1902692	regulation of neuroblast proliferation	BP
1	2	1.32129956088	-	3.60e-01	GO:0044027	hypermethylation of CpG island	BP
1	2	1.32129956088	-	3.60e-01	GO:0044029	hypomethylation of CpG island	BP
1	2	1.32129956088	-	3.60e-01	GO:1900221	regulation of amyloid-beta clearance	BP
1	2	1.32129956088	-	3.60e-01	GO:2000276	negative regulation of oxidative phosphorylation uncoupler activity	BP
1	2	1.32129956088	-	3.60e-01	GO:1904379	protein localization to cytosolic proteasome complex involved in ERAD pathway	BP
1	2	1.32129956088	-	3.60e-01	GO:0051445	regulation of meiotic cell cycle	BP
1	2	1.32129956088	-	3.60e-01	GO:0035511	oxidative DNA demethylation	BP
1	2	1.32129956088	-	3.60e-01	GO:0060978	angiogenesis involved in coronary vascular morphogenesis	BP
1	2	1.32129956088	-	3.60e-01	GO:0036344	platelet morphogenesis	BP
1	2	1.32129956088	-	3.60e-01	GO:0071396	cellular response to lipid	BP
1	2	1.32129956088	-	3.60e-01	GO:0015942	formate metabolic process	BP
1	2	1.32129956088	-	3.60e-01	GO:1903441	protein localization to ciliary membrane	BP
1	2	1.32129956088	-	3.60e-01	GO:2000473	positive regulation of hematopoietic stem cell migration	BP
1	2	1.32129956088	-	3.60e-01	GO:2000474	regulation of opioid receptor signaling pathway	BP
1	2	1.32129956088	-	3.60e-01	GO:0032986	protein-DNA complex disassembly	BP
1	2	1.32129956088	-	3.60e-01	GO:0006043	glucosamine catabolic process	BP
1	2	1.32129956088	-	3.60e-01	GO:1905386	positive regulation of protein localization to presynapse	BP
1	2	1.32129956088	-	3.60e-01	GO:0021722	superior olivary nucleus maturation	BP
1	2	1.32129956088	-	3.60e-01	GO:0046331	lateral inhibition	BP
1	2	1.32129956088	-	3.60e-01	GO:0035305	negative regulation of dephosphorylation	BP
1	2	1.32129956088	-	3.60e-01	GO:0032214	negative regulation of telomere maintenance via semi-conservative replication	BP
1	2	1.32129956088	-	3.60e-01	GO:0070230	positive regulation of lymphocyte apoptotic process	BP
1	2	1.32129956088	-	3.60e-01	GO:1904338	regulation of dopaminergic neuron differentiation	BP
1	2	1.32129956088	-	3.60e-01	GO:0045796	negative regulation of intestinal cholesterol absorption	BP
1	2	1.32129956088	-	3.60e-01	GO:0086097	phospholipase C-activating angiotensin-activated signaling pathway	BP
1	2	1.32129956088	-	3.60e-01	GO:0032943	mononuclear cell proliferation	BP
1	2	1.32129956088	-	3.60e-01	GO:0031328	positive regulation of cellular biosynthetic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0090308	regulation of methylation-dependent chromatin silencing	BP
1	2	1.32129956088	-	3.60e-01	GO:0072179	nephric duct formation	BP
1	2	1.32129956088	-	3.60e-01	GO:0097359	UDP-glucosylation	BP
1	2	1.32129956088	-	3.60e-01	GO:0033561	regulation of water loss via skin	BP
1	2	1.32129956088	-	3.60e-01	GO:0072697	protein localization to cell cortex	BP
1	2	1.32129956088	-	3.60e-01	GO:0097111	endoplasmic reticulum-Golgi intermediate compartment organization	BP
1	2	1.32129956088	-	3.60e-01	GO:0060713	labyrinthine layer morphogenesis	BP
1	2	1.32129956088	-	3.60e-01	GO:0002710	negative regulation of T cell mediated immunity	BP
1	2	1.32129956088	-	3.60e-01	GO:0002711	positive regulation of T cell mediated immunity	BP
1	2	1.32129956088	-	3.60e-01	GO:0002717	positive regulation of natural killer cell mediated immunity	BP
1	2	1.32129956088	-	3.60e-01	GO:0038194	thyroid-stimulating hormone signaling pathway	BP
1	2	1.32129956088	-	3.60e-01	GO:0045994	positive regulation of translational initiation by iron	BP
1	2	1.32129956088	-	3.60e-01	GO:0006163	purine nucleotide metabolic process	BP
1	2	1.32129956088	-	3.60e-01	GO:0072033	renal vesicle formation	BP
1	2	1.32129956088	-	3.60e-01	GO:1902938	regulation of intracellular calcium activated chloride channel activity	BP
35	70	1.32129956088	-	4.26e-09	GO:0002039	p53 binding	MF
14	28	1.32129956088	-	2.26e-04	GO:0033613	activating transcription factor binding	MF
8	16	1.32129956088	-	6.99e-03	GO:0000400	four-way junction DNA binding	MF
8	16	1.32129956088	-	6.99e-03	GO:0051393	alpha-actinin binding	MF
8	16	1.32129956088	-	6.99e-03	GO:0046965	retinoid X receptor binding	MF
3	6	1.32129956088	-	8.00e-03	GO:0045545	syndecan binding	MF
6	12	1.32129956088	-	1.16e-02	GO:0030695	GTPase regulator activity	MF
6	12	1.32129956088	-	1.94e-02	GO:0031994	insulin-like growth factor I binding	MF
5	10	1.32129956088	-	1.96e-02	GO:0016504	peptidase activator activity	MF
5	10	1.32129956088	-	3.28e-02	GO:0042805	actinin binding	MF
5	10	1.32129956088	-	3.28e-02	GO:0045294	alpha-catenin binding	MF
5	10	1.32129956088	-	3.28e-02	GO:0030957	Tat protein binding	MF
4	8	1.32129956088	-	3.34e-02	GO:0017151	DEAD/H-box RNA helicase binding	MF
2	4	1.32129956088	-	4.00e-02	GO:0016286	small conductance calcium-activated potassium channel activity	MF
2	4	1.32129956088	-	4.00e-02	GO:0004515	nicotinate-nucleotide adenylyltransferase activity	MF
4	8	1.32129956088	-	5.63e-02	GO:0097027	ubiquitin-protein transferase activator activity	MF
4	8	1.32129956088	-	5.63e-02	GO:0000150	recombinase activity	MF
4	8	1.32129956088	-	5.63e-02	GO:0031748	D1 dopamine receptor binding	MF
4	8	1.32129956088	-	5.63e-02	GO:0030306	ADP-ribosylation factor binding	MF
4	8	1.32129956088	-	5.63e-02	GO:0031995	insulin-like growth factor II binding	MF
4	8	1.32129956088	-	5.63e-02	GO:0035591	signaling adaptor activity	MF
3	6	1.32129956088	-	5.80e-02	GO:0098821	BMP receptor activity	MF
3	6	1.32129956088	-	9.89e-02	GO:0004704	NF-kappaB-inducing kinase activity	MF
3	6	1.32129956088	-	9.89e-02	GO:0005024	transforming growth factor beta-activated receptor activity	MF
3	6	1.32129956088	-	9.89e-02	GO:1903136	cuprous ion binding	MF
3	6	1.32129956088	-	9.89e-02	GO:0048406	nerve growth factor binding	MF
3	6	1.32129956088	-	9.89e-02	GO:0030275	LRR domain binding	MF
3	6	1.32129956088	-	9.89e-02	GO:0030911	TPR domain binding	MF
3	6	1.32129956088	-	9.89e-02	GO:0031730	CCR5 chemokine receptor binding	MF
3	6	1.32129956088	-	9.89e-02	GO:0000403	Y-form DNA binding	MF
3	6	1.32129956088	-	9.89e-02	GO:0035254	glutamate receptor binding	MF
3	6	1.32129956088	-	9.89e-02	GO:0071253	connexin binding	MF
3	6	1.32129956088	-	9.89e-02	GO:0050693	LBD domain binding	MF
3	6	1.32129956088	-	9.89e-02	GO:0032357	oxidized purine DNA binding	MF
2	4	1.32129956088	-	1.04e-01	GO:0001851	complement component C3b binding	MF
2	4	1.32129956088	-	1.04e-01	GO:0044323	retinoic acid-responsive element binding	MF
2	4	1.32129956088	-	1.04e-01	GO:0001032	RNA polymerase III type 3 promoter DNA binding	MF
2	4	1.32129956088	-	1.04e-01	GO:0004035	alkaline phosphatase activity	MF
2	4	1.32129956088	-	1.04e-01	GO:0051430	corticotropin-releasing hormone receptor 1 binding	MF
2	4	1.32129956088	-	1.81e-01	GO:0061676	importin-alpha family protein binding	MF
2	4	1.32129956088	-	1.81e-01	GO:0005105	type 1 fibroblast growth factor receptor binding	MF
2	4	1.32129956088	-	1.81e-01	GO:0043208	glycosphingolipid binding	MF
2	4	1.32129956088	-	1.81e-01	GO:0004740	pyruvate dehydrogenase (acetyl-transferring) kinase activity	MF
2	4	1.32129956088	-	1.81e-01	GO:0001012	RNA polymerase II regulatory region DNA binding	MF
2	4	1.32129956088	-	1.81e-01	GO:0031014	troponin T binding	MF
2	4	1.32129956088	-	1.81e-01	GO:1904288	BAT3 complex binding	MF
2	4	1.32129956088	-	1.81e-01	GO:0004677	DNA-dependent protein kinase activity	MF
2	4	1.32129956088	-	1.81e-01	GO:0030546	receptor activator activity	MF
2	4	1.32129956088	-	1.81e-01	GO:0030375	thyroid hormone receptor coactivator activity	MF
2	4	1.32129956088	-	1.81e-01	GO:0034056	estrogen response element binding	MF
2	4	1.32129956088	-	1.81e-01	GO:0031852	mu-type opioid receptor binding	MF
2	4	1.32129956088	-	1.81e-01	GO:0034191	apolipoprotein A-I receptor binding	MF
2	4	1.32129956088	-	1.81e-01	GO:0005087	Ran guanyl-nucleotide exchange factor activity	MF
2	4	1.32129956088	-	1.81e-01	GO:0008607	phosphorylase kinase regulator activity	MF
2	4	1.32129956088	-	1.81e-01	GO:0001882	nucleoside binding	MF
2	4	1.32129956088	-	1.81e-01	GO:0086089	voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization	MF
2	4	1.32129956088	-	1.81e-01	GO:0071535	RING-like zinc finger domain binding	MF
2	4	1.32129956088	-	1.81e-01	GO:0005497	androgen binding	MF
2	4	1.32129956088	-	1.81e-01	GO:0032564	dATP binding	MF
2	4	1.32129956088	-	1.81e-01	GO:0033192	calmodulin-dependent protein phosphatase activity	MF
2	4	1.32129956088	-	1.81e-01	GO:0016505	peptidase activator activity involved in apoptotic process	MF
2	4	1.32129956088	-	1.81e-01	GO:0097016	L27 domain binding	MF
2	4	1.32129956088	-	1.81e-01	GO:0004897	ciliary neurotrophic factor receptor activity	MF
2	4	1.32129956088	-	1.81e-01	GO:0061821	telomeric D-loop binding	MF
1	2	1.32129956088	-	2.00e-01	GO:0017057	6-phosphogluconolactonase activity	MF
1	2	1.32129956088	-	2.00e-01	GO:0051377	mannose-ethanolamine phosphotransferase activity	MF
1	2	1.32129956088	-	2.00e-01	GO:0017098	sulfonylurea receptor binding	MF
1	2	1.32129956088	-	2.00e-01	GO:0103073	anandamide amidohydrolase activity	MF
1	2	1.32129956088	-	2.00e-01	GO:0008294	calcium- and calmodulin-responsive adenylate cyclase activity	MF
1	2	1.32129956088	-	2.00e-01	GO:0005026	transforming growth factor beta receptor activity, type II	MF
1	2	1.32129956088	-	2.00e-01	GO:0004782	sulfinoalanine decarboxylase activity	MF
1	2	1.32129956088	-	2.00e-01	GO:0045145	single-stranded DNA 5'-3' exodeoxyribonuclease activity	MF
1	2	1.32129956088	-	2.00e-01	GO:0002134	UTP binding	MF
1	2	1.32129956088	-	2.00e-01	GO:0086062	voltage-gated sodium channel activity involved in Purkinje myocyte action potential	MF
1	2	1.32129956088	-	2.00e-01	GO:0017064	fatty acid amide hydrolase activity	MF
1	2	1.32129956088	-	2.00e-01	GO:0030549	acetylcholine receptor activator activity	MF
1	2	1.32129956088	-	2.00e-01	GO:0003920	GMP reductase activity	MF
1	2	1.32129956088	-	2.00e-01	GO:0060072	large conductance calcium-activated potassium channel activity	MF
1	2	1.32129956088	-	2.00e-01	GO:0016151	nickel cation binding	MF
1	2	1.32129956088	-	2.00e-01	GO:0016857	racemase and epimerase activity, acting on carbohydrates and derivatives	MF
1	2	1.32129956088	-	2.00e-01	GO:1903763	gap junction channel activity involved in cell communication by electrical coupling	MF
1	2	1.32129956088	-	2.00e-01	GO:0004066	asparagine synthase (glutamine-hydrolyzing) activity	MF
1	2	1.32129956088	-	2.00e-01	GO:0015168	glycerol transmembrane transporter activity	MF
1	2	1.32129956088	-	2.00e-01	GO:0019809	spermidine binding	MF
1	2	1.32129956088	-	2.00e-01	GO:0090555	phosphatidylethanolamine-translocating ATPase activity	MF
1	2	1.32129956088	-	2.00e-01	GO:0031685	adenosine receptor binding	MF
1	2	1.32129956088	-	2.00e-01	GO:0004140	dephospho-CoA kinase activity	MF
1	2	1.32129956088	-	2.00e-01	GO:0016433	rRNA (adenine) methyltransferase activity	MF
1	2	1.32129956088	-	2.00e-01	GO:0004458	D-lactate dehydrogenase (cytochrome) activity	MF
1	2	1.32129956088	-	2.00e-01	GO:0004750	ribulose-phosphate 3-epimerase activity	MF
1	2	1.32129956088	-	2.00e-01	GO:0046811	histone deacetylase inhibitor activity	MF
1	2	1.32129956088	-	2.00e-01	GO:0031208	POZ domain binding	MF
1	2	1.32129956088	-	2.00e-01	GO:0001607	neuromedin U receptor activity	MF
1	2	1.32129956088	-	2.00e-01	GO:0045509	interleukin-27 receptor activity	MF
1	2	1.32129956088	-	2.00e-01	GO:0102077	oleamide hydrolase activity	MF
1	2	1.32129956088	-	2.00e-01	GO:0004510	tryptophan 5-monooxygenase activity	MF
1	2	1.32129956088	-	2.00e-01	GO:0042284	sphingolipid delta-4 desaturase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0004996	thyroid-stimulating hormone receptor activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0004991	parathyroid hormone receptor activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0004667	prostaglandin-D synthase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0016362	activin receptor activity, type II	MF
1	2	1.32129956088	-	3.60e-01	GO:0004723	calcium-dependent protein serine/threonine phosphatase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0034736	cholesterol O-acyltransferase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0098531	transcription factor activity, direct ligand regulated sequence-specific DNA binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0048101	calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0004743	pyruvate kinase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0010698	acetyltransferase activator activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0019912	cyclin-dependent protein kinase activating kinase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0033142	progesterone receptor binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0004917	interleukin-7 receptor activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0004918	interleukin-8 receptor activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0031543	peptidyl-proline dioxygenase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0001632	leukotriene B4 receptor activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0050253	retinyl-palmitate esterase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0030984	kininogen binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0050682	AF-2 domain binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0019207	kinase regulator activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0061733	peptide-lysine-N-acetyltransferase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0015432	bile acid-exporting ATPase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0033883	pyridoxal phosphatase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0052642	lysophosphatidic acid phosphatase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0008311	double-stranded DNA 3'-5' exodeoxyribonuclease activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0070990	snRNP binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0035500	MH2 domain binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0008781	N-acylneuraminate cytidylyltransferase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0048256	flap endonuclease activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0004337	geranyltranstransferase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0032038	myosin II heavy chain binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0052815	medium-chain acyl-CoA hydrolase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0004356	glutamate-ammonia ligase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0004352	glutamate dehydrogenase (NAD+) activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0004161	dimethylallyltranstransferase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0008113	peptide-methionine (S)-S-oxide reductase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0016410	N-acyltransferase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0016411	acylglycerol O-acyltransferase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0035379	carbon dioxide transmembrane transporter activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0099609	microtubule lateral binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0086020	gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling	MF
1	2	1.32129956088	-	3.60e-01	GO:0019981	interleukin-6 binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0032422	purine-rich negative regulatory element binding	MF
1	2	1.32129956088	-	3.60e-01	GO:1904713	beta-catenin destruction complex binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0033857	diphosphoinositol-pentakisphosphate kinase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0047710	bis(5'-adenosyl)-triphosphatase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0016005	phospholipase A2 activator activity	MF
1	2	1.32129956088	-	3.60e-01	GO:1990404	protein ADP-ribosylase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0031749	D2 dopamine receptor binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0003968	RNA-directed 5'-3' RNA polymerase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0051717	inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0008263	pyrimidine-specific mismatch base pair DNA N-glycosylase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0004906	interferon-gamma receptor activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0015079	potassium ion transmembrane transporter activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0061749	forked DNA-dependent helicase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0016524	latrotoxin receptor activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0032810	sterol response element binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0019002	GMP binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0019948	SUMO activating enzyme activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0030337	DNA polymerase processivity factor activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0004053	arginase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0004530	deoxyribonuclease I activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0001003	RNA polymerase III type 2 promoter sequence-specific DNA binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0001002	RNA polymerase III type 1 promoter sequence-specific DNA binding	MF
1	2	1.32129956088	-	3.60e-01	GO:1901611	phosphatidylglycerol binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0061849	telomeric G-quadruplex DNA binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0008309	double-stranded DNA exodeoxyribonuclease activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0004119	cGMP-inhibited cyclic-nucleotide phosphodiesterase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0004915	interleukin-6 receptor activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0004913	interleukin-4 receptor activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0090541	MIT domain binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0015489	putrescine transmembrane transporter activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0070026	nitric oxide binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0030617	transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0004797	thymidine kinase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0004609	phosphatidylserine decarboxylase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0005128	erythropoietin receptor binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0005135	interleukin-3 receptor binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0001134	transcription factor activity, transcription factor recruiting	MF
1	2	1.32129956088	-	3.60e-01	GO:0010736	serum response element binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0030109	HLA-B specific inhibitory MHC class I receptor activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0086077	gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling	MF
1	2	1.32129956088	-	3.60e-01	GO:0030551	cyclic nucleotide binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0016890	site-specific endodeoxyribonuclease activity, specific for altered base	MF
1	2	1.32129956088	-	3.60e-01	GO:0035800	deubiquitinase activator activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0016534	cyclin-dependent protein kinase 5 activator activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0001071	nucleic acid binding transcription factor activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0097003	adipokinetic hormone receptor activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0005006	epidermal growth factor-activated receptor activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0003870	5-aminolevulinate synthase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0005110	frizzled-2 binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0035014	phosphatidylinositol 3-kinase regulator activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0008170	N-methyltransferase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0042903	tubulin deacetylase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0004357	glutamate-cysteine ligase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0004353	glutamate dehydrogenase [NAD(P)+] activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0098808	mRNA cap binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0005174	CD40 receptor binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0046969	NAD-dependent histone deacetylase activity (H3-K9 specific)	MF
1	2	1.32129956088	-	3.60e-01	GO:0097363	protein O-GlcNAc transferase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0004613	phosphoenolpyruvate carboxykinase (GTP) activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0017002	activin-activated receptor activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0005137	interleukin-5 receptor binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0001729	ceramide kinase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0004450	isocitrate dehydrogenase (NADP+) activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0033549	MAP kinase phosphatase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0032090	Pyrin domain binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0017042	glycosylceramidase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0031729	CCR4 chemokine receptor binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0004923	leukemia inhibitory factor receptor activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0004692	cGMP-dependent protein kinase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0030156	benzodiazepine receptor binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0016780	phosphotransferase activity, for other substituted phosphate groups	MF
1	2	1.32129956088	-	3.60e-01	GO:0070699	type II activin receptor binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0016881	acid-amino acid ligase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0004365	glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0070080	titin Z domain binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0001641	group II metabotropic glutamate receptor activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0004074	biliverdin reductase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0003989	acetyl-CoA carboxylase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0003980	UDP-glucose:glycoprotein glucosyltransferase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0038062	protein tyrosine kinase collagen receptor activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0033612	receptor serine/threonine kinase binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0005072	transforming growth factor beta receptor, cytoplasmic mediator activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0038025	reelin receptor activity	MF
1	2	1.32129956088	-	3.60e-01	GO:1990763	arrestin family protein binding	MF
1	2	1.32129956088	-	3.60e-01	GO:0008124	4-alpha-hydroxytetrahydrobiopterin dehydratase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0004342	glucosamine-6-phosphate deaminase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0043492	ATPase activity, coupled to movement of substances	MF
1	2	1.32129956088	-	3.60e-01	GO:0004817	cysteine-tRNA ligase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0004819	glutamine-tRNA ligase activity	MF
1	2	1.32129956088	-	3.60e-01	GO:0016667	oxidoreductase activity, acting on a sulfur group of donors	MF
1	2	1.32129956088	-	3.60e-01	GO:0005042	netrin receptor activity	MF
1	2	1.32129956088	-	3.60e-01	GO:1904854	proteasome core complex binding	MF
25	51	1.29273040868	-	1.44e-07	GO:0097110	scaffold protein binding	MF
24	49	1.29155221748	-	3.21e-06	GO:0042542	response to hydrogen peroxide	BP
24	49	1.29155221748	-	3.21e-06	GO:0036297	interstrand cross-link repair	BP
23	47	1.29027266526	-	8.17e-06	GO:0070936	protein K48-linked ubiquitination	BP
23	47	1.29027266526	-	1.12e-06	GO:0005080	protein kinase C binding	MF
22	45	1.28887808319	-	8.24e-06	GO:0031492	nucleosomal DNA binding	MF
35	72	1.28065757638	-	1.88e-08	GO:0032436	positive regulation of proteasomal ubiquitin-dependent protein catabolic process	BP
17	35	1.27947938518	-	5.39e-05	GO:0030544	Hsp70 protein binding	MF
143	295	1.27659975341	-	5.90e-30	GO:0031625	ubiquitin protein ligase binding	MF
30	62	1.2739938461	-	1.20e-07	GO:0043433	negative regulation of sequence-specific DNA binding transcription factor activity	BP
15	31	1.2739938461	-	3.61e-04	GO:0031663	lipopolysaccharide-mediated signaling pathway	BP
15	31	1.2739938461	-	2.28e-04	GO:0042169	SH2 domain binding	MF
14	29	1.27067348781	-	7.54e-05	GO:2000379	positive regulation of reactive oxygen species metabolic process	BP
53	110	1.26786030192	-	7.22e-14	GO:0030168	platelet activation	BP
66	137	1.26766159728	-	4.26e-14	GO:0051092	positive regulation of NF-kappaB transcription factor activity	BP
13	27	1.26685177686	-	5.98e-04	GO:0043392	negative regulation of DNA binding	BP
12	25	1.26240587182	-	3.46e-04	GO:0045648	positive regulation of erythrocyte differentiation	BP
12	25	1.26240587182	-	5.93e-04	GO:0002053	positive regulation of mesenchymal cell proliferation	BP
12	25	1.26240587182	-	9.71e-04	GO:0032757	positive regulation of interleukin-8 production	BP
12	25	1.26240587182	-	1.53e-03	GO:0051149	positive regulation of muscle cell differentiation	BP
34	71	1.25901528262	-	7.52e-08	GO:0051436	negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle	BP
22	46	1.25716922346	-	8.24e-06	GO:0030521	androgen receptor signaling pathway	BP
11	23	1.25716922346	-	5.60e-04	GO:0071398	cellular response to fatty acid	BP
11	23	1.25716922346	-	9.64e-04	GO:0034394	protein localization to cell surface	BP
11	23	1.25716922346	-	1.58e-03	GO:0007088	regulation of mitotic nuclear division	BP
11	23	1.25716922346	-	1.58e-03	GO:0050999	regulation of nitric-oxide synthase activity	BP
11	23	1.25716922346	-	2.49e-03	GO:2001235	positive regulation of apoptotic signaling pathway	BP
11	23	1.25716922346	-	1.58e-03	GO:0070412	R-SMAD binding	MF
41	86	1.25258681079	-	1.85e-09	GO:0048013	ephrin receptor signaling pathway	BP
10	21	1.25091023299	-	1.57e-03	GO:0097150	neuronal stem cell population maintenance	BP
10	21	1.25091023299	-	2.58e-03	GO:0051443	positive regulation of ubiquitin-protein transferase activity	BP
10	21	1.25091023299	-	2.58e-03	GO:0071901	negative regulation of protein serine/threonine kinase activity	BP
10	21	1.25091023299	-	4.06e-03	GO:0016922	ligand-dependent nuclear receptor binding	MF
38	80	1.24729897943	-	1.17e-08	GO:0031145	anaphase-promoting complex-dependent catabolic process	BP
189	398	1.24691736456	-	3.53e-41	GO:0019901	protein kinase binding	MF
47	99	1.24653179248	-	6.29e-13	GO:0046854	phosphatidylinositol phosphorylation	BP
28	59	1.24601143357	-	1.85e-07	GO:0031490	chromatin DNA binding	MF
37	78	1.24535070764	-	7.43e-09	GO:0006919	activation of cysteine-type endopeptidase activity involved in apoptotic process	BP
36	76	1.24329704888	-	7.32e-09	GO:0043410	positive regulation of MAPK cascade	BP
36	76	1.24329704888	-	4.62e-08	GO:0051437	positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition	BP
9	19	1.24329704888	-	2.57e-03	GO:0010613	positive regulation of cardiac muscle hypertrophy	BP
9	19	1.24329704888	-	6.64e-03	GO:0070987	error-free translesion synthesis	BP
50	106	1.23723529609	-	7.05e-11	GO:0042826	histone deacetylase binding	MF
66	140	1.23641066329	-	5.34e-16	GO:0007050	cell cycle arrest	BP
24	51	1.23383671963	-	1.20e-06	GO:0045860	positive regulation of protein kinase activity	BP
8	17	1.23383671963	-	6.99e-03	GO:0032479	regulation of type I interferon production	BP
8	17	1.23383671963	-	6.99e-03	GO:1990138	neuron projection extension	BP
8	17	1.23383671963	-	6.99e-03	GO:1904355	positive regulation of telomere capping	BP
8	17	1.23383671963	-	1.09e-02	GO:0007094	mitotic spindle assembly checkpoint	BP
8	17	1.23383671963	-	1.09e-02	GO:0007020	microtubule nucleation	BP
167	355	1.23332863896	-	1.56e-35	GO:0004674	protein serine/threonine kinase activity	MF
15	32	1.22819015649	-	4.72e-05	GO:0032007	negative regulation of TOR signaling	BP
15	32	1.22819015649	-	2.28e-04	GO:0070555	response to interleukin-1	BP
15	32	1.22819015649	-	5.55e-04	GO:1990090	cellular response to nerve growth factor stimulus	BP
15	32	1.22819015649	-	3.61e-04	GO:0051879	Hsp90 protein binding	MF
22	47	1.22614232784	-	1.79e-06	GO:0023014	signal transduction by protein phosphorylation	BP
29	62	1.22508424562	-	6.90e-08	GO:0042531	positive regulation of tyrosine phosphorylation of STAT protein	BP
7	15	1.22176388733	-	3.90e-03	GO:0006940	regulation of smooth muscle contraction	BP
7	15	1.22176388733	-	6.99e-03	GO:0006309	apoptotic DNA fragmentation	BP
7	15	1.22176388733	-	1.16e-02	GO:0045104	intermediate filament cytoskeleton organization	BP
7	15	1.22176388733	-	1.16e-02	GO:0070848	response to growth factor	BP
7	15	1.22176388733	-	1.80e-02	GO:1902230	negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage	BP
7	15	1.22176388733	-	1.80e-02	GO:0043923	positive regulation by host of viral transcription	BP
7	15	1.22176388733	-	1.16e-02	GO:0004702	signal transducer, downstream of receptor, with serine/threonine kinase activity	MF
21	45	1.22176388733	-	4.88e-06	GO:0032956	regulation of actin cytoskeleton organization	BP
20	43	1.21696290106	-	7.44e-07	GO:0045599	negative regulation of fat cell differentiation	BP
20	43	1.21696290106	-	3.36e-05	GO:1901215	negative regulation of neuron death	BP
13	28	1.21438435696	-	2.15e-04	GO:0071158	positive regulation of cell cycle arrest	BP
19	41	1.2116750697	-	3.40e-05	GO:0097191	extrinsic apoptotic signaling pathway	BP
19	41	1.2116750697	-	5.39e-05	GO:0030331	estrogen receptor binding	MF
63	136	1.21111664313	-	1.08e-13	GO:0042787	protein ubiquitination involved in ubiquitin-dependent protein catabolic process	BP
37	80	1.20882483162	-	7.43e-09	GO:0008013	beta-catenin binding	MF
123	266	1.20853163072	-	6.77e-25	GO:0000165	MAPK cascade	BP
36	78	1.20582234346	-	7.32e-09	GO:0008286	insulin receptor signaling pathway	BP
6	13	1.20582234346	-	3.06e-03	GO:0031643	positive regulation of myelination	BP
6	13	1.20582234346	-	6.36e-03	GO:2000773	negative regulation of cellular senescence	BP
6	13	1.20582234346	-	6.36e-03	GO:0045824	negative regulation of innate immune response	BP
6	13	1.20582234346	-	1.16e-02	GO:0090051	negative regulation of cell migration involved in sprouting angiogenesis	BP
6	13	1.20582234346	-	1.16e-02	GO:0071280	cellular response to copper ion	BP
6	13	1.20582234346	-	1.16e-02	GO:2000737	negative regulation of stem cell differentiation	BP
6	13	1.20582234346	-	1.16e-02	GO:0071391	cellular response to estrogen stimulus	BP
6	13	1.20582234346	-	1.94e-02	GO:0090162	establishment of epithelial cell polarity	BP
6	13	1.20582234346	-	1.94e-02	GO:0031274	positive regulation of pseudopodium assembly	BP
6	13	1.20582234346	-	1.94e-02	GO:0010745	negative regulation of macrophage derived foam cell differentiation	BP
6	13	1.20582234346	-	3.00e-02	GO:0045579	positive regulation of B cell differentiation	BP
6	13	1.20582234346	-	3.00e-02	GO:0061099	negative regulation of protein tyrosine kinase activity	BP
6	13	1.20582234346	-	3.00e-02	GO:1902176	negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway	BP
6	13	1.20582234346	-	3.00e-02	GO:0010498	proteasomal protein catabolic process	BP
6	13	1.20582234346	-	3.00e-02	GO:0051787	misfolded protein binding	MF
17	37	1.1993090365	-	3.21e-05	GO:0034332	adherens junction organization	BP
17	37	1.1993090365	-	3.21e-05	GO:0032720	negative regulation of tumor necrosis factor production	BP
17	37	1.1993090365	-	3.24e-04	GO:0070888	E-box binding	MF
11	24	1.19576867879	-	1.58e-03	GO:0042113	B cell activation	BP
11	24	1.19576867879	-	1.58e-03	GO:0033137	negative regulation of peptidyl-serine phosphorylation	BP
11	24	1.19576867879	-	2.49e-03	GO:0097352	autophagosome maturation	BP
33	72	1.19576867879	-	1.86e-07	GO:0000980	RNA polymerase II distal enhancer sequence-specific DNA binding	MF
32	70	1.19201654393	-	7.62e-08	GO:0032088	negative regulation of NF-kappaB transcription factor activity	BP
16	35	1.19201654393	-	1.42e-04	GO:0045787	positive regulation of cell cycle	BP
16	35	1.19201654393	-	2.24e-04	GO:0048536	spleen development	BP
200	438	1.19036869105	-	5.66e-41	GO:0006468	protein phosphorylation	BP
20	44	1.18379603713	-	1.30e-05	GO:0071363	cellular response to growth factor stimulus	BP
15	33	1.18379603713	-	8.29e-05	GO:0006298	mismatch repair	BP
10	22	1.18379603713	-	9.07e-04	GO:0097755	positive regulation of blood vessel diameter	BP
10	22	1.18379603713	-	2.58e-03	GO:0043536	positive regulation of blood vessel endothelial cell migration	BP
10	22	1.18379603713	-	2.58e-03	GO:0035924	cellular response to vascular endothelial growth factor stimulus	BP
10	22	1.18379603713	-	4.06e-03	GO:0002092	positive regulation of receptor internalization	BP
10	22	1.18379603713	-	6.12e-03	GO:0048568	embryonic organ development	BP
5	11	1.18379603713	-	1.04e-02	GO:0002089	lens morphogenesis in camera-type eye	BP
5	11	1.18379603713	-	1.96e-02	GO:0001893	maternal placenta development	BP
5	11	1.18379603713	-	1.96e-02	GO:0045745	positive regulation of G-protein coupled receptor protein signaling pathway	BP
5	11	1.18379603713	-	3.28e-02	GO:0051489	regulation of filopodium assembly	BP
5	11	1.18379603713	-	3.28e-02	GO:0001823	mesonephros development	BP
5	11	1.18379603713	-	3.28e-02	GO:0010591	regulation of lamellipodium assembly	BP
5	11	1.18379603713	-	3.28e-02	GO:2000009	negative regulation of protein localization to cell surface	BP
5	11	1.18379603713	-	3.28e-02	GO:0030033	microvillus assembly	BP
5	11	1.18379603713	-	3.28e-02	GO:0032515	negative regulation of phosphoprotein phosphatase activity	BP
5	11	1.18379603713	-	3.28e-02	GO:0042445	hormone metabolic process	BP
5	11	1.18379603713	-	3.28e-02	GO:0030850	prostate gland development	BP
5	11	1.18379603713	-	3.28e-02	GO:0007260	tyrosine phosphorylation of STAT protein	BP
5	11	1.18379603713	-	3.28e-02	GO:0019068	virion assembly	BP
5	11	1.18379603713	-	3.28e-02	GO:0035413	positive regulation of catenin import into nucleus	BP
5	11	1.18379603713	-	3.28e-02	GO:0045945	positive regulation of transcription from RNA polymerase III promoter	BP
5	11	1.18379603713	-	5.04e-02	GO:0042347	negative regulation of NF-kappaB import into nucleus	BP
5	11	1.18379603713	-	5.04e-02	GO:0071383	cellular response to steroid hormone stimulus	BP
5	11	1.18379603713	-	5.04e-02	GO:0090161	Golgi ribbon formation	BP
5	11	1.18379603713	-	5.04e-02	GO:0031065	positive regulation of histone deacetylation	BP
5	11	1.18379603713	-	5.04e-02	GO:0060765	regulation of androgen receptor signaling pathway	BP
5	11	1.18379603713	-	5.04e-02	GO:0016064	immunoglobulin mediated immune response	BP
5	11	1.18379603713	-	5.04e-02	GO:0006853	carnitine shuttle	BP
25	55	1.18379603713	-	4.99e-06	GO:0043621	protein self-association	MF
10	22	1.18379603713	-	4.91e-04	GO:0001158	enhancer sequence-specific DNA binding	MF
5	11	1.18379603713	-	4.67e-03	GO:0008199	ferric iron binding	MF
5	11	1.18379603713	-	3.28e-02	GO:0016407	acetyltransferase activity	MF
24	53	1.17834160704	-	1.98e-06	GO:0043406	positive regulation of MAP kinase activity	BP
19	42	1.17690965154	-	5.39e-05	GO:0014823	response to activity	BP
14	31	1.17445817255	-	3.69e-04	GO:0030217	T cell differentiation	BP
9	20	1.16929646743	-	4.24e-03	GO:0045862	positive regulation of proteolysis	BP
9	20	1.16929646743	-	6.64e-03	GO:0042276	error-prone translesion synthesis	BP
9	20	1.16929646743	-	6.64e-03	GO:0045861	negative regulation of proteolysis	BP
9	20	1.16929646743	-	9.96e-03	GO:0016601	Rac protein signal transduction	BP
9	20	1.16929646743	-	9.96e-03	GO:0042326	negative regulation of phosphorylation	BP
49	109	1.16782508022	-	3.62e-10	GO:0000187	activation of MAPK activity	BP
62	138	1.16697141449	-	2.58e-14	GO:0001934	positive regulation of protein phosphorylation	BP
13	29	1.16375828389	-	3.66e-04	GO:0051881	regulation of mitochondrial membrane potential	BP
21	47	1.15902813198	-	8.12e-06	GO:0051591	response to cAMP	BP
25	56	1.15780082859	-	2.01e-06	GO:0004722	protein serine/threonine phosphatase activity	MF
28	63	1.15137455944	-	1.23e-06	GO:0032091	negative regulation of protein binding	BP
12	27	1.15137455944	-	5.83e-03	GO:0045070	positive regulation of viral genome replication	BP
12	27	1.15137455944	-	5.83e-03	GO:0050690	regulation of defense response to virus by virus	BP
16	36	1.15137455944	-	1.42e-04	GO:0000079	regulation of cyclin-dependent protein serine/threonine kinase activity	BP
16	36	1.15137455944	-	2.24e-04	GO:0071392	cellular response to estradiol stimulus	BP
16	36	1.15137455944	-	1.08e-03	GO:0007257	activation of JUN kinase activity	BP
8	18	1.15137455944	-	2.39e-03	GO:2000377	regulation of reactive oxygen species metabolic process	BP
8	18	1.15137455944	-	4.23e-03	GO:0008585	female gonad development	BP
8	18	1.15137455944	-	4.23e-03	GO:0007597	blood coagulation, intrinsic pathway	BP
8	18	1.15137455944	-	4.23e-03	GO:0060324	face development	BP
4	9	1.15137455944	-	6.72e-03	GO:0007567	parturition	BP
8	18	1.15137455944	-	1.09e-02	GO:0030325	adrenal gland development	BP
8	18	1.15137455944	-	1.09e-02	GO:0098609	cell-cell adhesion	BP
8	18	1.15137455944	-	1.09e-02	GO:0007250	activation of NF-kappaB-inducing kinase activity	BP
8	18	1.15137455944	-	1.09e-02	GO:0001892	embryonic placenta development	BP
8	18	1.15137455944	-	1.09e-02	GO:0000185	activation of MAPKKK activity	BP
8	18	1.15137455944	-	1.09e-02	GO:0030225	macrophage differentiation	BP
8	18	1.15137455944	-	1.09e-02	GO:2000114	regulation of establishment of cell polarity	BP
8	18	1.15137455944	-	1.09e-02	GO:0035024	negative regulation of Rho protein signal transduction	BP
8	18	1.15137455944	-	1.09e-02	GO:0035066	positive regulation of histone acetylation	BP
8	18	1.15137455944	-	1.09e-02	GO:0035307	positive regulation of protein dephosphorylation	BP
8	18	1.15137455944	-	1.63e-02	GO:0000132	establishment of mitotic spindle orientation	BP
8	18	1.15137455944	-	1.63e-02	GO:0035904	aorta development	BP
8	18	1.15137455944	-	1.63e-02	GO:0031333	negative regulation of protein complex assembly	BP
4	9	1.15137455944	-	1.70e-02	GO:0051896	regulation of protein kinase B signaling	BP
4	9	1.15137455944	-	1.70e-02	GO:0042058	regulation of epidermal growth factor receptor signaling pathway	BP
4	9	1.15137455944	-	3.34e-02	GO:0086014	atrial cardiac muscle cell action potential	BP
4	9	1.15137455944	-	3.34e-02	GO:0046548	retinal rod cell development	BP
4	9	1.15137455944	-	3.34e-02	GO:0061072	iris morphogenesis	BP
4	9	1.15137455944	-	3.34e-02	GO:0048643	positive regulation of skeletal muscle tissue development	BP
4	9	1.15137455944	-	3.34e-02	GO:0002281	macrophage activation involved in immune response	BP
4	9	1.15137455944	-	3.34e-02	GO:0010907	positive regulation of glucose metabolic process	BP
4	9	1.15137455944	-	3.34e-02	GO:0097120	receptor localization to synapse	BP
4	9	1.15137455944	-	3.34e-02	GO:0046620	regulation of organ growth	BP
4	9	1.15137455944	-	3.34e-02	GO:0061314	Notch signaling involved in heart development	BP
4	9	1.15137455944	-	3.34e-02	GO:2000270	negative regulation of fibroblast apoptotic process	BP
4	9	1.15137455944	-	5.63e-02	GO:0070886	positive regulation of calcineurin-NFAT signaling cascade	BP
4	9	1.15137455944	-	5.63e-02	GO:0019953	sexual reproduction	BP
4	9	1.15137455944	-	5.63e-02	GO:2000001	regulation of DNA damage checkpoint	BP
4	9	1.15137455944	-	5.63e-02	GO:0006930	substrate-dependent cell migration, cell extension	BP
4	9	1.15137455944	-	5.63e-02	GO:0032886	regulation of microtubule-based process	BP
4	9	1.15137455944	-	5.63e-02	GO:1904469	positive regulation of tumor necrosis factor secretion	BP
4	9	1.15137455944	-	8.57e-02	GO:1901030	positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	BP
4	9	1.15137455944	-	8.57e-02	GO:0048489	synaptic vesicle transport	BP
4	9	1.15137455944	-	8.57e-02	GO:0022417	protein maturation by protein folding	BP
4	9	1.15137455944	-	8.57e-02	GO:0060627	regulation of vesicle-mediated transport	BP
4	9	1.15137455944	-	8.57e-02	GO:0010225	response to UV-C	BP
4	9	1.15137455944	-	8.57e-02	GO:0010833	telomere maintenance via telomere lengthening	BP
4	9	1.15137455944	-	8.57e-02	GO:0043534	blood vessel endothelial cell migration	BP
4	9	1.15137455944	-	8.57e-02	GO:0090557	establishment of endothelial intestinal barrier	BP
4	9	1.15137455944	-	8.57e-02	GO:0002262	myeloid cell homeostasis	BP
4	9	1.15137455944	-	8.57e-02	GO:0046621	negative regulation of organ growth	BP
4	9	1.15137455944	-	8.57e-02	GO:0038063	collagen-activated tyrosine kinase receptor signaling pathway	BP
8	18	1.15137455944	-	6.99e-03	GO:0098641	cadherin binding involved in cell-cell adhesion	MF
8	18	1.15137455944	-	6.99e-03	GO:0001190	transcriptional activator activity, RNA polymerase II transcription factor binding	MF
4	9	1.15137455944	-	5.63e-02	GO:0045236	CXCR chemokine receptor binding	MF
4	9	1.15137455944	-	8.57e-02	GO:0019869	chloride channel inhibitor activity	MF
4	9	1.15137455944	-	8.57e-02	GO:0003691	double-stranded telomeric DNA binding	MF
4	9	1.15137455944	-	8.57e-02	GO:0032183	SUMO binding	MF
4	9	1.15137455944	-	8.57e-02	GO:0002162	dystroglycan binding	MF
4	9	1.15137455944	-	8.57e-02	GO:0003680	AT DNA binding	MF
4	9	1.15137455944	-	8.57e-02	GO:0008821	crossover junction endodeoxyribonuclease activity	MF
4	9	1.15137455944	-	8.57e-02	GO:0019887	protein kinase regulator activity	MF
4	9	1.15137455944	-	8.57e-02	GO:0019855	calcium channel inhibitor activity	MF
47	106	1.14796795799	-	1.14e-10	GO:0051091	positive regulation of sequence-specific DNA binding transcription factor activity	BP
35	79	1.14680182965	-	7.34e-08	GO:0032869	cellular response to insulin stimulus	BP
19	43	1.14296231962	-	1.25e-05	GO:0030178	negative regulation of Wnt signaling pathway	BP
19	43	1.14296231962	-	3.40e-05	GO:0042110	T cell activation	BP
19	43	1.14296231962	-	2.71e-04	GO:0031397	negative regulation of protein ubiquitination	BP
15	34	1.14072731524	-	3.61e-04	GO:0032480	negative regulation of type I interferon production	BP
15	34	1.14072731524	-	1.71e-03	GO:0000731	DNA synthesis involved in DNA repair	BP
22	50	1.13687498974	-	1.31e-05	GO:0034097	response to cytokine	BP
11	25	1.13687498974	-	9.64e-04	GO:0046329	negative regulation of JNK cascade	BP
11	25	1.13687498974	-	2.49e-03	GO:0007569	cell aging	BP
11	25	1.13687498974	-	2.49e-03	GO:0043542	endothelial cell migration	BP
11	25	1.13687498974	-	9.28e-03	GO:0043027	cysteine-type endopeptidase inhibitor activity involved in apoptotic process	MF
21	48	1.12865448294	-	2.10e-05	GO:0000976	transcription regulatory region sequence-specific DNA binding	MF
14	32	1.12865448294	-	5.83e-04	GO:0043200	response to amino acid	BP
14	32	1.12865448294	-	8.94e-04	GO:0043967	histone H4 acetylation	BP
14	32	1.12865448294	-	8.94e-04	GO:0001932	regulation of protein phosphorylation	BP
14	32	1.12865448294	-	8.94e-04	GO:0032008	positive regulation of TOR signaling	BP
7	16	1.12865448294	-	1.96e-03	GO:0016446	somatic hypermutation of immunoglobulin genes	BP
7	16	1.12865448294	-	6.99e-03	GO:0048714	positive regulation of oligodendrocyte differentiation	BP
7	16	1.12865448294	-	1.16e-02	GO:0031293	membrane protein intracellular domain proteolysis	BP
7	16	1.12865448294	-	1.16e-02	GO:0048384	retinoic acid receptor signaling pathway	BP
7	16	1.12865448294	-	1.16e-02	GO:0043508	negative regulation of JUN kinase activity	BP
7	16	1.12865448294	-	1.16e-02	GO:0035855	megakaryocyte development	BP
7	16	1.12865448294	-	1.16e-02	GO:0070498	interleukin-1-mediated signaling pathway	BP
7	16	1.12865448294	-	1.80e-02	GO:0051893	regulation of focal adhesion assembly	BP
7	16	1.12865448294	-	2.66e-02	GO:0034142	toll-like receptor 4 signaling pathway	BP
7	16	1.12865448294	-	2.66e-02	GO:0008656	cysteine-type endopeptidase activator activity involved in apoptotic process	MF
7	16	1.12865448294	-	2.66e-02	GO:0070182	DNA polymerase binding	MF
125	286	1.12721250876	-	4.54e-22	GO:0008134	transcription factor binding	MF
10	23	1.11966569971	-	1.48e-02	GO:0051894	positive regulation of focal adhesion assembly	BP
10	23	1.11966569971	-	1.48e-02	GO:0030866	cortical actin cytoskeleton organization	BP
10	23	1.11966569971	-	1.48e-02	GO:0001954	positive regulation of cell-matrix adhesion	BP
10	23	1.11966569971	-	6.12e-03	GO:0035255	ionotropic glutamate receptor binding	MF
43	99	1.1182076955	-	4.53e-09	GO:0051726	regulation of cell cycle	BP
23	53	1.11694106237	-	1.95e-05	GO:0043401	steroid hormone mediated signaling pathway	BP
23	53	1.11694106237	-	1.95e-05	GO:0003707	steroid hormone receptor activity	MF
26	60	1.11484868341	-	1.26e-06	GO:0050727	regulation of inflammatory response	BP
13	30	1.11484868341	-	3.66e-04	GO:0048167	regulation of synaptic plasticity	BP
13	30	1.11484868341	-	9.44e-04	GO:0007281	germ cell development	BP
13	30	1.11484868341	-	4.32e-03	GO:0009314	response to radiation	BP
13	30	1.11484868341	-	5.98e-04	GO:0004693	cyclin-dependent protein serine/threonine kinase activity	MF
64	148	1.11184619525	-	1.00e-12	GO:0050852	T cell receptor signaling pathway	BP
32	74	1.11184619525	-	1.71e-08	GO:0007623	circadian rhythm	BP
32	74	1.11184619525	-	1.62e-06	GO:0043154	negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	BP
19	44	1.10979545568	-	7.26e-06	GO:0032870	cellular response to hormone stimulus	BP
22	51	1.10830583754	-	2.04e-05	GO:0048365	Rac GTPase binding	MF
56	130	1.10628666991	-	1.30e-09	GO:0000086	G2/M transition of mitotic cell cycle	BP
12	28	1.09890713954	-	6.85e-03	GO:0045739	positive regulation of DNA repair	BP
6	14	1.09890713954	-	1.16e-02	GO:0022011	myelination in peripheral nervous system	BP
6	14	1.09890713954	-	1.94e-02	GO:2000810	regulation of bicellular tight junction assembly	BP
6	14	1.09890713954	-	1.94e-02	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	BP
6	14	1.09890713954	-	1.94e-02	GO:1900006	positive regulation of dendrite development	BP
6	14	1.09890713954	-	1.94e-02	GO:0031641	regulation of myelination	BP
3	7	1.09890713954	-	2.72e-02	GO:1904628	cellular response to phorbol 13-acetate 12-myristate	BP
3	7	1.09890713954	-	2.72e-02	GO:0085029	extracellular matrix assembly	BP
6	14	1.09890713954	-	3.00e-02	GO:0001678	cellular glucose homeostasis	BP
6	14	1.09890713954	-	3.00e-02	GO:0071360	cellular response to exogenous dsRNA	BP
6	14	1.09890713954	-	3.00e-02	GO:0045589	regulation of regulatory T cell differentiation	BP
6	14	1.09890713954	-	3.00e-02	GO:0050892	intestinal absorption	BP
6	14	1.09890713954	-	4.39e-02	GO:0042953	lipoprotein transport	BP
6	14	1.09890713954	-	4.39e-02	GO:1902043	positive regulation of extrinsic apoptotic signaling pathway via death domain receptors	BP
6	14	1.09890713954	-	4.39e-02	GO:0045088	regulation of innate immune response	BP
6	14	1.09890713954	-	4.39e-02	GO:0043518	negative regulation of DNA damage response, signal transduction by p53 class mediator	BP
3	7	1.09890713954	-	5.80e-02	GO:0009620	response to fungus	BP
3	7	1.09890713954	-	5.80e-02	GO:0060740	prostate gland epithelium morphogenesis	BP
3	7	1.09890713954	-	5.80e-02	GO:0090336	positive regulation of brown fat cell differentiation	BP
3	7	1.09890713954	-	5.80e-02	GO:0034144	negative regulation of toll-like receptor 4 signaling pathway	BP
3	7	1.09890713954	-	5.80e-02	GO:0009950	dorsal/ventral axis specification	BP
3	7	1.09890713954	-	5.80e-02	GO:0003344	pericardium morphogenesis	BP
3	7	1.09890713954	-	5.80e-02	GO:0032927	positive regulation of activin receptor signaling pathway	BP
3	7	1.09890713954	-	5.80e-02	GO:0036302	atrioventricular canal development	BP
3	7	1.09890713954	-	9.89e-02	GO:0006972	hyperosmotic response	BP
3	7	1.09890713954	-	9.89e-02	GO:0034138	toll-like receptor 3 signaling pathway	BP
3	7	1.09890713954	-	9.89e-02	GO:0014009	glial cell proliferation	BP
3	7	1.09890713954	-	9.89e-02	GO:0032287	peripheral nervous system myelin maintenance	BP
3	7	1.09890713954	-	9.89e-02	GO:0019048	modulation by virus of host morphology or physiology	BP
3	7	1.09890713954	-	9.89e-02	GO:0072112	glomerular visceral epithelial cell differentiation	BP
3	7	1.09890713954	-	9.89e-02	GO:0006475	internal protein amino acid acetylation	BP
3	7	1.09890713954	-	9.89e-02	GO:0061384	heart trabecula morphogenesis	BP
3	7	1.09890713954	-	9.89e-02	GO:0051001	negative regulation of nitric-oxide synthase activity	BP
3	7	1.09890713954	-	9.89e-02	GO:0001841	neural tube formation	BP
3	7	1.09890713954	-	9.89e-02	GO:0097237	cellular response to toxic substance	BP
3	7	1.09890713954	-	9.89e-02	GO:0034983	peptidyl-lysine deacetylation	BP
3	7	1.09890713954	-	9.89e-02	GO:0007617	mating behavior	BP
3	7	1.09890713954	-	9.89e-02	GO:0051057	positive regulation of small GTPase mediated signal transduction	BP
3	7	1.09890713954	-	9.89e-02	GO:0016255	attachment of GPI anchor to protein	BP
3	7	1.09890713954	-	9.89e-02	GO:0006527	arginine catabolic process	BP
3	7	1.09890713954	-	9.89e-02	GO:1903214	regulation of protein targeting to mitochondrion	BP
3	7	1.09890713954	-	9.89e-02	GO:0014902	myotube differentiation	BP
3	7	1.09890713954	-	9.89e-02	GO:0008366	axon ensheathment	BP
3	7	1.09890713954	-	9.89e-02	GO:2000271	positive regulation of fibroblast apoptotic process	BP
3	7	1.09890713954	-	9.89e-02	GO:0035726	common myeloid progenitor cell proliferation	BP
3	7	1.09890713954	-	9.89e-02	GO:0051574	positive regulation of histone H3-K9 methylation	BP
3	7	1.09890713954	-	9.89e-02	GO:0043457	regulation of cellular respiration	BP
3	7	1.09890713954	-	1.48e-01	GO:0006595	polyamine metabolic process	BP
3	7	1.09890713954	-	1.48e-01	GO:0035385	Roundabout signaling pathway	BP
3	7	1.09890713954	-	1.48e-01	GO:0045650	negative regulation of macrophage differentiation	BP
3	7	1.09890713954	-	1.48e-01	GO:0050810	regulation of steroid biosynthetic process	BP
3	7	1.09890713954	-	1.48e-01	GO:0090267	positive regulation of mitotic cell cycle spindle assembly checkpoint	BP
3	7	1.09890713954	-	1.48e-01	GO:0030042	actin filament depolymerization	BP
3	7	1.09890713954	-	1.48e-01	GO:0070389	chaperone cofactor-dependent protein refolding	BP
3	7	1.09890713954	-	1.48e-01	GO:0030948	negative regulation of vascular endothelial growth factor receptor signaling pathway	BP
3	7	1.09890713954	-	1.48e-01	GO:1902741	positive regulation of interferon-alpha secretion	BP
3	7	1.09890713954	-	1.48e-01	GO:0043486	histone exchange	BP
3	7	1.09890713954	-	1.48e-01	GO:0061626	pharyngeal arch artery morphogenesis	BP
3	7	1.09890713954	-	1.48e-01	GO:1903071	positive regulation of ER-associated ubiquitin-dependent protein catabolic process	BP
3	7	1.09890713954	-	1.48e-01	GO:1903715	regulation of aerobic respiration	BP
3	7	1.09890713954	-	1.48e-01	GO:0042148	strand invasion	BP
3	7	1.09890713954	-	1.48e-01	GO:0048261	negative regulation of receptor-mediated endocytosis	BP
3	7	1.09890713954	-	1.48e-01	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	BP
3	7	1.09890713954	-	1.48e-01	GO:0030916	otic vesicle formation	BP
3	7	1.09890713954	-	1.48e-01	GO:0030953	astral microtubule organization	BP
3	7	1.09890713954	-	1.48e-01	GO:0035360	positive regulation of peroxisome proliferator activated receptor signaling pathway	BP
3	7	1.09890713954	-	1.48e-01	GO:0048708	astrocyte differentiation	BP
3	7	1.09890713954	-	1.48e-01	GO:0035280	miRNA loading onto RISC involved in gene silencing by miRNA	BP
3	7	1.09890713954	-	1.48e-01	GO:0071474	cellular hyperosmotic response	BP
3	7	1.09890713954	-	1.48e-01	GO:0034616	response to laminar fluid shear stress	BP
3	7	1.09890713954	-	1.48e-01	GO:0031642	negative regulation of myelination	BP
3	7	1.09890713954	-	1.48e-01	GO:0060290	transdifferentiation	BP
3	7	1.09890713954	-	1.48e-01	GO:0033601	positive regulation of mammary gland epithelial cell proliferation	BP
3	7	1.09890713954	-	1.48e-01	GO:0000492	box C/D snoRNP assembly	BP
3	7	1.09890713954	-	1.48e-01	GO:1903358	regulation of Golgi organization	BP
3	7	1.09890713954	-	1.48e-01	GO:0019064	fusion of virus membrane with host plasma membrane	BP
3	7	1.09890713954	-	1.48e-01	GO:0071447	cellular response to hydroperoxide	BP
3	7	1.09890713954	-	1.48e-01	GO:0035308	negative regulation of protein dephosphorylation	BP
3	7	1.09890713954	-	1.48e-01	GO:0010669	epithelial structure maintenance	BP
3	7	1.09890713954	-	1.48e-01	GO:0043496	regulation of protein homodimerization activity	BP
12	28	1.09890713954	-	6.85e-03	GO:0051059	NF-kappaB binding	MF
6	14	1.09890713954	-	1.94e-02	GO:0043274	phospholipase binding	MF
6	14	1.09890713954	-	4.39e-02	GO:1990381	ubiquitin-specific protease binding	MF
6	14	1.09890713954	-	4.39e-02	GO:0000983	transcription factor activity, RNA polymerase II core promoter sequence-specific	MF
6	14	1.09890713954	-	4.39e-02	GO:0032794	GTPase activating protein binding	MF
3	7	1.09890713954	-	9.89e-02	GO:0042608	T cell receptor binding	MF
3	7	1.09890713954	-	9.89e-02	GO:0001848	complement binding	MF
3	7	1.09890713954	-	1.48e-01	GO:0031433	telethonin binding	MF
3	7	1.09890713954	-	1.48e-01	GO:0004675	transmembrane receptor protein serine/threonine kinase activity	MF
3	7	1.09890713954	-	1.48e-01	GO:0004972	NMDA glutamate receptor activity	MF
3	7	1.09890713954	-	1.48e-01	GO:0004887	thyroid hormone receptor activity	MF
3	7	1.09890713954	-	1.48e-01	GO:0005138	interleukin-6 receptor binding	MF
3	7	1.09890713954	-	1.48e-01	GO:0004691	cAMP-dependent protein kinase activity	MF
3	7	1.09890713954	-	1.48e-01	GO:0005078	MAP-kinase scaffold activity	MF
3	7	1.09890713954	-	1.48e-01	GO:0008329	signaling pattern recognition receptor activity	MF
57	133	1.09890713954	-	8.33e-10	GO:1901796	regulation of signal transduction by p53 class mediator	BP
30	70	1.09890713954	-	1.39e-05	GO:0016241	regulation of macroautophagy	BP
18	42	1.09890713954	-	5.39e-04	GO:0045429	positive regulation of nitric oxide biosynthetic process	BP
9	21	1.09890713954	-	4.24e-03	GO:0051493	regulation of cytoskeleton organization	BP
9	21	1.09890713954	-	6.64e-03	GO:0042730	fibrinolysis	BP
9	21	1.09890713954	-	6.64e-03	GO:0001782	B cell homeostasis	BP
9	21	1.09890713954	-	2.36e-02	GO:0060828	regulation of canonical Wnt signaling pathway	BP
9	21	1.09890713954	-	2.36e-02	GO:0001836	release of cytochrome c from mitochondria	BP
27	63	1.09890713954	-	3.67e-05	GO:0043130	ubiquitin binding	MF
89	208	1.0965932737	-	2.52e-15	GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process	BP
73	172	1.08485936506	-	1.05e-15	GO:0042127	regulation of cell proliferation	BP
28	66	1.08426036358	-	7.85e-07	GO:0051291	protein heterooligomerization	BP
14	33	1.08426036358	-	5.83e-04	GO:0070830	bicellular tight junction assembly	BP
11	26	1.08029146137	-	3.23e-05	GO:0009880	embryonic pattern specification	BP
11	26	1.08029146137	-	5.60e-04	GO:0031069	hair follicle morphogenesis	BP
11	26	1.08029146137	-	2.49e-03	GO:0032715	negative regulation of interleukin-6 production	BP
11	26	1.08029146137	-	3.77e-03	GO:0010800	positive regulation of peptidyl-threonine phosphorylation	BP
11	26	1.08029146137	-	1.09e-02	GO:0035035	histone acetyltransferase binding	MF
24	57	1.07337204743	-	4.55e-05	GO:0003684	damaged DNA binding	MF
16	38	1.07337204743	-	5.18e-04	GO:0010634	positive regulation of epithelial cell migration	BP
16	38	1.07337204743	-	1.75e-03	GO:0031623	receptor internalization	BP
8	19	1.07337204743	-	4.23e-03	GO:0002028	regulation of sodium ion transport	BP
8	19	1.07337204743	-	1.63e-02	GO:0010906	regulation of glucose metabolic process	BP
8	19	1.07337204743	-	1.63e-02	GO:0031954	positive regulation of protein autophosphorylation	BP
8	19	1.07337204743	-	3.76e-02	GO:0070507	regulation of microtubule cytoskeleton organization	BP
13	31	1.06754296863	-	1.44e-03	GO:0061098	positive regulation of protein tyrosine kinase activity	BP
75	179	1.06630247411	-	6.67e-12	GO:0008022	protein C-terminus binding	MF
18	43	1.06495980762	-	4.30e-04	GO:0043280	positive regulation of cysteine-type endopeptidase activity involved in apoptotic process	BP
18	43	1.06495980762	-	7.04e-04	GO:0051496	positive regulation of stress fiber assembly	BP
92	220	1.06350180341	-	3.23e-15	GO:0032403	protein complex binding	MF
20	48	1.05826515504	-	7.92e-05	GO:0008542	visual learning	BP
15	36	1.05826515504	-	8.29e-05	GO:0045859	regulation of protein kinase activity	BP
10	24	1.05826515504	-	9.07e-04	GO:0030878	thyroid gland development	BP
10	24	1.05826515504	-	6.12e-03	GO:0042327	positive regulation of phosphorylation	BP
5	12	1.05826515504	-	1.04e-02	GO:2000727	positive regulation of cardiac muscle cell differentiation	BP
5	12	1.05826515504	-	1.04e-02	GO:0046889	positive regulation of lipid biosynthetic process	BP
5	12	1.05826515504	-	1.96e-02	GO:0034122	negative regulation of toll-like receptor signaling pathway	BP
5	12	1.05826515504	-	3.28e-02	GO:0001779	natural killer cell differentiation	BP
5	12	1.05826515504	-	3.28e-02	GO:0097028	dendritic cell differentiation	BP
5	12	1.05826515504	-	3.28e-02	GO:0019430	removal of superoxide radicals	BP
5	12	1.05826515504	-	3.28e-02	GO:0016540	protein autoprocessing	BP
5	12	1.05826515504	-	3.28e-02	GO:0009888	tissue development	BP
5	12	1.05826515504	-	3.28e-02	GO:0050868	negative regulation of T cell activation	BP
5	12	1.05826515504	-	5.04e-02	GO:0051764	actin crosslink formation	BP
5	12	1.05826515504	-	5.04e-02	GO:0060425	lung morphogenesis	BP
5	12	1.05826515504	-	5.04e-02	GO:0006107	oxaloacetate metabolic process	BP
5	12	1.05826515504	-	5.04e-02	GO:0045744	negative regulation of G-protein coupled receptor protein signaling pathway	BP
5	12	1.05826515504	-	7.26e-02	GO:0045724	positive regulation of cilium assembly	BP
5	12	1.05826515504	-	7.26e-02	GO:0003198	epithelial to mesenchymal transition involved in endocardial cushion formation	BP
15	36	1.05826515504	-	1.71e-03	GO:0043531	ADP binding	MF
5	12	1.05826515504	-	7.26e-02	GO:0042623	ATPase activity, coupled	MF
5	12	1.05826515504	-	7.26e-02	GO:0050998	nitric-oxide synthase binding	MF
5	12	1.05826515504	-	7.26e-02	GO:0042974	retinoic acid receptor binding	MF
32	77	1.05451302018	-	6.96e-07	GO:0042060	wound healing	BP
27	65	1.05381925001	-	5.77e-08	GO:0030512	negative regulation of transforming growth factor beta receptor signaling pathway	BP
17	41	1.05121039751	-	1.11e-03	GO:0010508	positive regulation of autophagy	BP
24	58	1.04828106647	-	5.11e-06	GO:0021766	hippocampus development	BP
12	29	1.04828106647	-	8.44e-03	GO:0000077	DNA damage checkpoint	BP
19	46	1.04566511826	-	2.71e-04	GO:0019902	phosphatase binding	MF
66	160	1.04376558535	-	1.16e-11	GO:0043123	positive regulation of I-kappaB kinase/NF-kappaB signaling	BP
21	51	1.04119164168	-	4.96e-05	GO:0010506	regulation of autophagy	BP
14	34	1.04119164168	-	4.33e-03	GO:0032212	positive regulation of telomere maintenance via telomerase	BP
7	17	1.04119164168	-	1.16e-02	GO:0006970	response to osmotic stress	BP
7	17	1.04119164168	-	1.80e-02	GO:0071354	cellular response to interleukin-6	BP
7	17	1.04119164168	-	1.80e-02	GO:1901800	positive regulation of proteasomal protein catabolic process	BP
7	17	1.04119164168	-	6.01e-02	GO:0035994	response to muscle stretch	BP
7	17	1.04119164168	-	6.01e-02	GO:0071539	protein localization to centrosome	BP
14	34	1.04119164168	-	3.38e-03	GO:0048487	beta-tubulin binding	MF
9	22	1.03179294368	-	2.57e-03	GO:0002227	innate immune response in mucosa	BP
9	22	1.03179294368	-	9.96e-03	GO:0060999	positive regulation of dendritic spine development	BP
9	22	1.03179294368	-	2.36e-02	GO:0045453	bone resorption	BP
9	22	1.03179294368	-	2.74e-02	GO:0000717	nucleotide-excision repair, DNA duplex unwinding	BP
135	330	1.03179294368	-	1.67e-20	GO:0019899	enzyme binding	MF
51	125	1.02794061819	-	1.50e-09	GO:0006470	protein dephosphorylation	BP
11	27	1.02584367735	-	3.77e-03	GO:2000352	negative regulation of endothelial cell apoptotic process	BP
11	27	1.02584367735	-	1.33e-02	GO:0043278	response to morphine	BP
13	32	1.02173927902	-	2.15e-04	GO:0048701	embryonic cranial skeleton morphogenesis	BP
13	32	1.02173927902	-	3.67e-03	GO:0042220	response to cocaine	BP
13	32	1.02173927902	-	6.80e-03	GO:0000281	mitotic cytokinesis	BP
15	37	1.01873679086	-	2.14e-03	GO:0007098	centrosome cycle	BP
17	42	1.01644497935	-	6.82e-04	GO:0034198	cellular response to amino acid starvation	BP
17	42	1.01644497935	-	6.82e-04	GO:0045668	negative regulation of osteoblast differentiation	BP
17	42	1.01644497935	-	1.11e-03	GO:0032947	protein complex scaffold activity	MF
19	47	1.01463822264	-	4.46e-04	GO:0032760	positive regulation of tumor necrosis factor production	BP
19	47	1.01463822264	-	5.96e-04	GO:0001046	core promoter sequence-specific DNA binding	MF
42	104	1.01317726552	-	1.35e-06	GO:0047485	protein N-terminus binding	MF
23	57	1.01197150277	-	1.27e-05	GO:0045669	positive regulation of osteoblast differentiation	BP
31	77	1.00870933057	-	1.50e-05	GO:0071260	cellular response to mechanical stimulus	BP
33	82	1.00814167562	-	7.42e-07	GO:0007229	integrin-mediated signaling pathway	BP
37	92	1.00719097045	-	2.35e-07	GO:0032355	response to estradiol	BP
49	122	1.00527206743	-	2.86e-08	GO:0017124	SH3 domain binding	MF
6	15	0.99937146599	-	1.16e-02	GO:0006112	energy reserve metabolic process	BP
6	15	0.99937146599	-	1.94e-02	GO:0048485	sympathetic nervous system development	BP
6	15	0.99937146599	-	1.94e-02	GO:0032461	positive regulation of protein oligomerization	BP
6	15	0.99937146599	-	3.00e-02	GO:0044849	estrous cycle	BP
6	15	0.99937146599	-	4.39e-02	GO:0030048	actin filament-based movement	BP
6	15	0.99937146599	-	4.39e-02	GO:0048872	homeostasis of number of cells	BP
6	15	0.99937146599	-	4.39e-02	GO:0071850	mitotic cell cycle arrest	BP
6	15	0.99937146599	-	4.39e-02	GO:0035458	cellular response to interferon-beta	BP
6	15	0.99937146599	-	4.39e-02	GO:1904646	cellular response to amyloid-beta	BP
6	15	0.99937146599	-	9.61e-02	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	BP
6	15	0.99937146599	-	9.61e-02	GO:1903543	positive regulation of exosomal secretion	BP
6	15	0.99937146599	-	9.61e-02	GO:0044257	cellular protein catabolic process	BP
6	15	0.99937146599	-	3.00e-02	GO:0030676	Rac guanyl-nucleotide exchange factor activity	MF
6	15	0.99937146599	-	3.00e-02	GO:0017016	Ras GTPase binding	MF
6	15	0.99937146599	-	4.39e-02	GO:0035326	enhancer binding	MF
6	15	0.99937146599	-	4.39e-02	GO:0001076	transcription factor activity, RNA polymerase II transcription factor binding	MF
6	15	0.99937146599	-	9.61e-02	GO:0070742	C2H2 zinc finger domain binding	MF
70	175	0.99937146599	-	3.10e-14	GO:0016055	Wnt signaling pathway	BP
38	95	0.99937146599	-	5.29e-06	GO:0016236	macroautophagy	BP
14	35	0.99937146599	-	5.62e-03	GO:0070534	protein K63-linked ubiquitination	BP
22	55	0.99937146599	-	8.61e-05	GO:0006950	response to stress	BP
18	45	0.99937146599	-	2.02e-04	GO:0034605	cellular response to heat	BP
18	45	0.99937146599	-	7.04e-04	GO:0006094	gluconeogenesis	BP
10	25	0.99937146599	-	6.12e-03	GO:0021983	pituitary gland development	BP
10	25	0.99937146599	-	6.12e-03	GO:0034612	response to tumor necrosis factor	BP
10	25	0.99937146599	-	6.12e-03	GO:0048709	oligodendrocyte differentiation	BP
10	25	0.99937146599	-	1.48e-02	GO:0006611	protein export from nucleus	BP
10	25	0.99937146599	-	1.73e-02	GO:0000083	regulation of transcription involved in G1/S transition of mitotic cell cycle	BP
10	25	0.99937146599	-	2.10e-02	GO:0071353	cellular response to interleukin-4	BP
32	80	0.99937146599	-	9.68e-06	GO:0006928	movement of cell or subcellular component	BP
8	20	0.99937146599	-	1.09e-02	GO:0042267	natural killer cell mediated cytotoxicity	BP
4	10	0.99937146599	-	3.34e-02	GO:0060306	regulation of membrane repolarization	BP
4	10	0.99937146599	-	3.34e-02	GO:0043304	regulation of mast cell degranulation	BP
2	5	0.99937146599	-	4.00e-02	GO:0003357	noradrenergic neuron differentiation	BP
2	5	0.99937146599	-	4.00e-02	GO:0042743	hydrogen peroxide metabolic process	BP
8	20	0.99937146599	-	4.36e-02	GO:0039702	viral budding via host ESCRT complex	BP
8	20	0.99937146599	-	4.36e-02	GO:0071526	semaphorin-plexin signaling pathway	BP
4	10	0.99937146599	-	5.63e-02	GO:0048681	negative regulation of axon regeneration	BP
4	10	0.99937146599	-	5.63e-02	GO:0003300	cardiac muscle hypertrophy	BP
4	10	0.99937146599	-	8.57e-02	GO:0050773	regulation of dendrite development	BP
4	10	0.99937146599	-	8.57e-02	GO:0010226	response to lithium ion	BP
4	10	0.99937146599	-	8.57e-02	GO:0060674	placenta blood vessel development	BP
4	10	0.99937146599	-	8.57e-02	GO:0002218	activation of innate immune response	BP
4	10	0.99937146599	-	8.57e-02	GO:0048711	positive regulation of astrocyte differentiation	BP
4	10	0.99937146599	-	8.57e-02	GO:0003014	renal system process	BP
4	10	0.99937146599	-	8.57e-02	GO:0045475	locomotor rhythm	BP
4	10	0.99937146599	-	8.57e-02	GO:0046626	regulation of insulin receptor signaling pathway	BP
2	5	0.99937146599	-	1.04e-01	GO:2001016	positive regulation of skeletal muscle cell differentiation	BP
2	5	0.99937146599	-	1.04e-01	GO:0002385	mucosal immune response	BP
2	5	0.99937146599	-	1.04e-01	GO:0033554	cellular response to stress	BP
2	5	0.99937146599	-	1.04e-01	GO:0003105	negative regulation of glomerular filtration	BP
2	5	0.99937146599	-	1.04e-01	GO:0046219	indolalkylamine biosynthetic process	BP
2	5	0.99937146599	-	1.04e-01	GO:0006144	purine nucleobase metabolic process	BP
2	5	0.99937146599	-	1.04e-01	GO:0021879	forebrain neuron differentiation	BP
2	5	0.99937146599	-	1.04e-01	GO:0003211	cardiac ventricle formation	BP
2	5	0.99937146599	-	1.04e-01	GO:0048513	animal organ development	BP
4	10	0.99937146599	-	1.21e-01	GO:0002031	G-protein coupled receptor internalization	BP
4	10	0.99937146599	-	1.21e-01	GO:0071711	basement membrane organization	BP
4	10	0.99937146599	-	1.21e-01	GO:2000178	negative regulation of neural precursor cell proliferation	BP
4	10	0.99937146599	-	1.21e-01	GO:0031115	negative regulation of microtubule polymerization	BP
4	10	0.99937146599	-	1.21e-01	GO:0034145	positive regulation of toll-like receptor 4 signaling pathway	BP
4	10	0.99937146599	-	1.21e-01	GO:0035871	protein K11-linked deubiquitination	BP
4	10	0.99937146599	-	1.21e-01	GO:0043114	regulation of vascular permeability	BP
4	10	0.99937146599	-	1.21e-01	GO:0032802	low-density lipoprotein particle receptor catabolic process	BP
4	10	0.99937146599	-	1.21e-01	GO:0070198	protein localization to chromosome, telomeric region	BP
4	10	0.99937146599	-	1.21e-01	GO:0042982	amyloid precursor protein metabolic process	BP
4	10	0.99937146599	-	1.21e-01	GO:0060252	positive regulation of glial cell proliferation	BP
4	10	0.99937146599	-	1.21e-01	GO:2000772	regulation of cellular senescence	BP
4	10	0.99937146599	-	1.21e-01	GO:0031000	response to caffeine	BP
4	10	0.99937146599	-	1.21e-01	GO:0035067	negative regulation of histone acetylation	BP
4	10	0.99937146599	-	1.21e-01	GO:0051775	response to redox state	BP
2	5	0.99937146599	-	1.81e-01	GO:0048733	sebaceous gland development	BP
2	5	0.99937146599	-	1.81e-01	GO:1905050	positive regulation of metallopeptidase activity	BP
2	5	0.99937146599	-	1.81e-01	GO:0007341	penetration of zona pellucida	BP
2	5	0.99937146599	-	1.81e-01	GO:0050851	antigen receptor-mediated signaling pathway	BP
2	5	0.99937146599	-	1.81e-01	GO:0003283	atrial septum development	BP
2	5	0.99937146599	-	1.81e-01	GO:0060666	dichotomous subdivision of terminal units involved in salivary gland branching	BP
2	5	0.99937146599	-	1.81e-01	GO:0050688	regulation of defense response to virus	BP
2	5	0.99937146599	-	1.81e-01	GO:0075044	autophagy of host cells involved in interaction with symbiont	BP
2	5	0.99937146599	-	1.81e-01	GO:2000035	regulation of stem cell division	BP
2	5	0.99937146599	-	1.81e-01	GO:0031113	regulation of microtubule polymerization	BP
2	5	0.99937146599	-	1.81e-01	GO:0048562	embryonic organ morphogenesis	BP
2	5	0.99937146599	-	1.81e-01	GO:0046600	negative regulation of centriole replication	BP
2	5	0.99937146599	-	1.81e-01	GO:0072602	interleukin-4 secretion	BP
2	5	0.99937146599	-	1.81e-01	GO:0032460	negative regulation of protein oligomerization	BP
2	5	0.99937146599	-	1.81e-01	GO:0070100	negative regulation of chemokine-mediated signaling pathway	BP
2	5	0.99937146599	-	1.81e-01	GO:0048496	maintenance of animal organ identity	BP
2	5	0.99937146599	-	1.81e-01	GO:0090266	regulation of mitotic cell cycle spindle assembly checkpoint	BP
2	5	0.99937146599	-	1.81e-01	GO:0090080	positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway	BP
2	5	0.99937146599	-	1.81e-01	GO:0072734	cellular response to staurosporine	BP
2	5	0.99937146599	-	1.81e-01	GO:0033033	negative regulation of myeloid cell apoptotic process	BP
2	5	0.99937146599	-	1.81e-01	GO:0032237	activation of store-operated calcium channel activity	BP
2	5	0.99937146599	-	1.81e-01	GO:0045636	positive regulation of melanocyte differentiation	BP
2	5	0.99937146599	-	1.81e-01	GO:0015696	ammonium transport	BP
2	5	0.99937146599	-	1.81e-01	GO:1901844	regulation of cell communication by electrical coupling involved in cardiac conduction	BP
2	5	0.99937146599	-	1.81e-01	GO:1901300	positive regulation of hydrogen peroxide-mediated programmed cell death	BP
2	5	0.99937146599	-	1.81e-01	GO:0035630	bone mineralization involved in bone maturation	BP
2	5	0.99937146599	-	1.81e-01	GO:2000110	negative regulation of macrophage apoptotic process	BP
2	5	0.99937146599	-	1.81e-01	GO:0048515	spermatid differentiation	BP
2	5	0.99937146599	-	1.81e-01	GO:0010989	negative regulation of low-density lipoprotein particle clearance	BP
2	5	0.99937146599	-	1.81e-01	GO:0090036	regulation of protein kinase C signaling	BP
2	5	0.99937146599	-	1.81e-01	GO:0050716	positive regulation of interleukin-1 secretion	BP
2	5	0.99937146599	-	1.81e-01	GO:0009414	response to water deprivation	BP
2	5	0.99937146599	-	1.81e-01	GO:0002155	regulation of thyroid hormone mediated signaling pathway	BP
2	5	0.99937146599	-	1.81e-01	GO:1901727	positive regulation of histone deacetylase activity	BP
2	5	0.99937146599	-	1.81e-01	GO:0086045	membrane depolarization during AV node cell action potential	BP
2	5	0.99937146599	-	1.81e-01	GO:0045542	positive regulation of cholesterol biosynthetic process	BP
2	5	0.99937146599	-	1.81e-01	GO:0072207	metanephric epithelium development	BP
2	5	0.99937146599	-	1.81e-01	GO:0043045	DNA methylation involved in embryo development	BP
2	5	0.99937146599	-	1.81e-01	GO:0021696	cerebellar cortex morphogenesis	BP
2	5	0.99937146599	-	1.81e-01	GO:0060613	fat pad development	BP
2	5	0.99937146599	-	1.81e-01	GO:0038027	apolipoprotein A-I-mediated signaling pathway	BP
2	5	0.99937146599	-	1.81e-01	GO:0031427	response to methotrexate	BP
2	5	0.99937146599	-	1.81e-01	GO:0006089	lactate metabolic process	BP
2	5	0.99937146599	-	2.63e-01	GO:0042541	hemoglobin biosynthetic process	BP
2	5	0.99937146599	-	2.63e-01	GO:0072656	maintenance of protein location in mitochondrion	BP
2	5	0.99937146599	-	2.63e-01	GO:0016191	synaptic vesicle uncoating	BP
2	5	0.99937146599	-	2.63e-01	GO:0099054	presynapse assembly	BP
2	5	0.99937146599	-	2.63e-01	GO:0046822	regulation of nucleocytoplasmic transport	BP
2	5	0.99937146599	-	2.63e-01	GO:0034137	positive regulation of toll-like receptor 2 signaling pathway	BP
2	5	0.99937146599	-	2.63e-01	GO:0036016	cellular response to interleukin-3	BP
2	5	0.99937146599	-	2.63e-01	GO:0055118	negative regulation of cardiac muscle contraction	BP
2	5	0.99937146599	-	2.63e-01	GO:0031622	positive regulation of fever generation	BP
2	5	0.99937146599	-	2.63e-01	GO:1903432	regulation of TORC1 signaling	BP
2	5	0.99937146599	-	2.63e-01	GO:0048194	Golgi vesicle budding	BP
2	5	0.99937146599	-	2.63e-01	GO:0033599	regulation of mammary gland epithelial cell proliferation	BP
2	5	0.99937146599	-	2.63e-01	GO:0035509	negative regulation of myosin-light-chain-phosphatase activity	BP
2	5	0.99937146599	-	2.63e-01	GO:0010656	negative regulation of muscle cell apoptotic process	BP
2	5	0.99937146599	-	2.63e-01	GO:0065004	protein-DNA complex assembly	BP
2	5	0.99937146599	-	2.63e-01	GO:0060744	mammary gland branching involved in thelarche	BP
2	5	0.99937146599	-	2.63e-01	GO:1902749	regulation of cell cycle G2/M phase transition	BP
2	5	0.99937146599	-	2.63e-01	GO:1902961	positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process	BP
2	5	0.99937146599	-	2.63e-01	GO:0022027	interkinetic nuclear migration	BP
2	5	0.99937146599	-	2.63e-01	GO:0000707	meiotic DNA recombinase assembly	BP
2	5	0.99937146599	-	2.63e-01	GO:1905007	positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation	BP
2	5	0.99937146599	-	2.63e-01	GO:1902262	apoptotic process involved in blood vessel morphogenesis	BP
2	5	0.99937146599	-	2.63e-01	GO:0045063	T-helper 1 cell differentiation	BP
2	5	0.99937146599	-	2.63e-01	GO:0019640	glucuronate catabolic process to xylulose 5-phosphate	BP
2	5	0.99937146599	-	2.63e-01	GO:0045646	regulation of erythrocyte differentiation	BP
2	5	0.99937146599	-	2.63e-01	GO:0010936	negative regulation of macrophage cytokine production	BP
2	5	0.99937146599	-	2.63e-01	GO:0046602	regulation of mitotic centrosome separation	BP
2	5	0.99937146599	-	2.63e-01	GO:0060179	male mating behavior	BP
2	5	0.99937146599	-	2.63e-01	GO:0034109	homotypic cell-cell adhesion	BP
2	5	0.99937146599	-	2.63e-01	GO:0000212	meiotic spindle organization	BP
2	5	0.99937146599	-	2.63e-01	GO:0010830	regulation of myotube differentiation	BP
2	5	0.99937146599	-	2.63e-01	GO:0014031	mesenchymal cell development	BP
2	5	0.99937146599	-	2.63e-01	GO:0038084	vascular endothelial growth factor signaling pathway	BP
2	5	0.99937146599	-	2.63e-01	GO:1903912	negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation	BP
2	5	0.99937146599	-	2.63e-01	GO:0010310	regulation of hydrogen peroxide metabolic process	BP
2	5	0.99937146599	-	2.63e-01	GO:0032747	positive regulation of interleukin-23 production	BP
2	5	0.99937146599	-	2.63e-01	GO:0048841	regulation of axon extension involved in axon guidance	BP
2	5	0.99937146599	-	2.63e-01	GO:0038007	netrin-activated signaling pathway	BP
2	5	0.99937146599	-	2.63e-01	GO:1904354	negative regulation of telomere capping	BP
2	5	0.99937146599	-	2.63e-01	GO:0018401	peptidyl-proline hydroxylation to 4-hydroxy-L-proline	BP
2	5	0.99937146599	-	2.63e-01	GO:2000821	regulation of grooming behavior	BP
2	5	0.99937146599	-	2.63e-01	GO:0042699	follicle-stimulating hormone signaling pathway	BP
2	5	0.99937146599	-	2.63e-01	GO:0002082	regulation of oxidative phosphorylation	BP
2	5	0.99937146599	-	2.63e-01	GO:1904504	positive regulation of lipophagy	BP
2	5	0.99937146599	-	2.63e-01	GO:0030854	positive regulation of granulocyte differentiation	BP
2	5	0.99937146599	-	2.63e-01	GO:0001757	somite specification	BP
2	5	0.99937146599	-	2.63e-01	GO:0090074	negative regulation of protein homodimerization activity	BP
2	5	0.99937146599	-	2.63e-01	GO:1900086	positive regulation of peptidyl-tyrosine autophosphorylation	BP
2	5	0.99937146599	-	2.63e-01	GO:0010040	response to iron(II) ion	BP
2	5	0.99937146599	-	2.63e-01	GO:0071864	positive regulation of cell proliferation in bone marrow	BP
2	5	0.99937146599	-	2.63e-01	GO:2000582	positive regulation of ATP-dependent microtubule motor activity, plus-end-directed	BP
2	5	0.99937146599	-	2.63e-01	GO:0060603	mammary gland duct morphogenesis	BP
2	5	0.99937146599	-	2.63e-01	GO:0046883	regulation of hormone secretion	BP
2	5	0.99937146599	-	2.63e-01	GO:0032713	negative regulation of interleukin-4 production	BP
2	5	0.99937146599	-	2.63e-01	GO:0060762	regulation of branching involved in mammary gland duct morphogenesis	BP
2	5	0.99937146599	-	2.63e-01	GO:0036336	dendritic cell migration	BP
2	5	0.99937146599	-	2.63e-01	GO:2000052	positive regulation of non-canonical Wnt signaling pathway	BP
2	5	0.99937146599	-	2.63e-01	GO:0002260	lymphocyte homeostasis	BP
2	5	0.99937146599	-	2.63e-01	GO:0002725	negative regulation of T cell cytokine production	BP
2	5	0.99937146599	-	2.63e-01	GO:0045040	protein import into mitochondrial outer membrane	BP
2	5	0.99937146599	-	2.63e-01	GO:2000809	positive regulation of synaptic vesicle clustering	BP
2	5	0.99937146599	-	2.63e-01	GO:0033133	positive regulation of glucokinase activity	BP
2	5	0.99937146599	-	2.63e-01	GO:0098887	neurotransmitter receptor transport, endosome to postsynaptic membrane	BP
2	5	0.99937146599	-	2.63e-01	GO:0060157	urinary bladder development	BP
2	5	0.99937146599	-	2.63e-01	GO:0033153	T cell receptor V(D)J recombination	BP
2	5	0.99937146599	-	2.63e-01	GO:0044314	protein K27-linked ubiquitination	BP
2	5	0.99937146599	-	2.63e-01	GO:0045541	negative regulation of cholesterol biosynthetic process	BP
2	5	0.99937146599	-	2.63e-01	GO:0051344	negative regulation of cyclic-nucleotide phosphodiesterase activity	BP
2	5	0.99937146599	-	2.63e-01	GO:2000969	positive regulation of AMPA receptor activity	BP
2	5	0.99937146599	-	2.63e-01	GO:0051302	regulation of cell division	BP
2	5	0.99937146599	-	2.63e-01	GO:0030263	apoptotic chromosome condensation	BP
2	5	0.99937146599	-	2.63e-01	GO:0010626	negative regulation of Schwann cell proliferation	BP
2	5	0.99937146599	-	2.63e-01	GO:0051388	positive regulation of neurotrophin TRK receptor signaling pathway	BP
2	5	0.99937146599	-	2.63e-01	GO:0045794	negative regulation of cell volume	BP
2	5	0.99937146599	-	2.63e-01	GO:0051023	regulation of immunoglobulin secretion	BP
2	5	0.99937146599	-	2.63e-01	GO:1903361	protein localization to basolateral plasma membrane	BP
8	20	0.99937146599	-	3.76e-02	GO:0030159	receptor signaling complex scaffold activity	MF
4	10	0.99937146599	-	5.63e-02	GO:0019911	structural constituent of myelin sheath	MF
4	10	0.99937146599	-	8.57e-02	GO:0030296	protein tyrosine kinase activator activity	MF
4	10	0.99937146599	-	8.57e-02	GO:0051428	peptide hormone receptor binding	MF
4	10	0.99937146599	-	8.57e-02	GO:0001222	transcription corepressor binding	MF
2	5	0.99937146599	-	1.04e-01	GO:0042392	sphingosine-1-phosphate phosphatase activity	MF
2	5	0.99937146599	-	1.04e-01	GO:0043141	ATP-dependent 5'-3' DNA helicase activity	MF
2	5	0.99937146599	-	1.81e-01	GO:0071813	lipoprotein particle binding	MF
2	5	0.99937146599	-	1.81e-01	GO:0005127	ciliary neurotrophic factor receptor binding	MF
2	5	0.99937146599	-	1.81e-01	GO:0070290	N-acylphosphatidylethanolamine-specific phospholipase D activity	MF
2	5	0.99937146599	-	1.81e-01	GO:1990254	keratin filament binding	MF
2	5	0.99937146599	-	1.81e-01	GO:0051575	5'-deoxyribose-5-phosphate lyase activity	MF
2	5	0.99937146599	-	1.81e-01	GO:0031694	alpha-2A adrenergic receptor binding	MF
2	5	0.99937146599	-	2.63e-01	GO:0051525	NFAT protein binding	MF
2	5	0.99937146599	-	2.63e-01	GO:0097100	supercoiled DNA binding	MF
2	5	0.99937146599	-	2.63e-01	GO:0048029	monosaccharide binding	MF
2	5	0.99937146599	-	2.63e-01	GO:0003923	GPI-anchor transamidase activity	MF
2	5	0.99937146599	-	2.63e-01	GO:0048495	Roundabout binding	MF
2	5	0.99937146599	-	2.63e-01	GO:0019210	kinase inhibitor activity	MF
2	5	0.99937146599	-	2.63e-01	GO:0032184	SUMO polymer binding	MF
2	5	0.99937146599	-	2.63e-01	GO:0035325	Toll-like receptor binding	MF
2	5	0.99937146599	-	2.63e-01	GO:0070883	pre-miRNA binding	MF
2	5	0.99937146599	-	2.63e-01	GO:0038132	neuregulin binding	MF
2	5	0.99937146599	-	2.63e-01	GO:0044547	DNA topoisomerase binding	MF
2	5	0.99937146599	-	2.63e-01	GO:0008379	thioredoxin peroxidase activity	MF
2	5	0.99937146599	-	2.63e-01	GO:0071532	ankyrin repeat binding	MF
2	5	0.99937146599	-	2.63e-01	GO:0004839	ubiquitin activating enzyme activity	MF
2	5	0.99937146599	-	2.63e-01	GO:0005134	interleukin-2 receptor binding	MF
2	5	0.99937146599	-	2.63e-01	GO:0004844	uracil DNA N-glycosylase activity	MF
2	5	0.99937146599	-	2.63e-01	GO:0008046	axon guidance receptor activity	MF
2	5	0.99937146599	-	2.63e-01	GO:0001875	lipopolysaccharide receptor activity	MF
2	5	0.99937146599	-	2.63e-01	GO:0019960	C-X3-C chemokine binding	MF
2	5	0.99937146599	-	2.63e-01	GO:0000988	transcription factor activity, protein binding	MF
2	5	0.99937146599	-	2.63e-01	GO:0000975	regulatory region DNA binding	MF
107	269	0.991304184722	-	6.10e-18	GO:0016579	protein deubiquitination	BP
15	38	0.980262643043	-	3.61e-04	GO:0001657	ureteric bud development	BP
15	38	0.980262643043	-	2.14e-03	GO:0004721	phosphoprotein phosphatase activity	MF
71	180	0.979193584053	-	1.61e-12	GO:0016477	cell migration	BP
26	66	0.97734515966	-	8.10e-05	GO:0046330	positive regulation of JNK cascade	BP
13	33	0.97734515966	-	3.67e-03	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	BP
11	28	0.973376257457	-	5.60e-04	GO:0007131	reciprocal meiotic recombination	BP
11	28	0.973376257457	-	2.49e-03	GO:0048873	homeostasis of number of cells within a tissue	BP
11	28	0.973376257457	-	2.49e-03	GO:0097193	intrinsic apoptotic signaling pathway	BP
11	28	0.973376257457	-	9.28e-03	GO:0030010	establishment of cell polarity	BP
99	252	0.973376257457	-	4.07e-13	GO:0019904	protein domain specific binding	MF
31	79	0.971715123087	-	4.70e-07	GO:0031295	T cell costimulation	BP
18	46	0.967662606263	-	9.36e-04	GO:0031532	actin cytoskeleton reorganization	BP
18	46	0.967662606263	-	1.84e-03	GO:0031100	animal organ regeneration	BP
9	23	0.967662606263	-	2.74e-02	GO:0090398	cellular senescence	BP
9	23	0.967662606263	-	2.74e-02	GO:0005978	glycogen biosynthetic process	BP
9	23	0.967662606263	-	3.32e-02	GO:0043044	ATP-dependent chromatin remodeling	BP
48	123	0.96374755626	-	1.06e-08	GO:0002223	stimulatory C-type lectin receptor signaling pathway	BP
64	164	0.96374755626	-	4.98e-11	GO:0090090	negative regulation of canonical Wnt signaling pathway	BP
94	241	0.962999076325	-	4.39e-16	GO:0042981	regulation of apoptotic process	BP
35	90	0.958729481493	-	1.24e-06	GO:0010976	positive regulation of neuron projection development	BP
21	54	0.958729481493	-	7.18e-04	GO:0075733	intracellular transport of virus	BP
14	36	0.958729481493	-	3.38e-03	GO:0043507	positive regulation of JUN kinase activity	BP
14	36	0.958729481493	-	4.33e-03	GO:0001837	epithelial to mesenchymal transition	BP
7	18	0.958729481493	-	1.80e-02	GO:0002076	osteoblast development	BP
7	18	0.958729481493	-	1.80e-02	GO:0046427	positive regulation of JAK-STAT cascade	BP
7	18	0.958729481493	-	2.66e-02	GO:0017015	regulation of transforming growth factor beta receptor signaling pathway	BP
7	18	0.958729481493	-	6.01e-02	GO:0001894	tissue homeostasis	BP
7	18	0.958729481493	-	6.92e-02	GO:0043523	regulation of neuron apoptotic process	BP
7	18	0.958729481493	-	6.92e-02	GO:0031116	positive regulation of microtubule polymerization	BP
7	18	0.958729481493	-	6.92e-02	GO:0010039	response to iron ion	BP
14	36	0.958729481493	-	5.62e-03	GO:0019888	protein phosphatase regulator activity	MF
7	18	0.958729481493	-	6.01e-02	GO:0019955	cytokine binding	MF
40	103	0.956727128582	-	2.24e-08	GO:0006469	negative regulation of protein kinase activity	BP
111	286	0.955844090449	-	4.39e-14	GO:0045296	cadherin binding	MF
19	49	0.954517230206	-	4.09e-06	GO:0051898	negative regulation of protein kinase B signaling	BP
19	49	0.954517230206	-	5.96e-04	GO:0001085	RNA polymerase II transcription factor binding	MF
12	31	0.952065751212	-	5.83e-03	GO:0072332	intrinsic apoptotic signaling pathway by p53 class mediator	BP
12	31	0.952065751212	-	6.85e-03	GO:0046326	positive regulation of glucose import	BP
12	31	0.952065751212	-	1.07e-02	GO:0045773	positive regulation of axon extension	BP
12	31	0.952065751212	-	2.13e-02	GO:0097421	liver regeneration	BP
310	801	0.951765533743	-	4.96e-43	GO:0042802	identical protein binding	MF
51	132	0.949330783491	-	2.51e-08	GO:0043524	negative regulation of neuron apoptotic process	BP
17	44	0.949330783491	-	5.47e-06	GO:0046426	negative regulation of JAK-STAT cascade	BP
22	57	0.94784116535	-	4.65e-04	GO:0048661	positive regulation of smooth muscle cell proliferation	BP
37	96	0.945790425785	-	6.22e-07	GO:0042593	glucose homeostasis	BP
40	104	0.942787937624	-	7.16e-07	GO:0071456	cellular response to hypoxia	BP
10	26	0.942787937624	-	1.73e-02	GO:0070371	ERK1 and ERK2 cascade	BP
5	13	0.942787937624	-	1.96e-02	GO:0001775	cell activation	BP
5	13	0.942787937624	-	1.96e-02	GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway	BP
5	13	0.942787937624	-	1.96e-02	GO:0010001	glial cell differentiation	BP
10	26	0.942787937624	-	2.10e-02	GO:0071108	protein K48-linked deubiquitination	BP
10	26	0.942787937624	-	2.62e-02	GO:0007017	microtubule-based process	BP
5	13	0.942787937624	-	3.28e-02	GO:0007398	ectoderm development	BP
5	13	0.942787937624	-	3.28e-02	GO:0097435	supramolecular fiber organization	BP
5	13	0.942787937624	-	3.28e-02	GO:0060389	pathway-restricted SMAD protein phosphorylation	BP
5	13	0.942787937624	-	5.04e-02	GO:0010717	regulation of epithelial to mesenchymal transition	BP
5	13	0.942787937624	-	5.04e-02	GO:0010763	positive regulation of fibroblast migration	BP
5	13	0.942787937624	-	5.04e-02	GO:0007171	activation of transmembrane receptor protein tyrosine kinase activity	BP
5	13	0.942787937624	-	5.04e-02	GO:0032228	regulation of synaptic transmission, GABAergic	BP
5	13	0.942787937624	-	5.04e-02	GO:0006995	cellular response to nitrogen starvation	BP
5	13	0.942787937624	-	5.04e-02	GO:0045995	regulation of embryonic development	BP
5	13	0.942787937624	-	7.26e-02	GO:0007096	regulation of exit from mitosis	BP
5	13	0.942787937624	-	7.26e-02	GO:0035909	aorta morphogenesis	BP
5	13	0.942787937624	-	7.26e-02	GO:0019395	fatty acid oxidation	BP
5	13	0.942787937624	-	7.26e-02	GO:0010821	regulation of mitochondrion organization	BP
5	13	0.942787937624	-	7.26e-02	GO:0010952	positive regulation of peptidase activity	BP
5	13	0.942787937624	-	7.26e-02	GO:0035810	positive regulation of urine volume	BP
5	13	0.942787937624	-	7.26e-02	GO:2000273	positive regulation of receptor activity	BP
5	13	0.942787937624	-	1.54e-01	GO:0001774	microglial cell activation	BP
5	13	0.942787937624	-	1.54e-01	GO:0086064	cell communication by electrical coupling involved in cardiac conduction	BP
5	13	0.942787937624	-	1.54e-01	GO:0070208	protein heterotrimerization	BP
5	13	0.942787937624	-	1.54e-01	GO:0035729	cellular response to hepatocyte growth factor stimulus	BP
5	13	0.942787937624	-	1.54e-01	GO:1904264	ubiquitin protein ligase activity involved in ERAD pathway	MF
5	13	0.942787937624	-	1.54e-01	GO:0034450	ubiquitin-ubiquitin ligase activity	MF
5	13	0.942787937624	-	1.54e-01	GO:0035497	cAMP response element binding	MF
71	185	0.939665219866	-	1.03e-12	GO:0007411	axon guidance	BP
13	34	0.934276437768	-	4.32e-03	GO:0002931	response to ischemia	BP
13	34	0.934276437768	-	6.80e-03	GO:2001240	negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	BP
13	34	0.934276437768	-	1.56e-02	GO:0051020	GTPase binding	MF
8	21	0.928982138099	-	4.36e-02	GO:0003148	outflow tract septum morphogenesis	BP
11	29	0.922750184387	-	2.49e-03	GO:0045776	negative regulation of blood pressure	BP
11	29	0.922750184387	-	3.77e-03	GO:0001569	branching involved in blood vessel morphogenesis	BP
11	29	0.922750184387	-	1.09e-02	GO:0010033	response to organic substance	BP
11	29	0.922750184387	-	3.23e-02	GO:0006294	nucleotide-excision repair, preincision complex assembly	BP
14	37	0.919201117306	-	5.62e-03	GO:0048469	cell maturation	BP
14	37	0.919201117306	-	1.19e-02	GO:0042769	DNA damage response, detection of DNA damage	BP
14	37	0.919201117306	-	3.38e-03	GO:0005547	phosphatidylinositol-3,4,5-trisphosphate binding	MF
23	61	0.914124179372	-	7.29e-04	GO:0021987	cerebral cortex development	BP
52	138	0.913214822241	-	8.26e-08	GO:0008360	regulation of cell shape	BP
26	69	0.913214822241	-	2.82e-04	GO:0097190	apoptotic signaling pathway	BP
66	176	0.906262061599	-	1.07e-16	GO:0038095	Fc-epsilon receptor signaling pathway	BP
21	56	0.906262061599	-	1.08e-04	GO:0009612	response to mechanical stimulus	BP
21	56	0.906262061599	-	1.36e-04	GO:0042475	odontogenesis of dentin-containing tooth	BP
12	32	0.906262061599	-	1.53e-03	GO:0007498	mesoderm development	BP
12	32	0.906262061599	-	5.83e-03	GO:0048147	negative regulation of fibroblast proliferation	BP
6	16	0.906262061599	-	6.36e-03	GO:0030322	stabilization of membrane potential	BP
9	24	0.906262061599	-	9.96e-03	GO:0055088	lipid homeostasis	BP
12	32	0.906262061599	-	1.07e-02	GO:0001974	blood vessel remodeling	BP
12	32	0.906262061599	-	2.13e-02	GO:1900026	positive regulation of substrate adhesion-dependent cell spreading	BP
12	32	0.906262061599	-	2.13e-02	GO:0071549	cellular response to dexamethasone stimulus	BP
6	16	0.906262061599	-	4.39e-02	GO:0042307	positive regulation of protein import into nucleus	BP
6	16	0.906262061599	-	4.39e-02	GO:0048593	camera-type eye morphogenesis	BP
3	8	0.906262061599	-	5.80e-02	GO:0034392	negative regulation of smooth muscle cell apoptotic process	BP
3	8	0.906262061599	-	5.80e-02	GO:0097264	self proteolysis	BP
3	8	0.906262061599	-	5.80e-02	GO:0060373	regulation of ventricular cardiac muscle cell membrane depolarization	BP
3	8	0.906262061599	-	5.80e-02	GO:0051782	negative regulation of cell division	BP
6	16	0.906262061599	-	9.61e-02	GO:0010608	posttranscriptional regulation of gene expression	BP
6	16	0.906262061599	-	9.61e-02	GO:0035162	embryonic hemopoiesis	BP
6	16	0.906262061599	-	9.61e-02	GO:0043968	histone H2A acetylation	BP
6	16	0.906262061599	-	9.61e-02	GO:0010633	negative regulation of epithelial cell migration	BP
3	8	0.906262061599	-	9.89e-02	GO:0046324	regulation of glucose import	BP
3	8	0.906262061599	-	9.89e-02	GO:0035137	hindlimb morphogenesis	BP
3	8	0.906262061599	-	9.89e-02	GO:0042698	ovulation cycle	BP
3	8	0.906262061599	-	9.89e-02	GO:0060087	relaxation of vascular smooth muscle	BP
3	8	0.906262061599	-	9.89e-02	GO:0090140	regulation of mitochondrial fission	BP
3	8	0.906262061599	-	9.89e-02	GO:0060259	regulation of feeding behavior	BP
3	8	0.906262061599	-	9.89e-02	GO:0060736	prostate gland growth	BP
3	8	0.906262061599	-	9.89e-02	GO:0051152	positive regulation of smooth muscle cell differentiation	BP
3	8	0.906262061599	-	9.89e-02	GO:0007143	female meiotic nuclear division	BP
3	8	0.906262061599	-	9.89e-02	GO:0051026	chiasma assembly	BP
6	16	0.906262061599	-	1.10e-01	GO:0032270	positive regulation of cellular protein metabolic process	BP
6	16	0.906262061599	-	1.10e-01	GO:0030224	monocyte differentiation	BP
6	16	0.906262061599	-	1.10e-01	GO:0006275	regulation of DNA replication	BP
6	16	0.906262061599	-	1.10e-01	GO:0030889	negative regulation of B cell proliferation	BP
3	8	0.906262061599	-	1.48e-01	GO:0033629	negative regulation of cell adhesion mediated by integrin	BP
3	8	0.906262061599	-	1.48e-01	GO:0009629	response to gravity	BP
3	8	0.906262061599	-	1.48e-01	GO:0060982	coronary artery morphogenesis	BP
3	8	0.906262061599	-	1.48e-01	GO:0050663	cytokine secretion	BP
3	8	0.906262061599	-	1.48e-01	GO:0016264	gap junction assembly	BP
3	8	0.906262061599	-	1.48e-01	GO:1904263	positive regulation of TORC1 signaling	BP
3	8	0.906262061599	-	1.48e-01	GO:0001766	membrane raft polarization	BP
3	8	0.906262061599	-	1.48e-01	GO:1902715	positive regulation of interferon-gamma secretion	BP
3	8	0.906262061599	-	1.48e-01	GO:0090150	establishment of protein localization to membrane	BP
3	8	0.906262061599	-	1.48e-01	GO:0035912	dorsal aorta morphogenesis	BP
3	8	0.906262061599	-	1.48e-01	GO:0051963	regulation of synapse assembly	BP
3	8	0.906262061599	-	2.03e-01	GO:0045348	positive regulation of MHC class II biosynthetic process	BP
3	8	0.906262061599	-	2.03e-01	GO:0032471	negative regulation of endoplasmic reticulum calcium ion concentration	BP
3	8	0.906262061599	-	2.03e-01	GO:0042775	mitochondrial ATP synthesis coupled electron transport	BP
3	8	0.906262061599	-	2.03e-01	GO:0033622	integrin activation	BP
3	8	0.906262061599	-	2.03e-01	GO:0006782	protoporphyrinogen IX biosynthetic process	BP
3	8	0.906262061599	-	2.03e-01	GO:0051569	regulation of histone H3-K4 methylation	BP
3	8	0.906262061599	-	2.03e-01	GO:0010224	response to UV-B	BP
3	8	0.906262061599	-	2.03e-01	GO:0045647	negative regulation of erythrocyte differentiation	BP
3	8	0.906262061599	-	2.03e-01	GO:1990416	cellular response to brain-derived neurotrophic factor stimulus	BP
3	8	0.906262061599	-	2.03e-01	GO:2000510	positive regulation of dendritic cell chemotaxis	BP
3	8	0.906262061599	-	2.03e-01	GO:0051683	establishment of Golgi localization	BP
3	8	0.906262061599	-	2.03e-01	GO:1902305	regulation of sodium ion transmembrane transport	BP
3	8	0.906262061599	-	2.03e-01	GO:0048227	plasma membrane to endosome transport	BP
3	8	0.906262061599	-	2.03e-01	GO:0060732	positive regulation of inositol phosphate biosynthetic process	BP
3	8	0.906262061599	-	2.03e-01	GO:0030422	production of siRNA involved in RNA interference	BP
3	8	0.906262061599	-	2.03e-01	GO:0001960	negative regulation of cytokine-mediated signaling pathway	BP
3	8	0.906262061599	-	2.03e-01	GO:0035093	spermatogenesis, exchange of chromosomal proteins	BP
3	8	0.906262061599	-	2.03e-01	GO:0035196	production of miRNAs involved in gene silencing by miRNA	BP
3	8	0.906262061599	-	2.03e-01	GO:0002011	morphogenesis of an epithelial sheet	BP
3	8	0.906262061599	-	2.03e-01	GO:0042753	positive regulation of circadian rhythm	BP
3	8	0.906262061599	-	2.03e-01	GO:0050691	regulation of defense response to virus by host	BP
3	8	0.906262061599	-	2.03e-01	GO:0014909	smooth muscle cell migration	BP
3	8	0.906262061599	-	2.03e-01	GO:2000774	positive regulation of cellular senescence	BP
3	8	0.906262061599	-	2.03e-01	GO:2000020	positive regulation of male gonad development	BP
3	8	0.906262061599	-	2.03e-01	GO:0006002	fructose 6-phosphate metabolic process	BP
3	8	0.906262061599	-	2.03e-01	GO:0050891	multicellular organismal water homeostasis	BP
3	8	0.906262061599	-	5.80e-02	GO:0019213	deacetylase activity	MF
6	16	0.906262061599	-	9.61e-02	GO:0097602	cullin family protein binding	MF
3	8	0.906262061599	-	9.89e-02	GO:0001162	RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding	MF
3	8	0.906262061599	-	9.89e-02	GO:0015271	outward rectifier potassium channel activity	MF
3	8	0.906262061599	-	1.48e-01	GO:0005113	patched binding	MF
3	8	0.906262061599	-	1.48e-01	GO:0005005	transmembrane-ephrin receptor activity	MF
3	8	0.906262061599	-	1.48e-01	GO:0043008	ATP-dependent protein binding	MF
3	8	0.906262061599	-	2.03e-01	GO:0001094	TFIID-class transcription factor binding	MF
3	8	0.906262061599	-	2.03e-01	GO:0032036	myosin heavy chain binding	MF
3	8	0.906262061599	-	2.03e-01	GO:0001164	RNA polymerase I CORE element sequence-specific DNA binding	MF
3	8	0.906262061599	-	2.03e-01	GO:0015037	peptide disulfide oxidoreductase activity	MF
3	8	0.906262061599	-	2.03e-01	GO:0001849	complement component C1q binding	MF
3	8	0.906262061599	-	2.03e-01	GO:0000340	RNA 7-methylguanosine cap binding	MF
15	40	0.906262061599	-	2.75e-03	GO:0043434	response to peptide hormone	BP
15	40	0.906262061599	-	2.75e-03	GO:0021762	substantia nigra development	BP
15	40	0.906262061599	-	3.60e-03	GO:0032024	positive regulation of insulin secretion	BP
31	83	0.900456439918	-	1.31e-04	GO:0010389	regulation of G2/M transition of mitotic cell cycle	BP
22	59	0.898088130153	-	4.65e-04	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	MF
120	322	0.897273278372	-	4.03e-18	GO:0043065	positive regulation of apoptotic process	BP
19	51	0.89680173235	-	1.40e-03	GO:0051592	response to calcium ion	BP
19	51	0.89680173235	-	1.40e-03	GO:0040008	regulation of growth	BP
19	51	0.89680173235	-	1.70e-03	GO:0010977	negative regulation of neuron projection development	BP
19	51	0.89680173235	-	3.74e-03	GO:0051865	protein autoubiquitination	BP
13	35	0.892456262074	-	1.39e-02	GO:0000723	telomere maintenance	BP
13	35	0.892456262074	-	1.56e-02	GO:0005057	signal transducer activity, downstream of receptor	MF
142	383	0.889846098457	-	9.52e-22	GO:0035556	intracellular signal transduction	BP
20	54	0.888340153602	-	1.38e-03	GO:0071560	cellular response to transforming growth factor beta stimulus	BP
10	27	0.888340153602	-	4.06e-03	GO:0007628	adult walking behavior	BP
10	27	0.888340153602	-	2.62e-02	GO:0007093	mitotic cell cycle checkpoint	BP
10	27	0.888340153602	-	4.90e-02	GO:0032200	telomere organization	BP
10	27	0.888340153602	-	2.62e-02	GO:0061631	ubiquitin conjugating enzyme activity	MF
44	119	0.885913416207	-	1.63e-06	GO:0030308	negative regulation of cell growth	BP
17	46	0.885200446071	-	6.82e-04	GO:0003151	outflow tract morphogenesis	BP
17	46	0.885200446071	-	1.47e-03	GO:0007611	learning or memory	BP
119	322	0.885200446071	-	8.54e-14	GO:0016032	viral process	BP
24	65	0.88389424857	-	7.90e-04	GO:0000226	microtubule cytoskeleton organization	BP
69	187	0.882929557768	-	3.07e-11	GO:0030335	positive regulation of cell migration	BP
21	57	0.880726969492	-	1.79e-04	GO:0043087	regulation of GTPase activity	BP
28	76	0.880726969492	-	2.82e-04	GO:0016925	protein sumoylation	BP
14	38	0.880726969492	-	1.41e-02	GO:0030049	muscle filament sliding	BP
7	19	0.880726969492	-	6.01e-02	GO:0071385	cellular response to glucocorticoid stimulus	BP
7	19	0.880726969492	-	6.92e-02	GO:0046716	muscle cell cellular homeostasis	BP
7	19	0.880726969492	-	6.92e-02	GO:0030099	myeloid cell differentiation	BP
7	19	0.880726969492	-	8.19e-02	GO:0008637	apoptotic mitochondrial changes	BP
7	19	0.880726969492	-	8.19e-02	GO:0043011	myeloid dendritic cell differentiation	BP
7	19	0.880726969492	-	6.01e-02	GO:0070530	K63-linked polyubiquitin modification-dependent protein binding	MF
7	19	0.880726969492	-	6.01e-02	GO:0030506	ankyrin binding	MF
22	60	0.873840583906	-	1.10e-03	GO:0030334	regulation of cell migration	BP
11	30	0.873840583906	-	9.28e-03	GO:0031667	response to nutrient levels	BP
11	30	0.873840583906	-	1.33e-02	GO:0007616	long-term memory	BP
11	30	0.873840583906	-	3.60e-02	GO:0036258	multivesicular body assembly	BP
11	30	0.873840583906	-	3.23e-02	GO:0001205	transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding	MF
26	71	0.871992159514	-	1.09e-05	GO:0071300	cellular response to retinoic acid	BP
8	22	0.86186794224	-	1.63e-02	GO:0045671	negative regulation of osteoclast differentiation	BP
4	11	0.86186794224	-	3.34e-02	GO:0042551	neuron maturation	BP
4	11	0.86186794224	-	3.34e-02	GO:0022010	central nervous system myelination	BP
8	22	0.86186794224	-	4.36e-02	GO:1901224	positive regulation of NIK/NF-kappaB signaling	BP
8	22	0.86186794224	-	4.36e-02	GO:0048754	branching morphogenesis of an epithelial tube	BP
8	22	0.86186794224	-	4.36e-02	GO:0043623	cellular protein complex assembly	BP
4	11	0.86186794224	-	5.63e-02	GO:0031639	plasminogen activation	BP
4	11	0.86186794224	-	5.63e-02	GO:0030857	negative regulation of epithelial cell differentiation	BP
4	11	0.86186794224	-	5.63e-02	GO:0043586	tongue development	BP
4	11	0.86186794224	-	5.63e-02	GO:0060088	auditory receptor cell stereocilium organization	BP
4	11	0.86186794224	-	5.63e-02	GO:0048016	inositol phosphate-mediated signaling	BP
8	22	0.86186794224	-	6.35e-02	GO:0030316	osteoclast differentiation	BP
4	11	0.86186794224	-	8.57e-02	GO:0030278	regulation of ossification	BP
4	11	0.86186794224	-	8.57e-02	GO:0032703	negative regulation of interleukin-2 production	BP
4	11	0.86186794224	-	8.57e-02	GO:0022409	positive regulation of cell-cell adhesion	BP
4	11	0.86186794224	-	8.57e-02	GO:0060055	angiogenesis involved in wound healing	BP
4	11	0.86186794224	-	1.21e-01	GO:0045899	positive regulation of RNA polymerase II transcriptional preinitiation complex assembly	BP
4	11	0.86186794224	-	1.21e-01	GO:0071223	cellular response to lipoteichoic acid	BP
4	11	0.86186794224	-	1.21e-01	GO:1903204	negative regulation of oxidative stress-induced neuron death	BP
4	11	0.86186794224	-	1.21e-01	GO:0050732	negative regulation of peptidyl-tyrosine phosphorylation	BP
4	11	0.86186794224	-	1.21e-01	GO:0033234	negative regulation of protein sumoylation	BP
4	11	0.86186794224	-	1.21e-01	GO:0098911	regulation of ventricular cardiac muscle cell action potential	BP
4	11	0.86186794224	-	1.21e-01	GO:0006473	protein acetylation	BP
4	11	0.86186794224	-	1.21e-01	GO:0048596	embryonic camera-type eye morphogenesis	BP
4	11	0.86186794224	-	1.21e-01	GO:0031915	positive regulation of synaptic plasticity	BP
4	11	0.86186794224	-	1.21e-01	GO:0050862	positive regulation of T cell receptor signaling pathway	BP
4	11	0.86186794224	-	1.21e-01	GO:0032688	negative regulation of interferon-beta production	BP
4	11	0.86186794224	-	1.21e-01	GO:0043517	positive regulation of DNA damage response, signal transduction by p53 class mediator	BP
4	11	0.86186794224	-	2.47e-01	GO:0050927	positive regulation of positive chemotaxis	BP
4	11	0.86186794224	-	2.47e-01	GO:0010884	positive regulation of lipid storage	BP
4	11	0.86186794224	-	2.47e-01	GO:0006983	ER overload response	BP
4	11	0.86186794224	-	2.47e-01	GO:0070914	UV-damage excision repair	BP
4	11	0.86186794224	-	2.47e-01	GO:0003279	cardiac septum development	BP
4	11	0.86186794224	-	2.47e-01	GO:1901653	cellular response to peptide	BP
4	11	0.86186794224	-	2.47e-01	GO:0006266	DNA ligation	BP
4	11	0.86186794224	-	2.47e-01	GO:0043306	positive regulation of mast cell degranulation	BP
4	11	0.86186794224	-	2.47e-01	GO:0006600	creatine metabolic process	BP
4	11	0.86186794224	-	2.47e-01	GO:0071372	cellular response to follicle-stimulating hormone stimulus	BP
4	11	0.86186794224	-	2.47e-01	GO:0035563	positive regulation of chromatin binding	BP
4	11	0.86186794224	-	2.47e-01	GO:0071481	cellular response to X-ray	BP
4	11	0.86186794224	-	2.47e-01	GO:1903364	positive regulation of cellular protein catabolic process	BP
12	33	0.86186794224	-	1.07e-02	GO:0016791	phosphatase activity	MF
4	11	0.86186794224	-	8.57e-02	GO:0001206	transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding	MF
4	11	0.86186794224	-	8.57e-02	GO:0004629	phospholipase C activity	MF
4	11	0.86186794224	-	2.47e-01	GO:0035615	clathrin adaptor activity	MF
4	11	0.86186794224	-	2.47e-01	GO:0070410	co-SMAD binding	MF
20	55	0.86186794224	-	7.75e-04	GO:0048812	neuron projection morphogenesis	BP
45	124	0.85895634682	-	4.56e-06	GO:0006461	protein complex assembly	BP
58	160	0.857352461118	-	1.70e-07	GO:0001666	response to hypoxia	BP
72	199	0.854599941776	-	6.04e-09	GO:0003714	transcription corepressor activity	MF
13	36	0.851814277576	-	9.44e-04	GO:0032467	positive regulation of cytokinesis	BP
13	36	0.851814277576	-	5.34e-03	GO:0010942	positive regulation of cell death	BP
106	294	0.849547670604	-	1.41e-15	GO:0010628	positive regulation of gene expression	BP
9	25	0.847368372545	-	6.64e-03	GO:0060349	bone morphogenesis	BP
9	25	0.847368372545	-	4.08e-02	GO:0045737	positive regulation of cyclin-dependent protein serine/threonine kinase activity	BP
9	25	0.847368372545	-	4.08e-02	GO:0048678	response to axon injury	BP
9	25	0.847368372545	-	7.40e-02	GO:0061621	canonical glycolysis	BP
9	25	0.847368372545	-	7.40e-02	GO:0000188	inactivation of MAPK activity	BP
23	64	0.844861516935	-	8.31e-04	GO:0035690	cellular response to drug	BP
14	39	0.843252264073	-	4.33e-03	GO:0000422	autophagy of mitochondrion	BP
35	98	0.835872733707	-	2.11e-05	GO:0035335	peptidyl-tyrosine dephosphorylation	BP
20	56	0.835872733707	-	1.38e-03	GO:0009267	cellular response to starvation	BP
10	28	0.835872733707	-	4.06e-03	GO:0001755	neural crest cell migration	BP
5	14	0.835872733707	-	4.67e-03	GO:0051481	negative regulation of cytosolic calcium ion concentration	BP
15	42	0.835872733707	-	9.30e-03	GO:0006986	response to unfolded protein	BP
10	28	0.835872733707	-	1.48e-02	GO:0003281	ventricular septum development	BP
5	14	0.835872733707	-	1.96e-02	GO:0021854	hypothalamus development	BP
5	14	0.835872733707	-	1.96e-02	GO:1901223	negative regulation of NIK/NF-kappaB signaling	BP
10	28	0.835872733707	-	2.10e-02	GO:0005977	glycogen metabolic process	BP
5	14	0.835872733707	-	3.28e-02	GO:0010666	positive regulation of cardiac muscle cell apoptotic process	BP
5	14	0.835872733707	-	5.04e-02	GO:0043303	mast cell degranulation	BP
5	14	0.835872733707	-	5.04e-02	GO:0061045	negative regulation of wound healing	BP
5	14	0.835872733707	-	7.26e-02	GO:0019079	viral genome replication	BP
5	14	0.835872733707	-	7.26e-02	GO:0045721	negative regulation of gluconeogenesis	BP
5	14	0.835872733707	-	7.26e-02	GO:0006098	pentose-phosphate shunt	BP
5	14	0.835872733707	-	7.26e-02	GO:0071425	hematopoietic stem cell proliferation	BP
5	14	0.835872733707	-	7.26e-02	GO:0042325	regulation of phosphorylation	BP
5	14	0.835872733707	-	7.26e-02	GO:2000678	negative regulation of transcription regulatory region DNA binding	BP
5	14	0.835872733707	-	7.26e-02	GO:2001275	positive regulation of glucose import in response to insulin stimulus	BP
5	14	0.835872733707	-	1.54e-01	GO:0072657	protein localization to membrane	BP
5	14	0.835872733707	-	1.54e-01	GO:0033147	negative regulation of intracellular estrogen receptor signaling pathway	BP
5	14	0.835872733707	-	1.54e-01	GO:0044130	negative regulation of growth of symbiont in host	BP
5	14	0.835872733707	-	1.54e-01	GO:0001817	regulation of cytokine production	BP
5	14	0.835872733707	-	1.54e-01	GO:2000045	regulation of G1/S transition of mitotic cell cycle	BP
5	14	0.835872733707	-	1.54e-01	GO:0001921	positive regulation of receptor recycling	BP
5	14	0.835872733707	-	1.54e-01	GO:0050768	negative regulation of neurogenesis	BP
5	14	0.835872733707	-	1.74e-01	GO:0043122	regulation of I-kappaB kinase/NF-kappaB signaling	BP
10	28	0.835872733707	-	4.06e-03	GO:0005496	steroid binding	MF
5	14	0.835872733707	-	5.04e-02	GO:0005523	tropomyosin binding	MF
5	14	0.835872733707	-	1.74e-01	GO:0005528	FK506 binding	MF
5	14	0.835872733707	-	1.74e-01	GO:0034236	protein kinase A catalytic subunit binding	MF
166	467	0.829060252515	-	4.66e-22	GO:0043066	negative regulation of apoptotic process	BP
11	31	0.826534869128	-	1.33e-02	GO:0060412	ventricular septum morphogenesis	BP
11	31	0.826534869128	-	3.23e-02	GO:0034504	protein localization to nucleus	BP
11	31	0.826534869128	-	1.09e-02	GO:0050699	WW domain binding	MF
144	407	0.822339578054	-	9.71e-21	GO:0008285	negative regulation of cell proliferation	BP
12	34	0.818799220348	-	3.46e-04	GO:0060045	positive regulation of cardiac muscle cell proliferation	BP
12	34	0.818799220348	-	2.73e-02	GO:0051973	positive regulation of telomerase activity	BP
6	17	0.818799220348	-	3.00e-02	GO:0009948	anterior/posterior axis specification	BP
6	17	0.818799220348	-	3.00e-02	GO:0048514	blood vessel morphogenesis	BP
6	17	0.818799220348	-	3.00e-02	GO:0001953	negative regulation of cell-matrix adhesion	BP
6	17	0.818799220348	-	4.39e-02	GO:0010975	regulation of neuron projection development	BP
6	17	0.818799220348	-	4.39e-02	GO:0007043	cell-cell junction assembly	BP
6	17	0.818799220348	-	4.39e-02	GO:0050767	regulation of neurogenesis	BP
6	17	0.818799220348	-	9.61e-02	GO:0071380	cellular response to prostaglandin E stimulus	BP
6	17	0.818799220348	-	9.61e-02	GO:0006103	2-oxoglutarate metabolic process	BP
6	17	0.818799220348	-	9.61e-02	GO:0070935	3'-UTR-mediated mRNA stabilization	BP
6	17	0.818799220348	-	1.28e-01	GO:0031668	cellular response to extracellular stimulus	BP
6	17	0.818799220348	-	1.28e-01	GO:0070266	necroptotic process	BP
6	17	0.818799220348	-	9.61e-02	GO:0048037	cofactor binding	MF
6	17	0.818799220348	-	9.61e-02	GO:0000987	core promoter proximal region sequence-specific DNA binding	MF
19	54	0.814339572158	-	3.74e-03	GO:0006325	chromatin organization	BP
13	37	0.81228591339	-	1.39e-02	GO:0042149	cellular response to glucose starvation	BP
13	37	0.81228591339	-	1.39e-02	GO:0010507	negative regulation of autophagy	BP
13	37	0.81228591339	-	1.80e-02	GO:0006605	protein targeting	BP
13	37	0.81228591339	-	3.63e-02	GO:0006296	nucleotide-excision repair, DNA incision, 5'-to lesion	BP
33	94	0.811104828558	-	3.68e-06	GO:0051897	positive regulation of protein kinase B signaling	BP
35	100	0.806726388048	-	2.85e-04	GO:0000082	G1/S transition of mitotic cell cycle	BP
14	40	0.806726388048	-	2.72e-03	GO:0032526	response to retinoic acid	BP
14	40	0.806726388048	-	4.33e-03	GO:1905515	non-motile cilium assembly	BP
14	40	0.806726388048	-	5.62e-03	GO:0007162	negative regulation of cell adhesion	BP
14	40	0.806726388048	-	1.41e-02	GO:0034613	cellular protein localization	BP
7	20	0.806726388048	-	6.92e-02	GO:0010971	positive regulation of G2/M transition of mitotic cell cycle	BP
7	20	0.806726388048	-	6.92e-02	GO:0071310	cellular response to organic substance	BP
7	20	0.806726388048	-	9.82e-02	GO:0045663	positive regulation of myoblast differentiation	BP
14	40	0.806726388048	-	2.72e-02	GO:0004407	histone deacetylase activity	MF
31	89	0.799762440298	-	1.09e-04	GO:0004725	protein tyrosine phosphatase activity	MF
31	89	0.799762440298	-	2.62e-04	GO:0051087	chaperone binding	MF
24	69	0.797737604821	-	7.90e-04	GO:0050790	regulation of catalytic activity	BP
16	46	0.797737604821	-	6.11e-03	GO:0007519	skeletal muscle tissue development	BP
8	23	0.797737604821	-	6.35e-02	GO:0000070	mitotic sister chromatid segregation	BP
8	23	0.797737604821	-	1.11e-01	GO:0006297	nucleotide-excision repair, DNA gap filling	BP
57	164	0.796637570424	-	4.12e-08	GO:0007507	heart development	BP
34	98	0.794052558013	-	4.99e-04	GO:1902036	regulation of hematopoietic stem cell differentiation	BP
17	49	0.794052558013	-	4.00e-03	GO:0071230	cellular response to amino acid stimulus	BP
9	26	0.790784844179	-	3.32e-02	GO:0033077	T cell differentiation in thymus	BP
9	26	0.790784844179	-	8.17e-02	GO:0051225	spindle assembly	BP
9	26	0.790784844179	-	7.40e-02	GO:0043015	gamma-tubulin binding	MF
19	55	0.787867360797	-	5.96e-04	GO:0000902	cell morphogenesis	BP
19	55	0.787867360797	-	1.40e-03	GO:0071277	cellular response to calcium ion	BP
19	55	0.787867360797	-	1.70e-03	GO:0060548	negative regulation of cell death	BP
29	84	0.786963133226	-	1.12e-03	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	BP
10	29	0.785246660637	-	2.10e-02	GO:0007205	protein kinase C-activating G-protein coupled receptor signaling pathway	BP
10	29	0.785246660637	-	2.10e-02	GO:0090200	positive regulation of release of cytochrome c from mitochondria	BP
10	29	0.785246660637	-	4.90e-02	GO:0045765	regulation of angiogenesis	BP
10	29	0.785246660637	-	4.90e-02	GO:1903146	regulation of autophagy of mitochondrion	BP
33	96	0.780731179515	-	1.17e-03	GO:0097711	ciliary basal body-plasma membrane docking	BP
22	64	0.780731179515	-	1.48e-03	GO:0035019	somatic stem cell population maintenance	BP
11	32	0.780731179515	-	3.23e-02	GO:0071479	cellular response to ionizing radiation	BP
11	32	0.780731179515	-	4.12e-02	GO:0046677	response to antibiotic	BP
12	35	0.776979044654	-	3.21e-02	GO:0019985	translesion synthesis	BP
13	38	0.773811765575	-	3.63e-02	GO:0006289	nucleotide-excision repair	BP
13	38	0.773811765575	-	3.99e-02	GO:0033683	nucleotide-excision repair, DNA incision	BP
13	38	0.773811765575	-	2.14e-02	GO:0001105	RNA polymerase II transcription coactivator activity	MF
42	123	0.771102478317	-	1.07e-05	GO:0002576	platelet degranulation	BP
14	41	0.771102478317	-	1.41e-02	GO:0007595	lactation	BP
15	44	0.768758537849	-	1.67e-02	GO:0034260	negative regulation of GTPase activity	BP
15	44	0.768758537849	-	1.67e-02	GO:0051290	protein heterotetramerization	BP
15	44	0.768758537849	-	3.52e-02	GO:0007077	mitotic nuclear envelope disassembly	BP
54	159	0.763304107757	-	1.24e-08	GO:0010629	negative regulation of gene expression	BP
19	56	0.761872152264	-	8.62e-03	GO:0004197	cysteine-type endopeptidase activity	MF
20	59	0.760584606403	-	1.71e-04	GO:0004860	protein kinase inhibitor activity	MF
21	62	0.759420673269	-	1.89e-03	GO:0045727	positive regulation of translation	BP
22	65	0.758363366486	-	1.10e-03	GO:0031647	regulation of protein stability	BP
26	77	0.754952738324	-	8.19e-04	GO:0003690	double-stranded DNA binding	MF
174	516	0.753015801303	-	4.77e-17	GO:0045893	positive regulation of transcription, DNA-templated	BP
33	98	0.750983836121	-	4.81e-05	GO:0001764	neuron migration	BP
91	272	0.741631359826	-	4.19e-11	GO:0001077	transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding	MF
252	755	0.738246650165	-	2.57e-27	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	BP
50	150	0.736337060156	-	1.57e-05	GO:0050821	protein stabilization	BP
10	30	0.736337060156	-	4.06e-03	GO:0045930	negative regulation of mitotic cell cycle	BP
19	57	0.736337060156	-	4.27e-03	GO:0071333	cellular response to glucose stimulus	BP
10	30	0.736337060156	-	6.12e-03	GO:0042104	positive regulation of activated T cell proliferation	BP
18	54	0.736337060156	-	6.38e-03	GO:0030097	hemopoiesis	BP
9	27	0.736337060156	-	6.64e-03	GO:0009755	hormone-mediated signaling pathway	BP
12	36	0.736337060156	-	1.07e-02	GO:0001568	blood vessel development	BP
6	18	0.736337060156	-	1.16e-02	GO:0060044	negative regulation of cardiac muscle cell proliferation	BP
13	39	0.736337060156	-	1.56e-02	GO:0060291	long-term synaptic potentiation	BP
5	15	0.736337060156	-	1.96e-02	GO:0001963	synaptic transmission, dopaminergic	BP
10	30	0.736337060156	-	2.10e-02	GO:0001707	mesoderm formation	BP
13	39	0.736337060156	-	2.14e-02	GO:0050714	positive regulation of protein secretion	BP
14	42	0.736337060156	-	2.72e-02	GO:0030218	erythrocyte differentiation	BP
3	9	0.736337060156	-	2.72e-02	GO:0045141	meiotic telomere clustering	BP
12	36	0.736337060156	-	2.73e-02	GO:0030177	positive regulation of Wnt signaling pathway	BP
5	15	0.736337060156	-	3.28e-02	GO:0010569	regulation of double-strand break repair via homologous recombination	BP
13	39	0.736337060156	-	3.99e-02	GO:0030890	positive regulation of B cell proliferation	BP
8	24	0.736337060156	-	4.36e-02	GO:0007159	leukocyte cell-cell adhesion	BP
8	24	0.736337060156	-	4.36e-02	GO:0031334	positive regulation of protein complex assembly	BP
6	18	0.736337060156	-	4.39e-02	GO:0030279	negative regulation of ossification	BP
5	15	0.736337060156	-	5.04e-02	GO:1904754	positive regulation of vascular associated smooth muscle cell migration	BP
8	24	0.736337060156	-	5.22e-02	GO:0032435	negative regulation of proteasomal ubiquitin-dependent protein catabolic process	BP
4	12	0.736337060156	-	5.63e-02	GO:0032026	response to magnesium ion	BP
3	9	0.736337060156	-	5.80e-02	GO:0050778	positive regulation of immune response	BP
3	9	0.736337060156	-	5.80e-02	GO:0043583	ear development	BP
7	21	0.736337060156	-	6.92e-02	GO:0035902	response to immobilization stress	BP
7	21	0.736337060156	-	6.92e-02	GO:0046697	decidualization	BP
5	15	0.736337060156	-	7.26e-02	GO:0010759	positive regulation of macrophage chemotaxis	BP
5	15	0.736337060156	-	7.26e-02	GO:0010832	negative regulation of myotube differentiation	BP
5	15	0.736337060156	-	7.26e-02	GO:0006691	leukotriene metabolic process	BP
9	27	0.736337060156	-	7.40e-02	GO:0006754	ATP biosynthetic process	BP
7	21	0.736337060156	-	8.19e-02	GO:0050870	positive regulation of T cell activation	BP
4	12	0.736337060156	-	8.57e-02	GO:0007041	lysosomal transport	BP
7	21	0.736337060156	-	9.82e-02	GO:0030879	mammary gland development	BP
3	9	0.736337060156	-	9.89e-02	GO:0003073	regulation of systemic arterial blood pressure	BP
3	9	0.736337060156	-	9.89e-02	GO:0048617	embryonic foregut morphogenesis	BP
3	9	0.736337060156	-	9.89e-02	GO:0002315	marginal zone B cell differentiation	BP
3	9	0.736337060156	-	9.89e-02	GO:0046887	positive regulation of hormone secretion	BP
3	9	0.736337060156	-	9.89e-02	GO:0032099	negative regulation of appetite	BP
3	9	0.736337060156	-	9.89e-02	GO:2000304	positive regulation of ceramide biosynthetic process	BP
2	6	0.736337060156	-	1.04e-01	GO:0045143	homologous chromosome segregation	BP
2	6	0.736337060156	-	1.04e-01	GO:0044245	polysaccharide digestion	BP
2	6	0.736337060156	-	1.04e-01	GO:0001696	gastric acid secretion	BP
2	6	0.736337060156	-	1.04e-01	GO:0048512	circadian behavior	BP
2	6	0.736337060156	-	1.04e-01	GO:0006880	intracellular sequestering of iron ion	BP
2	6	0.736337060156	-	1.04e-01	GO:0048856	anatomical structure development	BP
2	6	0.736337060156	-	1.04e-01	GO:0090370	negative regulation of cholesterol efflux	BP
2	6	0.736337060156	-	1.04e-01	GO:0051155	positive regulation of striated muscle cell differentiation	BP
6	18	0.736337060156	-	1.10e-01	GO:0045954	positive regulation of natural killer cell mediated cytotoxicity	BP
8	24	0.736337060156	-	1.11e-01	GO:2000778	positive regulation of interleukin-6 secretion	BP
4	12	0.736337060156	-	1.21e-01	GO:0021846	cell proliferation in forebrain	BP
4	12	0.736337060156	-	1.21e-01	GO:0030239	myofibril assembly	BP
4	12	0.736337060156	-	1.21e-01	GO:0032695	negative regulation of interleukin-12 production	BP
4	12	0.736337060156	-	1.21e-01	GO:0030516	regulation of axon extension	BP
4	12	0.736337060156	-	1.21e-01	GO:0043616	keratinocyte proliferation	BP
4	12	0.736337060156	-	1.21e-01	GO:0042592	homeostatic process	BP
4	12	0.736337060156	-	1.21e-01	GO:0035641	locomotory exploration behavior	BP
4	12	0.736337060156	-	1.21e-01	GO:0072520	seminiferous tubule development	BP
4	12	0.736337060156	-	1.21e-01	GO:0007600	sensory perception	BP
6	18	0.736337060156	-	1.28e-01	GO:0048260	positive regulation of receptor-mediated endocytosis	BP
6	18	0.736337060156	-	1.28e-01	GO:1902236	negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway	BP
6	18	0.736337060156	-	1.28e-01	GO:0045445	myoblast differentiation	BP
6	18	0.736337060156	-	1.28e-01	GO:0045664	regulation of neuron differentiation	BP
3	9	0.736337060156	-	1.48e-01	GO:2001223	negative regulation of neuron migration	BP
3	9	0.736337060156	-	1.48e-01	GO:0003374	dynamin family protein polymerization involved in mitochondrial fission	BP
3	9	0.736337060156	-	1.48e-01	GO:0038166	angiotensin-activated signaling pathway	BP
3	9	0.736337060156	-	1.48e-01	GO:0021702	cerebellar Purkinje cell differentiation	BP
3	9	0.736337060156	-	1.48e-01	GO:0007599	hemostasis	BP
3	9	0.736337060156	-	1.48e-01	GO:0035845	photoreceptor cell outer segment organization	BP
3	9	0.736337060156	-	1.48e-01	GO:0045124	regulation of bone resorption	BP
3	9	0.736337060156	-	1.48e-01	GO:0060253	negative regulation of glial cell proliferation	BP
3	9	0.736337060156	-	1.48e-01	GO:0090277	positive regulation of peptide hormone secretion	BP
3	9	0.736337060156	-	1.48e-01	GO:0061351	neural precursor cell proliferation	BP
5	15	0.736337060156	-	1.54e-01	GO:0048738	cardiac muscle tissue development	BP
5	15	0.736337060156	-	1.54e-01	GO:0060347	heart trabecula formation	BP
5	15	0.736337060156	-	1.54e-01	GO:0007548	sex differentiation	BP
5	15	0.736337060156	-	1.54e-01	GO:0001824	blastocyst development	BP
5	15	0.736337060156	-	1.54e-01	GO:0002042	cell migration involved in sprouting angiogenesis	BP
5	15	0.736337060156	-	1.54e-01	GO:0090303	positive regulation of wound healing	BP
5	15	0.736337060156	-	1.54e-01	GO:0015671	oxygen transport	BP
7	21	0.736337060156	-	1.66e-01	GO:0006295	nucleotide-excision repair, DNA incision, 3'-to lesion	BP
7	21	0.736337060156	-	1.66e-01	GO:0006293	nucleotide-excision repair, preincision complex stabilization	BP
5	15	0.736337060156	-	1.74e-01	GO:0033146	regulation of intracellular estrogen receptor signaling pathway	BP
5	15	0.736337060156	-	1.74e-01	GO:0097067	cellular response to thyroid hormone stimulus	BP
5	15	0.736337060156	-	1.74e-01	GO:0014898	cardiac muscle hypertrophy in response to stress	BP
5	15	0.736337060156	-	1.74e-01	GO:0032469	endoplasmic reticulum calcium ion homeostasis	BP
5	15	0.736337060156	-	1.74e-01	GO:0032743	positive regulation of interleukin-2 production	BP
5	15	0.736337060156	-	1.74e-01	GO:2000353	positive regulation of endothelial cell apoptotic process	BP
5	15	0.736337060156	-	1.74e-01	GO:0090141	positive regulation of mitochondrial fission	BP
5	15	0.736337060156	-	1.74e-01	GO:0034162	toll-like receptor 9 signaling pathway	BP
2	6	0.736337060156	-	1.81e-01	GO:0060267	positive regulation of respiratory burst	BP
2	6	0.736337060156	-	1.81e-01	GO:0086015	SA node cell action potential	BP
2	6	0.736337060156	-	1.81e-01	GO:0010694	positive regulation of alkaline phosphatase activity	BP
2	6	0.736337060156	-	1.81e-01	GO:0021853	cerebral cortex GABAergic interneuron migration	BP
2	6	0.736337060156	-	1.81e-01	GO:0040012	regulation of locomotion	BP
2	6	0.736337060156	-	1.81e-01	GO:0021884	forebrain neuron development	BP
2	6	0.736337060156	-	1.81e-01	GO:0003100	regulation of systemic arterial blood pressure by endothelin	BP
2	6	0.736337060156	-	1.81e-01	GO:0060426	lung vasculature development	BP
2	6	0.736337060156	-	1.81e-01	GO:0051005	negative regulation of lipoprotein lipase activity	BP
2	6	0.736337060156	-	1.81e-01	GO:0044241	lipid digestion	BP
2	6	0.736337060156	-	1.81e-01	GO:0042866	pyruvate biosynthetic process	BP
2	6	0.736337060156	-	1.81e-01	GO:1904468	negative regulation of tumor necrosis factor secretion	BP
2	6	0.736337060156	-	1.81e-01	GO:1900118	negative regulation of execution phase of apoptosis	BP
2	6	0.736337060156	-	1.81e-01	GO:0055123	digestive system development	BP
2	6	0.736337060156	-	1.81e-01	GO:0061000	negative regulation of dendritic spine development	BP
5	15	0.736337060156	-	1.99e-01	GO:0051571	positive regulation of histone H3-K4 methylation	BP
1	3	0.736337060156	-	2.00e-01	GO:2000816	negative regulation of mitotic sister chromatid separation	BP
1	3	0.736337060156	-	2.00e-01	GO:0070172	positive regulation of tooth mineralization	BP
1	3	0.736337060156	-	2.00e-01	GO:0042269	regulation of natural killer cell mediated cytotoxicity	BP
1	3	0.736337060156	-	2.00e-01	GO:0038093	Fc receptor signaling pathway	BP
1	3	0.736337060156	-	2.00e-01	GO:0060913	cardiac cell fate determination	BP
1	3	0.736337060156	-	2.00e-01	GO:0060914	heart formation	BP
1	3	0.736337060156	-	2.00e-01	GO:0034628	'de novo' NAD biosynthetic process from aspartate	BP
1	3	0.736337060156	-	2.00e-01	GO:0060541	respiratory system development	BP
1	3	0.736337060156	-	2.00e-01	GO:0061044	negative regulation of vascular wound healing	BP
1	3	0.736337060156	-	2.00e-01	GO:0034505	tooth mineralization	BP
1	3	0.736337060156	-	2.00e-01	GO:1905913	negative regulation of calcium ion export from cell	BP
1	3	0.736337060156	-	2.00e-01	GO:0038171	cannabinoid signaling pathway	BP
1	3	0.736337060156	-	2.00e-01	GO:0001842	neural fold formation	BP
1	3	0.736337060156	-	2.00e-01	GO:0042369	vitamin D catabolic process	BP
1	3	0.736337060156	-	2.00e-01	GO:0086047	membrane depolarization during Purkinje myocyte cell action potential	BP
1	3	0.736337060156	-	2.00e-01	GO:0071877	regulation of adrenergic receptor signaling pathway	BP
1	3	0.736337060156	-	2.00e-01	GO:0044240	multicellular organismal lipid catabolic process	BP
1	3	0.736337060156	-	2.00e-01	GO:0060447	bud outgrowth involved in lung branching	BP
1	3	0.736337060156	-	2.00e-01	GO:1903122	negative regulation of TRAIL-activated apoptotic signaling pathway	BP
1	3	0.736337060156	-	2.00e-01	GO:0044691	tooth eruption	BP
1	3	0.736337060156	-	2.00e-01	GO:1990918	double-strand break repair involved in meiotic recombination	BP
3	9	0.736337060156	-	2.03e-01	GO:0048193	Golgi vesicle transport	BP
3	9	0.736337060156	-	2.03e-01	GO:0042119	neutrophil activation	BP
3	9	0.736337060156	-	2.03e-01	GO:0010762	regulation of fibroblast migration	BP
3	9	0.736337060156	-	2.03e-01	GO:0097484	dendrite extension	BP
3	9	0.736337060156	-	2.03e-01	GO:0006353	DNA-templated transcription, termination	BP
3	9	0.736337060156	-	2.03e-01	GO:0021675	nerve development	BP
3	9	0.736337060156	-	2.03e-01	GO:0001818	negative regulation of cytokine production	BP
3	9	0.736337060156	-	2.03e-01	GO:0000733	DNA strand renaturation	BP
3	9	0.736337060156	-	2.03e-01	GO:0006105	succinate metabolic process	BP
3	9	0.736337060156	-	2.03e-01	GO:0006111	regulation of gluconeogenesis	BP
3	9	0.736337060156	-	2.03e-01	GO:0003197	endocardial cushion development	BP
3	9	0.736337060156	-	2.03e-01	GO:0010950	positive regulation of endopeptidase activity	BP
3	9	0.736337060156	-	2.03e-01	GO:0002726	positive regulation of T cell cytokine production	BP
3	9	0.736337060156	-	2.03e-01	GO:0042088	T-helper 1 type immune response	BP
3	9	0.736337060156	-	2.03e-01	GO:0030299	intestinal cholesterol absorption	BP
3	9	0.736337060156	-	2.03e-01	GO:0039694	viral RNA genome replication	BP
6	18	0.736337060156	-	2.32e-01	GO:0030705	cytoskeleton-dependent intracellular transport	BP
6	18	0.736337060156	-	2.32e-01	GO:1904380	endoplasmic reticulum mannose trimming	BP
4	12	0.736337060156	-	2.47e-01	GO:0050921	positive regulation of chemotaxis	BP
4	12	0.736337060156	-	2.47e-01	GO:0021670	lateral ventricle development	BP
4	12	0.736337060156	-	2.47e-01	GO:0045779	negative regulation of bone resorption	BP
2	6	0.736337060156	-	2.63e-01	GO:1902254	negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator	BP
2	6	0.736337060156	-	2.63e-01	GO:0043152	induction of bacterial agglutination	BP
2	6	0.736337060156	-	2.63e-01	GO:0003179	heart valve morphogenesis	BP
2	6	0.736337060156	-	2.63e-01	GO:0038092	nodal signaling pathway	BP
2	6	0.736337060156	-	2.63e-01	GO:0045953	negative regulation of natural killer cell mediated cytotoxicity	BP
2	6	0.736337060156	-	2.63e-01	GO:0032364	oxygen homeostasis	BP
2	6	0.736337060156	-	2.63e-01	GO:0060664	epithelial cell proliferation involved in salivary gland morphogenesis	BP
2	6	0.736337060156	-	2.63e-01	GO:1901621	negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning	BP
2	6	0.736337060156	-	2.63e-01	GO:0061037	negative regulation of cartilage development	BP
2	6	0.736337060156	-	2.63e-01	GO:0042536	negative regulation of tumor necrosis factor biosynthetic process	BP
2	6	0.736337060156	-	2.63e-01	GO:0060136	embryonic process involved in female pregnancy	BP
2	6	0.736337060156	-	2.63e-01	GO:0061469	regulation of type B pancreatic cell proliferation	BP
2	6	0.736337060156	-	2.63e-01	GO:0001957	intramembranous ossification	BP
2	6	0.736337060156	-	2.63e-01	GO:0031960	response to corticosteroid	BP
2	6	0.736337060156	-	2.63e-01	GO:0060428	lung epithelium development	BP
2	6	0.736337060156	-	2.63e-01	GO:0072540	T-helper 17 cell lineage commitment	BP
2	6	0.736337060156	-	2.63e-01	GO:0050707	regulation of cytokine secretion	BP
2	6	0.736337060156	-	2.63e-01	GO:0032494	response to peptidoglycan	BP
2	6	0.736337060156	-	2.63e-01	GO:0042693	muscle cell fate commitment	BP
2	6	0.736337060156	-	2.63e-01	GO:0070257	positive regulation of mucus secretion	BP
2	6	0.736337060156	-	2.63e-01	GO:2000780	negative regulation of double-strand break repair	BP
2	6	0.736337060156	-	2.63e-01	GO:0032792	negative regulation of CREB transcription factor activity	BP
2	6	0.736337060156	-	2.63e-01	GO:0032808	lacrimal gland development	BP
2	6	0.736337060156	-	2.63e-01	GO:0010637	negative regulation of mitochondrial fusion	BP
2	6	0.736337060156	-	2.63e-01	GO:0032717	negative regulation of interleukin-8 production	BP
2	6	0.736337060156	-	2.63e-01	GO:0051099	positive regulation of binding	BP
2	6	0.736337060156	-	2.63e-01	GO:0021902	commitment of neuronal cell to specific neuron type in forebrain	BP
2	6	0.736337060156	-	2.63e-01	GO:0033211	adiponectin-activated signaling pathway	BP
2	6	0.736337060156	-	2.63e-01	GO:0042415	norepinephrine metabolic process	BP
2	6	0.736337060156	-	2.63e-01	GO:0046850	regulation of bone remodeling	BP
2	6	0.736337060156	-	2.63e-01	GO:0001768	establishment of T cell polarity	BP
2	6	0.736337060156	-	2.63e-01	GO:0006929	substrate-dependent cell migration	BP
2	6	0.736337060156	-	2.63e-01	GO:0033157	regulation of intracellular protein transport	BP
2	6	0.736337060156	-	2.63e-01	GO:0051150	regulation of smooth muscle cell differentiation	BP
2	6	0.736337060156	-	2.63e-01	GO:0001878	response to yeast	BP
2	6	0.736337060156	-	2.63e-01	GO:0045719	negative regulation of glycogen biosynthetic process	BP
2	6	0.736337060156	-	2.63e-01	GO:0048478	replication fork protection	BP
2	6	0.736337060156	-	2.63e-01	GO:0010960	magnesium ion homeostasis	BP
2	6	0.736337060156	-	2.63e-01	GO:0042421	norepinephrine biosynthetic process	BP
4	12	0.736337060156	-	2.74e-01	GO:0055003	cardiac myofibril assembly	BP
4	12	0.736337060156	-	2.74e-01	GO:0021819	layer formation in cerebral cortex	BP
4	12	0.736337060156	-	2.74e-01	GO:0047496	vesicle transport along microtubule	BP
4	12	0.736337060156	-	2.74e-01	GO:0010801	negative regulation of peptidyl-threonine phosphorylation	BP
4	12	0.736337060156	-	2.74e-01	GO:0046688	response to copper ion	BP
4	12	0.736337060156	-	2.74e-01	GO:0090179	planar cell polarity pathway involved in neural tube closure	BP
4	12	0.736337060156	-	2.74e-01	GO:0035518	histone H2A monoubiquitination	BP
4	12	0.736337060156	-	2.74e-01	GO:0021954	central nervous system neuron development	BP
2	6	0.736337060156	-	3.45e-01	GO:0010757	negative regulation of plasminogen activation	BP
2	6	0.736337060156	-	3.45e-01	GO:0042092	type 2 immune response	BP
2	6	0.736337060156	-	3.45e-01	GO:0048642	negative regulation of skeletal muscle tissue development	BP
2	6	0.736337060156	-	3.45e-01	GO:0098532	histone H3-K27 trimethylation	BP
2	6	0.736337060156	-	3.45e-01	GO:0019076	viral release from host cell	BP
2	6	0.736337060156	-	3.45e-01	GO:0032288	myelin assembly	BP
2	6	0.736337060156	-	3.45e-01	GO:0012501	programmed cell death	BP
2	6	0.736337060156	-	3.45e-01	GO:0090647	modulation of age-related behavioral decline	BP
2	6	0.736337060156	-	3.45e-01	GO:0097062	dendritic spine maintenance	BP
2	6	0.736337060156	-	3.45e-01	GO:0010265	SCF complex assembly	BP
2	6	0.736337060156	-	3.45e-01	GO:1900271	regulation of long-term synaptic potentiation	BP
2	6	0.736337060156	-	3.45e-01	GO:0070269	pyroptosis	BP
2	6	0.736337060156	-	3.45e-01	GO:2000288	positive regulation of myoblast proliferation	BP
2	6	0.736337060156	-	3.45e-01	GO:0036465	synaptic vesicle recycling	BP
2	6	0.736337060156	-	3.45e-01	GO:0055013	cardiac muscle cell development	BP
2	6	0.736337060156	-	3.45e-01	GO:0003180	aortic valve morphogenesis	BP
2	6	0.736337060156	-	3.45e-01	GO:0003223	ventricular compact myocardium morphogenesis	BP
2	6	0.736337060156	-	3.45e-01	GO:0034105	positive regulation of tissue remodeling	BP
2	6	0.736337060156	-	3.45e-01	GO:0036006	cellular response to macrophage colony-stimulating factor stimulus	BP
2	6	0.736337060156	-	3.45e-01	GO:0034315	regulation of Arp2/3 complex-mediated actin nucleation	BP
2	6	0.736337060156	-	3.45e-01	GO:0010835	regulation of protein ADP-ribosylation	BP
2	6	0.736337060156	-	3.45e-01	GO:2001046	positive regulation of integrin-mediated signaling pathway	BP
2	6	0.736337060156	-	3.45e-01	GO:0014033	neural crest cell differentiation	BP
2	6	0.736337060156	-	3.45e-01	GO:0030031	cell projection assembly	BP
2	6	0.736337060156	-	3.45e-01	GO:0003309	type B pancreatic cell differentiation	BP
2	6	0.736337060156	-	3.45e-01	GO:0060770	negative regulation of epithelial cell proliferation involved in prostate gland development	BP
2	6	0.736337060156	-	3.45e-01	GO:0044794	positive regulation by host of viral process	BP
2	6	0.736337060156	-	3.45e-01	GO:0060501	positive regulation of epithelial cell proliferation involved in lung morphogenesis	BP
2	6	0.736337060156	-	3.45e-01	GO:1902231	positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage	BP
2	6	0.736337060156	-	3.45e-01	GO:0030853	negative regulation of granulocyte differentiation	BP
2	6	0.736337060156	-	3.45e-01	GO:0006531	aspartate metabolic process	BP
2	6	0.736337060156	-	3.45e-01	GO:0071638	negative regulation of monocyte chemotactic protein-1 production	BP
2	6	0.736337060156	-	3.45e-01	GO:0006189	'de novo' IMP biosynthetic process	BP
2	6	0.736337060156	-	3.45e-01	GO:1903026	negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding	BP
2	6	0.736337060156	-	3.45e-01	GO:0070585	protein localization to mitochondrion	BP
2	6	0.736337060156	-	3.45e-01	GO:0071470	cellular response to osmotic stress	BP
2	6	0.736337060156	-	3.45e-01	GO:0000018	regulation of DNA recombination	BP
2	6	0.736337060156	-	3.45e-01	GO:1901018	positive regulation of potassium ion transmembrane transporter activity	BP
2	6	0.736337060156	-	3.45e-01	GO:0016576	histone dephosphorylation	BP
2	6	0.736337060156	-	3.45e-01	GO:0060760	positive regulation of response to cytokine stimulus	BP
2	6	0.736337060156	-	3.45e-01	GO:0046929	negative regulation of neurotransmitter secretion	BP
2	6	0.736337060156	-	3.45e-01	GO:0070200	establishment of protein localization to telomere	BP
2	6	0.736337060156	-	3.45e-01	GO:0001765	membrane raft assembly	BP
2	6	0.736337060156	-	3.45e-01	GO:0046599	regulation of centriole replication	BP
2	6	0.736337060156	-	3.45e-01	GO:0032680	regulation of tumor necrosis factor production	BP
2	6	0.736337060156	-	3.45e-01	GO:0001956	positive regulation of neurotransmitter secretion	BP
2	6	0.736337060156	-	3.45e-01	GO:0031087	deadenylation-independent decapping of nuclear-transcribed mRNA	BP
2	6	0.736337060156	-	3.45e-01	GO:0033194	response to hydroperoxide	BP
2	6	0.736337060156	-	3.45e-01	GO:0042045	epithelial fluid transport	BP
2	6	0.736337060156	-	3.45e-01	GO:0071218	cellular response to misfolded protein	BP
2	6	0.736337060156	-	3.45e-01	GO:0097242	amyloid-beta clearance	BP
2	6	0.736337060156	-	3.45e-01	GO:0006207	'de novo' pyrimidine nucleobase biosynthetic process	BP
2	6	0.736337060156	-	3.45e-01	GO:0007435	salivary gland morphogenesis	BP
2	6	0.736337060156	-	3.45e-01	GO:0042426	choline catabolic process	BP
2	6	0.736337060156	-	3.45e-01	GO:0051964	negative regulation of synapse assembly	BP
1	3	0.736337060156	-	3.60e-01	GO:0010751	negative regulation of nitric oxide mediated signal transduction	BP
1	3	0.736337060156	-	3.60e-01	GO:0021524	visceral motor neuron differentiation	BP
1	3	0.736337060156	-	3.60e-01	GO:0002554	serotonin secretion by platelet	BP
1	3	0.736337060156	-	3.60e-01	GO:0002374	cytokine secretion involved in immune response	BP
1	3	0.736337060156	-	3.60e-01	GO:2001225	regulation of chloride transport	BP
1	3	0.736337060156	-	3.60e-01	GO:0000052	citrulline metabolic process	BP
1	3	0.736337060156	-	3.60e-01	GO:0061368	behavioral response to formalin induced pain	BP
1	3	0.736337060156	-	3.60e-01	GO:0045950	negative regulation of mitotic recombination	BP
1	3	0.736337060156	-	3.60e-01	GO:0070970	interleukin-2 secretion	BP
1	3	0.736337060156	-	3.60e-01	GO:1901205	negative regulation of adrenergic receptor signaling pathway involved in heart process	BP
1	3	0.736337060156	-	3.60e-01	GO:1901201	regulation of extracellular matrix assembly	BP
1	3	0.736337060156	-	3.60e-01	GO:0071224	cellular response to peptidoglycan	BP
1	3	0.736337060156	-	3.60e-01	GO:1904693	midbrain morphogenesis	BP
1	3	0.736337060156	-	3.60e-01	GO:1904694	negative regulation of vascular smooth muscle contraction	BP
1	3	0.736337060156	-	3.60e-01	GO:0002667	regulation of T cell anergy	BP
1	3	0.736337060156	-	3.60e-01	GO:0060066	oviduct development	BP
1	3	0.736337060156	-	3.60e-01	GO:0032289	central nervous system myelin formation	BP
1	3	0.736337060156	-	3.60e-01	GO:0018963	phthalate metabolic process	BP
1	3	0.736337060156	-	3.60e-01	GO:0045726	positive regulation of integrin biosynthetic process	BP
1	3	0.736337060156	-	3.60e-01	GO:0072278	metanephric comma-shaped body morphogenesis	BP
1	3	0.736337060156	-	3.60e-01	GO:0032732	positive regulation of interleukin-1 production	BP
1	3	0.736337060156	-	3.60e-01	GO:0072102	glomerulus morphogenesis	BP
1	3	0.736337060156	-	3.60e-01	GO:0010387	COP9 signalosome assembly	BP
1	3	0.736337060156	-	3.60e-01	GO:0001781	neutrophil apoptotic process	BP
1	3	0.736337060156	-	3.60e-01	GO:0001787	natural killer cell proliferation	BP
1	3	0.736337060156	-	3.60e-01	GO:0061031	endodermal digestive tract morphogenesis	BP
1	3	0.736337060156	-	3.60e-01	GO:2000078	positive regulation of type B pancreatic cell development	BP
1	3	0.736337060156	-	3.60e-01	GO:1900138	negative regulation of phospholipase A2 activity	BP
1	3	0.736337060156	-	3.60e-01	GO:0009436	glyoxylate catabolic process	BP
1	3	0.736337060156	-	3.60e-01	GO:2000401	regulation of lymphocyte migration	BP
1	3	0.736337060156	-	3.60e-01	GO:0051246	regulation of protein metabolic process	BP
1	3	0.736337060156	-	3.60e-01	GO:0045607	regulation of auditory receptor cell differentiation	BP
1	3	0.736337060156	-	3.60e-01	GO:0045605	negative regulation of epidermal cell differentiation	BP
1	3	0.736337060156	-	3.60e-01	GO:0051797	regulation of hair follicle development	BP
1	3	0.736337060156	-	3.60e-01	GO:0051490	negative regulation of filopodium assembly	BP
1	3	0.736337060156	-	3.60e-01	GO:0032918	spermidine acetylation	BP
1	3	0.736337060156	-	3.60e-01	GO:0003278	apoptotic process involved in heart morphogenesis	BP
1	3	0.736337060156	-	3.60e-01	GO:0055014	atrial cardiac muscle cell development	BP
1	3	0.736337060156	-	3.60e-01	GO:1900425	negative regulation of defense response to bacterium	BP
1	3	0.736337060156	-	3.60e-01	GO:0021533	cell differentiation in hindbrain	BP
1	3	0.736337060156	-	3.60e-01	GO:0061146	Peyer's patch morphogenesis	BP
1	3	0.736337060156	-	3.60e-01	GO:0002369	T cell cytokine production	BP
1	3	0.736337060156	-	3.60e-01	GO:0044336	canonical Wnt signaling pathway involved in negative regulation of apoptotic process	BP
1	3	0.736337060156	-	3.60e-01	GO:1904000	positive regulation of eating behavior	BP
1	3	0.736337060156	-	3.60e-01	GO:0002891	positive regulation of immunoglobulin mediated immune response	BP
1	3	0.736337060156	-	3.60e-01	GO:0010573	vascular endothelial growth factor production	BP
1	3	0.736337060156	-	3.60e-01	GO:0032596	protein transport into membrane raft	BP
1	3	0.736337060156	-	3.60e-01	GO:2001140	positive regulation of phospholipid transport	BP
1	3	0.736337060156	-	3.60e-01	GO:0030718	germ-line stem cell population maintenance	BP
1	3	0.736337060156	-	3.60e-01	GO:0035701	hematopoietic stem cell migration	BP
1	3	0.736337060156	-	3.60e-01	GO:0061184	positive regulation of dermatome development	BP
1	3	0.736337060156	-	3.60e-01	GO:1903426	regulation of reactive oxygen species biosynthetic process	BP
1	3	0.736337060156	-	3.60e-01	GO:0070634	transepithelial ammonium transport	BP
1	3	0.736337060156	-	3.60e-01	GO:0033076	isoquinoline alkaloid metabolic process	BP
1	3	0.736337060156	-	3.60e-01	GO:0002774	Fc receptor mediated inhibitory signaling pathway	BP
1	3	0.736337060156	-	3.60e-01	GO:0071543	diphosphoinositol polyphosphate metabolic process	BP
1	3	0.736337060156	-	3.60e-01	GO:0009957	epidermal cell fate specification	BP
1	3	0.736337060156	-	3.60e-01	GO:1903691	positive regulation of wound healing, spreading of epidermal cells	BP
1	3	0.736337060156	-	3.60e-01	GO:0042997	negative regulation of Golgi to plasma membrane protein transport	BP
1	3	0.736337060156	-	3.60e-01	GO:0097581	lamellipodium organization	BP
1	3	0.736337060156	-	3.60e-01	GO:1900164	nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry	BP
1	3	0.736337060156	-	3.60e-01	GO:0048382	mesendoderm development	BP
1	3	0.736337060156	-	3.60e-01	GO:1905075	positive regulation of occluding junction disassembly	BP
1	3	0.736337060156	-	3.60e-01	GO:0003192	mitral valve formation	BP
1	3	0.736337060156	-	3.60e-01	GO:0030104	water homeostasis	BP
1	3	0.736337060156	-	3.60e-01	GO:0097477	lateral motor column neuron migration	BP
1	3	0.736337060156	-	3.60e-01	GO:0006532	aspartate biosynthetic process	BP
1	3	0.736337060156	-	3.60e-01	GO:0032696	negative regulation of interleukin-13 production	BP
1	3	0.736337060156	-	3.60e-01	GO:0071630	ubiquitin-dependent catabolism of misfolded proteins by nucleus-associated proteasome	BP
1	3	0.736337060156	-	3.60e-01	GO:0060947	cardiac vascular smooth muscle cell differentiation	BP
1	3	0.736337060156	-	3.60e-01	GO:0060940	epithelial to mesenchymal transition involved in cardiac fibroblast development	BP
1	3	0.736337060156	-	3.60e-01	GO:0010866	regulation of triglyceride biosynthetic process	BP
1	3	0.736337060156	-	3.60e-01	GO:0060164	regulation of timing of neuron differentiation	BP
1	3	0.736337060156	-	3.60e-01	GO:0048302	regulation of isotype switching to IgG isotypes	BP
1	3	0.736337060156	-	3.60e-01	GO:1902990	mitotic telomere maintenance via semi-conservative replication	BP
1	3	0.736337060156	-	3.60e-01	GO:0061113	pancreas morphogenesis	BP
1	3	0.736337060156	-	3.60e-01	GO:1902414	protein localization to cell junction	BP
1	3	0.736337060156	-	3.60e-01	GO:0010827	regulation of glucose transport	BP
1	3	0.736337060156	-	3.60e-01	GO:0010823	negative regulation of mitochondrion organization	BP
1	3	0.736337060156	-	3.60e-01	GO:0043585	nose morphogenesis	BP
1	3	0.736337060156	-	3.60e-01	GO:0031649	heat generation	BP
1	3	0.736337060156	-	3.60e-01	GO:0002820	negative regulation of adaptive immune response	BP
1	3	0.736337060156	-	3.60e-01	GO:0010636	positive regulation of mitochondrial fusion	BP
1	3	0.736337060156	-	3.60e-01	GO:0072350	tricarboxylic acid metabolic process	BP
1	3	0.736337060156	-	3.60e-01	GO:1904349	positive regulation of small intestine smooth muscle contraction	BP
1	3	0.736337060156	-	3.60e-01	GO:0071288	cellular response to mercury ion	BP
1	3	0.736337060156	-	3.60e-01	GO:0016476	regulation of embryonic cell shape	BP
1	3	0.736337060156	-	3.60e-01	GO:0003358	noradrenergic neuron development	BP
1	3	0.736337060156	-	3.60e-01	GO:0003350	pulmonary myocardium development	BP
1	3	0.736337060156	-	3.60e-01	GO:0032485	regulation of Ral protein signal transduction	BP
1	3	0.736337060156	-	3.60e-01	GO:0035470	positive regulation of vascular wound healing	BP
1	3	0.736337060156	-	3.60e-01	GO:0060486	Clara cell differentiation	BP
1	3	0.736337060156	-	3.60e-01	GO:0019062	virion attachment to host cell	BP
1	3	0.736337060156	-	3.60e-01	GO:0046452	dihydrofolate metabolic process	BP
1	3	0.736337060156	-	3.60e-01	GO:0086048	membrane depolarization during bundle of His cell action potential	BP
1	3	0.736337060156	-	3.60e-01	GO:0015742	alpha-ketoglutarate transport	BP
1	3	0.736337060156	-	3.60e-01	GO:0035411	catenin import into nucleus	BP
1	3	0.736337060156	-	3.60e-01	GO:0036023	embryonic skeletal limb joint morphogenesis	BP
1	3	0.736337060156	-	3.60e-01	GO:1902617	response to fluoride	BP
1	3	0.736337060156	-	3.60e-01	GO:0061762	CAMKK-AMPK signaling cascade	BP
1	3	0.736337060156	-	3.60e-01	GO:0007418	ventral midline development	BP
1	3	0.736337060156	-	3.60e-01	GO:0044805	late nucleophagy	BP
1	3	0.736337060156	-	3.60e-01	GO:0002025	norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure	BP
1	3	0.736337060156	-	3.60e-01	GO:0002023	reduction of food intake in response to dietary excess	BP
1	3	0.736337060156	-	3.60e-01	GO:1990089	response to nerve growth factor	BP
1	3	0.736337060156	-	3.60e-01	GO:0071393	cellular response to progesterone stimulus	BP
1	3	0.736337060156	-	3.60e-01	GO:0035720	intraciliary anterograde transport	BP
1	3	0.736337060156	-	3.60e-01	GO:1903445	protein transport from ciliary membrane to plasma membrane	BP
1	3	0.736337060156	-	3.60e-01	GO:2000479	regulation of cAMP-dependent protein kinase activity	BP
1	3	0.736337060156	-	3.60e-01	GO:0021914	negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning	BP
1	3	0.736337060156	-	3.60e-01	GO:0010454	negative regulation of cell fate commitment	BP
1	3	0.736337060156	-	3.60e-01	GO:0061009	common bile duct development	BP
1	3	0.736337060156	-	3.60e-01	GO:0050893	sensory processing	BP
1	3	0.736337060156	-	3.60e-01	GO:1900106	positive regulation of hyaluranon cable assembly	BP
1	3	0.736337060156	-	3.60e-01	GO:0050954	sensory perception of mechanical stimulus	BP
1	3	0.736337060156	-	3.60e-01	GO:1902093	positive regulation of flagellated sperm motility	BP
1	3	0.736337060156	-	3.60e-01	GO:0042427	serotonin biosynthetic process	BP
3	9	0.736337060156	-	3.96e-01	GO:0045657	positive regulation of monocyte differentiation	BP
3	9	0.736337060156	-	3.96e-01	GO:0031053	primary miRNA processing	BP
3	9	0.736337060156	-	3.96e-01	GO:0010761	fibroblast migration	BP
3	9	0.736337060156	-	3.96e-01	GO:0046641	positive regulation of alpha-beta T cell proliferation	BP
3	9	0.736337060156	-	3.96e-01	GO:0050807	regulation of synapse organization	BP
3	9	0.736337060156	-	3.96e-01	GO:0071340	skeletal muscle acetylcholine-gated channel clustering	BP
3	9	0.736337060156	-	3.96e-01	GO:1903076	regulation of protein localization to plasma membrane	BP
3	9	0.736337060156	-	3.96e-01	GO:0032463	negative regulation of protein homooligomerization	BP
3	9	0.736337060156	-	3.96e-01	GO:0060670	branching involved in labyrinthine layer morphogenesis	BP
3	9	0.736337060156	-	3.96e-01	GO:0006265	DNA topological change	BP
3	9	0.736337060156	-	3.96e-01	GO:0043268	positive regulation of potassium ion transport	BP
3	9	0.736337060156	-	3.96e-01	GO:0070933	histone H4 deacetylation	BP
3	9	0.736337060156	-	3.96e-01	GO:0000722	telomere maintenance via recombination	BP
3	9	0.736337060156	-	3.96e-01	GO:0022407	regulation of cell-cell adhesion	BP
1	3	0.736337060156	-	4.88e-01	GO:0034776	response to histamine	BP
1	3	0.736337060156	-	4.88e-01	GO:0060266	negative regulation of respiratory burst involved in inflammatory response	BP
1	3	0.736337060156	-	4.88e-01	GO:0055005	ventricular cardiac myofibril assembly	BP
1	3	0.736337060156	-	4.88e-01	GO:0002457	T cell antigen processing and presentation	BP
1	3	0.736337060156	-	4.88e-01	GO:0001738	morphogenesis of a polarized epithelium	BP
1	3	0.736337060156	-	4.88e-01	GO:0033387	putrescine biosynthetic process from ornithine	BP
1	3	0.736337060156	-	4.88e-01	GO:2000819	regulation of nucleotide-excision repair	BP
1	3	0.736337060156	-	4.88e-01	GO:0097155	fasciculation of sensory neuron axon	BP
1	3	0.736337060156	-	4.88e-01	GO:0002924	negative regulation of humoral immune response mediated by circulating immunoglobulin	BP
1	3	0.736337060156	-	4.88e-01	GO:0045079	negative regulation of chemokine biosynthetic process	BP
1	3	0.736337060156	-	4.88e-01	GO:0035993	deltoid tuberosity development	BP
1	3	0.736337060156	-	4.88e-01	GO:0070562	regulation of vitamin D receptor signaling pathway	BP
1	3	0.736337060156	-	4.88e-01	GO:1902255	positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator	BP
1	3	0.736337060156	-	4.88e-01	GO:0060923	cardiac muscle cell fate commitment	BP
1	3	0.736337060156	-	4.88e-01	GO:0090230	regulation of centromere complex assembly	BP
1	3	0.736337060156	-	4.88e-01	GO:0014707	branchiomeric skeletal muscle development	BP
1	3	0.736337060156	-	4.88e-01	GO:0035617	stress granule disassembly	BP
1	3	0.736337060156	-	4.88e-01	GO:0060492	lung induction	BP
1	3	0.736337060156	-	4.88e-01	GO:0060491	regulation of cell projection assembly	BP
1	3	0.736337060156	-	4.88e-01	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	BP
1	3	0.736337060156	-	4.88e-01	GO:1905098	negative regulation of guanyl-nucleotide exchange factor activity	BP
1	3	0.736337060156	-	4.88e-01	GO:0044774	mitotic DNA integrity checkpoint	BP
1	3	0.736337060156	-	4.88e-01	GO:0000054	ribosomal subunit export from nucleus	BP
1	3	0.736337060156	-	4.88e-01	GO:0008218	bioluminescence	BP
1	3	0.736337060156	-	4.88e-01	GO:0035425	autocrine signaling	BP
1	3	0.736337060156	-	4.88e-01	GO:0072011	glomerular endothelium development	BP
1	3	0.736337060156	-	4.88e-01	GO:1903748	negative regulation of establishment of protein localization to mitochondrion	BP
1	3	0.736337060156	-	4.88e-01	GO:0016052	carbohydrate catabolic process	BP
1	3	0.736337060156	-	4.88e-01	GO:1904031	positive regulation of cyclin-dependent protein kinase activity	BP
1	3	0.736337060156	-	4.88e-01	GO:0002331	pre-B cell allelic exclusion	BP
1	3	0.736337060156	-	4.88e-01	GO:1900453	negative regulation of long term synaptic depression	BP
1	3	0.736337060156	-	4.88e-01	GO:1900452	regulation of long term synaptic depression	BP
1	3	0.736337060156	-	4.88e-01	GO:0007113	endomitotic cell cycle	BP
1	3	0.736337060156	-	4.88e-01	GO:0046209	nitric oxide metabolic process	BP
1	3	0.736337060156	-	4.88e-01	GO:0030538	embryonic genitalia morphogenesis	BP
1	3	0.736337060156	-	4.88e-01	GO:0098904	regulation of AV node cell action potential	BP
1	3	0.736337060156	-	4.88e-01	GO:0098903	regulation of membrane repolarization during action potential	BP
1	3	0.736337060156	-	4.88e-01	GO:0098908	regulation of neuronal action potential	BP
1	3	0.736337060156	-	4.88e-01	GO:0010560	positive regulation of glycoprotein biosynthetic process	BP
1	3	0.736337060156	-	4.88e-01	GO:0015874	norepinephrine transport	BP
1	3	0.736337060156	-	4.88e-01	GO:0002669	positive regulation of T cell anergy	BP
1	3	0.736337060156	-	4.88e-01	GO:0061738	late endosomal microautophagy	BP
1	3	0.736337060156	-	4.88e-01	GO:0072331	signal transduction by p53 class mediator	BP
1	3	0.736337060156	-	4.88e-01	GO:0006740	NADPH regeneration	BP
1	3	0.736337060156	-	4.88e-01	GO:0031627	telomeric loop formation	BP
1	3	0.736337060156	-	4.88e-01	GO:0008298	intracellular mRNA localization	BP
1	3	0.736337060156	-	4.88e-01	GO:0010817	regulation of hormone levels	BP
1	3	0.736337060156	-	4.88e-01	GO:0030001	metal ion transport	BP
1	3	0.736337060156	-	4.88e-01	GO:0003331	positive regulation of extracellular matrix constituent secretion	BP
1	3	0.736337060156	-	4.88e-01	GO:0060024	rhythmic synaptic transmission	BP
1	3	0.736337060156	-	4.88e-01	GO:1903660	negative regulation of complement-dependent cytotoxicity	BP
1	3	0.736337060156	-	4.88e-01	GO:0032506	cytokinetic process	BP
1	3	0.736337060156	-	4.88e-01	GO:0071386	cellular response to corticosterone stimulus	BP
1	3	0.736337060156	-	4.88e-01	GO:0060559	positive regulation of calcidiol 1-monooxygenase activity	BP
1	3	0.736337060156	-	4.88e-01	GO:0097061	dendritic spine organization	BP
1	3	0.736337060156	-	4.88e-01	GO:0048871	multicellular organismal homeostasis	BP
1	3	0.736337060156	-	4.88e-01	GO:0055096	low-density lipoprotein particle mediated signaling	BP
1	3	0.736337060156	-	4.88e-01	GO:1901896	positive regulation of calcium-transporting ATPase activity	BP
1	3	0.736337060156	-	4.88e-01	GO:0002429	immune response-activating cell surface receptor signaling pathway	BP
1	3	0.736337060156	-	4.88e-01	GO:0046320	regulation of fatty acid oxidation	BP
1	3	0.736337060156	-	4.88e-01	GO:0035330	regulation of hippo signaling	BP
1	3	0.736337060156	-	4.88e-01	GO:0089700	protein kinase D signaling	BP
1	3	0.736337060156	-	4.88e-01	GO:0061819	telomeric DNA-containing double minutes formation	BP
1	3	0.736337060156	-	4.88e-01	GO:0070487	monocyte aggregation	BP
1	3	0.736337060156	-	4.88e-01	GO:0072574	hepatocyte proliferation	BP
1	3	0.736337060156	-	4.88e-01	GO:0060743	epithelial cell maturation involved in prostate gland development	BP
1	3	0.736337060156	-	4.88e-01	GO:0060741	prostate gland stromal morphogenesis	BP
1	3	0.736337060156	-	4.88e-01	GO:0032202	telomere assembly	BP
1	3	0.736337060156	-	4.88e-01	GO:1990928	response to amino acid starvation	BP
1	3	0.736337060156	-	4.88e-01	GO:0021775	smoothened signaling pathway involved in ventral spinal cord interneuron specification	BP
1	3	0.736337060156	-	4.88e-01	GO:0021776	smoothened signaling pathway involved in spinal cord motor neuron cell fate specification	BP
1	3	0.736337060156	-	4.88e-01	GO:0021773	striatal medium spiny neuron differentiation	BP
1	3	0.736337060156	-	4.88e-01	GO:0071895	odontoblast differentiation	BP
1	3	0.736337060156	-	4.88e-01	GO:0036123	histone H3-K9 dimethylation	BP
1	3	0.736337060156	-	4.88e-01	GO:2000286	receptor internalization involved in canonical Wnt signaling pathway	BP
1	3	0.736337060156	-	4.88e-01	GO:0072537	fibroblast activation	BP
1	3	0.736337060156	-	4.88e-01	GO:0002282	microglial cell activation involved in immune response	BP
1	3	0.736337060156	-	4.88e-01	GO:0032911	negative regulation of transforming growth factor beta1 production	BP
1	3	0.736337060156	-	4.88e-01	GO:0003274	endocardial cushion fusion	BP
1	3	0.736337060156	-	4.88e-01	GO:0014854	response to inactivity	BP
1	3	0.736337060156	-	4.88e-01	GO:2000291	regulation of myoblast proliferation	BP
1	3	0.736337060156	-	4.88e-01	GO:0045061	thymic T cell selection	BP
1	3	0.736337060156	-	4.88e-01	GO:0090435	protein localization to nuclear envelope	BP
1	3	0.736337060156	-	4.88e-01	GO:2000138	positive regulation of cell proliferation involved in heart morphogenesis	BP
1	3	0.736337060156	-	4.88e-01	GO:0030865	cortical cytoskeleton organization	BP
1	3	0.736337060156	-	4.88e-01	GO:2001212	regulation of vasculogenesis	BP
1	3	0.736337060156	-	4.88e-01	GO:1904715	negative regulation of chaperone-mediated autophagy	BP
1	3	0.736337060156	-	4.88e-01	GO:0038123	toll-like receptor TLR1:TLR2 signaling pathway	BP
1	3	0.736337060156	-	4.88e-01	GO:0033273	response to vitamin	BP
1	3	0.736337060156	-	4.88e-01	GO:1903070	negative regulation of ER-associated ubiquitin-dependent protein catabolic process	BP
1	3	0.736337060156	-	4.88e-01	GO:0035986	senescence-associated heterochromatin focus assembly	BP
1	3	0.736337060156	-	4.88e-01	GO:0048880	sensory system development	BP
1	3	0.736337060156	-	4.88e-01	GO:0014719	skeletal muscle satellite cell activation	BP
1	3	0.736337060156	-	4.88e-01	GO:0045351	type I interferon biosynthetic process	BP
1	3	0.736337060156	-	4.88e-01	GO:0000432	positive regulation of transcription from RNA polymerase II promoter by glucose	BP
1	3	0.736337060156	-	4.88e-01	GO:1903751	negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide	BP
1	3	0.736337060156	-	4.88e-01	GO:0032782	bile acid secretion	BP
1	3	0.736337060156	-	4.88e-01	GO:1902186	regulation of viral release from host cell	BP
1	3	0.736337060156	-	4.88e-01	GO:0047484	regulation of response to osmotic stress	BP
1	3	0.736337060156	-	4.88e-01	GO:1902309	negative regulation of peptidyl-serine dephosphorylation	BP
1	3	0.736337060156	-	4.88e-01	GO:0098910	regulation of atrial cardiac muscle cell action potential	BP
1	3	0.736337060156	-	4.88e-01	GO:0001812	positive regulation of type I hypersensitivity	BP
1	3	0.736337060156	-	4.88e-01	GO:0031063	regulation of histone deacetylation	BP
1	3	0.736337060156	-	4.88e-01	GO:0060675	ureteric bud morphogenesis	BP
1	3	0.736337060156	-	4.88e-01	GO:1902445	regulation of mitochondrial membrane permeability involved in programmed necrotic cell death	BP
1	3	0.736337060156	-	4.88e-01	GO:0070672	response to interleukin-15	BP
1	3	0.736337060156	-	4.88e-01	GO:0070673	response to interleukin-18	BP
1	3	0.736337060156	-	4.88e-01	GO:0070671	response to interleukin-12	BP
1	3	0.736337060156	-	4.88e-01	GO:1901491	negative regulation of lymphangiogenesis	BP
1	3	0.736337060156	-	4.88e-01	GO:1904044	response to aldosterone	BP
1	3	0.736337060156	-	4.88e-01	GO:0000350	generation of catalytic spliceosome for second transesterification step	BP
1	3	0.736337060156	-	4.88e-01	GO:0070358	actin polymerization-dependent cell motility	BP
1	3	0.736337060156	-	4.88e-01	GO:0009236	cobalamin biosynthetic process	BP
1	3	0.736337060156	-	4.88e-01	GO:0060633	negative regulation of transcription initiation from RNA polymerase II promoter	BP
1	3	0.736337060156	-	4.88e-01	GO:1990737	response to manganese-induced endoplasmic reticulum stress	BP
1	3	0.736337060156	-	4.88e-01	GO:0052405	negative regulation by host of symbiont molecular function	BP
1	3	0.736337060156	-	4.88e-01	GO:0051987	positive regulation of attachment of spindle microtubules to kinetochore	BP
1	3	0.736337060156	-	4.88e-01	GO:0048769	sarcomerogenesis	BP
1	3	0.736337060156	-	4.88e-01	GO:0099590	neurotransmitter receptor internalization	BP
1	3	0.736337060156	-	4.88e-01	GO:0090245	axis elongation involved in somitogenesis	BP
1	3	0.736337060156	-	4.88e-01	GO:0010641	positive regulation of platelet-derived growth factor receptor signaling pathway	BP
1	3	0.736337060156	-	4.88e-01	GO:0021587	cerebellum morphogenesis	BP
1	3	0.736337060156	-	4.88e-01	GO:0030917	midbrain-hindbrain boundary development	BP
1	3	0.736337060156	-	4.88e-01	GO:0015966	diadenosine tetraphosphate biosynthetic process	BP
1	3	0.736337060156	-	4.88e-01	GO:0021965	spinal cord ventral commissure morphogenesis	BP
1	3	0.736337060156	-	4.88e-01	GO:0007006	mitochondrial membrane organization	BP
1	3	0.736337060156	-	4.88e-01	GO:0006438	valyl-tRNA aminoacylation	BP
1	3	0.736337060156	-	4.88e-01	GO:0035583	sequestering of TGFbeta in extracellular matrix	BP
1	3	0.736337060156	-	4.88e-01	GO:0031440	regulation of mRNA 3'-end processing	BP
1	3	0.736337060156	-	4.88e-01	GO:0044205	'de novo' UMP biosynthetic process	BP
1	3	0.736337060156	-	4.88e-01	GO:0006222	UMP biosynthetic process	BP
1	3	0.736337060156	-	4.88e-01	GO:1905037	autophagosome organization	BP
1	3	0.736337060156	-	4.88e-01	GO:0045408	regulation of interleukin-6 biosynthetic process	BP
1	3	0.736337060156	-	4.88e-01	GO:0021545	cranial nerve development	BP
1	3	0.736337060156	-	4.88e-01	GO:0030951	establishment or maintenance of microtubule cytoskeleton polarity	BP
1	3	0.736337060156	-	4.88e-01	GO:0034435	cholesterol esterification	BP
1	3	0.736337060156	-	4.88e-01	GO:1902774	late endosome to lysosome transport	BP
1	3	0.736337060156	-	4.88e-01	GO:0042998	positive regulation of Golgi to plasma membrane protein transport	BP
1	3	0.736337060156	-	4.88e-01	GO:1902896	terminal web assembly	BP
1	3	0.736337060156	-	4.88e-01	GO:1903679	positive regulation of cap-independent translational initiation	BP
1	3	0.736337060156	-	4.88e-01	GO:0023021	termination of signal transduction	BP
1	3	0.736337060156	-	4.88e-01	GO:0003383	apical constriction	BP
1	3	0.736337060156	-	4.88e-01	GO:0090204	protein localization to nuclear pore	BP
1	3	0.736337060156	-	4.88e-01	GO:0007412	axon target recognition	BP
1	3	0.736337060156	-	4.88e-01	GO:0018312	peptidyl-serine ADP-ribosylation	BP
1	3	0.736337060156	-	4.88e-01	GO:2000297	negative regulation of synapse maturation	BP
1	3	0.736337060156	-	4.88e-01	GO:0030859	polarized epithelial cell differentiation	BP
1	3	0.736337060156	-	4.88e-01	GO:0048388	endosomal lumen acidification	BP
1	3	0.736337060156	-	4.88e-01	GO:0048385	regulation of retinoic acid receptor signaling pathway	BP
1	3	0.736337060156	-	4.88e-01	GO:0035166	post-embryonic hemopoiesis	BP
1	3	0.736337060156	-	4.88e-01	GO:0033861	negative regulation of NAD(P)H oxidase activity	BP
1	3	0.736337060156	-	4.88e-01	GO:0035633	maintenance of permeability of blood-brain barrier	BP
1	3	0.736337060156	-	4.88e-01	GO:0060126	somatotropin secreting cell differentiation	BP
1	3	0.736337060156	-	4.88e-01	GO:0060129	thyroid-stimulating hormone-secreting cell differentiation	BP
1	3	0.736337060156	-	4.88e-01	GO:2001034	positive regulation of double-strand break repair via nonhomologous end joining	BP
1	3	0.736337060156	-	4.88e-01	GO:0001754	eye photoreceptor cell differentiation	BP
1	3	0.736337060156	-	4.88e-01	GO:0044752	response to human chorionic gonadotropin	BP
1	3	0.736337060156	-	4.88e-01	GO:0071373	cellular response to luteinizing hormone stimulus	BP
1	3	0.736337060156	-	4.88e-01	GO:0016480	negative regulation of transcription from RNA polymerase III promoter	BP
1	3	0.736337060156	-	4.88e-01	GO:0046058	cAMP metabolic process	BP
1	3	0.736337060156	-	4.88e-01	GO:0033128	negative regulation of histone phosphorylation	BP
1	3	0.736337060156	-	4.88e-01	GO:1905765	negative regulation of protection from non-homologous end joining at telomere	BP
1	3	0.736337060156	-	4.88e-01	GO:0060948	cardiac vascular smooth muscle cell development	BP
1	3	0.736337060156	-	4.88e-01	GO:0060160	negative regulation of dopamine receptor signaling pathway	BP
1	3	0.736337060156	-	4.88e-01	GO:0019448	L-cysteine catabolic process	BP
1	3	0.736337060156	-	4.88e-01	GO:0034112	positive regulation of homotypic cell-cell adhesion	BP
1	3	0.736337060156	-	4.88e-01	GO:1902037	negative regulation of hematopoietic stem cell differentiation	BP
1	3	0.736337060156	-	4.88e-01	GO:1902991	regulation of amyloid precursor protein catabolic process	BP
1	3	0.736337060156	-	4.88e-01	GO:0006533	aspartate catabolic process	BP
1	3	0.736337060156	-	4.88e-01	GO:0010829	negative regulation of glucose transport	BP
1	3	0.736337060156	-	4.88e-01	GO:1903595	positive regulation of histamine secretion by mast cell	BP
1	3	0.736337060156	-	4.88e-01	GO:1903598	positive regulation of gap junction assembly	BP
1	3	0.736337060156	-	4.88e-01	GO:0071472	cellular response to salt stress	BP
1	3	0.736337060156	-	4.88e-01	GO:0071475	cellular hyperosmotic salinity response	BP
1	3	0.736337060156	-	4.88e-01	GO:0030185	nitric oxide transport	BP
1	3	0.736337060156	-	4.88e-01	GO:0060083	smooth muscle contraction involved in micturition	BP
1	3	0.736337060156	-	4.88e-01	GO:0003095	pressure natriuresis	BP
1	3	0.736337060156	-	4.88e-01	GO:0048541	Peyer's patch development	BP
1	3	0.736337060156	-	4.88e-01	GO:0046886	positive regulation of hormone biosynthetic process	BP
1	3	0.736337060156	-	4.88e-01	GO:0070669	response to interleukin-2	BP
1	3	0.736337060156	-	4.88e-01	GO:0060297	regulation of sarcomere organization	BP
1	3	0.736337060156	-	4.88e-01	GO:1900212	negative regulation of mesenchymal cell apoptotic process involved in metanephros development	BP
1	3	0.736337060156	-	4.88e-01	GO:0045123	cellular extravasation	BP
1	3	0.736337060156	-	4.88e-01	GO:0033605	positive regulation of catecholamine secretion	BP
1	3	0.736337060156	-	4.88e-01	GO:0039529	RIG-I signaling pathway	BP
1	3	0.736337060156	-	4.88e-01	GO:0031998	regulation of fatty acid beta-oxidation	BP
1	3	0.736337060156	-	4.88e-01	GO:0043504	mitochondrial DNA repair	BP
1	3	0.736337060156	-	4.88e-01	GO:0045837	negative regulation of membrane potential	BP
1	3	0.736337060156	-	4.88e-01	GO:0045163	clustering of voltage-gated potassium channels	BP
1	3	0.736337060156	-	4.88e-01	GO:0006272	leading strand elongation	BP
1	3	0.736337060156	-	4.88e-01	GO:0060763	mammary duct terminal end bud growth	BP
1	3	0.736337060156	-	4.88e-01	GO:0050717	positive regulation of interleukin-1 alpha secretion	BP
1	3	0.736337060156	-	4.88e-01	GO:1902510	regulation of apoptotic DNA fragmentation	BP
1	3	0.736337060156	-	4.88e-01	GO:0001555	oocyte growth	BP
1	3	0.736337060156	-	4.88e-01	GO:2000051	negative regulation of non-canonical Wnt signaling pathway	BP
1	3	0.736337060156	-	4.88e-01	GO:0032527	protein exit from endoplasmic reticulum	BP
1	3	0.736337060156	-	4.88e-01	GO:0034201	response to oleic acid	BP
1	3	0.736337060156	-	4.88e-01	GO:0060688	regulation of morphogenesis of a branching structure	BP
1	3	0.736337060156	-	4.88e-01	GO:1902723	negative regulation of skeletal muscle satellite cell proliferation	BP
1	3	0.736337060156	-	4.88e-01	GO:1902725	negative regulation of satellite cell differentiation	BP
1	3	0.736337060156	-	4.88e-01	GO:0007079	mitotic chromosome movement towards spindle pole	BP
1	3	0.736337060156	-	4.88e-01	GO:0002408	myeloid dendritic cell chemotaxis	BP
1	3	0.736337060156	-	4.88e-01	GO:0048742	regulation of skeletal muscle fiber development	BP
1	3	0.736337060156	-	4.88e-01	GO:0039689	negative stranded viral RNA replication	BP
1	3	0.736337060156	-	4.88e-01	GO:0051586	positive regulation of dopamine uptake involved in synaptic transmission	BP
1	3	0.736337060156	-	4.88e-01	GO:0030888	regulation of B cell proliferation	BP
1	3	0.736337060156	-	4.88e-01	GO:0033687	osteoblast proliferation	BP
1	3	0.736337060156	-	4.88e-01	GO:0033685	negative regulation of luteinizing hormone secretion	BP
1	3	0.736337060156	-	4.88e-01	GO:0021553	olfactory nerve development	BP
1	3	0.736337060156	-	4.88e-01	GO:1904845	cellular response to L-glutamine	BP
1	3	0.736337060156	-	4.88e-01	GO:0032608	interferon-beta production	BP
1	3	0.736337060156	-	4.88e-01	GO:0001936	regulation of endothelial cell proliferation	BP
1	3	0.736337060156	-	4.88e-01	GO:1901315	negative regulation of histone H2A K63-linked ubiquitination	BP
1	3	0.736337060156	-	4.88e-01	GO:0032649	regulation of interferon-gamma production	BP
1	3	0.736337060156	-	4.88e-01	GO:0045007	depurination	BP
1	3	0.736337060156	-	4.88e-01	GO:0051222	positive regulation of protein transport	BP
1	3	0.736337060156	-	4.88e-01	GO:2000301	negative regulation of synaptic vesicle exocytosis	BP
1	3	0.736337060156	-	4.88e-01	GO:2001027	negative regulation of endothelial cell chemotaxis	BP
1	3	0.736337060156	-	4.88e-01	GO:0002158	osteoclast proliferation	BP
1	3	0.736337060156	-	4.88e-01	GO:0019060	intracellular transport of viral protein in host cell	BP
1	3	0.736337060156	-	4.88e-01	GO:2000670	positive regulation of dendritic cell apoptotic process	BP
1	3	0.736337060156	-	4.88e-01	GO:0060313	negative regulation of blood vessel remodeling	BP
1	3	0.736337060156	-	4.88e-01	GO:0033159	negative regulation of protein import into nucleus, translocation	BP
1	3	0.736337060156	-	4.88e-01	GO:0097091	synaptic vesicle clustering	BP
1	3	0.736337060156	-	4.88e-01	GO:0051154	negative regulation of striated muscle cell differentiation	BP
1	3	0.736337060156	-	4.88e-01	GO:0044313	protein K6-linked deubiquitination	BP
1	3	0.736337060156	-	4.88e-01	GO:0060979	vasculogenesis involved in coronary vascular morphogenesis	BP
1	3	0.736337060156	-	4.88e-01	GO:0060193	positive regulation of lipase activity	BP
1	3	0.736337060156	-	4.88e-01	GO:0060197	cloacal septation	BP
1	3	0.736337060156	-	4.88e-01	GO:0009051	pentose-phosphate shunt, oxidative branch	BP
1	3	0.736337060156	-	4.88e-01	GO:0060350	endochondral bone morphogenesis	BP
1	3	0.736337060156	-	4.88e-01	GO:0007500	mesodermal cell fate determination	BP
1	3	0.736337060156	-	4.88e-01	GO:0002068	glandular epithelial cell development	BP
1	3	0.736337060156	-	4.88e-01	GO:0032765	positive regulation of mast cell cytokine production	BP
1	3	0.736337060156	-	4.88e-01	GO:0071875	adrenergic receptor signaling pathway	BP
1	3	0.736337060156	-	4.88e-01	GO:0071871	response to epinephrine	BP
1	3	0.736337060156	-	4.88e-01	GO:0061357	positive regulation of Wnt protein secretion	BP
1	3	0.736337060156	-	4.88e-01	GO:0071409	cellular response to cycloheximide	BP
1	3	0.736337060156	-	4.88e-01	GO:0045682	regulation of epidermis development	BP
1	3	0.736337060156	-	4.88e-01	GO:0051306	mitotic sister chromatid separation	BP
1	3	0.736337060156	-	4.88e-01	GO:0071931	positive regulation of transcription involved in G1/S transition of mitotic cell cycle	BP
1	3	0.736337060156	-	4.88e-01	GO:0045715	negative regulation of low-density lipoprotein particle receptor biosynthetic process	BP
1	3	0.736337060156	-	4.88e-01	GO:0035494	SNARE complex disassembly	BP
1	3	0.736337060156	-	4.88e-01	GO:0043084	penile erection	BP
1	3	0.736337060156	-	4.88e-01	GO:1900222	negative regulation of amyloid-beta clearance	BP
1	3	0.736337060156	-	4.88e-01	GO:0032252	secretory granule localization	BP
1	3	0.736337060156	-	4.88e-01	GO:0001560	regulation of cell growth by extracellular stimulus	BP
1	3	0.736337060156	-	4.88e-01	GO:0043988	histone H3-S28 phosphorylation	BP
1	3	0.736337060156	-	4.88e-01	GO:0043987	histone H3-S10 phosphorylation	BP
1	3	0.736337060156	-	4.88e-01	GO:0044406	adhesion of symbiont to host	BP
1	3	0.736337060156	-	4.88e-01	GO:0046134	pyrimidine nucleoside biosynthetic process	BP
1	3	0.736337060156	-	4.88e-01	GO:0033058	directional locomotion	BP
1	3	0.736337060156	-	4.88e-01	GO:0010273	detoxification of copper ion	BP
1	3	0.736337060156	-	4.88e-01	GO:0017085	response to insecticide	BP
1	3	0.736337060156	-	4.88e-01	GO:0051572	negative regulation of histone H3-K4 methylation	BP
1	3	0.736337060156	-	4.88e-01	GO:0071727	cellular response to triacyl bacterial lipopeptide	BP
1	3	0.736337060156	-	4.88e-01	GO:1901671	positive regulation of superoxide dismutase activity	BP
1	3	0.736337060156	-	4.88e-01	GO:0003006	developmental process involved in reproduction	BP
1	3	0.736337060156	-	4.88e-01	GO:1990167	protein K27-linked deubiquitination	BP
1	3	0.736337060156	-	4.88e-01	GO:1990168	protein K33-linked deubiquitination	BP
1	3	0.736337060156	-	4.88e-01	GO:0032946	positive regulation of mononuclear cell proliferation	BP
1	3	0.736337060156	-	4.88e-01	GO:0061577	calcium ion transmembrane transport via high voltage-gated calcium channel	BP
1	3	0.736337060156	-	4.88e-01	GO:0097680	double-strand break repair via classical nonhomologous end joining	BP
1	3	0.736337060156	-	4.88e-01	GO:0060221	retinal rod cell differentiation	BP
1	3	0.736337060156	-	4.88e-01	GO:0060715	syncytiotrophoblast cell differentiation involved in labyrinthine layer development	BP
1	3	0.736337060156	-	4.88e-01	GO:0009447	putrescine catabolic process	BP
1	3	0.736337060156	-	4.88e-01	GO:0048014	Tie signaling pathway	BP
1	3	0.736337060156	-	4.88e-01	GO:0045425	positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process	BP
1	3	0.736337060156	-	4.88e-01	GO:0090116	C-5 methylation of cytosine	BP
1	3	0.736337060156	-	4.88e-01	GO:1990910	response to hypobaric hypoxia	BP
37	111	0.736337060156	-	2.45e-05	GO:0044325	ion channel binding	MF
18	54	0.736337060156	-	6.38e-03	GO:0031072	heat shock protein binding	MF
10	30	0.736337060156	-	1.73e-02	GO:0016874	ligase activity	MF
13	39	0.736337060156	-	3.99e-02	GO:0019894	kinesin binding	MF
2	6	0.736337060156	-	4.00e-02	GO:0003828	alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity	MF
10	30	0.736337060156	-	6.19e-02	GO:0005164	tumor necrosis factor receptor binding	MF
5	15	0.736337060156	-	7.26e-02	GO:0016594	glycine binding	MF
3	9	0.736337060156	-	1.48e-01	GO:0031404	chloride ion binding	MF
2	6	0.736337060156	-	1.81e-01	GO:0004630	phospholipase D activity	MF
2	6	0.736337060156	-	1.81e-01	GO:0016810	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds	MF
2	6	0.736337060156	-	1.81e-01	GO:0004024	alcohol dehydrogenase activity, zinc-dependent	MF
2	6	0.736337060156	-	1.81e-01	GO:0070097	delta-catenin binding	MF
5	15	0.736337060156	-	1.99e-01	GO:0034185	apolipoprotein binding	MF
1	3	0.736337060156	-	2.00e-01	GO:0004949	cannabinoid receptor activity	MF
1	3	0.736337060156	-	2.00e-01	GO:0030144	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity	MF
1	3	0.736337060156	-	2.00e-01	GO:0102007	acyl-L-homoserine-lactone lactonohydrolase activity	MF
1	3	0.736337060156	-	2.00e-01	GO:0000309	nicotinamide-nucleotide adenylyltransferase activity	MF
1	3	0.736337060156	-	2.00e-01	GO:0004803	transposase activity	MF
1	3	0.736337060156	-	2.00e-01	GO:0030298	receptor signaling protein tyrosine kinase activator activity	MF
3	9	0.736337060156	-	2.03e-01	GO:0000774	adenyl-nucleotide exchange factor activity	MF
3	9	0.736337060156	-	2.03e-01	GO:0030291	protein serine/threonine kinase inhibitor activity	MF
2	6	0.736337060156	-	2.63e-01	GO:0004468	lysine N-acetyltransferase activity, acting on acetyl phosphate as donor	MF
2	6	0.736337060156	-	2.63e-01	GO:0019208	phosphatase regulator activity	MF
2	6	0.736337060156	-	2.63e-01	GO:0004430	1-phosphatidylinositol 4-kinase activity	MF
4	12	0.736337060156	-	2.74e-01	GO:0048185	activin binding	MF
2	6	0.736337060156	-	3.45e-01	GO:0003958	NADPH-hemoprotein reductase activity	MF
2	6	0.736337060156	-	3.45e-01	GO:0000014	single-stranded DNA endodeoxyribonuclease activity	MF
2	6	0.736337060156	-	3.45e-01	GO:0016004	phospholipase activator activity	MF
2	6	0.736337060156	-	3.45e-01	GO:1990239	steroid hormone binding	MF
2	6	0.736337060156	-	3.45e-01	GO:0017108	5'-flap endonuclease activity	MF
2	6	0.736337060156	-	3.45e-01	GO:0001221	transcription cofactor binding	MF
2	6	0.736337060156	-	3.45e-01	GO:0061133	endopeptidase activator activity	MF
2	6	0.736337060156	-	3.45e-01	GO:0036402	proteasome-activating ATPase activity	MF
2	6	0.736337060156	-	3.45e-01	GO:0019237	centromeric DNA binding	MF
1	3	0.736337060156	-	3.60e-01	GO:0015234	thiamine transmembrane transporter activity	MF
1	3	0.736337060156	-	3.60e-01	GO:0010521	telomerase inhibitor activity	MF
1	3	0.736337060156	-	3.60e-01	GO:0030369	ICAM-3 receptor activity	MF
1	3	0.736337060156	-	3.60e-01	GO:0003918	DNA topoisomerase type II (ATP-hydrolyzing) activity	MF
1	3	0.736337060156	-	3.60e-01	GO:0019958	C-X-C chemokine binding	MF
1	3	0.736337060156	-	3.60e-01	GO:0019862	IgA binding	MF
1	3	0.736337060156	-	3.60e-01	GO:0048403	brain-derived neurotrophic factor binding	MF
1	3	0.736337060156	-	3.60e-01	GO:0052812	phosphatidylinositol-3,4-bisphosphate 5-kinase activity	MF
1	3	0.736337060156	-	3.60e-01	GO:0002046	opsin binding	MF
1	3	0.736337060156	-	3.60e-01	GO:0035373	chondroitin sulfate proteoglycan binding	MF
1	3	0.736337060156	-	3.60e-01	GO:0005119	smoothened binding	MF
1	3	0.736337060156	-	3.60e-01	GO:0070573	metallodipeptidase activity	MF
1	3	0.736337060156	-	3.60e-01	GO:0035276	ethanol binding	MF
1	3	0.736337060156	-	3.60e-01	GO:0015403	thiamine uptake transmembrane transporter activity	MF
1	3	0.736337060156	-	3.60e-01	GO:0004117	calmodulin-dependent cyclic-nucleotide phosphodiesterase activity	MF
1	3	0.736337060156	-	3.60e-01	GO:0023024	MHC class I protein complex binding	MF
1	3	0.736337060156	-	3.60e-01	GO:0004605	phosphatidate cytidylyltransferase activity	MF
1	3	0.736337060156	-	3.60e-01	GO:0004069	L-aspartate:2-oxoglutarate aminotransferase activity	MF
1	3	0.736337060156	-	3.60e-01	GO:0060002	plus-end directed microfilament motor activity	MF
1	3	0.736337060156	-	3.60e-01	GO:0004802	transketolase activity	MF
1	3	0.736337060156	-	3.60e-01	GO:0004145	diamine N-acetyltransferase activity	MF
1	3	0.736337060156	-	3.60e-01	GO:0003941	L-serine ammonia-lyase activity	MF
1	3	0.736337060156	-	3.60e-01	GO:0046625	sphingolipid binding	MF
1	3	0.736337060156	-	3.60e-01	GO:0015299	solute:proton antiporter activity	MF
1	3	0.736337060156	-	3.60e-01	GO:0004965	G-protein coupled GABA receptor activity	MF
1	3	0.736337060156	-	3.60e-01	GO:0005277	acetylcholine transmembrane transporter activity	MF
1	3	0.736337060156	-	3.60e-01	GO:0008321	Ral guanyl-nucleotide exchange factor activity	MF
3	9	0.736337060156	-	3.96e-01	GO:0008179	adenylate cyclase binding	MF
3	9	0.736337060156	-	3.96e-01	GO:0017081	chloride channel regulator activity	MF
3	9	0.736337060156	-	3.96e-01	GO:0035197	siRNA binding	MF
1	3	0.736337060156	-	4.88e-01	GO:0005471	ATP:ADP antiporter activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0102148	N-acetyl-beta-D-galactosaminidase activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0035614	snRNA stem-loop binding	MF
1	3	0.736337060156	-	4.88e-01	GO:0086056	voltage-gated calcium channel activity involved in AV node cell action potential	MF
1	3	0.736337060156	-	4.88e-01	GO:0001159	core promoter proximal region DNA binding	MF
1	3	0.736337060156	-	4.88e-01	GO:0004040	amidase activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0004505	phenylalanine 4-monooxygenase activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0019828	aspartic-type endopeptidase inhibitor activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0004165	dodecenoyl-CoA delta-isomerase activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0060230	lipoprotein lipase activator activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0061628	H3K27me3 modified histone binding	MF
1	3	0.736337060156	-	4.88e-01	GO:0005157	macrophage colony-stimulating factor receptor binding	MF
1	3	0.736337060156	-	4.88e-01	GO:0010484	H3 histone acetyltransferase activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0031531	thyrotropin-releasing hormone receptor binding	MF
1	3	0.736337060156	-	4.88e-01	GO:0044729	hemi-methylated DNA-binding	MF
1	3	0.736337060156	-	4.88e-01	GO:0001161	intronic transcription regulatory region sequence-specific DNA binding	MF
1	3	0.736337060156	-	4.88e-01	GO:0005094	Rho GDP-dissociation inhibitor activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0080130	L-phenylalanine:2-oxoglutarate aminotransferase activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0035662	Toll-like receptor 4 binding	MF
1	3	0.736337060156	-	4.88e-01	GO:0035663	Toll-like receptor 2 binding	MF
1	3	0.736337060156	-	4.88e-01	GO:0015207	adenine transmembrane transporter activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0016278	lysine N-methyltransferase activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0030622	U4atac snRNA binding	MF
1	3	0.736337060156	-	4.88e-01	GO:0005010	insulin-like growth factor-activated receptor activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0042954	lipoprotein transporter activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0019211	phosphatase activator activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0015616	DNA translocase activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0005166	neurotrophin p75 receptor binding	MF
1	3	0.736337060156	-	4.88e-01	GO:0016684	oxidoreductase activity, acting on peroxide as acceptor	MF
1	3	0.736337060156	-	4.88e-01	GO:0004832	valine-tRNA ligase activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0008525	phosphatidylcholine transporter activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0003886	DNA (cytosine-5-)-methyltransferase activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0034714	type III transforming growth factor beta receptor binding	MF
1	3	0.736337060156	-	4.88e-01	GO:0005333	norepinephrine transmembrane transporter activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0047045	testosterone 17-beta-dehydrogenase (NADP+) activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0071987	WD40-repeat domain binding	MF
1	3	0.736337060156	-	4.88e-01	GO:0004396	hexokinase activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0004563	beta-N-acetylhexosaminidase activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0016532	superoxide dismutase copper chaperone activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0070095	fructose-6-phosphate binding	MF
1	3	0.736337060156	-	4.88e-01	GO:0070325	lipoprotein particle receptor binding	MF
1	3	0.736337060156	-	4.88e-01	GO:0003872	6-phosphofructokinase activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0004886	9-cis retinoic acid receptor activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0070051	fibrinogen binding	MF
1	3	0.736337060156	-	4.88e-01	GO:0061649	ubiquitin modification-dependent histone binding	MF
1	3	0.736337060156	-	4.88e-01	GO:0008513	secondary active organic cation transmembrane transporter activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0031826	type 2A serotonin receptor binding	MF
1	3	0.736337060156	-	4.88e-01	GO:0042625	ATPase coupled ion transmembrane transporter activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0008242	omega peptidase activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0032767	copper-dependent protein binding	MF
1	3	0.736337060156	-	4.88e-01	GO:0016888	endodeoxyribonuclease activity, producing 5'-phosphomonoesters	MF
1	3	0.736337060156	-	4.88e-01	GO:0016508	long-chain-enoyl-CoA hydratase activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0000822	inositol hexakisphosphate binding	MF
1	3	0.736337060156	-	4.88e-01	GO:0030292	protein tyrosine kinase inhibitor activity	MF
1	3	0.736337060156	-	4.88e-01	GO:1990599	3' overhang single-stranded DNA endodeoxyribonuclease activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0004514	nicotinate-nucleotide diphosphorylase (carboxylating) activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0003985	acetyl-CoA C-acetyltransferase activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0022843	voltage-gated cation channel activity	MF
1	3	0.736337060156	-	4.88e-01	GO:0016429	tRNA (adenine-N1-)-methyltransferase activity	MF
68	205	0.729282302623	-	6.57e-08	GO:0004871	signal transducer activity	MF
43	130	0.725196502551	-	5.97e-13	GO:0038096	Fc-gamma receptor signaling pathway involved in phagocytosis	BP
35	106	0.722662123259	-	6.23e-05	GO:0002020	protease binding	MF
35	106	0.722662123259	-	3.96e-04	GO:0005200	structural constituent of cytoskeleton	MF
54	164	0.718635058423	-	4.56e-06	GO:0007568	aging	BP
27	82	0.718635058423	-	2.31e-03	GO:0008543	fibroblast growth factor receptor signaling pathway	BP
22	67	0.714641989057	-	1.24e-02	GO:0038061	NIK/NF-kappaB signaling	BP
20	61	0.712490318202	-	5.90e-03	GO:0006302	double-strand break repair	BP
19	58	0.711246079194	-	1.70e-03	GO:0050679	positive regulation of epithelial cell proliferation	BP
19	58	0.711246079194	-	1.75e-02	GO:0007266	Rho protein signal transduction	BP
18	55	0.709864848795	-	3.24e-03	GO:0001570	vasculogenesis	BP
68	208	0.708322683987	-	3.94e-07	GO:0006974	cellular response to DNA damage stimulus	BP
17	52	0.708322683987	-	8.36e-03	GO:0060326	cell chemotaxis	BP
16	49	0.706589716762	-	5.08e-03	GO:0071320	cellular response to cAMP	BP
16	49	0.706589716762	-	2.87e-02	GO:0032481	positive regulation of type I interferon production	BP
31	95	0.705640262934	-	2.75e-03	GO:0000278	mitotic cell cycle	BP
156	479	0.702819934004	-	1.25e-15	GO:0045892	negative regulation of transcription, DNA-templated	BP
24	74	0.69680869597	-	6.25e-03	GO:0001843	neural tube closure	BP
12	37	0.69680869597	-	2.73e-02	GO:0009790	embryo development	BP
12	37	0.69680869597	-	5.32e-02	GO:0034446	substrate adhesion-dependent cell spreading	BP
12	37	0.69680869597	-	5.82e-02	GO:0000183	chromatin silencing at rDNA	BP
83	256	0.696338992225	-	1.77e-08	GO:0007049	cell cycle	BP
11	34	0.693268338265	-	1.33e-02	GO:0001890	placenta development	BP
11	34	0.693268338265	-	1.33e-02	GO:0030513	positive regulation of BMP signaling pathway	BP
11	34	0.693268338265	-	4.81e-02	GO:0031624	ubiquitin conjugating enzyme binding	MF
61	189	0.689794474219	-	7.22e-07	GO:0005516	calmodulin binding	MF
10	31	0.689031345378	-	6.19e-02	GO:0031122	cytoplasmic microtubule organization	BP
10	31	0.689031345378	-	5.44e-02	GO:1990841	promoter-specific chromatin binding	MF
79	245	0.688442370052	-	1.62e-06	GO:0003713	transcription coactivator activity	MF
114	354	0.686584024959	-	1.66e-10	GO:0008283	cell proliferation	BP
9	28	0.683869640262	-	2.36e-02	GO:0043029	T cell homeostasis	BP
9	28	0.683869640262	-	4.08e-02	GO:0016358	dendrite development	BP
9	28	0.683869640262	-	4.08e-02	GO:0048863	stem cell differentiation	BP
9	28	0.683869640262	-	7.40e-02	GO:0050766	positive regulation of phagocytosis	BP
18	56	0.683869640262	-	1.38e-02	GO:0003712	transcription cofactor activity	MF
34	106	0.680841947565	-	1.48e-05	GO:0005178	integrin binding	MF
33	103	0.679193153053	-	7.18e-04	GO:0045471	response to ethanol	BP
8	25	0.677443371103	-	1.63e-02	GO:1900745	positive regulation of p38MAPK cascade	BP
16	50	0.677443371103	-	1.64e-02	GO:0071407	cellular response to organic cyclic compound	BP
8	25	0.677443371103	-	1.11e-01	GO:0030041	actin filament polymerization	BP
8	25	0.677443371103	-	1.11e-01	GO:0060612	adipose tissue development	BP
8	25	0.677443371103	-	1.11e-01	GO:0051602	response to electrical stimulus	BP
8	25	0.677443371103	-	1.22e-01	GO:0055010	ventricular cardiac muscle tissue morphogenesis	BP
8	25	0.677443371103	-	1.22e-01	GO:0060976	coronary vasculature development	BP
8	25	0.677443371103	-	1.36e-01	GO:0032735	positive regulation of interleukin-12 production	BP
63	197	0.676527664921	-	4.39e-07	GO:0000287	magnesium ion binding	MF
15	47	0.673601304808	-	3.76e-02	GO:0016575	histone deacetylation	BP
14	44	0.669222864298	-	5.03e-02	GO:0002224	toll-like receptor signaling pathway	BP
7	22	0.669222864298	-	6.01e-02	GO:0031016	pancreas development	BP
7	22	0.669222864298	-	6.92e-02	GO:0030101	natural killer cell activation	BP
7	22	0.669222864298	-	8.19e-02	GO:0001816	cytokine production	BP
7	22	0.669222864298	-	8.19e-02	GO:0030111	regulation of Wnt signaling pathway	BP
7	22	0.669222864298	-	1.81e-01	GO:0016050	vesicle organization	BP
7	22	0.669222864298	-	6.92e-02	GO:0005104	fibroblast growth factor receptor binding	MF
117	368	0.668102324404	-	2.15e-10	GO:0003682	chromatin binding	MF
34	107	0.667295415727	-	3.82e-05	GO:0030336	negative regulation of cell migration	BP
67	211	0.666289562628	-	6.69e-06	GO:0061630	ubiquitin protein ligase activity	MF
20	63	0.665947732265	-	5.90e-03	GO:0009611	response to wounding	BP
20	63	0.665947732265	-	7.30e-03	GO:0032092	positive regulation of protein binding	BP
20	63	0.665947732265	-	2.44e-02	GO:0006303	double-strand break repair via nonhomologous end joining	BP
26	82	0.664187274401	-	1.46e-03	GO:0035264	multicellular organism growth	BP
38	120	0.662336478713	-	4.63e-04	GO:0071222	cellular response to lipopolysaccharide	BP
6	19	0.658334548155	-	1.16e-02	GO:0023019	signal transduction involved in regulation of gene expression	BP
12	38	0.658334548155	-	3.21e-02	GO:0045214	sarcomere organization	BP
6	19	0.658334548155	-	9.61e-02	GO:0007520	myoblast fusion	BP
6	19	0.658334548155	-	1.10e-01	GO:0008156	negative regulation of DNA replication	BP
6	19	0.658334548155	-	2.32e-01	GO:0046597	negative regulation of viral entry into host cell	BP
6	19	0.658334548155	-	2.46e-01	GO:2001243	negative regulation of intrinsic apoptotic signaling pathway	BP
60	190	0.658334548155	-	7.72e-08	GO:0070374	positive regulation of ERK1 and ERK2 cascade	BP
29	92	0.655718599948	-	1.89e-04	GO:0009636	response to toxic substance	BP
23	73	0.655036958055	-	3.17e-06	GO:0030216	keratinocyte differentiation	BP
28	89	0.652921051969	-	3.77e-03	GO:0034599	cellular response to oxidative stress	BP
166	528	0.651944872866	-	6.86e-15	GO:0006915	apoptotic process	BP
66	210	0.65144816257	-	1.03e-05	GO:0044212	transcription regulatory region DNA binding	MF
22	70	0.65144816257	-	7.03e-03	GO:0001889	liver development	BP
11	35	0.65144816257	-	1.67e-02	GO:0002062	chondrocyte differentiation	BP
11	35	0.65144816257	-	7.73e-02	GO:0045786	negative regulation of cell cycle	BP
38	121	0.650363837047	-	4.63e-04	GO:0090263	positive regulation of canonical Wnt signaling pathway	BP
21	67	0.647527793199	-	2.05e-02	GO:0045652	regulation of megakaryocyte differentiation	BP
47	150	0.647069722059	-	6.14e-04	GO:0006367	transcription initiation from RNA polymerase II promoter	BP
20	64	0.643227655765	-	3.35e-03	GO:0006310	DNA recombination	BP
10	32	0.643227655765	-	5.44e-02	GO:0040018	positive regulation of multicellular organism growth	BP
5	16	0.643227655765	-	7.26e-02	GO:0032924	activin receptor signaling pathway	BP
10	32	0.643227655765	-	1.21e-01	GO:0006335	DNA replication-dependent nucleosome assembly	BP
5	16	0.643227655765	-	1.54e-01	GO:0045109	intermediate filament organization	BP
5	16	0.643227655765	-	1.54e-01	GO:0032012	regulation of ARF protein signal transduction	BP
5	16	0.643227655765	-	1.74e-01	GO:0030502	negative regulation of bone mineralization	BP
5	16	0.643227655765	-	1.74e-01	GO:0032874	positive regulation of stress-activated MAPK cascade	BP
5	16	0.643227655765	-	1.74e-01	GO:0003222	ventricular trabecula myocardium morphogenesis	BP
5	16	0.643227655765	-	1.99e-01	GO:0061136	regulation of proteasomal protein catabolic process	BP
5	16	0.643227655765	-	1.99e-01	GO:0010259	multicellular organism aging	BP
5	16	0.643227655765	-	1.99e-01	GO:0006349	regulation of gene expression by genetic imprinting	BP
5	16	0.643227655765	-	1.99e-01	GO:0007026	negative regulation of microtubule depolymerization	BP
5	16	0.643227655765	-	3.42e-01	GO:0003203	endocardial cushion morphogenesis	BP
5	16	0.643227655765	-	3.42e-01	GO:0014002	astrocyte development	BP
5	16	0.643227655765	-	3.42e-01	GO:0036503	ERAD pathway	BP
5	16	0.643227655765	-	1.96e-02	GO:0022841	potassium ion leak channel activity	MF
5	16	0.643227655765	-	1.99e-01	GO:0023026	MHC class II protein complex binding	MF
49	157	0.641388656101	-	2.51e-05	GO:0007010	cytoskeleton organization	BP
14	45	0.636801386606	-	1.19e-02	GO:0035914	skeletal muscle cell differentiation	BP
14	45	0.636801386606	-	8.98e-02	GO:0000910	cytokinesis	BP
23	74	0.635408151306	-	1.71e-02	GO:0061418	regulation of transcription from RNA polymerase II promoter in response to hypoxia	BP
9	29	0.633243567192	-	9.22e-02	GO:0051491	positive regulation of filopodium assembly	BP
9	29	0.633243567192	-	9.22e-02	GO:0004003	ATP-dependent DNA helicase activity	MF
13	42	0.62942185624	-	1.39e-02	GO:0001658	branching involved in ureteric bud morphogenesis	BP
39	126	0.62942185624	-	2.10e-04	GO:0007264	small GTPase mediated signal transduction	BP
93	302	0.622053632661	-	2.11e-08	GO:0042493	response to drug	BP
24	78	0.620859842737	-	6.50e-04	GO:0030324	lung development	BP
20	65	0.620859842737	-	6.47e-03	GO:0050796	regulation of insulin secretion	BP
8	26	0.620859842737	-	1.09e-02	GO:0042755	eating behavior	BP
8	26	0.620859842737	-	3.76e-02	GO:0090102	cochlea development	BP
8	26	0.620859842737	-	4.36e-02	GO:0010719	negative regulation of epithelial to mesenchymal transition	BP
8	26	0.620859842737	-	1.11e-01	GO:0015758	glucose transport	BP
4	13	0.620859842737	-	1.21e-01	GO:0051693	actin filament capping	BP
4	13	0.620859842737	-	2.47e-01	GO:0051145	smooth muscle cell differentiation	BP
4	13	0.620859842737	-	2.47e-01	GO:0060996	dendritic spine development	BP
4	13	0.620859842737	-	2.74e-01	GO:0060413	atrial septum morphogenesis	BP
4	13	0.620859842737	-	2.74e-01	GO:0032740	positive regulation of interleukin-17 production	BP
4	13	0.620859842737	-	2.74e-01	GO:0019725	cellular homeostasis	BP
4	13	0.620859842737	-	2.74e-01	GO:0051085	chaperone mediated protein folding requiring cofactor	BP
4	13	0.620859842737	-	2.74e-01	GO:2000059	negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process	BP
4	13	0.620859842737	-	2.74e-01	GO:0045780	positive regulation of bone resorption	BP
4	13	0.620859842737	-	2.74e-01	GO:0060317	cardiac epithelial to mesenchymal transition	BP
4	13	0.620859842737	-	2.74e-01	GO:0071872	cellular response to epinephrine stimulus	BP
4	13	0.620859842737	-	2.74e-01	GO:1902166	negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	BP
4	13	0.620859842737	-	2.74e-01	GO:0060047	heart contraction	BP
4	13	0.620859842737	-	3.08e-01	GO:0060134	prepulse inhibition	BP
4	13	0.620859842737	-	3.08e-01	GO:0033630	positive regulation of cell adhesion mediated by integrin	BP
4	13	0.620859842737	-	3.08e-01	GO:0006809	nitric oxide biosynthetic process	BP
4	13	0.620859842737	-	3.08e-01	GO:0070986	left/right axis specification	BP
16	52	0.620859842737	-	2.87e-02	GO:0008092	cytoskeletal protein binding	MF
4	13	0.620859842737	-	3.08e-01	GO:0044548	S100 protein binding	MF
4	13	0.620859842737	-	3.08e-01	GO:0017160	Ral GTPase binding	MF
319	1041	0.614957821343	-	8.59e-27	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	BP
15	49	0.613480312371	-	4.11e-02	GO:0030374	ligand-dependent nuclear receptor transcription coactivator activity	MF
22	72	0.610806178073	-	7.03e-03	GO:0051289	protein homotetramerization	BP
25	82	0.607603746034	-	8.83e-03	GO:0030307	positive regulation of cell growth	BP
67	220	0.606029037811	-	2.28e-05	GO:0000209	protein polyubiquitination	BP
21	69	0.605092526878	-	1.01e-02	GO:0001938	positive regulation of endothelial cell proliferation	BP
7	23	0.605092526878	-	6.92e-02	GO:0008037	cell recognition	BP
7	23	0.605092526878	-	1.66e-01	GO:2000463	positive regulation of excitatory postsynaptic potential	BP
7	23	0.605092526878	-	1.66e-01	GO:0048675	axon extension	BP
7	23	0.605092526878	-	1.81e-01	GO:0007422	peripheral nervous system development	BP
7	23	0.605092526878	-	1.81e-01	GO:0003009	skeletal muscle contraction	BP
7	23	0.605092526878	-	9.82e-02	GO:0017134	fibroblast growth factor binding	MF
7	23	0.605092526878	-	1.81e-01	GO:0042162	telomeric DNA binding	MF
24	79	0.602481313422	-	7.34e-03	GO:0004843	thiol-dependent ubiquitin-specific protease activity	MF
20	66	0.598833536407	-	1.61e-02	GO:0003705	transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding	MF
109	360	0.597630789325	-	2.29e-10	GO:0000978	RNA polymerase II core promoter proximal region sequence-specific DNA binding	MF
13	43	0.595474524317	-	3.63e-02	GO:0007566	embryo implantation	BP
145	480	0.594318055284	-	5.64e-15	GO:0008284	positive regulation of cell proliferation	BP
19	63	0.591947150821	-	2.05e-02	GO:0051384	response to glucocorticoid	BP
69	229	0.590620229559	-	1.93e-05	GO:0061024	membrane organization	BP
25	83	0.590116319305	-	5.16e-03	GO:0046718	viral entry into host cell	BP
21	70	0.584333966711	-	2.23e-03	GO:0001558	regulation of cell growth	BP
21	70	0.584333966711	-	1.01e-02	GO:0007015	actin filament organization	BP
9	30	0.584333966711	-	3.32e-02	GO:0042476	odontogenesis	BP
9	30	0.584333966711	-	9.22e-02	GO:0021915	neural tube development	BP
12	40	0.584333966711	-	2.73e-02	GO:0032570	response to progesterone	BP
3	10	0.584333966711	-	5.80e-02	GO:0048387	negative regulation of retinoic acid receptor signaling pathway	BP
12	40	0.584333966711	-	6.50e-02	GO:0021549	cerebellum development	BP
3	10	0.584333966711	-	9.89e-02	GO:0060174	limb bud formation	BP
3	10	0.584333966711	-	1.48e-01	GO:0045598	regulation of fat cell differentiation	BP
3	10	0.584333966711	-	1.48e-01	GO:0030432	peristalsis	BP
3	10	0.584333966711	-	1.48e-01	GO:0010838	positive regulation of keratinocyte proliferation	BP
3	10	0.584333966711	-	1.48e-01	GO:0009100	glycoprotein metabolic process	BP
3	10	0.584333966711	-	2.03e-01	GO:0048096	chromatin-mediated maintenance of transcription	BP
3	10	0.584333966711	-	2.03e-01	GO:0060411	cardiac septum morphogenesis	BP
3	10	0.584333966711	-	2.03e-01	GO:0046325	negative regulation of glucose import	BP
3	10	0.584333966711	-	2.03e-01	GO:0071168	protein localization to chromatin	BP
3	10	0.584333966711	-	2.03e-01	GO:0031953	negative regulation of protein autophosphorylation	BP
3	10	0.584333966711	-	2.03e-01	GO:0045741	positive regulation of epidermal growth factor-activated receptor activity	BP
3	10	0.584333966711	-	2.03e-01	GO:0002237	response to molecule of bacterial origin	BP
3	10	0.584333966711	-	2.03e-01	GO:0016322	neuron remodeling	BP
3	10	0.584333966711	-	2.03e-01	GO:0048853	forebrain morphogenesis	BP
3	10	0.584333966711	-	2.03e-01	GO:0019370	leukotriene biosynthetic process	BP
6	20	0.584333966711	-	2.32e-01	GO:0032211	negative regulation of telomere maintenance via telomerase	BP
3	10	0.584333966711	-	3.96e-01	GO:0046638	positive regulation of alpha-beta T cell differentiation	BP
3	10	0.584333966711	-	3.96e-01	GO:2001224	positive regulation of neuron migration	BP
3	10	0.584333966711	-	3.96e-01	GO:0060340	positive regulation of type I interferon-mediated signaling pathway	BP
3	10	0.584333966711	-	3.96e-01	GO:0016331	morphogenesis of embryonic epithelium	BP
3	10	0.584333966711	-	3.96e-01	GO:0046007	negative regulation of activated T cell proliferation	BP
3	10	0.584333966711	-	3.96e-01	GO:0032060	bleb assembly	BP
3	10	0.584333966711	-	3.96e-01	GO:0071548	response to dexamethasone	BP
3	10	0.584333966711	-	3.96e-01	GO:0010739	positive regulation of protein kinase A signaling	BP
3	10	0.584333966711	-	3.96e-01	GO:2000786	positive regulation of autophagosome assembly	BP
3	10	0.584333966711	-	3.96e-01	GO:0034115	negative regulation of heterotypic cell-cell adhesion	BP
3	10	0.584333966711	-	3.96e-01	GO:0003181	atrioventricular valve morphogenesis	BP
3	10	0.584333966711	-	3.96e-01	GO:0034244	negative regulation of transcription elongation from RNA polymerase II promoter	BP
3	10	0.584333966711	-	4.30e-01	GO:1902188	positive regulation of viral release from host cell	BP
3	10	0.584333966711	-	4.30e-01	GO:0033327	Leydig cell differentiation	BP
3	10	0.584333966711	-	4.30e-01	GO:0006884	cell volume homeostasis	BP
3	10	0.584333966711	-	4.30e-01	GO:2000300	regulation of synaptic vesicle exocytosis	BP
3	10	0.584333966711	-	4.30e-01	GO:0002446	neutrophil mediated immunity	BP
3	10	0.584333966711	-	4.30e-01	GO:2000637	positive regulation of gene silencing by miRNA	BP
3	10	0.584333966711	-	4.30e-01	GO:0042416	dopamine biosynthetic process	BP
3	10	0.584333966711	-	4.30e-01	GO:2001020	regulation of response to DNA damage stimulus	BP
3	10	0.584333966711	-	4.30e-01	GO:1990001	inhibition of cysteine-type endopeptidase activity involved in apoptotic process	BP
3	10	0.584333966711	-	4.30e-01	GO:0046785	microtubule polymerization	BP
6	20	0.584333966711	-	9.61e-02	GO:0031267	small GTPase binding	MF
6	20	0.584333966711	-	1.28e-01	GO:0005086	ARF guanyl-nucleotide exchange factor activity	MF
3	10	0.584333966711	-	3.96e-01	GO:0039706	co-receptor binding	MF
3	10	0.584333966711	-	4.30e-01	GO:0031702	type 1 angiotensin receptor binding	MF
3	10	0.584333966711	-	4.30e-01	GO:1990782	protein tyrosine kinase binding	MF
3	10	0.584333966711	-	4.30e-01	GO:0003724	RNA helicase activity	MF
3	10	0.584333966711	-	4.30e-01	GO:0034452	dynactin binding	MF
20	67	0.577138465307	-	2.62e-02	GO:0051259	protein oligomerization	BP
17	57	0.575872387963	-	4.08e-02	GO:0035722	interleukin-12-mediated signaling pathway	BP
14	47	0.574065631258	-	5.37e-02	GO:0006909	phagocytosis	BP
22	74	0.571277813886	-	1.26e-03	GO:0005089	Rho guanyl-nucleotide exchange factor activity	MF
19	64	0.569227074321	-	9.45e-03	GO:0043627	response to estrogen	BP
19	64	0.569227074321	-	1.06e-02	GO:0032868	response to insulin	BP
24	81	0.566412058714	-	3.79e-03	GO:0060070	canonical Wnt signaling pathway	BP
16	54	0.566412058714	-	3.20e-02	GO:0008104	protein localization	BP
8	27	0.566412058714	-	1.22e-01	GO:0031297	replication fork processing	BP
13	44	0.562307660381	-	8.26e-02	GO:0045785	positive regulation of cell adhesion	BP
96	325	0.561966153683	-	4.64e-08	GO:0004842	ubiquitin-protein transferase activity	MF
100	339	0.560014287516	-	1.85e-06	GO:0051301	cell division	BP
145	492	0.558694145553	-	7.09e-12	GO:0046982	protein heterodimerization activity	MF
33	112	0.558338758178	-	1.20e-04	GO:0007417	central nervous system development	BP
63	214	0.557112497976	-	4.07e-06	GO:0000977	RNA polymerase II regulatory region sequence-specific DNA binding	MF
20	68	0.555764814515	-	1.44e-02	GO:0009749	response to glucose	BP
5	17	0.555764814515	-	1.96e-02	GO:1904706	negative regulation of vascular smooth muscle cell proliferation	BP
20	68	0.555764814515	-	2.44e-02	GO:0034976	response to endoplasmic reticulum stress	BP
10	34	0.555764814515	-	5.44e-02	GO:0030501	positive regulation of bone mineralization	BP
5	17	0.555764814515	-	1.54e-01	GO:0001708	cell fate specification	BP
5	17	0.555764814515	-	1.74e-01	GO:0050804	modulation of chemical synaptic transmission	BP
5	17	0.555764814515	-	1.74e-01	GO:0021537	telencephalon development	BP
5	17	0.555764814515	-	1.74e-01	GO:0045582	positive regulation of T cell differentiation	BP
5	17	0.555764814515	-	1.99e-01	GO:0048255	mRNA stabilization	BP
5	17	0.555764814515	-	1.99e-01	GO:0021542	dentate gyrus development	BP
5	17	0.555764814515	-	3.42e-01	GO:0031589	cell-substrate adhesion	BP
5	17	0.555764814515	-	3.42e-01	GO:0045638	negative regulation of myeloid cell differentiation	BP
5	17	0.555764814515	-	1.54e-01	GO:0008301	DNA binding, bending	MF
5	17	0.555764814515	-	1.54e-01	GO:0017049	GTP-Rho binding	MF
5	17	0.555764814515	-	3.42e-01	GO:0034237	protein kinase A regulatory subunit binding	MF
15	51	0.555764814515	-	9.30e-03	GO:0048666	neuron development	BP
17	58	0.550781407	-	1.11e-02	GO:0050680	negative regulation of epithelial cell proliferation	BP
24	82	0.548710056981	-	3.30e-02	GO:0006338	chromatin remodeling	BP
33	113	0.545514717821	-	1.17e-03	GO:0007219	Notch signaling pathway	BP
169	579	0.544759459171	-	1.50e-13	GO:0043547	positive regulation of GTPase activity	BP
7	24	0.543691982214	-	8.19e-02	GO:0051899	membrane depolarization	BP
7	24	0.543691982214	-	2.00e-01	GO:0051966	regulation of synaptic transmission, glutamatergic	BP
7	24	0.543691982214	-	3.03e-01	GO:0070536	protein K63-linked deubiquitination	BP
28	96	0.543691982214	-	1.03e-02	GO:0003697	single-stranded DNA binding	MF
63	216	0.543691982214	-	1.27e-05	GO:0001525	angiogenesis	BP
59	203	0.538606693054	-	2.03e-04	GO:0006281	DNA repair	BP
36	124	0.537028251933	-	4.81e-04	GO:0030036	actin cytoskeleton organization	BP
9	31	0.537028251933	-	7.82e-04	GO:0010667	negative regulation of cardiac muscle cell apoptotic process	BP
9	31	0.537028251933	-	7.40e-02	GO:0051017	actin filament bundle assembly	BP
53	183	0.533520177157	-	1.47e-04	GO:0007596	blood coagulation	BP
11	38	0.532803666071	-	7.73e-02	GO:0045184	establishment of protein localization	BP
24	83	0.531222630252	-	3.37e-03	GO:0009887	animal organ morphogenesis	BP
13	45	0.529886182689	-	1.80e-02	GO:0048839	inner ear development	BP
13	45	0.529886182689	-	4.48e-02	GO:0030900	forebrain development	BP
123	426	0.529104445991	-	3.90e-09	GO:0016567	protein ubiquitination	BP
17	59	0.526119352766	-	2.23e-02	GO:0042102	positive regulation of T cell proliferation	BP
17	59	0.526119352766	-	9.51e-03	GO:0042277	peptide binding	MF
19	66	0.524832954963	-	5.98e-02	GO:0016197	endosomal transport	BP
21	73	0.523792424776	-	5.55e-02	GO:0006283	transcription-coupled nucleotide-excision repair	BP
27	94	0.521598211363	-	9.42e-03	GO:0008584	male gonad development	BP
31	108	0.520608369101	-	2.75e-03	GO:0006914	autophagy	BP
45	157	0.518531908316	-	3.25e-06	GO:0046983	protein dimerization activity	MF
50	175	0.51394463882	-	5.99e-04	GO:0001701	in utero embryonic development	BP
36	126	0.51394463882	-	8.19e-03	GO:0033209	tumor necrosis factor-mediated signaling pathway	BP
10	35	0.51394463882	-	1.73e-02	GO:0045494	photoreceptor cell maintenance	BP
12	42	0.51394463882	-	3.21e-02	GO:0001541	ovarian follicle development	BP
2	7	0.51394463882	-	4.00e-02	GO:0045026	plasma membrane fusion	BP
8	28	0.51394463882	-	5.22e-02	GO:0060338	regulation of type I interferon-mediated signaling pathway	BP
8	28	0.51394463882	-	5.22e-02	GO:0048706	embryonic skeletal system development	BP
4	14	0.51394463882	-	5.63e-02	GO:0010614	negative regulation of cardiac muscle hypertrophy	BP
18	63	0.51394463882	-	8.05e-02	GO:0007059	chromosome segregation	BP
2	7	0.51394463882	-	1.04e-01	GO:2000272	negative regulation of receptor activity	BP
10	35	0.51394463882	-	1.12e-01	GO:0033574	response to testosterone	BP
2	7	0.51394463882	-	1.81e-01	GO:0045606	positive regulation of epidermal cell differentiation	BP
2	7	0.51394463882	-	1.81e-01	GO:0048066	developmental pigmentation	BP
2	7	0.51394463882	-	1.81e-01	GO:0035356	cellular triglyceride homeostasis	BP
2	7	0.51394463882	-	1.81e-01	GO:0021516	dorsal spinal cord development	BP
2	7	0.51394463882	-	1.81e-01	GO:0032049	cardiolipin biosynthetic process	BP
8	28	0.51394463882	-	2.27e-01	GO:0000060	protein import into nucleus, translocation	BP
8	28	0.51394463882	-	2.27e-01	GO:0051603	proteolysis involved in cellular protein catabolic process	BP
6	21	0.51394463882	-	2.32e-01	GO:0048844	artery morphogenesis	BP
6	21	0.51394463882	-	2.32e-01	GO:0045672	positive regulation of osteoclast differentiation	BP
4	14	0.51394463882	-	2.47e-01	GO:0010875	positive regulation of cholesterol efflux	BP
4	14	0.51394463882	-	2.47e-01	GO:0003407	neural retina development	BP
2	7	0.51394463882	-	2.63e-01	GO:0003209	cardiac atrium morphogenesis	BP
2	7	0.51394463882	-	2.63e-01	GO:0003416	endochondral bone growth	BP
2	7	0.51394463882	-	2.63e-01	GO:0045187	regulation of circadian sleep/wake cycle, sleep	BP
2	7	0.51394463882	-	2.63e-01	GO:1903546	protein localization to photoreceptor outer segment	BP
2	7	0.51394463882	-	2.63e-01	GO:1904948	midbrain dopaminergic neuron differentiation	BP
2	7	0.51394463882	-	2.63e-01	GO:0033135	regulation of peptidyl-serine phosphorylation	BP
2	7	0.51394463882	-	2.63e-01	GO:0060463	lung lobe morphogenesis	BP
2	7	0.51394463882	-	2.63e-01	GO:0044828	negative regulation by host of viral genome replication	BP
2	7	0.51394463882	-	2.63e-01	GO:0070431	nucleotide-binding oligomerization domain containing 2 signaling pathway	BP
2	7	0.51394463882	-	2.63e-01	GO:2000252	negative regulation of feeding behavior	BP
2	7	0.51394463882	-	2.63e-01	GO:0036089	cleavage furrow formation	BP
2	7	0.51394463882	-	2.63e-01	GO:0045581	negative regulation of T cell differentiation	BP
2	7	0.51394463882	-	2.63e-01	GO:0045198	establishment of epithelial cell apical/basal polarity	BP
2	7	0.51394463882	-	2.63e-01	GO:0019227	neuronal action potential propagation	BP
2	7	0.51394463882	-	2.63e-01	GO:1901098	positive regulation of autophagosome maturation	BP
2	7	0.51394463882	-	2.63e-01	GO:0021559	trigeminal nerve development	BP
2	7	0.51394463882	-	2.63e-01	GO:0042989	sequestering of actin monomers	BP
2	7	0.51394463882	-	2.63e-01	GO:0070613	regulation of protein processing	BP
2	7	0.51394463882	-	2.63e-01	GO:0060710	chorio-allantoic fusion	BP
6	21	0.51394463882	-	2.65e-01	GO:0032402	melanosome transport	BP
4	14	0.51394463882	-	2.74e-01	GO:1902017	regulation of cilium assembly	BP
4	14	0.51394463882	-	2.74e-01	GO:0045056	transcytosis	BP
4	14	0.51394463882	-	3.08e-01	GO:0060441	epithelial tube branching involved in lung morphogenesis	BP
2	7	0.51394463882	-	3.45e-01	GO:0048539	bone marrow development	BP
2	7	0.51394463882	-	3.45e-01	GO:0048251	elastic fiber assembly	BP
2	7	0.51394463882	-	3.45e-01	GO:1902430	negative regulation of amyloid-beta formation	BP
2	7	0.51394463882	-	3.45e-01	GO:0043951	negative regulation of cAMP-mediated signaling	BP
2	7	0.51394463882	-	3.45e-01	GO:0007256	activation of JNKK activity	BP
2	7	0.51394463882	-	3.45e-01	GO:0010837	regulation of keratinocyte proliferation	BP
2	7	0.51394463882	-	3.45e-01	GO:0014037	Schwann cell differentiation	BP
2	7	0.51394463882	-	3.45e-01	GO:0043305	negative regulation of mast cell degranulation	BP
2	7	0.51394463882	-	3.45e-01	GO:1904667	negative regulation of ubiquitin protein ligase activity	BP
2	7	0.51394463882	-	3.45e-01	GO:0032926	negative regulation of activin receptor signaling pathway	BP
2	7	0.51394463882	-	3.45e-01	GO:1900246	positive regulation of RIG-I signaling pathway	BP
2	7	0.51394463882	-	3.45e-01	GO:0030814	regulation of cAMP metabolic process	BP
2	7	0.51394463882	-	3.45e-01	GO:0061154	endothelial tube morphogenesis	BP
2	7	0.51394463882	-	3.45e-01	GO:0019054	modulation by virus of host process	BP
2	7	0.51394463882	-	3.45e-01	GO:0002860	positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target	BP
2	7	0.51394463882	-	3.45e-01	GO:0060576	intestinal epithelial cell development	BP
2	7	0.51394463882	-	3.45e-01	GO:0071281	cellular response to iron ion	BP
2	7	0.51394463882	-	3.45e-01	GO:0055075	potassium ion homeostasis	BP
2	7	0.51394463882	-	3.45e-01	GO:0070050	neuron cellular homeostasis	BP
2	7	0.51394463882	-	3.45e-01	GO:0021554	optic nerve development	BP
2	7	0.51394463882	-	3.45e-01	GO:0002091	negative regulation of receptor internalization	BP
2	7	0.51394463882	-	3.45e-01	GO:0051014	actin filament severing	BP
2	7	0.51394463882	-	3.45e-01	GO:0046069	cGMP catabolic process	BP
2	7	0.51394463882	-	3.45e-01	GO:0050861	positive regulation of B cell receptor signaling pathway	BP
2	7	0.51394463882	-	3.45e-01	GO:0009649	entrainment of circadian clock	BP
2	7	0.51394463882	-	3.45e-01	GO:0060972	left/right pattern formation	BP
2	7	0.51394463882	-	3.45e-01	GO:0021860	pyramidal neuron development	BP
2	7	0.51394463882	-	3.45e-01	GO:0017121	phospholipid scrambling	BP
2	7	0.51394463882	-	3.45e-01	GO:0060840	artery development	BP
2	7	0.51394463882	-	3.45e-01	GO:0048671	negative regulation of collateral sprouting	BP
2	7	0.51394463882	-	3.45e-01	GO:0042297	vocal learning	BP
2	7	0.51394463882	-	3.45e-01	GO:0060017	parathyroid gland development	BP
2	7	0.51394463882	-	3.45e-01	GO:0045822	negative regulation of heart contraction	BP
2	7	0.51394463882	-	3.45e-01	GO:0042129	regulation of T cell proliferation	BP
4	14	0.51394463882	-	5.00e-01	GO:0010243	response to organonitrogen compound	BP
4	14	0.51394463882	-	5.00e-01	GO:2001234	negative regulation of apoptotic signaling pathway	BP
4	14	0.51394463882	-	5.00e-01	GO:0030970	retrograde protein transport, ER to cytosol	BP
2	7	0.51394463882	-	6.33e-01	GO:0007221	positive regulation of transcription of Notch receptor target	BP
2	7	0.51394463882	-	6.33e-01	GO:0090050	positive regulation of cell migration involved in sprouting angiogenesis	BP
2	7	0.51394463882	-	6.33e-01	GO:0044770	cell cycle phase transition	BP
2	7	0.51394463882	-	6.33e-01	GO:0032324	molybdopterin cofactor biosynthetic process	BP
2	7	0.51394463882	-	6.33e-01	GO:0034340	response to type I interferon	BP
2	7	0.51394463882	-	6.33e-01	GO:0001961	positive regulation of cytokine-mediated signaling pathway	BP
2	7	0.51394463882	-	6.33e-01	GO:0016458	gene silencing	BP
2	7	0.51394463882	-	6.33e-01	GO:0031848	protection from non-homologous end joining at telomere	BP
2	7	0.51394463882	-	6.33e-01	GO:0002741	positive regulation of cytokine secretion involved in immune response	BP
2	7	0.51394463882	-	6.33e-01	GO:0007253	cytoplasmic sequestering of NF-kappaB	BP
2	7	0.51394463882	-	6.33e-01	GO:0045359	positive regulation of interferon-beta biosynthetic process	BP
2	7	0.51394463882	-	6.33e-01	GO:0097428	protein maturation by iron-sulfur cluster transfer	BP
2	7	0.51394463882	-	6.33e-01	GO:0048820	hair follicle maturation	BP
2	7	0.51394463882	-	6.33e-01	GO:0048102	autophagic cell death	BP
2	7	0.51394463882	-	6.33e-01	GO:0071233	cellular response to leucine	BP
2	7	0.51394463882	-	6.33e-01	GO:0002819	regulation of adaptive immune response	BP
2	7	0.51394463882	-	6.33e-01	GO:0010941	regulation of cell death	BP
2	7	0.51394463882	-	6.33e-01	GO:0048699	generation of neurons	BP
2	7	0.51394463882	-	6.33e-01	GO:0042167	heme catabolic process	BP
2	7	0.51394463882	-	6.33e-01	GO:0021785	branchiomotor neuron axon guidance	BP
2	7	0.51394463882	-	6.33e-01	GO:0071169	establishment of protein localization to chromatin	BP
2	7	0.51394463882	-	6.33e-01	GO:2000394	positive regulation of lamellipodium morphogenesis	BP
2	7	0.51394463882	-	6.33e-01	GO:0035773	insulin secretion involved in cellular response to glucose stimulus	BP
2	7	0.51394463882	-	6.33e-01	GO:0009635	response to herbicide	BP
2	7	0.51394463882	-	6.33e-01	GO:0060008	Sertoli cell differentiation	BP
2	7	0.51394463882	-	6.33e-01	GO:0030050	vesicle transport along actin filament	BP
2	7	0.51394463882	-	6.33e-01	GO:0035065	regulation of histone acetylation	BP
2	7	0.51394463882	-	6.33e-01	GO:0014049	positive regulation of glutamate secretion	BP
2	7	0.51394463882	-	6.33e-01	GO:0061002	negative regulation of dendritic spine morphogenesis	BP
42	147	0.51394463882	-	4.89e-04	GO:0051015	actin filament binding	MF
4	14	0.51394463882	-	8.57e-02	GO:0070403	NAD+ binding	MF
2	7	0.51394463882	-	1.81e-01	GO:0008519	ammonium transmembrane transporter activity	MF
8	28	0.51394463882	-	2.43e-01	GO:0046966	thyroid hormone receptor binding	MF
2	7	0.51394463882	-	2.63e-01	GO:0030297	transmembrane receptor protein tyrosine kinase activator activity	MF
4	14	0.51394463882	-	2.74e-01	GO:0050700	CARD domain binding	MF
4	14	0.51394463882	-	2.74e-01	GO:0005344	oxygen transporter activity	MF
4	14	0.51394463882	-	3.08e-01	GO:0016538	cyclin-dependent protein serine/threonine kinase regulator activity	MF
2	7	0.51394463882	-	3.45e-01	GO:0035374	chondroitin sulfate binding	MF
2	7	0.51394463882	-	3.45e-01	GO:0000405	bubble DNA binding	MF
2	7	0.51394463882	-	3.45e-01	GO:1901981	phosphatidylinositol phosphate binding	MF
6	21	0.51394463882	-	4.09e-01	GO:0017022	myosin binding	MF
4	14	0.51394463882	-	5.00e-01	GO:0035198	miRNA binding	MF
4	14	0.51394463882	-	5.00e-01	GO:0070063	RNA polymerase binding	MF
4	14	0.51394463882	-	5.00e-01	GO:0005041	low-density lipoprotein receptor activity	MF
2	7	0.51394463882	-	6.33e-01	GO:0005114	type II transforming growth factor beta receptor binding	MF
2	7	0.51394463882	-	6.33e-01	GO:0003720	telomerase activity	MF
2	7	0.51394463882	-	6.33e-01	GO:0034618	arginine binding	MF
2	7	0.51394463882	-	6.33e-01	GO:0008603	cAMP-dependent protein kinase regulator activity	MF
41	144	0.508926564053	-	3.41e-04	GO:0001228	transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding	MF
28	99	0.499297862856	-	3.20e-03	GO:0030182	neuron differentiation	BP
24	85	0.496871125461	-	3.62e-02	GO:0030165	PDZ domain binding	MF
22	78	0.495328960653	-	2.75e-03	GO:0035023	regulation of Rho protein signal transduction	BP
22	78	0.495328960653	-	2.35e-02	GO:0000724	double-strand break repair via homologous recombination	BP
11	39	0.495328960653	-	4.81e-02	GO:0006633	fatty acid biosynthetic process	BP
11	39	0.495328960653	-	8.44e-02	GO:0050918	positive chemotaxis	BP
11	39	0.495328960653	-	1.67e-02	GO:0015459	potassium channel regulator activity	MF
51	181	0.493879015766	-	1.55e-12	GO:0031424	keratinization	BP
20	71	0.49348053626	-	2.86e-02	GO:0060333	interferon-gamma-mediated signaling pathway	BP
9	32	0.49122456232	-	8.17e-02	GO:0071773	cellular response to BMP stimulus	BP
9	32	0.49122456232	-	9.22e-02	GO:0001654	eye development	BP
9	32	0.49122456232	-	2.57e-01	GO:0042594	response to starvation	BP
45	160	0.49122456232	-	5.74e-04	GO:0032496	response to lipopolysaccharide	BP
16	57	0.488409546713	-	2.87e-02	GO:0007612	learning	BP
23	82	0.487309512317	-	9.48e-03	GO:0060021	palate development	BP
14	50	0.48479829316	-	1.02e-02	GO:0045600	positive regulation of fat cell differentiation	BP
7	25	0.48479829316	-	9.82e-02	GO:0050715	positive regulation of cytokine secretion	BP
7	25	0.48479829316	-	1.81e-01	GO:0051924	regulation of calcium ion transport	BP
7	25	0.48479829316	-	2.00e-01	GO:0022604	regulation of cell morphogenesis	BP
12	43	0.479997306897	-	1.86e-01	GO:1904837	beta-catenin-TCF complex assembly	BP
17	61	0.478025064565	-	1.99e-02	GO:0006879	cellular iron ion homeostasis	BP
32	115	0.475809509933	-	6.00e-03	GO:0005085	guanyl-nucleotide exchange factor activity	MF
10	36	0.473302654323	-	4.90e-02	GO:0086091	regulation of heart rate by cardiac conduction	BP
5	18	0.473302654323	-	5.04e-02	GO:0030539	male genitalia development	BP
5	18	0.473302654323	-	7.26e-02	GO:0060307	regulation of ventricular cardiac muscle cell membrane repolarization	BP
5	18	0.473302654323	-	7.26e-02	GO:0036342	post-anal tail morphogenesis	BP
15	54	0.473302654323	-	1.18e-01	GO:0016049	cell growth	BP
5	18	0.473302654323	-	1.74e-01	GO:1903861	positive regulation of dendrite extension	BP
5	18	0.473302654323	-	1.99e-01	GO:0061512	protein localization to cilium	BP
5	18	0.473302654323	-	1.99e-01	GO:0030318	melanocyte differentiation	BP
5	18	0.473302654323	-	3.42e-01	GO:0032418	lysosome localization	BP
5	18	0.473302654323	-	3.60e-01	GO:0051000	positive regulation of nitric-oxide synthase activity	BP
5	18	0.473302654323	-	3.83e-01	GO:0007004	telomere maintenance via telomerase	BP
5	18	0.473302654323	-	3.83e-01	GO:0006337	nucleosome disassembly	BP
5	18	0.473302654323	-	3.28e-02	GO:0005520	insulin-like growth factor binding	MF
23	83	0.469822085588	-	2.30e-03	GO:0050728	negative regulation of inflammatory response	BP
18	65	0.468856749291	-	1.54e-02	GO:0030183	B cell differentiation	BP
39	141	0.467150427341	-	1.12e-03	GO:0051056	regulation of small GTPase mediated signal transduction	BP
13	47	0.467150427341	-	8.26e-02	GO:0051781	positive regulation of cell division	BP
60	217	0.466638924042	-	1.02e-04	GO:0044267	cellular protein metabolic process	BP
24	87	0.46331856575	-	3.30e-02	GO:0019216	regulation of lipid metabolic process	BP
8	29	0.46331856575	-	5.22e-02	GO:0030163	protein catabolic process	BP
16	58	0.46331856575	-	8.29e-02	GO:0050729	positive regulation of inflammatory response	BP
8	29	0.46331856575	-	2.15e-01	GO:0008234	cysteine-type peptidase activity	MF
8	29	0.46331856575	-	3.50e-01	GO:0043021	ribonucleoprotein complex binding	MF
43	156	0.462162096717	-	3.88e-04	GO:0006511	ubiquitin-dependent protein catabolic process	BP
11	40	0.458803084628	-	1.33e-02	GO:0001895	retina homeostasis	BP
11	40	0.458803084628	-	9.35e-02	GO:0009968	negative regulation of signal transduction	BP
28	102	0.456229140964	-	1.16e-02	GO:0001649	osteoblast differentiation	BP
12	44	0.446830442961	-	1.07e-01	GO:0032880	regulation of protein localization	BP
6	22	0.446830442961	-	1.10e-01	GO:0019915	lipid storage	BP
3	11	0.446830442961	-	1.48e-01	GO:0015867	ATP transport	BP
3	11	0.446830442961	-	1.48e-01	GO:0002064	epithelial cell development	BP
3	11	0.446830442961	-	2.03e-01	GO:0006346	methylation-dependent chromatin silencing	BP
3	11	0.446830442961	-	2.03e-01	GO:0003323	type B pancreatic cell development	BP
3	11	0.446830442961	-	2.03e-01	GO:0033690	positive regulation of osteoblast proliferation	BP
6	22	0.446830442961	-	2.32e-01	GO:0010842	retina layer formation	BP
6	22	0.446830442961	-	2.46e-01	GO:0042832	defense response to protozoan	BP
6	22	0.446830442961	-	2.65e-01	GO:0030520	intracellular estrogen receptor signaling pathway	BP
3	11	0.446830442961	-	3.96e-01	GO:0050673	epithelial cell proliferation	BP
3	11	0.446830442961	-	3.96e-01	GO:0002675	positive regulation of acute inflammatory response	BP
3	11	0.446830442961	-	3.96e-01	GO:0046488	phosphatidylinositol metabolic process	BP
3	11	0.446830442961	-	3.96e-01	GO:0022038	corpus callosum development	BP
3	11	0.446830442961	-	3.96e-01	GO:0045670	regulation of osteoclast differentiation	BP
3	11	0.446830442961	-	3.96e-01	GO:0055078	sodium ion homeostasis	BP
3	11	0.446830442961	-	3.96e-01	GO:0048745	smooth muscle tissue development	BP
3	11	0.446830442961	-	3.96e-01	GO:0097202	activation of cysteine-type endopeptidase activity	BP
3	11	0.446830442961	-	3.96e-01	GO:2000188	regulation of cholesterol homeostasis	BP
6	22	0.446830442961	-	4.22e-01	GO:0006306	DNA methylation	BP
3	11	0.446830442961	-	4.30e-01	GO:0040015	negative regulation of multicellular organism growth	BP
3	11	0.446830442961	-	4.30e-01	GO:0032204	regulation of telomere maintenance	BP
3	11	0.446830442961	-	4.30e-01	GO:0050848	regulation of calcium-mediated signaling	BP
3	11	0.446830442961	-	4.30e-01	GO:0014075	response to amine	BP
3	11	0.446830442961	-	4.30e-01	GO:1903428	positive regulation of reactive oxygen species biosynthetic process	BP
3	11	0.446830442961	-	4.30e-01	GO:0043116	negative regulation of vascular permeability	BP
3	11	0.446830442961	-	4.30e-01	GO:0021756	striatum development	BP
3	11	0.446830442961	-	4.30e-01	GO:0001833	inner cell mass cell proliferation	BP
3	11	0.446830442961	-	4.69e-01	GO:0045762	positive regulation of adenylate cyclase activity	BP
3	11	0.446830442961	-	4.69e-01	GO:0034067	protein localization to Golgi apparatus	BP
3	11	0.446830442961	-	4.69e-01	GO:0042535	positive regulation of tumor necrosis factor biosynthetic process	BP
3	11	0.446830442961	-	4.69e-01	GO:0032700	negative regulation of interleukin-17 production	BP
3	11	0.446830442961	-	4.69e-01	GO:0045806	negative regulation of endocytosis	BP
3	11	0.446830442961	-	4.69e-01	GO:0010390	histone monoubiquitination	BP
3	11	0.446830442961	-	4.69e-01	GO:0000302	response to reactive oxygen species	BP
3	11	0.446830442961	-	4.69e-01	GO:0042417	dopamine metabolic process	BP
3	11	0.446830442961	-	4.69e-01	GO:1902902	negative regulation of autophagosome assembly	BP
3	11	0.446830442961	-	4.69e-01	GO:0051382	kinetochore assembly	BP
3	11	0.446830442961	-	4.69e-01	GO:0051024	positive regulation of immunoglobulin secretion	BP
3	11	0.446830442961	-	1.48e-01	GO:0015078	hydrogen ion transmembrane transporter activity	MF
3	11	0.446830442961	-	2.03e-01	GO:0003993	acid phosphatase activity	MF
3	11	0.446830442961	-	2.03e-01	GO:0035925	mRNA 3'-UTR AU-rich region binding	MF
3	11	0.446830442961	-	4.30e-01	GO:0042054	histone methyltransferase activity	MF
3	11	0.446830442961	-	4.69e-01	GO:0016208	AMP binding	MF
3	11	0.446830442961	-	4.69e-01	GO:0031432	titin binding	MF
3	11	0.446830442961	-	4.69e-01	GO:0017154	semaphorin receptor activity	MF
9	33	0.446830442961	-	3.32e-02	GO:0019731	antibacterial humoral response	BP
9	33	0.446830442961	-	7.40e-02	GO:0001937	negative regulation of endothelial cell proliferation	BP
25	92	0.441593794595	-	4.01e-02	GO:0060071	Wnt signaling pathway, planar cell polarity pathway	BP
301	1114	0.433385720297	-	3.82e-26	GO:0007165	signal transduction	BP
34	126	0.431482478628	-	1.36e-02	GO:0006897	endocytosis	BP
7	26	0.428214764794	-	9.82e-02	GO:0030534	adult behavior	BP
7	26	0.428214764794	-	1.81e-01	GO:0016573	histone acetylation	BP
7	26	0.428214764794	-	1.81e-01	GO:0001656	metanephros development	BP
7	26	0.428214764794	-	3.18e-01	GO:0006096	glycolytic process	BP
7	26	0.428214764794	-	3.03e-01	GO:0043014	alpha-tubulin binding	MF
11	41	0.423179174897	-	8.44e-02	GO:0009725	response to hormone	BP
39	146	0.41687722086	-	5.17e-03	GO:0016887	ATPase activity	MF
12	45	0.414408965269	-	1.01e-01	GO:1903507	negative regulation of nucleic acid-templated transcription	BP
4	15	0.414408965269	-	1.21e-01	GO:0051604	protein maturation	BP
8	30	0.414408965269	-	1.36e-01	GO:0007163	establishment or maintenance of cell polarity	BP
4	15	0.414408965269	-	2.47e-01	GO:0060314	regulation of ryanodine-sensitive calcium-release channel activity	BP
4	15	0.414408965269	-	2.47e-01	GO:0010812	negative regulation of cell-substrate adhesion	BP
4	15	0.414408965269	-	2.74e-01	GO:0086005	ventricular cardiac muscle cell action potential	BP
4	15	0.414408965269	-	3.08e-01	GO:0032793	positive regulation of CREB transcription factor activity	BP
8	30	0.414408965269	-	3.62e-01	GO:0090307	mitotic spindle assembly	BP
4	15	0.414408965269	-	5.00e-01	GO:0006622	protein targeting to lysosome	BP
4	15	0.414408965269	-	5.00e-01	GO:0007095	mitotic G2 DNA damage checkpoint	BP
4	15	0.414408965269	-	5.00e-01	GO:0031573	intra-S DNA damage checkpoint	BP
4	15	0.414408965269	-	5.00e-01	GO:0010586	miRNA metabolic process	BP
4	15	0.414408965269	-	5.00e-01	GO:0010288	response to lead ion	BP
4	15	0.414408965269	-	5.00e-01	GO:0006414	translational elongation	BP
4	15	0.414408965269	-	5.19e-01	GO:0051895	negative regulation of focal adhesion assembly	BP
4	15	0.414408965269	-	5.19e-01	GO:2000484	positive regulation of interleukin-8 secretion	BP
4	15	0.414408965269	-	5.19e-01	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	BP
4	15	0.414408965269	-	5.19e-01	GO:0048168	regulation of neuronal synaptic plasticity	BP
12	45	0.414408965269	-	1.16e-01	GO:0003774	motor activity	MF
16	60	0.414408965269	-	1.35e-01	GO:0003725	double-stranded RNA binding	MF
4	15	0.414408965269	-	5.00e-01	GO:0036002	pre-mRNA binding	MF
4	15	0.414408965269	-	5.19e-01	GO:0005521	lamin binding	MF
392	1472	0.412447448936	-	2.01e-21	GO:0005524	ATP binding	MF
21	79	0.409836235479	-	5.55e-02	GO:0051117	ATPase binding	MF
13	49	0.407029434903	-	2.81e-01	GO:0045814	negative regulation of gene expression, epigenetic	BP
18	68	0.40376172107	-	7.30e-02	GO:0045444	fat cell differentiation	BP
19	72	0.399302072879	-	1.35e-01	GO:0031146	SCF-dependent proteasomal ubiquitin-dependent protein catabolic process	BP
35	133	0.395300142321	-	6.94e-03	GO:0001078	transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding	MF
20	76	0.395300142321	-	6.47e-03	GO:0016525	negative regulation of angiogenesis	BP
10	38	0.395300142321	-	1.73e-02	GO:0009409	response to cold	BP
15	57	0.395300142321	-	1.84e-02	GO:0060395	SMAD protein signal transduction	BP
5	19	0.395300142321	-	1.54e-01	GO:0042744	hydrogen peroxide catabolic process	BP
5	19	0.395300142321	-	1.74e-01	GO:0002052	positive regulation of neuroblast proliferation	BP
5	19	0.395300142321	-	1.99e-01	GO:0045216	cell-cell junction organization	BP
5	19	0.395300142321	-	1.99e-01	GO:0048557	embryonic digestive tract morphogenesis	BP
5	19	0.395300142321	-	3.42e-01	GO:0007413	axonal fasciculation	BP
5	19	0.395300142321	-	3.60e-01	GO:0051968	positive regulation of synaptic transmission, glutamatergic	BP
5	19	0.395300142321	-	3.83e-01	GO:0042776	mitochondrial ATP synthesis coupled proton transport	BP
5	19	0.395300142321	-	5.63e-01	GO:0051298	centrosome duplication	BP
5	19	0.395300142321	-	3.83e-01	GO:0001965	G-protein alpha-subunit binding	MF
21	80	0.391688888769	-	7.67e-02	GO:0030674	protein binding, bridging	MF
27	103	0.389686535858	-	3.66e-02	GO:0031175	neuron projection development	BP
17	65	0.386394589099	-	1.52e-01	GO:0030433	ubiquitin-dependent ERAD pathway	BP
23	88	0.385429898297	-	4.87e-03	GO:0030509	BMP signaling pathway	BP
71	272	0.383583839132	-	3.27e-04	GO:0003779	actin binding	MF
6	23	0.382700105542	-	2.46e-01	GO:0009954	proximal/distal pattern formation	BP
6	23	0.382700105542	-	2.65e-01	GO:0031018	endocrine pancreas development	BP
6	23	0.382700105542	-	4.38e-01	GO:0090316	positive regulation of intracellular protein transport	BP
12	46	0.382700105542	-	2.55e-01	GO:0008307	structural constituent of muscle	MF
14	54	0.373766980772	-	9.43e-02	GO:0045665	negative regulation of neuron differentiation	BP
7	27	0.373766980772	-	2.00e-01	GO:0001958	endochondral ossification	BP
7	27	0.373766980772	-	3.03e-01	GO:0035987	endodermal cell differentiation	BP
7	27	0.373766980772	-	3.18e-01	GO:0051281	positive regulation of release of sequestered calcium ion into cytosol	BP
7	27	0.373766980772	-	4.69e-01	GO:0032728	positive regulation of interferon-beta production	BP
7	27	0.373766980772	-	1.66e-01	GO:0003785	actin monomer binding	MF
7	27	0.373766980772	-	1.66e-01	GO:0004435	phosphatidylinositol phospholipase C activity	MF
7	27	0.373766980772	-	2.00e-01	GO:0004857	enzyme inhibitor activity	MF
7	27	0.373766980772	-	4.69e-01	GO:0017048	Rho GTPase binding	MF
92	356	0.369128085968	-	1.08e-05	GO:0005102	receptor binding	MF
8	31	0.367103250491	-	1.22e-01	GO:0048565	digestive tract development	BP
8	31	0.367103250491	-	2.15e-01	GO:0048286	lung alveolus development	BP
8	31	0.367103250491	-	2.43e-01	GO:0048662	negative regulation of smooth muscle cell proliferation	BP
8	31	0.367103250491	-	3.50e-01	GO:0006284	base-excision repair	BP
17	66	0.36436828277	-	9.77e-02	GO:0030855	epithelial cell differentiation	BP
18	70	0.361941545375	-	1.63e-01	GO:0007584	response to nutrient	BP
9	35	0.361941545375	-	1.73e-01	GO:0050808	synapse organization	BP
29	113	0.35910159359	-	1.89e-04	GO:0070268	cornification	BP
10	39	0.357825436903	-	1.73e-02	GO:2000134	negative regulation of G1/S transition of mitotic cell cycle	BP
11	43	0.354466424813	-	4.81e-02	GO:0045165	cell fate commitment	BP
11	43	0.354466424813	-	2.27e-01	GO:0032508	DNA duplex unwinding	BP
12	47	0.351673209921	-	2.55e-01	GO:0010595	positive regulation of endothelial cell migration	BP
13	51	0.349313937047	-	8.26e-02	GO:0008344	adult locomotory behavior	BP
29	114	0.34639054184	-	3.20e-02	GO:0071356	cellular response to tumor necrosis factor	BP
15	59	0.345547107124	-	6.82e-02	GO:0006968	cellular defense response	BP
105	413	0.345547107124	-	4.37e-06	GO:0006357	regulation of transcription from RNA polymerase II promoter	BP
33	130	0.343325867208	-	9.26e-02	GO:0042393	histone binding	MF
20	79	0.339446907588	-	4.41e-02	GO:0005543	phospholipid binding	MF
23	91	0.337066876736	-	4.57e-02	GO:0006464	cellular protein modification process	BP
26	103	0.335238751835	-	1.13e-02	GO:0010468	regulation of gene expression	BP
43	171	0.329711800694	-	1.71e-04	GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	MF
53	211	0.328120826734	-	3.64e-03	GO:0008017	microtubule binding	MF
192	766	0.325061479674	-	1.68e-08	GO:0042803	protein homodimerization activity	MF
12	48	0.321299560878	-	2.73e-02	GO:0061844	antimicrobial humoral immune response mediated by antimicrobial peptide	BP
3	12	0.321299560878	-	1.48e-01	GO:0046323	glucose import	BP
3	12	0.321299560878	-	1.48e-01	GO:0001964	startle response	BP
7	28	0.321299560878	-	1.66e-01	GO:0045746	negative regulation of Notch signaling pathway	BP
12	48	0.321299560878	-	1.68e-01	GO:0000045	autophagosome assembly	BP
12	48	0.321299560878	-	1.86e-01	GO:0061077	chaperone-mediated protein folding	BP
7	28	0.321299560878	-	2.00e-01	GO:0035116	embryonic hindlimb morphogenesis	BP
14	56	0.321299560878	-	2.17e-01	GO:0006006	glucose metabolic process	BP
6	24	0.321299560878	-	2.46e-01	GO:0048589	developmental growth	BP
6	24	0.321299560878	-	2.65e-01	GO:0014003	oligodendrocyte development	BP
7	28	0.321299560878	-	3.03e-01	GO:0042407	cristae formation	BP
3	12	0.321299560878	-	3.96e-01	GO:0000050	urea cycle	BP
3	12	0.321299560878	-	3.96e-01	GO:0046849	bone remodeling	BP
3	12	0.321299560878	-	3.96e-01	GO:0030277	maintenance of gastrointestinal epithelium	BP
3	12	0.321299560878	-	3.96e-01	GO:0001655	urogenital system development	BP
3	12	0.321299560878	-	3.96e-01	GO:0032963	collagen metabolic process	BP
6	24	0.321299560878	-	4.22e-01	GO:0055007	cardiac muscle cell differentiation	BP
6	24	0.321299560878	-	4.22e-01	GO:0002040	sprouting angiogenesis	BP
3	12	0.321299560878	-	4.30e-01	GO:0045078	positive regulation of interferon-gamma biosynthetic process	BP
3	12	0.321299560878	-	4.30e-01	GO:0001706	endoderm formation	BP
3	12	0.321299560878	-	4.30e-01	GO:0002009	morphogenesis of an epithelium	BP
3	12	0.321299560878	-	4.30e-01	GO:0002003	angiotensin maturation	BP
3	12	0.321299560878	-	4.30e-01	GO:0002437	inflammatory response to antigenic stimulus	BP
3	12	0.321299560878	-	4.30e-01	GO:0051310	metaphase plate congression	BP
3	12	0.321299560878	-	4.30e-01	GO:0046622	positive regulation of organ growth	BP
3	12	0.321299560878	-	4.30e-01	GO:0008206	bile acid metabolic process	BP
3	12	0.321299560878	-	4.30e-01	GO:0030195	negative regulation of blood coagulation	BP
3	12	0.321299560878	-	4.30e-01	GO:2000279	negative regulation of DNA biosynthetic process	BP
3	12	0.321299560878	-	4.69e-01	GO:0001736	establishment of planar polarity	BP
3	12	0.321299560878	-	4.69e-01	GO:0031054	pre-miRNA processing	BP
3	12	0.321299560878	-	4.69e-01	GO:2000406	positive regulation of T cell migration	BP
3	12	0.321299560878	-	4.69e-01	GO:0060707	trophoblast giant cell differentiation	BP
3	12	0.321299560878	-	4.69e-01	GO:0045199	maintenance of epithelial cell apical/basal polarity	BP
3	12	0.321299560878	-	4.69e-01	GO:0043922	negative regulation by host of viral transcription	BP
3	12	0.321299560878	-	4.69e-01	GO:0060218	hematopoietic stem cell differentiation	BP
3	12	0.321299560878	-	4.69e-01	GO:0003215	cardiac right ventricle morphogenesis	BP
6	24	0.321299560878	-	6.08e-01	GO:0035235	ionotropic glutamate receptor signaling pathway	BP
6	24	0.321299560878	-	6.08e-01	GO:0046686	response to cadmium ion	BP
3	12	0.321299560878	-	7.16e-01	GO:0000244	spliceosomal tri-snRNP complex assembly	BP
3	12	0.321299560878	-	7.16e-01	GO:0031629	synaptic vesicle fusion to presynaptic active zone membrane	BP
3	12	0.321299560878	-	7.16e-01	GO:0048821	erythrocyte development	BP
3	12	0.321299560878	-	7.16e-01	GO:0006301	postreplication repair	BP
3	12	0.321299560878	-	7.16e-01	GO:0048747	muscle fiber development	BP
3	12	0.321299560878	-	7.16e-01	GO:0010955	negative regulation of protein processing	BP
3	12	0.321299560878	-	7.16e-01	GO:0035418	protein localization to synapse	BP
3	12	0.321299560878	-	7.16e-01	GO:0045086	positive regulation of interleukin-2 biosynthetic process	BP
3	12	0.321299560878	-	7.16e-01	GO:0010818	T cell chemotaxis	BP
3	12	0.321299560878	-	7.16e-01	GO:0010458	exit from mitosis	BP
3	12	0.321299560878	-	2.03e-01	GO:0005542	folic acid binding	MF
6	24	0.321299560878	-	2.65e-01	GO:0005487	nucleocytoplasmic transporter activity	MF
3	12	0.321299560878	-	4.30e-01	GO:0008331	high voltage-gated calcium channel activity	MF
3	12	0.321299560878	-	7.16e-01	GO:0051010	microtubule plus-end binding	MF
23	92	0.321299560878	-	9.48e-03	GO:0007160	cell-matrix adhesion	BP
5	20	0.321299560878	-	3.28e-02	GO:0007130	synaptonemal complex assembly	BP
22	88	0.321299560878	-	3.71e-02	GO:0007565	female pregnancy	BP
27	108	0.321299560878	-	7.48e-02	GO:0009615	response to virus	BP
4	16	0.321299560878	-	8.57e-02	GO:0050709	negative regulation of protein secretion	BP
2	8	0.321299560878	-	1.81e-01	GO:1900747	negative regulation of vascular endothelial growth factor signaling pathway	BP
2	8	0.321299560878	-	1.81e-01	GO:0042074	cell migration involved in gastrulation	BP
2	8	0.321299560878	-	1.81e-01	GO:0050863	regulation of T cell activation	BP
1	4	0.321299560878	-	2.00e-01	GO:0006949	syncytium formation	BP
1	4	0.321299560878	-	2.00e-01	GO:0051295	establishment of meiotic spindle localization	BP
1	4	0.321299560878	-	2.00e-01	GO:1903609	negative regulation of inward rectifier potassium channel activity	BP
1	4	0.321299560878	-	2.00e-01	GO:0048859	formation of anatomical boundary	BP
1	4	0.321299560878	-	2.00e-01	GO:1903845	negative regulation of cellular response to transforming growth factor beta stimulus	BP
1	4	0.321299560878	-	2.00e-01	GO:0006710	androgen catabolic process	BP
9	36	0.321299560878	-	2.57e-01	GO:0051209	release of sequestered calcium ion into cytosol	BP
2	8	0.321299560878	-	2.63e-01	GO:0031666	positive regulation of lipopolysaccharide-mediated signaling pathway	BP
2	8	0.321299560878	-	2.63e-01	GO:0031017	exocrine pancreas development	BP
2	8	0.321299560878	-	2.63e-01	GO:0051151	negative regulation of smooth muscle cell differentiation	BP
2	8	0.321299560878	-	2.63e-01	GO:0003085	negative regulation of systemic arterial blood pressure	BP
10	40	0.321299560878	-	3.02e-01	GO:0009411	response to UV	BP
4	16	0.321299560878	-	3.08e-01	GO:0021522	spinal cord motor neuron differentiation	BP
4	16	0.321299560878	-	3.08e-01	GO:0019674	NAD metabolic process	BP
4	16	0.321299560878	-	3.08e-01	GO:0035567	non-canonical Wnt signaling pathway	BP
4	16	0.321299560878	-	3.08e-01	GO:0045616	regulation of keratinocyte differentiation	BP
5	20	0.321299560878	-	3.42e-01	GO:0060716	labyrinthine layer blood vessel development	BP
2	8	0.321299560878	-	3.45e-01	GO:0044342	type B pancreatic cell proliferation	BP
2	8	0.321299560878	-	3.45e-01	GO:0006704	glucocorticoid biosynthetic process	BP
2	8	0.321299560878	-	3.45e-01	GO:2000369	regulation of clathrin-dependent endocytosis	BP
2	8	0.321299560878	-	3.45e-01	GO:0060137	maternal process involved in parturition	BP
2	8	0.321299560878	-	3.45e-01	GO:0060339	negative regulation of type I interferon-mediated signaling pathway	BP
2	8	0.321299560878	-	3.45e-01	GO:0048843	negative regulation of axon extension involved in axon guidance	BP
2	8	0.321299560878	-	3.45e-01	GO:0007494	midgut development	BP
2	8	0.321299560878	-	3.45e-01	GO:0040036	regulation of fibroblast growth factor receptor signaling pathway	BP
2	8	0.321299560878	-	3.45e-01	GO:2000427	positive regulation of apoptotic cell clearance	BP
2	8	0.321299560878	-	3.45e-01	GO:0060539	diaphragm development	BP
2	8	0.321299560878	-	3.45e-01	GO:0008593	regulation of Notch signaling pathway	BP
2	8	0.321299560878	-	3.45e-01	GO:0048339	paraxial mesoderm development	BP
2	8	0.321299560878	-	3.45e-01	GO:0061635	regulation of protein complex stability	BP
5	20	0.321299560878	-	3.60e-01	GO:0010804	negative regulation of tumor necrosis factor-mediated signaling pathway	BP
5	20	0.321299560878	-	3.60e-01	GO:0035584	calcium-mediated signaling using intracellular calcium source	BP
1	4	0.321299560878	-	3.60e-01	GO:1904954	canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation	BP
1	4	0.321299560878	-	3.60e-01	GO:0021521	ventral spinal cord interneuron specification	BP
1	4	0.321299560878	-	3.60e-01	GO:0051919	positive regulation of fibrinolysis	BP
1	4	0.321299560878	-	3.60e-01	GO:2000724	positive regulation of cardiac vascular smooth muscle cell differentiation	BP
1	4	0.321299560878	-	3.60e-01	GO:1901991	negative regulation of mitotic cell cycle phase transition	BP
1	4	0.321299560878	-	3.60e-01	GO:0046208	spermine catabolic process	BP
1	4	0.321299560878	-	3.60e-01	GO:0051447	negative regulation of meiotic cell cycle	BP
1	4	0.321299560878	-	3.60e-01	GO:0060455	negative regulation of gastric acid secretion	BP
1	4	0.321299560878	-	3.60e-01	GO:0019439	aromatic compound catabolic process	BP
1	4	0.321299560878	-	3.60e-01	GO:0046684	response to pyrethroid	BP
1	4	0.321299560878	-	3.60e-01	GO:0006772	thiamine metabolic process	BP
1	4	0.321299560878	-	3.60e-01	GO:0051454	intracellular pH elevation	BP
1	4	0.321299560878	-	3.60e-01	GO:1901657	glycosyl compound metabolic process	BP
1	4	0.321299560878	-	3.60e-01	GO:0070295	renal water absorption	BP
1	4	0.321299560878	-	3.60e-01	GO:2001206	positive regulation of osteoclast development	BP
1	4	0.321299560878	-	3.60e-01	GO:0035092	sperm chromatin condensation	BP
1	4	0.321299560878	-	3.60e-01	GO:0043587	tongue morphogenesis	BP
1	4	0.321299560878	-	3.60e-01	GO:0072086	specification of loop of Henle identity	BP
1	4	0.321299560878	-	3.60e-01	GO:0032483	regulation of Rab protein signal transduction	BP
1	4	0.321299560878	-	3.60e-01	GO:0021555	midbrain-hindbrain boundary morphogenesis	BP
1	4	0.321299560878	-	3.60e-01	GO:1900194	negative regulation of oocyte maturation	BP
1	4	0.321299560878	-	3.60e-01	GO:0048609	multicellular organismal reproductive process	BP
1	4	0.321299560878	-	3.60e-01	GO:0042662	negative regulation of mesodermal cell fate specification	BP
1	4	0.321299560878	-	3.60e-01	GO:0019556	histidine catabolic process to glutamate and formamide	BP
1	4	0.321299560878	-	3.60e-01	GO:0019557	histidine catabolic process to glutamate and formate	BP
1	4	0.321299560878	-	3.60e-01	GO:0071934	thiamine transmembrane transport	BP
1	4	0.321299560878	-	3.60e-01	GO:0007386	compartment pattern specification	BP
1	4	0.321299560878	-	3.60e-01	GO:0051647	nucleus localization	BP
5	20	0.321299560878	-	3.83e-01	GO:0002230	positive regulation of defense response to virus by host	BP
9	36	0.321299560878	-	3.88e-01	GO:0007223	Wnt signaling pathway, calcium modulating pathway	BP
9	36	0.321299560878	-	3.98e-01	GO:0006953	acute-phase response	BP
1	4	0.321299560878	-	4.88e-01	GO:0036438	maintenance of lens transparency	BP
1	4	0.321299560878	-	4.88e-01	GO:0086016	AV node cell action potential	BP
1	4	0.321299560878	-	4.88e-01	GO:0071494	cellular response to UV-C	BP
1	4	0.321299560878	-	4.88e-01	GO:0031547	brain-derived neurotrophic factor receptor signaling pathway	BP
1	4	0.321299560878	-	4.88e-01	GO:0043652	engulfment of apoptotic cell	BP
1	4	0.321299560878	-	4.88e-01	GO:0031936	negative regulation of chromatin silencing	BP
1	4	0.321299560878	-	4.88e-01	GO:0072189	ureter development	BP
1	4	0.321299560878	-	4.88e-01	GO:0035751	regulation of lysosomal lumen pH	BP
1	4	0.321299560878	-	4.88e-01	GO:0002666	positive regulation of T cell tolerance induction	BP
1	4	0.321299560878	-	4.88e-01	GO:0061739	protein lipidation involved in autophagosome assembly	BP
1	4	0.321299560878	-	4.88e-01	GO:0022414	reproductive process	BP
1	4	0.321299560878	-	4.88e-01	GO:0001780	neutrophil homeostasis	BP
1	4	0.321299560878	-	4.88e-01	GO:1901911	adenosine 5'-(hexahydrogen pentaphosphate) catabolic process	BP
1	4	0.321299560878	-	4.88e-01	GO:0035502	metanephric part of ureteric bud development	BP
1	4	0.321299560878	-	4.88e-01	GO:0061030	epithelial cell differentiation involved in mammary gland alveolus development	BP
1	4	0.321299560878	-	4.88e-01	GO:0070384	Harderian gland development	BP
1	4	0.321299560878	-	4.88e-01	GO:1903862	positive regulation of oxidative phosphorylation	BP
1	4	0.321299560878	-	4.88e-01	GO:0006054	N-acetylneuraminate metabolic process	BP
1	4	0.321299560878	-	4.88e-01	GO:0072144	glomerular mesangial cell development	BP
1	4	0.321299560878	-	4.88e-01	GO:0070858	negative regulation of bile acid biosynthetic process	BP
1	4	0.321299560878	-	4.88e-01	GO:0090298	negative regulation of mitochondrial DNA replication	BP
1	4	0.321299560878	-	4.88e-01	GO:0003273	cell migration involved in endocardial cushion formation	BP
1	4	0.321299560878	-	4.88e-01	GO:0046878	positive regulation of saliva secretion	BP
1	4	0.321299560878	-	4.88e-01	GO:2000653	regulation of genetic imprinting	BP
1	4	0.321299560878	-	4.88e-01	GO:0003231	cardiac ventricle development	BP
1	4	0.321299560878	-	4.88e-01	GO:0001951	intestinal D-glucose absorption	BP
1	4	0.321299560878	-	4.88e-01	GO:0002360	T cell lineage commitment	BP
1	4	0.321299560878	-	4.88e-01	GO:0072600	establishment of protein localization to Golgi	BP
1	4	0.321299560878	-	4.88e-01	GO:0007127	meiosis I	BP
1	4	0.321299560878	-	4.88e-01	GO:0032811	negative regulation of epinephrine secretion	BP
1	4	0.321299560878	-	4.88e-01	GO:0006779	porphyrin-containing compound biosynthetic process	BP
1	4	0.321299560878	-	4.88e-01	GO:0032374	regulation of cholesterol transport	BP
1	4	0.321299560878	-	4.88e-01	GO:0072221	metanephric distal convoluted tubule development	BP
1	4	0.321299560878	-	4.88e-01	GO:0031064	negative regulation of histone deacetylation	BP
1	4	0.321299560878	-	4.88e-01	GO:0015842	aminergic neurotransmitter loading into synaptic vesicle	BP
1	4	0.321299560878	-	4.88e-01	GO:0046726	positive regulation by virus of viral protein levels in host cell	BP
1	4	0.321299560878	-	4.88e-01	GO:0002677	negative regulation of chronic inflammatory response	BP
1	4	0.321299560878	-	4.88e-01	GO:0035112	genitalia morphogenesis	BP
1	4	0.321299560878	-	4.88e-01	GO:1900738	positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway	BP
1	4	0.321299560878	-	4.88e-01	GO:1900245	positive regulation of MDA-5 signaling pathway	BP
1	4	0.321299560878	-	4.88e-01	GO:1904358	positive regulation of telomere maintenance via telomere lengthening	BP
1	4	0.321299560878	-	4.88e-01	GO:0033631	cell-cell adhesion mediated by integrin	BP
1	4	0.321299560878	-	4.88e-01	GO:1902731	negative regulation of chondrocyte proliferation	BP
1	4	0.321299560878	-	4.88e-01	GO:0000730	DNA recombinase assembly	BP
1	4	0.321299560878	-	4.88e-01	GO:0048713	regulation of oligodendrocyte differentiation	BP
1	4	0.321299560878	-	4.88e-01	GO:0098706	ferric iron import across plasma membrane	BP
1	4	0.321299560878	-	4.88e-01	GO:0032414	positive regulation of ion transmembrane transporter activity	BP
1	4	0.321299560878	-	4.88e-01	GO:0070741	response to interleukin-6	BP
1	4	0.321299560878	-	4.88e-01	GO:0072675	osteoclast fusion	BP
1	4	0.321299560878	-	4.88e-01	GO:0034154	toll-like receptor 7 signaling pathway	BP
1	4	0.321299560878	-	4.88e-01	GO:2000546	positive regulation of endothelial cell chemotaxis to fibroblast growth factor	BP
1	4	0.321299560878	-	4.88e-01	GO:0072218	metanephric ascending thin limb development	BP
1	4	0.321299560878	-	4.88e-01	GO:0051294	establishment of spindle orientation	BP
1	4	0.321299560878	-	4.88e-01	GO:0014028	notochord formation	BP
1	4	0.321299560878	-	4.88e-01	GO:0006760	folic acid-containing compound metabolic process	BP
1	4	0.321299560878	-	4.88e-01	GO:0032348	negative regulation of aldosterone biosynthetic process	BP
1	4	0.321299560878	-	4.88e-01	GO:0033088	negative regulation of immature T cell proliferation in thymus	BP
1	4	0.321299560878	-	4.88e-01	GO:0014061	regulation of norepinephrine secretion	BP
1	4	0.321299560878	-	4.88e-01	GO:0042759	long-chain fatty acid biosynthetic process	BP
1	4	0.321299560878	-	4.88e-01	GO:0035886	vascular smooth muscle cell differentiation	BP
1	4	0.321299560878	-	4.88e-01	GO:0060686	negative regulation of prostatic bud formation	BP
1	4	0.321299560878	-	4.88e-01	GO:0060684	epithelial-mesenchymal cell signaling	BP
1	4	0.321299560878	-	4.88e-01	GO:0036101	leukotriene B4 catabolic process	BP
1	4	0.321299560878	-	4.88e-01	GO:0003257	positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation	BP
1	4	0.321299560878	-	4.88e-01	GO:1901165	positive regulation of trophoblast cell migration	BP
1	4	0.321299560878	-	4.88e-01	GO:0060113	inner ear receptor cell differentiation	BP
1	4	0.321299560878	-	4.88e-01	GO:0032392	DNA geometric change	BP
1	4	0.321299560878	-	4.88e-01	GO:0006655	phosphatidylglycerol biosynthetic process	BP
1	4	0.321299560878	-	4.88e-01	GO:0006659	phosphatidylserine biosynthetic process	BP
1	4	0.321299560878	-	4.88e-01	GO:0021938	smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation	BP
1	4	0.321299560878	-	4.88e-01	GO:0071603	endothelial cell-cell adhesion	BP
1	4	0.321299560878	-	4.88e-01	GO:0018243	protein O-linked glycosylation via threonine	BP
1	4	0.321299560878	-	4.88e-01	GO:0060971	embryonic heart tube left/right pattern formation	BP
1	4	0.321299560878	-	4.88e-01	GO:0071442	positive regulation of histone H3-K14 acetylation	BP
1	4	0.321299560878	-	4.88e-01	GO:0060841	venous blood vessel development	BP
1	4	0.321299560878	-	4.88e-01	GO:0001839	neural plate morphogenesis	BP
1	4	0.321299560878	-	4.88e-01	GO:0006562	proline catabolic process	BP
1	4	0.321299560878	-	4.88e-01	GO:0006007	glucose catabolic process	BP
1	4	0.321299560878	-	4.88e-01	GO:1901909	diadenosine hexaphosphate catabolic process	BP
1	4	0.321299560878	-	4.88e-01	GO:1901907	diadenosine pentaphosphate catabolic process	BP
1	4	0.321299560878	-	4.88e-01	GO:2000065	negative regulation of cortisol biosynthetic process	BP
1	4	0.321299560878	-	4.88e-01	GO:0007023	post-chaperonin tubulin folding pathway	BP
1	4	0.321299560878	-	4.88e-01	GO:0010897	negative regulation of triglyceride catabolic process	BP
1	4	0.321299560878	-	4.88e-01	GO:0010453	regulation of cell fate commitment	BP
1	4	0.321299560878	-	4.88e-01	GO:0014827	intestine smooth muscle contraction	BP
1	4	0.321299560878	-	4.88e-01	GO:0006084	acetyl-CoA metabolic process	BP
1	4	0.321299560878	-	4.88e-01	GO:0072177	mesonephric duct development	BP
1	4	0.321299560878	-	4.88e-01	GO:0070901	mitochondrial tRNA methylation	BP
1	4	0.321299560878	-	4.88e-01	GO:0044262	cellular carbohydrate metabolic process	BP
4	16	0.321299560878	-	5.00e-01	GO:0048265	response to pain	BP
4	16	0.321299560878	-	5.00e-01	GO:0060292	long term synaptic depression	BP
4	16	0.321299560878	-	5.00e-01	GO:0060216	definitive hemopoiesis	BP
4	16	0.321299560878	-	5.00e-01	GO:2000147	positive regulation of cell motility	BP
4	16	0.321299560878	-	5.19e-01	GO:0021772	olfactory bulb development	BP
4	16	0.321299560878	-	5.19e-01	GO:2000179	positive regulation of neural precursor cell proliferation	BP
4	16	0.321299560878	-	5.43e-01	GO:0060236	regulation of mitotic spindle organization	BP
4	16	0.321299560878	-	5.43e-01	GO:0000380	alternative mRNA splicing, via spliceosome	BP
5	20	0.321299560878	-	5.63e-01	GO:0007051	spindle organization	BP
2	8	0.321299560878	-	6.33e-01	GO:0048103	somatic stem cell division	BP
2	8	0.321299560878	-	6.33e-01	GO:0051103	DNA ligation involved in DNA repair	BP
2	8	0.321299560878	-	6.33e-01	GO:0060993	kidney morphogenesis	BP
2	8	0.321299560878	-	6.33e-01	GO:0045416	positive regulation of interleukin-8 biosynthetic process	BP
2	8	0.321299560878	-	6.33e-01	GO:0001959	regulation of cytokine-mediated signaling pathway	BP
2	8	0.321299560878	-	6.33e-01	GO:0048312	intracellular distribution of mitochondria	BP
2	8	0.321299560878	-	6.33e-01	GO:0033993	response to lipid	BP
2	8	0.321299560878	-	6.33e-01	GO:0072091	regulation of stem cell proliferation	BP
2	8	0.321299560878	-	6.33e-01	GO:0072678	T cell migration	BP
2	8	0.321299560878	-	6.33e-01	GO:0051549	positive regulation of keratinocyte migration	BP
2	8	0.321299560878	-	6.33e-01	GO:0003254	regulation of membrane depolarization	BP
2	8	0.321299560878	-	6.33e-01	GO:0016188	synaptic vesicle maturation	BP
2	8	0.321299560878	-	6.33e-01	GO:0060315	negative regulation of ryanodine-sensitive calcium-release channel activity	BP
2	8	0.321299560878	-	6.33e-01	GO:0072711	cellular response to hydroxyurea	BP
2	8	0.321299560878	-	6.65e-01	GO:0060100	positive regulation of phagocytosis, engulfment	BP
2	8	0.321299560878	-	6.65e-01	GO:0048739	cardiac muscle fiber development	BP
2	8	0.321299560878	-	6.65e-01	GO:1901799	negative regulation of proteasomal protein catabolic process	BP
2	8	0.321299560878	-	6.65e-01	GO:0071493	cellular response to UV-B	BP
2	8	0.321299560878	-	6.65e-01	GO:0061179	negative regulation of insulin secretion involved in cellular response to glucose stimulus	BP
2	8	0.321299560878	-	6.65e-01	GO:0045630	positive regulation of T-helper 2 cell differentiation	BP
2	8	0.321299560878	-	6.65e-01	GO:0047497	mitochondrion transport along microtubule	BP
2	8	0.321299560878	-	6.65e-01	GO:1900029	positive regulation of ruffle assembly	BP
2	8	0.321299560878	-	6.65e-01	GO:0007097	nuclear migration	BP
2	8	0.321299560878	-	6.65e-01	GO:0001825	blastocyst formation	BP
2	8	0.321299560878	-	6.65e-01	GO:0044387	negative regulation of protein kinase activity by regulation of protein phosphorylation	BP
2	8	0.321299560878	-	6.65e-01	GO:0010882	regulation of cardiac muscle contraction by calcium ion signaling	BP
2	8	0.321299560878	-	6.65e-01	GO:0035331	negative regulation of hippo signaling	BP
2	8	0.321299560878	-	6.65e-01	GO:0097345	mitochondrial outer membrane permeabilization	BP
2	8	0.321299560878	-	6.65e-01	GO:0075713	establishment of integrated proviral latency	BP
2	8	0.321299560878	-	6.65e-01	GO:0072383	plus-end-directed vesicle transport along microtubule	BP
2	8	0.321299560878	-	6.65e-01	GO:0033173	calcineurin-NFAT signaling cascade	BP
2	8	0.321299560878	-	6.65e-01	GO:0006268	DNA unwinding involved in DNA replication	BP
2	8	0.321299560878	-	6.65e-01	GO:0030851	granulocyte differentiation	BP
2	8	0.321299560878	-	6.65e-01	GO:0072015	glomerular visceral epithelial cell development	BP
2	8	0.321299560878	-	6.65e-01	GO:2000096	positive regulation of Wnt signaling pathway, planar cell polarity pathway	BP
2	8	0.321299560878	-	6.65e-01	GO:0019934	cGMP-mediated signaling	BP
2	8	0.321299560878	-	6.65e-01	GO:0016574	histone ubiquitination	BP
2	8	0.321299560878	-	6.65e-01	GO:1990253	cellular response to leucine starvation	BP
2	8	0.321299560878	-	6.65e-01	GO:0045830	positive regulation of isotype switching	BP
2	8	0.321299560878	-	6.65e-01	GO:0045839	negative regulation of mitotic nuclear division	BP
2	8	0.321299560878	-	6.65e-01	GO:0010467	gene expression	BP
2	8	0.321299560878	-	6.65e-01	GO:0048743	positive regulation of skeletal muscle fiber development	BP
2	8	0.321299560878	-	6.65e-01	GO:0070206	protein trimerization	BP
2	8	0.321299560878	-	6.65e-01	GO:0035457	cellular response to interferon-alpha	BP
2	8	0.321299560878	-	6.65e-01	GO:0033151	V(D)J recombination	BP
2	8	0.321299560878	-	6.65e-01	GO:0007270	neuron-neuron synaptic transmission	BP
2	8	0.321299560878	-	6.65e-01	GO:0010457	centriole-centriole cohesion	BP
2	8	0.321299560878	-	6.65e-01	GO:0060711	labyrinthine layer development	BP
2	8	0.321299560878	-	6.65e-01	GO:0071312	cellular response to alkaloid	BP
1	4	0.321299560878	-	1.00e+00	GO:0060263	regulation of respiratory burst	BP
1	4	0.321299560878	-	1.00e+00	GO:0033522	histone H2A ubiquitination	BP
1	4	0.321299560878	-	1.00e+00	GO:0061084	negative regulation of protein refolding	BP
1	4	0.321299560878	-	1.00e+00	GO:0010922	positive regulation of phosphatase activity	BP
1	4	0.321299560878	-	1.00e+00	GO:0071359	cellular response to dsRNA	BP
1	4	0.321299560878	-	1.00e+00	GO:0061470	T follicular helper cell differentiation	BP
1	4	0.321299560878	-	1.00e+00	GO:0035995	detection of muscle stretch	BP
1	4	0.321299560878	-	1.00e+00	GO:0010716	negative regulation of extracellular matrix disassembly	BP
1	4	0.321299560878	-	1.00e+00	GO:0060355	positive regulation of cell adhesion molecule production	BP
1	4	0.321299560878	-	1.00e+00	GO:2001013	epithelial cell proliferation involved in renal tubule morphogenesis	BP
1	4	0.321299560878	-	1.00e+00	GO:1901798	positive regulation of signal transduction by p53 class mediator	BP
1	4	0.321299560878	-	1.00e+00	GO:0098534	centriole assembly	BP
1	4	0.321299560878	-	1.00e+00	GO:0010523	negative regulation of calcium ion transport into cytosol	BP
1	4	0.321299560878	-	1.00e+00	GO:0035426	extracellular matrix-cell signaling	BP
1	4	0.321299560878	-	1.00e+00	GO:0051142	positive regulation of NK T cell proliferation	BP
1	4	0.321299560878	-	1.00e+00	GO:0071847	TNFSF11-mediated signaling pathway	BP
1	4	0.321299560878	-	1.00e+00	GO:0008588	release of cytoplasmic sequestered NF-kappaB	BP
1	4	0.321299560878	-	1.00e+00	GO:1900454	positive regulation of long term synaptic depression	BP
1	4	0.321299560878	-	1.00e+00	GO:0071459	protein localization to chromosome, centromeric region	BP
1	4	0.321299560878	-	1.00e+00	GO:1901509	regulation of endothelial tube morphogenesis	BP
1	4	0.321299560878	-	1.00e+00	GO:0009048	dosage compensation by inactivation of X chromosome	BP
1	4	0.321299560878	-	1.00e+00	GO:1900024	regulation of substrate adhesion-dependent cell spreading	BP
1	4	0.321299560878	-	1.00e+00	GO:2000563	positive regulation of CD4-positive, alpha-beta T cell proliferation	BP
1	4	0.321299560878	-	1.00e+00	GO:0060669	embryonic placenta morphogenesis	BP
1	4	0.321299560878	-	1.00e+00	GO:0002070	epithelial cell maturation	BP
1	4	0.321299560878	-	1.00e+00	GO:1905832	positive regulation of spindle assembly	BP
1	4	0.321299560878	-	1.00e+00	GO:0006741	NADP biosynthetic process	BP
1	4	0.321299560878	-	1.00e+00	GO:0071922	regulation of cohesin loading	BP
1	4	0.321299560878	-	1.00e+00	GO:0042159	lipoprotein catabolic process	BP
1	4	0.321299560878	-	1.00e+00	GO:0000972	transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery	BP
1	4	0.321299560878	-	1.00e+00	GO:0033591	response to L-ascorbic acid	BP
1	4	0.321299560878	-	1.00e+00	GO:0033625	positive regulation of integrin activation	BP
1	4	0.321299560878	-	1.00e+00	GO:0065002	intracellular protein transmembrane transport	BP
1	4	0.321299560878	-	1.00e+00	GO:0048254	snoRNA localization	BP
1	4	0.321299560878	-	1.00e+00	GO:0051409	response to nitrosative stress	BP
1	4	0.321299560878	-	1.00e+00	GO:0090168	Golgi reassembly	BP
1	4	0.321299560878	-	1.00e+00	GO:0016080	synaptic vesicle targeting	BP
1	4	0.321299560878	-	1.00e+00	GO:0071896	protein localization to adherens junction	BP
1	4	0.321299560878	-	1.00e+00	GO:0003413	chondrocyte differentiation involved in endochondral bone morphogenesis	BP
1	4	0.321299560878	-	1.00e+00	GO:0010155	regulation of proton transport	BP
1	4	0.321299560878	-	1.00e+00	GO:2000825	positive regulation of androgen receptor activity	BP
1	4	0.321299560878	-	1.00e+00	GO:0060708	spongiotrophoblast differentiation	BP
1	4	0.321299560878	-	1.00e+00	GO:0010970	transport along microtubule	BP
1	4	0.321299560878	-	1.00e+00	GO:0035948	positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter	BP
1	4	0.321299560878	-	1.00e+00	GO:0015722	canalicular bile acid transport	BP
1	4	0.321299560878	-	1.00e+00	GO:0031394	positive regulation of prostaglandin biosynthetic process	BP
1	4	0.321299560878	-	1.00e+00	GO:0018119	peptidyl-cysteine S-nitrosylation	BP
1	4	0.321299560878	-	1.00e+00	GO:0010724	regulation of definitive erythrocyte differentiation	BP
1	4	0.321299560878	-	1.00e+00	GO:1905907	negative regulation of amyloid fibril formation	BP
1	4	0.321299560878	-	1.00e+00	GO:0006907	pinocytosis	BP
1	4	0.321299560878	-	1.00e+00	GO:0090244	Wnt signaling pathway involved in somitogenesis	BP
1	4	0.321299560878	-	1.00e+00	GO:0019086	late viral transcription	BP
1	4	0.321299560878	-	1.00e+00	GO:0038124	toll-like receptor TLR6:TLR2 signaling pathway	BP
1	4	0.321299560878	-	1.00e+00	GO:0034088	maintenance of mitotic sister chromatid cohesion	BP
1	4	0.321299560878	-	1.00e+00	GO:0045356	positive regulation of interferon-alpha biosynthetic process	BP
1	4	0.321299560878	-	1.00e+00	GO:0030174	regulation of DNA-dependent DNA replication initiation	BP
1	4	0.321299560878	-	1.00e+00	GO:0060421	positive regulation of heart growth	BP
1	4	0.321299560878	-	1.00e+00	GO:2001044	regulation of integrin-mediated signaling pathway	BP
1	4	0.321299560878	-	1.00e+00	GO:0072344	rescue of stalled ribosome	BP
1	4	0.321299560878	-	1.00e+00	GO:0031670	cellular response to nutrient	BP
1	4	0.321299560878	-	1.00e+00	GO:0032375	negative regulation of cholesterol transport	BP
1	4	0.321299560878	-	1.00e+00	GO:0032376	positive regulation of cholesterol transport	BP
1	4	0.321299560878	-	1.00e+00	GO:1901020	negative regulation of calcium ion transmembrane transporter activity	BP
1	4	0.321299560878	-	1.00e+00	GO:0001667	ameboidal-type cell migration	BP
1	4	0.321299560878	-	1.00e+00	GO:0022615	protein to membrane docking	BP
1	4	0.321299560878	-	1.00e+00	GO:0070670	response to interleukin-4	BP
1	4	0.321299560878	-	1.00e+00	GO:2000002	negative regulation of DNA damage checkpoint	BP
1	4	0.321299560878	-	1.00e+00	GO:1905867	epididymis development	BP
1	4	0.321299560878	-	1.00e+00	GO:0060033	anatomical structure regression	BP
1	4	0.321299560878	-	1.00e+00	GO:0033634	positive regulation of cell-cell adhesion mediated by integrin	BP
1	4	0.321299560878	-	1.00e+00	GO:1904294	positive regulation of ERAD pathway	BP
1	4	0.321299560878	-	1.00e+00	GO:0030910	olfactory placode formation	BP
1	4	0.321299560878	-	1.00e+00	GO:0042482	positive regulation of odontogenesis	BP
1	4	0.321299560878	-	1.00e+00	GO:0051414	response to cortisol	BP
1	4	0.321299560878	-	1.00e+00	GO:1901888	regulation of cell junction assembly	BP
1	4	0.321299560878	-	1.00e+00	GO:0006432	phenylalanyl-tRNA aminoacylation	BP
1	4	0.321299560878	-	1.00e+00	GO:1900825	regulation of membrane depolarization during cardiac muscle cell action potential	BP
1	4	0.321299560878	-	1.00e+00	GO:1903690	negative regulation of wound healing, spreading of epidermal cells	BP
1	4	0.321299560878	-	1.00e+00	GO:0008105	asymmetric protein localization	BP
1	4	0.321299560878	-	1.00e+00	GO:0032611	interleukin-1 beta production	BP
1	4	0.321299560878	-	1.00e+00	GO:1901842	negative regulation of high voltage-gated calcium channel activity	BP
1	4	0.321299560878	-	1.00e+00	GO:0003402	planar cell polarity pathway involved in axis elongation	BP
1	4	0.321299560878	-	1.00e+00	GO:0007621	negative regulation of female receptivity	BP
1	4	0.321299560878	-	1.00e+00	GO:0002906	negative regulation of mature B cell apoptotic process	BP
1	4	0.321299560878	-	1.00e+00	GO:0097623	potassium ion export across plasma membrane	BP
1	4	0.321299560878	-	1.00e+00	GO:0006642	triglyceride mobilization	BP
1	4	0.321299560878	-	1.00e+00	GO:0010735	positive regulation of transcription via serum response element binding	BP
1	4	0.321299560878	-	1.00e+00	GO:0032417	positive regulation of sodium:proton antiporter activity	BP
1	4	0.321299560878	-	1.00e+00	GO:0006933	negative regulation of cell adhesion involved in substrate-bound cell migration	BP
1	4	0.321299560878	-	1.00e+00	GO:2000664	positive regulation of interleukin-5 secretion	BP
1	4	0.321299560878	-	1.00e+00	GO:0010988	regulation of low-density lipoprotein particle clearance	BP
1	4	0.321299560878	-	1.00e+00	GO:0048305	immunoglobulin secretion	BP
1	4	0.321299560878	-	1.00e+00	GO:0060364	frontal suture morphogenesis	BP
1	4	0.321299560878	-	1.00e+00	GO:0051351	positive regulation of ligase activity	BP
1	4	0.321299560878	-	1.00e+00	GO:0071677	positive regulation of mononuclear cell migration	BP
1	4	0.321299560878	-	1.00e+00	GO:0006538	glutamate catabolic process	BP
1	4	0.321299560878	-	1.00e+00	GO:0018216	peptidyl-arginine methylation	BP
1	4	0.321299560878	-	1.00e+00	GO:2000391	positive regulation of neutrophil extravasation	BP
1	4	0.321299560878	-	1.00e+00	GO:0016071	mRNA metabolic process	BP
1	4	0.321299560878	-	1.00e+00	GO:0010826	negative regulation of centrosome duplication	BP
1	4	0.321299560878	-	1.00e+00	GO:0045324	late endosome to vacuole transport	BP
1	4	0.321299560878	-	1.00e+00	GO:0032042	mitochondrial DNA metabolic process	BP
1	4	0.321299560878	-	1.00e+00	GO:0035771	interleukin-4-mediated signaling pathway	BP
1	4	0.321299560878	-	1.00e+00	GO:0051464	positive regulation of cortisol secretion	BP
1	4	0.321299560878	-	1.00e+00	GO:0015853	adenine transport	BP
1	4	0.321299560878	-	1.00e+00	GO:0008038	neuron recognition	BP
1	4	0.321299560878	-	1.00e+00	GO:0045876	positive regulation of sister chromatid cohesion	BP
1	4	0.321299560878	-	1.00e+00	GO:0035523	protein K29-linked deubiquitination	BP
1	4	0.321299560878	-	1.00e+00	GO:0061056	sclerotome development	BP
1	4	0.321299560878	-	1.00e+00	GO:0070192	chromosome organization involved in meiotic cell cycle	BP
1	4	0.321299560878	-	1.00e+00	GO:0019262	N-acetylneuraminate catabolic process	BP
1	4	0.321299560878	-	1.00e+00	GO:0070973	protein localization to endoplasmic reticulum exit site	BP
1	4	0.321299560878	-	1.00e+00	GO:0010463	mesenchymal cell proliferation	BP
1	4	0.321299560878	-	1.00e+00	GO:0030223	neutrophil differentiation	BP
1	4	0.321299560878	-	1.00e+00	GO:0034698	response to gonadotropin	BP
1	4	0.321299560878	-	1.00e+00	GO:0006273	lagging strand elongation	BP
1	4	0.321299560878	-	1.00e+00	GO:0072553	terminal button organization	BP
1	4	0.321299560878	-	1.00e+00	GO:0034205	amyloid-beta formation	BP
1	4	0.321299560878	-	1.00e+00	GO:0022009	central nervous system vasculogenesis	BP
1	4	0.321299560878	-	1.00e+00	GO:0031860	telomeric 3' overhang formation	BP
1	4	0.321299560878	-	1.00e+00	GO:0045986	negative regulation of smooth muscle contraction	BP
1	4	0.321299560878	-	1.00e+00	GO:2000343	positive regulation of chemokine (C-X-C motif) ligand 2 production	BP
1	4	0.321299560878	-	1.00e+00	GO:2000346	negative regulation of hepatocyte proliferation	BP
1	4	0.321299560878	-	1.00e+00	GO:0043932	ossification involved in bone remodeling	BP
1	4	0.321299560878	-	1.00e+00	GO:0070164	negative regulation of adiponectin secretion	BP
1	4	0.321299560878	-	1.00e+00	GO:0006482	protein demethylation	BP
1	4	0.321299560878	-	1.00e+00	GO:0060485	mesenchyme development	BP
1	4	0.321299560878	-	1.00e+00	GO:0008088	axo-dendritic transport	BP
1	4	0.321299560878	-	1.00e+00	GO:0044571	[2Fe-2S] cluster assembly	BP
1	4	0.321299560878	-	1.00e+00	GO:2000676	positive regulation of type B pancreatic cell apoptotic process	BP
1	4	0.321299560878	-	1.00e+00	GO:0009157	deoxyribonucleoside monophosphate biosynthetic process	BP
1	4	0.321299560878	-	1.00e+00	GO:2001137	positive regulation of endocytic recycling	BP
1	4	0.321299560878	-	1.00e+00	GO:0018242	protein O-linked glycosylation via serine	BP
1	4	0.321299560878	-	1.00e+00	GO:1905342	positive regulation of protein localization to kinetochore	BP
1	4	0.321299560878	-	1.00e+00	GO:0051771	negative regulation of nitric-oxide synthase biosynthetic process	BP
1	4	0.321299560878	-	1.00e+00	GO:1904925	positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization	BP
1	4	0.321299560878	-	1.00e+00	GO:0070459	prolactin secretion	BP
1	4	0.321299560878	-	1.00e+00	GO:0090235	regulation of metaphase plate congression	BP
1	4	0.321299560878	-	1.00e+00	GO:0098792	xenophagy	BP
1	4	0.321299560878	-	1.00e+00	GO:0051345	positive regulation of hydrolase activity	BP
1	4	0.321299560878	-	1.00e+00	GO:0006526	arginine biosynthetic process	BP
1	4	0.321299560878	-	1.00e+00	GO:0060842	arterial endothelial cell differentiation	BP
1	4	0.321299560878	-	1.00e+00	GO:0097485	neuron projection guidance	BP
1	4	0.321299560878	-	1.00e+00	GO:0022405	hair cycle process	BP
1	4	0.321299560878	-	1.00e+00	GO:0043553	negative regulation of phosphatidylinositol 3-kinase activity	BP
1	4	0.321299560878	-	1.00e+00	GO:0061041	regulation of wound healing	BP
1	4	0.321299560878	-	1.00e+00	GO:0030260	entry into host cell	BP
1	4	0.321299560878	-	1.00e+00	GO:0072289	metanephric nephron tubule formation	BP
1	4	0.321299560878	-	1.00e+00	GO:0048861	leukemia inhibitory factor signaling pathway	BP
1	4	0.321299560878	-	1.00e+00	GO:0043328	protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway	BP
1	4	0.321299560878	-	1.00e+00	GO:0072108	positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis	BP
1	4	0.321299560878	-	1.00e+00	GO:0035303	regulation of dephosphorylation	BP
1	4	0.321299560878	-	1.00e+00	GO:2000189	positive regulation of cholesterol homeostasis	BP
1	4	0.321299560878	-	1.00e+00	GO:0071726	cellular response to diacyl bacterial lipopeptide	BP
1	4	0.321299560878	-	1.00e+00	GO:0014829	vascular smooth muscle contraction	BP
1	4	0.321299560878	-	1.00e+00	GO:0090306	spindle assembly involved in meiosis	BP
1	4	0.321299560878	-	1.00e+00	GO:0000904	cell morphogenesis involved in differentiation	BP
1	4	0.321299560878	-	1.00e+00	GO:2000373	positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity	BP
1	4	0.321299560878	-	1.00e+00	GO:0021764	amygdala development	BP
1	4	0.321299560878	-	1.00e+00	GO:0015670	carbon dioxide transport	BP
1	4	0.321299560878	-	1.00e+00	GO:0007431	salivary gland development	BP
1	4	0.321299560878	-	1.00e+00	GO:0010499	proteasomal ubiquitin-independent protein catabolic process	BP
1	4	0.321299560878	-	1.00e+00	GO:0021957	corticospinal tract morphogenesis	BP
1	4	0.321299560878	-	1.00e+00	GO:0097114	NMDA glutamate receptor clustering	BP
1	4	0.321299560878	-	1.00e+00	GO:0071315	cellular response to morphine	BP
1	4	0.321299560878	-	1.00e+00	GO:0046425	regulation of JAK-STAT cascade	BP
1	4	0.321299560878	-	1.00e+00	GO:0006166	purine ribonucleoside salvage	BP
2	8	0.321299560878	-	1.81e-01	GO:0015108	chloride transmembrane transporter activity	MF
2	8	0.321299560878	-	2.63e-01	GO:0004536	deoxyribonuclease activity	MF
2	8	0.321299560878	-	2.63e-01	GO:0004022	alcohol dehydrogenase (NAD) activity	MF
2	8	0.321299560878	-	3.45e-01	GO:0004865	protein serine/threonine phosphatase inhibitor activity	MF
2	8	0.321299560878	-	3.45e-01	GO:0004439	phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity	MF
2	8	0.321299560878	-	3.45e-01	GO:0032052	bile acid binding	MF
1	4	0.321299560878	-	3.60e-01	GO:0031628	opioid receptor binding	MF
1	4	0.321299560878	-	3.60e-01	GO:0005332	gamma-aminobutyric acid:sodium symporter activity	MF
1	4	0.321299560878	-	3.60e-01	GO:1990430	extracellular matrix protein binding	MF
1	4	0.321299560878	-	3.60e-01	GO:0055077	gap junction hemi-channel activity	MF
1	4	0.321299560878	-	3.60e-01	GO:0008948	oxaloacetate decarboxylase activity	MF
1	4	0.321299560878	-	3.60e-01	GO:0015252	hydrogen ion channel activity	MF
1	4	0.321299560878	-	3.60e-01	GO:0005223	intracellular cGMP activated cation channel activity	MF
1	4	0.321299560878	-	3.60e-01	GO:0051431	corticotropin-releasing hormone receptor 2 binding	MF
5	20	0.321299560878	-	3.83e-01	GO:0004520	endodeoxyribonuclease activity	MF
1	4	0.321299560878	-	4.88e-01	GO:0008509	anion transmembrane transporter activity	MF
1	4	0.321299560878	-	4.88e-01	GO:0005219	ryanodine-sensitive calcium-release channel activity	MF
1	4	0.321299560878	-	4.88e-01	GO:0004647	phosphoserine phosphatase activity	MF
1	4	0.321299560878	-	4.88e-01	GO:0090722	receptor-receptor interaction	MF
1	4	0.321299560878	-	4.88e-01	GO:0036094	small molecule binding	MF
1	4	0.321299560878	-	4.88e-01	GO:0004634	phosphopyruvate hydratase activity	MF
1	4	0.321299560878	-	4.88e-01	GO:0048763	calcium-induced calcium release activity	MF
1	4	0.321299560878	-	4.88e-01	GO:0000298	endopolyphosphatase activity	MF
1	4	0.321299560878	-	4.88e-01	GO:0050051	leukotriene-B4 20-monooxygenase activity	MF
1	4	0.321299560878	-	4.88e-01	GO:0034431	bis(5'-adenosyl)-hexaphosphatase activity	MF
1	4	0.321299560878	-	4.88e-01	GO:0034432	bis(5'-adenosyl)-pentaphosphatase activity	MF
1	4	0.321299560878	-	4.88e-01	GO:0001515	opioid peptide activity	MF
1	4	0.321299560878	-	4.88e-01	GO:0018685	alkane 1-monooxygenase activity	MF
1	4	0.321299560878	-	4.88e-01	GO:0008486	diphosphoinositol-polyphosphate diphosphatase activity	MF
1	4	0.321299560878	-	4.88e-01	GO:0052848	inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity	MF
1	4	0.321299560878	-	4.88e-01	GO:0052845	inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity	MF
1	4	0.321299560878	-	4.88e-01	GO:0052844	inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity	MF
1	4	0.321299560878	-	4.88e-01	GO:0052847	inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity	MF
1	4	0.321299560878	-	4.88e-01	GO:0052846	inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity	MF
1	4	0.321299560878	-	4.88e-01	GO:0052841	inositol bisdiphosphate tetrakisphosphate diphosphatase activity	MF
1	4	0.321299560878	-	4.88e-01	GO:0052840	inositol diphosphate tetrakisphosphate diphosphatase activity	MF
1	4	0.321299560878	-	4.88e-01	GO:0052843	inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity	MF
1	4	0.321299560878	-	4.88e-01	GO:0052842	inositol diphosphate pentakisphosphate diphosphatase activity	MF
1	4	0.321299560878	-	4.88e-01	GO:0004687	myosin light chain kinase activity	MF
1	4	0.321299560878	-	4.88e-01	GO:0042030	ATPase inhibitor activity	MF
1	4	0.321299560878	-	4.88e-01	GO:0042287	MHC protein binding	MF
1	4	0.321299560878	-	4.88e-01	GO:0030229	very-low-density lipoprotein particle receptor activity	MF
1	4	0.321299560878	-	4.88e-01	GO:0008453	alanine-glyoxylate transaminase activity	MF
1	4	0.321299560878	-	4.88e-01	GO:0090554	phosphatidylcholine-translocating ATPase activity	MF
1	4	0.321299560878	-	4.88e-01	GO:0052795	exo-alpha-(2->6)-sialidase activity	MF
1	4	0.321299560878	-	4.88e-01	GO:0052794	exo-alpha-(2->3)-sialidase activity	MF
1	4	0.321299560878	-	4.88e-01	GO:0052796	exo-alpha-(2->8)-sialidase activity	MF
1	4	0.321299560878	-	4.88e-01	GO:0051380	norepinephrine binding	MF
4	16	0.321299560878	-	5.43e-01	GO:0008353	RNA polymerase II carboxy-terminal domain kinase activity	MF
5	20	0.321299560878	-	5.63e-01	GO:0003756	protein disulfide isomerase activity	MF
2	8	0.321299560878	-	6.33e-01	GO:0036310	annealing helicase activity	MF
2	8	0.321299560878	-	6.33e-01	GO:0042379	chemokine receptor binding	MF
2	8	0.321299560878	-	6.33e-01	GO:0102991	myristoyl-CoA hydrolase activity	MF
2	8	0.321299560878	-	6.33e-01	GO:0004300	enoyl-CoA hydratase activity	MF
2	8	0.321299560878	-	6.65e-01	GO:0003857	3-hydroxyacyl-CoA dehydrogenase activity	MF
2	8	0.321299560878	-	6.65e-01	GO:0031406	carboxylic acid binding	MF
2	8	0.321299560878	-	6.65e-01	GO:0051011	microtubule minus-end binding	MF
2	8	0.321299560878	-	6.65e-01	GO:0005049	nuclear export signal receptor activity	MF
1	4	0.321299560878	-	1.00e+00	GO:0017018	myosin phosphatase activity	MF
1	4	0.321299560878	-	1.00e+00	GO:0034485	phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity	MF
1	4	0.321299560878	-	1.00e+00	GO:0030160	GKAP/Homer scaffold activity	MF
1	4	0.321299560878	-	1.00e+00	GO:0097643	amylin receptor activity	MF
1	4	0.321299560878	-	1.00e+00	GO:0003917	DNA topoisomerase type I activity	MF
1	4	0.321299560878	-	1.00e+00	GO:0004706	JUN kinase kinase kinase activity	MF
1	4	0.321299560878	-	1.00e+00	GO:0005025	transforming growth factor beta receptor activity, type I	MF
1	4	0.321299560878	-	1.00e+00	GO:0004082	bisphosphoglycerate mutase activity	MF
1	4	0.321299560878	-	1.00e+00	GO:0004784	superoxide dismutase activity	MF
1	4	0.321299560878	-	1.00e+00	GO:0047696	beta-adrenergic receptor kinase activity	MF
1	4	0.321299560878	-	1.00e+00	GO:1905394	retromer complex binding	MF
1	4	0.321299560878	-	1.00e+00	GO:0033743	peptide-methionine (R)-S-oxide reductase activity	MF
1	4	0.321299560878	-	1.00e+00	GO:0034186	apolipoprotein A-I binding	MF
1	4	0.321299560878	-	1.00e+00	GO:0005329	dopamine transmembrane transporter activity	MF
1	4	0.321299560878	-	1.00e+00	GO:0045569	TRAIL binding	MF
1	4	0.321299560878	-	1.00e+00	GO:0005172	vascular endothelial growth factor receptor binding	MF
1	4	0.321299560878	-	1.00e+00	GO:0004945	angiotensin type II receptor activity	MF
1	4	0.321299560878	-	1.00e+00	GO:0008026	ATP-dependent helicase activity	MF
1	4	0.321299560878	-	1.00e+00	GO:0046538	2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity	MF
1	4	0.321299560878	-	1.00e+00	GO:0003696	satellite DNA binding	MF
1	4	0.321299560878	-	1.00e+00	GO:0004090	carbonyl reductase (NADPH) activity	MF
1	4	0.321299560878	-	1.00e+00	GO:0043532	angiostatin binding	MF
1	4	0.321299560878	-	1.00e+00	GO:0019834	phospholipase A2 inhibitor activity	MF
1	4	0.321299560878	-	1.00e+00	GO:0019158	mannokinase activity	MF
1	4	0.321299560878	-	1.00e+00	GO:0043199	sulfate binding	MF
1	4	0.321299560878	-	1.00e+00	GO:0017136	NAD-dependent histone deacetylase activity	MF
1	4	0.321299560878	-	1.00e+00	GO:0004974	leukotriene receptor activity	MF
1	4	0.321299560878	-	1.00e+00	GO:0032795	heterotrimeric G-protein binding	MF
1	4	0.321299560878	-	1.00e+00	GO:0003873	6-phosphofructo-2-kinase activity	MF
1	4	0.321299560878	-	1.00e+00	GO:0004525	ribonuclease III activity	MF
1	4	0.321299560878	-	1.00e+00	GO:0015085	calcium ion transmembrane transporter activity	MF
1	4	0.321299560878	-	1.00e+00	GO:0035312	5'-3' exodeoxyribonuclease activity	MF
1	4	0.321299560878	-	1.00e+00	GO:0004656	procollagen-proline 4-dioxygenase activity	MF
1	4	0.321299560878	-	1.00e+00	GO:0008865	fructokinase activity	MF
1	4	0.321299560878	-	1.00e+00	GO:0070053	thrombospondin receptor activity	MF
1	4	0.321299560878	-	1.00e+00	GO:0086007	voltage-gated calcium channel activity involved in cardiac muscle cell action potential	MF
1	4	0.321299560878	-	1.00e+00	GO:0009008	DNA-methyltransferase activity	MF
1	4	0.321299560878	-	1.00e+00	GO:0034648	histone demethylase activity (H3-dimethyl-K4 specific)	MF
1	4	0.321299560878	-	1.00e+00	GO:0003960	NADPH:quinone reductase activity	MF
1	4	0.321299560878	-	1.00e+00	GO:0043047	single-stranded telomeric DNA binding	MF
1	4	0.321299560878	-	1.00e+00	GO:0060090	binding, bridging	MF
1	4	0.321299560878	-	1.00e+00	GO:0044020	histone methyltransferase activity (H4-R3 specific)	MF
1	4	0.321299560878	-	1.00e+00	GO:0042296	ISG15 transferase activity	MF
1	4	0.321299560878	-	1.00e+00	GO:0004301	epoxide hydrolase activity	MF
1	4	0.321299560878	-	1.00e+00	GO:0043515	kinetochore binding	MF
146	588	0.311451774921	-	2.78e-06	GO:0006366	transcription from RNA polymerase II promoter	BP
26	105	0.307493761353	-	1.76e-01	GO:0043488	regulation of mRNA stability	BP
18	73	0.30140000344	-	1.16e-01	GO:0001618	virus receptor activity	MF
29	118	0.296637506643	-	2.03e-02	GO:0045766	positive regulation of angiogenesis	BP
14	57	0.29576446877	-	9.43e-02	GO:0001947	heart looping	BP
12	49	0.291552217484	-	3.60e-01	GO:0010212	response to ionizing radiation	BP
11	45	0.288878083185	-	1.41e-01	GO:0042552	myelination	BP
11	45	0.288878083185	-	2.27e-01	GO:0060048	cardiac muscle contraction	BP
20	82	0.285675651147	-	2.62e-02	GO:0007409	axonogenesis	BP
10	41	0.285675651147	-	3.02e-01	GO:0004402	histone acetyltransferase activity	MF
18	74	0.281771196691	-	8.65e-05	GO:0050853	B cell receptor signaling pathway	BP
8	33	0.276905441519	-	1.11e-01	GO:0042100	B cell proliferation	BP
8	33	0.276905441519	-	2.43e-01	GO:0003007	heart morphogenesis	BP
8	33	0.276905441519	-	5.06e-01	GO:0030100	regulation of endocytosis	BP
8	33	0.276905441519	-	6.35e-02	GO:0005267	potassium channel activity	MF
8	33	0.276905441519	-	1.11e-01	GO:0017080	sodium channel regulator activity	MF
8	33	0.276905441519	-	2.15e-01	GO:0004866	endopeptidase inhibitor activity	MF
2184	9019	0.275304936539	-	3.07e-103	GO:0005515	protein binding	MF
7	29	0.270673487808	-	3.37e-01	GO:0042056	chemoattractant activity	MF
105	436	0.267360753767	-	4.30e-10	GO:0045087	innate immune response	BP
24	100	0.262405871824	-	8.09e-02	GO:0006979	response to oxidative stress	BP
6	25	0.262405871824	-	4.22e-01	GO:0043473	pigmentation	BP
6	25	0.262405871824	-	4.38e-01	GO:0001975	response to amphetamine	BP
11	46	0.257169223458	-	3.23e-02	GO:0030514	negative regulation of BMP signaling pathway	BP
11	46	0.257169223458	-	2.20e-01	GO:0032755	positive regulation of interleukin-6 production	BP
11	46	0.257169223458	-	1.49e-01	GO:0008047	enzyme activator activity	MF
16	67	0.25521037042	-	2.72e-01	GO:0042147	retrograde transport, endosome to Golgi	BP
21	88	0.254185365019	-	3.05e-02	GO:0090630	activation of GTPase activity	BP
5	21	0.250910232986	-	1.54e-01	GO:0007369	gastrulation	BP
5	21	0.250910232986	-	3.60e-01	GO:0000266	mitochondrial fission	BP
5	21	0.250910232986	-	3.83e-01	GO:0051497	negative regulation of stress fiber assembly	BP
5	21	0.250910232986	-	5.63e-01	GO:0006913	nucleocytoplasmic transport	BP
5	21	0.250910232986	-	5.76e-01	GO:0045921	positive regulation of exocytosis	BP
5	21	0.250910232986	-	5.93e-01	GO:0045807	positive regulation of endocytosis	BP
5	21	0.250910232986	-	3.42e-01	GO:0005112	Notch binding	MF
5	21	0.250910232986	-	3.60e-01	GO:0048018	receptor agonist activity	MF
5	21	0.250910232986	-	5.93e-01	GO:0050750	low-density lipoprotein particle receptor binding	MF
18	76	0.243297048876	-	1.63e-01	GO:0006661	phosphatidylinositol biosynthetic process	BP
27	114	0.243297048876	-	1.04e-01	GO:0051082	unfolded protein binding	MF
28	119	0.233836719627	-	4.04e-02	GO:0006935	chemotaxis	BP
20	85	0.233836719627	-	2.62e-02	GO:1903955	positive regulation of protein targeting to mitochondrion	BP
4	17	0.233836719627	-	2.74e-01	GO:0044030	regulation of DNA methylation	BP
4	17	0.233836719627	-	2.74e-01	GO:0043537	negative regulation of blood vessel endothelial cell migration	BP
4	17	0.233836719627	-	2.74e-01	GO:0046847	filopodium assembly	BP
4	17	0.233836719627	-	2.74e-01	GO:0097009	energy homeostasis	BP
4	17	0.233836719627	-	3.08e-01	GO:0043171	peptide catabolic process	BP
4	17	0.233836719627	-	3.08e-01	GO:0014850	response to muscle activity	BP
4	17	0.233836719627	-	3.08e-01	GO:0045019	negative regulation of nitric oxide biosynthetic process	BP
4	17	0.233836719627	-	3.08e-01	GO:0006939	smooth muscle contraction	BP
8	34	0.233836719627	-	3.50e-01	GO:0045540	regulation of cholesterol biosynthetic process	BP
4	17	0.233836719627	-	5.00e-01	GO:0030193	regulation of blood coagulation	BP
4	17	0.233836719627	-	5.19e-01	GO:0002407	dendritic cell chemotaxis	BP
4	17	0.233836719627	-	5.19e-01	GO:0006893	Golgi to plasma membrane transport	BP
4	17	0.233836719627	-	5.19e-01	GO:0071404	cellular response to low-density lipoprotein particle stimulus	BP
4	17	0.233836719627	-	5.19e-01	GO:0032722	positive regulation of chemokine production	BP
4	17	0.233836719627	-	5.43e-01	GO:0048535	lymph node development	BP
4	17	0.233836719627	-	5.43e-01	GO:0008045	motor neuron axon guidance	BP
4	17	0.233836719627	-	5.43e-01	GO:0003746	translation elongation factor activity	MF
4	17	0.233836719627	-	5.43e-01	GO:0070300	phosphatidic acid binding	MF
4	17	0.233836719627	-	5.43e-01	GO:0050431	transforming growth factor beta binding	MF
4	17	0.233836719627	-	5.43e-01	GO:0001223	transcription coactivator binding	MF
4	17	0.233836719627	-	7.61e-01	GO:0003678	DNA helicase activity	MF
4	17	0.233836719627	-	7.61e-01	GO:0071837	HMG box domain binding	MF
23	98	0.230151672819	-	6.68e-02	GO:0016310	phosphorylation	BP
15	64	0.228190156486	-	1.66e-01	GO:0007224	smoothened signaling pathway	BP
11	47	0.226142327837	-	1.41e-01	GO:0006631	fatty acid metabolic process	BP
7	30	0.221763887327	-	3.03e-01	GO:0030901	midbrain development	BP
14	60	0.221763887327	-	4.06e-01	GO:0010972	negative regulation of G2/M transition of mitotic cell cycle	BP
10	43	0.216962901063	-	1.87e-01	GO:0001756	somitogenesis	BP
85	368	0.207128540958	-	2.99e-04	GO:0006954	inflammatory response	BP
3	13	0.205822343458	-	9.89e-02	GO:0051560	mitochondrial calcium ion homeostasis	BP
3	13	0.205822343458	-	1.48e-01	GO:0061051	positive regulation of cell growth involved in cardiac muscle cell development	BP
3	13	0.205822343458	-	2.03e-01	GO:0048599	oocyte development	BP
9	39	0.205822343458	-	2.57e-01	GO:0030326	embryonic limb morphogenesis	BP
3	13	0.205822343458	-	3.96e-01	GO:0072488	ammonium transmembrane transport	BP
3	13	0.205822343458	-	3.96e-01	GO:0010839	negative regulation of keratinocyte proliferation	BP
3	13	0.205822343458	-	3.96e-01	GO:0071318	cellular response to ATP	BP
6	26	0.205822343458	-	4.09e-01	GO:0007202	activation of phospholipase C activity	BP
6	26	0.205822343458	-	4.22e-01	GO:0060173	limb development	BP
3	13	0.205822343458	-	4.30e-01	GO:0050777	negative regulation of immune response	BP
3	13	0.205822343458	-	4.30e-01	GO:0090501	RNA phosphodiester bond hydrolysis	BP
3	13	0.205822343458	-	4.30e-01	GO:0031076	embryonic camera-type eye development	BP
3	13	0.205822343458	-	4.69e-01	GO:0071712	ER-associated misfolded protein catabolic process	BP
3	13	0.205822343458	-	4.69e-01	GO:0050806	positive regulation of synaptic transmission	BP
3	13	0.205822343458	-	4.69e-01	GO:0001967	suckling behavior	BP
3	13	0.205822343458	-	4.69e-01	GO:0099133	ATP hydrolysis coupled anion transmembrane transport	BP
3	13	0.205822343458	-	4.69e-01	GO:0044319	wound healing, spreading of cells	BP
3	13	0.205822343458	-	4.69e-01	GO:0008610	lipid biosynthetic process	BP
3	13	0.205822343458	-	7.16e-01	GO:0046039	GTP metabolic process	BP
3	13	0.205822343458	-	7.16e-01	GO:2000010	positive regulation of protein localization to cell surface	BP
3	13	0.205822343458	-	7.16e-01	GO:0071361	cellular response to ethanol	BP
3	13	0.205822343458	-	7.16e-01	GO:0034453	microtubule anchoring	BP
3	13	0.205822343458	-	7.16e-01	GO:0030194	positive regulation of blood coagulation	BP
3	13	0.205822343458	-	7.32e-01	GO:1900025	negative regulation of substrate adhesion-dependent cell spreading	BP
3	13	0.205822343458	-	7.32e-01	GO:0001829	trophectodermal cell differentiation	BP
3	13	0.205822343458	-	7.32e-01	GO:0048024	regulation of mRNA splicing, via spliceosome	BP
3	13	0.205822343458	-	4.69e-01	GO:0001191	transcriptional repressor activity, RNA polymerase II transcription factor binding	MF
3	13	0.205822343458	-	7.16e-01	GO:0043024	ribosomal small subunit binding	MF
3	13	0.205822343458	-	7.32e-01	GO:0017017	MAP kinase tyrosine/serine/threonine phosphatase activity	MF
65	282	0.204116021507	-	1.93e-03	GO:0005096	GTPase activator activity	MF
20	87	0.200284159916	-	1.04e-01	GO:0001227	transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding	MF
11	48	0.195768678794	-	9.35e-02	GO:0010862	positive regulation of pathway-restricted SMAD protein phosphorylation	BP
8	35	0.192016543933	-	2.27e-01	GO:0035094	response to nicotine	BP
8	35	0.192016543933	-	3.50e-01	GO:0048813	dendrite morphogenesis	BP
8	35	0.192016543933	-	6.72e-01	GO:0008094	DNA-dependent ATPase activity	MF
28	123	0.186139977596	-	3.43e-03	GO:0019221	cytokine-mediated signaling pathway	BP
5	22	0.183796037128	-	3.83e-01	GO:0048488	synaptic vesicle endocytosis	BP
5	22	0.183796037128	-	5.93e-01	GO:0006607	NLS-bearing protein import into nucleus	BP
5	22	0.183796037128	-	5.93e-01	GO:0048278	vesicle docking	BP
5	22	0.183796037128	-	5.93e-01	GO:0050769	positive regulation of neurogenesis	BP
5	22	0.183796037128	-	3.83e-01	GO:0017056	structural constituent of nuclear pore	MF
5	22	0.183796037128	-	3.83e-01	GO:0008198	ferrous iron binding	MF
5	22	0.183796037128	-	5.63e-01	GO:0015035	protein disulfide oxidoreductase activity	MF
31	137	0.177463788304	-	2.71e-01	GO:0006260	DNA replication	BP
38	168	0.176909651542	-	7.52e-02	GO:0060271	cilium assembly	BP
7	31	0.174458172548	-	3.03e-01	GO:0035115	embryonic forelimb morphogenesis	BP
7	31	0.174458172548	-	3.03e-01	GO:0045907	positive regulation of vasoconstriction	BP
7	31	0.174458172548	-	4.82e-01	GO:0021510	spinal cord development	BP
14	62	0.174458172548	-	6.33e-01	GO:0045815	positive regulation of gene expression, epigenetic	BP
14	62	0.174458172548	-	2.23e-01	GO:0050839	cell adhesion molecule binding	MF
7	31	0.174458172548	-	3.37e-01	GO:0015026	coreceptor activity	MF
13	58	0.163758283891	-	3.79e-01	GO:0048306	calcium-dependent protein binding	MF
14	63	0.151374559435	-	2.23e-01	GO:0007613	memory	BP
14	63	0.151374559435	-	3.05e-01	GO:0030593	neutrophil chemotaxis	BP
14	63	0.151374559435	-	4.13e-01	GO:0017148	negative regulation of translation	BP
6	27	0.151374559435	-	4.22e-01	GO:0010575	positive regulation of vascular endothelial growth factor production	BP
6	27	0.151374559435	-	4.22e-01	GO:0035774	positive regulation of insulin secretion involved in cellular response to glucose stimulus	BP
18	81	0.151374559435	-	5.75e-01	GO:0060964	regulation of gene silencing by miRNA	BP
6	27	0.151374559435	-	8.09e-01	GO:0050718	positive regulation of interleukin-1 beta secretion	BP
18	81	0.151374559435	-	2.90e-02	GO:0008233	peptidase activity	MF
6	27	0.151374559435	-	2.46e-01	GO:0001530	lipopolysaccharide binding	MF
12	54	0.151374559435	-	4.87e-01	GO:0004386	helicase activity	MF
2	9	0.151374559435	-	4.00e-02	GO:1904685	positive regulation of metalloendopeptidase activity	BP
2	9	0.151374559435	-	1.04e-01	GO:0016051	carbohydrate biosynthetic process	BP
4	18	0.151374559435	-	1.21e-01	GO:2000117	negative regulation of cysteine-type endopeptidase activity	BP
2	9	0.151374559435	-	1.81e-01	GO:0060371	regulation of atrial cardiac muscle cell membrane depolarization	BP
2	9	0.151374559435	-	1.81e-01	GO:0043266	regulation of potassium ion transport	BP
2	9	0.151374559435	-	2.63e-01	GO:0046549	retinal cone cell development	BP
2	9	0.151374559435	-	2.63e-01	GO:0097186	amelogenesis	BP
2	9	0.151374559435	-	2.63e-01	GO:0098703	calcium ion import across plasma membrane	BP
2	9	0.151374559435	-	2.63e-01	GO:0045580	regulation of T cell differentiation	BP
2	9	0.151374559435	-	3.45e-01	GO:0098773	skin epidermis development	BP
2	9	0.151374559435	-	3.45e-01	GO:0043117	positive regulation of vascular permeability	BP
2	9	0.151374559435	-	3.45e-01	GO:0071679	commissural neuron axon guidance	BP
2	9	0.151374559435	-	3.45e-01	GO:0071435	potassium ion export	BP
2	9	0.151374559435	-	3.45e-01	GO:0015866	ADP transport	BP
2	9	0.151374559435	-	3.45e-01	GO:0042448	progesterone metabolic process	BP
16	72	0.151374559435	-	3.46e-01	GO:0045454	cell redox homeostasis	BP
16	72	0.151374559435	-	3.52e-01	GO:0071347	cellular response to interleukin-1	BP
4	18	0.151374559435	-	5.00e-01	GO:0060037	pharyngeal system development	BP
4	18	0.151374559435	-	5.00e-01	GO:0035249	synaptic transmission, glutamatergic	BP
4	18	0.151374559435	-	5.00e-01	GO:0071294	cellular response to zinc ion	BP
4	18	0.151374559435	-	5.19e-01	GO:0090026	positive regulation of monocyte chemotaxis	BP
2	9	0.151374559435	-	6.33e-01	GO:0042118	endothelial cell activation	BP
2	9	0.151374559435	-	6.33e-01	GO:0030903	notochord development	BP
2	9	0.151374559435	-	6.33e-01	GO:0061549	sympathetic ganglion development	BP
2	9	0.151374559435	-	6.33e-01	GO:0010579	positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway	BP
2	9	0.151374559435	-	6.33e-01	GO:0060039	pericardium development	BP
2	9	0.151374559435	-	6.33e-01	GO:0006518	peptide metabolic process	BP
2	9	0.151374559435	-	6.33e-01	GO:0014883	transition between fast and slow fiber	BP
2	9	0.151374559435	-	6.33e-01	GO:0072358	cardiovascular system development	BP
2	9	0.151374559435	-	6.33e-01	GO:0050713	negative regulation of interleukin-1 beta secretion	BP
2	9	0.151374559435	-	6.33e-01	GO:0030643	cellular phosphate ion homeostasis	BP
2	9	0.151374559435	-	6.33e-01	GO:0003143	embryonic heart tube morphogenesis	BP
2	9	0.151374559435	-	6.33e-01	GO:0035767	endothelial cell chemotaxis	BP
2	9	0.151374559435	-	6.33e-01	GO:0097011	cellular response to granulocyte macrophage colony-stimulating factor stimulus	BP
2	9	0.151374559435	-	6.65e-01	GO:0003208	cardiac ventricle morphogenesis	BP
2	9	0.151374559435	-	6.65e-01	GO:1904153	negative regulation of retrograde protein transport, ER to cytosol	BP
2	9	0.151374559435	-	6.65e-01	GO:0032206	positive regulation of telomere maintenance	BP
2	9	0.151374559435	-	6.65e-01	GO:0035999	tetrahydrofolate interconversion	BP
2	9	0.151374559435	-	6.65e-01	GO:0060231	mesenchymal to epithelial transition	BP
2	9	0.151374559435	-	6.65e-01	GO:0034101	erythrocyte homeostasis	BP
2	9	0.151374559435	-	6.65e-01	GO:0071236	cellular response to antibiotic	BP
2	9	0.151374559435	-	6.65e-01	GO:1902857	positive regulation of non-motile cilium assembly	BP
2	9	0.151374559435	-	6.65e-01	GO:0060124	positive regulation of growth hormone secretion	BP
2	9	0.151374559435	-	6.65e-01	GO:0071243	cellular response to arsenic-containing substance	BP
2	9	0.151374559435	-	6.65e-01	GO:0042908	xenobiotic transport	BP
2	9	0.151374559435	-	6.65e-01	GO:0035562	negative regulation of chromatin binding	BP
4	18	0.151374559435	-	7.61e-01	GO:0045948	positive regulation of translational initiation	BP
4	18	0.151374559435	-	7.61e-01	GO:0061003	positive regulation of dendritic spine morphogenesis	BP
4	18	0.151374559435	-	7.70e-01	GO:1901741	positive regulation of myoblast fusion	BP
4	18	0.151374559435	-	7.70e-01	GO:0010824	regulation of centrosome duplication	BP
4	18	0.151374559435	-	7.70e-01	GO:0002026	regulation of the force of heart contraction	BP
2	9	0.151374559435	-	1.00e+00	GO:0034384	high-density lipoprotein particle clearance	BP
2	9	0.151374559435	-	1.00e+00	GO:0007196	adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway	BP
2	9	0.151374559435	-	1.00e+00	GO:0043030	regulation of macrophage activation	BP
2	9	0.151374559435	-	1.00e+00	GO:0043653	mitochondrial fragmentation involved in apoptotic process	BP
2	9	0.151374559435	-	1.00e+00	GO:0050687	negative regulation of defense response to virus	BP
2	9	0.151374559435	-	1.00e+00	GO:0050880	regulation of blood vessel size	BP
2	9	0.151374559435	-	1.00e+00	GO:0050774	negative regulation of dendrite morphogenesis	BP
2	9	0.151374559435	-	1.00e+00	GO:0006903	vesicle targeting	BP
2	9	0.151374559435	-	1.00e+00	GO:0008228	opsonization	BP
2	9	0.151374559435	-	1.00e+00	GO:0003149	membranous septum morphogenesis	BP
2	9	0.151374559435	-	1.00e+00	GO:2000008	regulation of protein localization to cell surface	BP
2	9	0.151374559435	-	1.00e+00	GO:0008635	activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c	BP
2	9	0.151374559435	-	1.00e+00	GO:0051315	attachment of mitotic spindle microtubules to kinetochore	BP
2	9	0.151374559435	-	1.00e+00	GO:0008608	attachment of spindle microtubules to kinetochore	BP
2	9	0.151374559435	-	1.00e+00	GO:0033689	negative regulation of osteoblast proliferation	BP
2	9	0.151374559435	-	1.00e+00	GO:0031497	chromatin assembly	BP
2	9	0.151374559435	-	1.00e+00	GO:0035456	response to interferon-beta	BP
2	9	0.151374559435	-	1.00e+00	GO:0046598	positive regulation of viral entry into host cell	BP
2	9	0.151374559435	-	1.00e+00	GO:0045080	positive regulation of chemokine biosynthetic process	BP
2	9	0.151374559435	-	1.00e+00	GO:0021895	cerebral cortex neuron differentiation	BP
2	9	0.151374559435	-	1.81e-01	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	MF
4	18	0.151374559435	-	2.74e-01	GO:0016746	transferase activity, transferring acyl groups	MF
2	9	0.151374559435	-	3.45e-01	GO:0047498	calcium-dependent phospholipase A2 activity	MF
2	9	0.151374559435	-	3.45e-01	GO:0004114	3',5'-cyclic-nucleotide phosphodiesterase activity	MF
2	9	0.151374559435	-	3.45e-01	GO:0070700	BMP receptor binding	MF
2	9	0.151374559435	-	6.33e-01	GO:0071933	Arp2/3 complex binding	MF
2	9	0.151374559435	-	6.33e-01	GO:0016918	retinal binding	MF
2	9	0.151374559435	-	6.33e-01	GO:0008035	high-density lipoprotein particle binding	MF
2	9	0.151374559435	-	6.65e-01	GO:0052659	inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity	MF
2	9	0.151374559435	-	6.65e-01	GO:0070679	inositol 1,4,5 trisphosphate binding	MF
4	18	0.151374559435	-	7.61e-01	GO:0051371	muscle alpha-actinin binding	MF
4	18	0.151374559435	-	7.61e-01	GO:0030234	enzyme regulator activity	MF
2	9	0.151374559435	-	1.00e+00	GO:0044389	ubiquitin-like protein ligase binding	MF
2	9	0.151374559435	-	1.00e+00	GO:0061578	Lys63-specific deubiquitinase activity	MF
45	203	0.147816740022	-	9.35e-05	GO:0050900	leukocyte migration	BP
25	113	0.144976788237	-	1.24e-01	GO:0006334	nucleosome assembly	BP
17	77	0.141975861433	-	6.41e-02	GO:0045666	positive regulation of neuron differentiation	BP
17	77	0.141975861433	-	2.09e-01	GO:0043085	positive regulation of catalytic activity	BP
181	820	0.141665348455	-	5.31e-08	GO:0003700	transcription factor activity, sequence-specific DNA binding	MF
9	41	0.133672557702	-	3.98e-01	GO:0043010	camera-type eye development	BP
16	73	0.131475001998	-	2.60e-01	GO:0006816	calcium ion transport	BP
7	32	0.128654482935	-	4.82e-01	GO:0003091	renal water homeostasis	BP
7	32	0.128654482935	-	8.25e-01	GO:0007052	mitotic spindle organization	BP
52	238	0.126921515711	-	2.30e-03	GO:0007166	cell surface receptor signaling pathway	BP
24	110	0.124902348074	-	4.60e-01	GO:0016569	covalent chromatin modification	BP
10	46	0.119665699708	-	3.14e-01	GO:0043647	inositol phosphate metabolic process	BP
5	23	0.119665699708	-	3.42e-01	GO:1904707	positive regulation of vascular smooth muscle cell proliferation	BP
5	23	0.119665699708	-	3.83e-01	GO:0001819	positive regulation of cytokine production	BP
5	23	0.119665699708	-	3.83e-01	GO:0009617	response to bacterium	BP
10	46	0.119665699708	-	4.40e-01	GO:0009408	response to heat	BP
5	23	0.119665699708	-	5.63e-01	GO:0048741	skeletal muscle fiber development	BP
5	23	0.119665699708	-	5.76e-01	GO:0008306	associative learning	BP
5	23	0.119665699708	-	5.76e-01	GO:0051928	positive regulation of calcium ion transport	BP
5	23	0.119665699708	-	5.93e-01	GO:0071345	cellular response to cytokine stimulus	BP
5	23	0.119665699708	-	7.89e-01	GO:0043001	Golgi to plasma membrane protein transport	BP
10	46	0.119665699708	-	5.62e-01	GO:0000149	SNARE binding	MF
5	23	0.119665699708	-	5.76e-01	GO:0070840	dynein complex binding	MF
5	23	0.119665699708	-	5.93e-01	GO:0030742	GTP-dependent protein binding	MF
13	60	0.11484868341	-	7.44e-01	GO:0019003	GDP binding	MF
8	37	0.111846195249	-	8.37e-01	GO:0006110	regulation of glycolytic process	BP
11	51	0.108305837543	-	7.23e-01	GO:0006521	regulation of cellular amino acid metabolic process	BP
11	51	0.108305837543	-	3.26e-01	GO:0030145	manganese ion binding	MF
42	195	0.106286669907	-	2.43e-02	GO:0030198	extracellular matrix organization	BP
17	79	0.104981653951	-	5.59e-01	GO:0007030	Golgi organization	BP
3	14	0.0989071395412	-	1.48e-01	GO:0048149	behavioral response to ethanol	BP
3	14	0.0989071395412	-	1.48e-01	GO:0061049	cell growth involved in cardiac muscle cell development	BP
6	28	0.0989071395412	-	2.32e-01	GO:0086010	membrane depolarization during action potential	BP
3	14	0.0989071395412	-	3.96e-01	GO:0001675	acrosome assembly	BP
3	14	0.0989071395412	-	4.30e-01	GO:0002063	chondrocyte development	BP
3	14	0.0989071395412	-	4.69e-01	GO:0090280	positive regulation of calcium ion import	BP
3	14	0.0989071395412	-	4.69e-01	GO:0045947	negative regulation of translational initiation	BP
6	28	0.0989071395412	-	6.17e-01	GO:0043484	regulation of RNA splicing	BP
6	28	0.0989071395412	-	6.17e-01	GO:0090023	positive regulation of neutrophil chemotaxis	BP
6	28	0.0989071395412	-	6.29e-01	GO:0001662	behavioral fear response	BP
6	28	0.0989071395412	-	6.29e-01	GO:0070207	protein homotrimerization	BP
3	14	0.0989071395412	-	7.16e-01	GO:0071625	vocalization behavior	BP
3	14	0.0989071395412	-	7.16e-01	GO:0060038	cardiac muscle cell proliferation	BP
3	14	0.0989071395412	-	7.16e-01	GO:0006536	glutamate metabolic process	BP
3	14	0.0989071395412	-	7.32e-01	GO:2000785	regulation of autophagosome assembly	BP
3	14	0.0989071395412	-	7.32e-01	GO:1901673	regulation of mitotic spindle assembly	BP
3	14	0.0989071395412	-	1.00e+00	GO:0034975	protein folding in endoplasmic reticulum	BP
3	14	0.0989071395412	-	1.00e+00	GO:0022904	respiratory electron transport chain	BP
3	14	0.0989071395412	-	1.00e+00	GO:0060644	mammary gland epithelial cell differentiation	BP
3	14	0.0989071395412	-	1.00e+00	GO:0033365	protein localization to organelle	BP
6	28	0.0989071395412	-	4.22e-01	GO:0044183	protein binding involved in protein folding	MF
6	28	0.0989071395412	-	4.38e-01	GO:0008139	nuclear localization sequence binding	MF
3	14	0.0989071395412	-	4.69e-01	GO:0047555	3',5'-cyclic-GMP phosphodiesterase activity	MF
3	14	0.0989071395412	-	7.16e-01	GO:0050811	GABA receptor binding	MF
3	14	0.0989071395412	-	7.32e-01	GO:0005095	GTPase inhibitor activity	MF
3	14	0.0989071395412	-	1.00e+00	GO:0031005	filamin binding	MF
19	89	0.0934936433548	-	4.88e-01	GO:1990830	cellular response to leukemia inhibitory factor	BP
13	61	0.0910019414558	-	2.89e-01	GO:0005518	collagen binding	MF
10	47	0.0886388040873	-	2.06e-01	GO:0019722	calcium-mediated signaling	BP
7	33	0.0842603635768	-	1.66e-01	GO:0043330	response to exogenous dsRNA	BP
21	99	0.0842603635768	-	2.73e-01	GO:0006936	muscle contraction	BP
7	33	0.0842603635768	-	4.82e-01	GO:0051262	protein tetramerization	BP
7	33	0.0842603635768	-	8.25e-01	GO:0008219	cell death	BP
7	33	0.0842603635768	-	9.82e-02	GO:0004869	cysteine-type endopeptidase inhibitor activity	MF
12	57	0.073372047434	-	4.79e-01	GO:0071346	cellular response to interferon-gamma	BP
8	38	0.073372047434	-	6.35e-02	GO:0009566	fertilization	BP
4	19	0.073372047434	-	3.08e-01	GO:0010881	regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion	BP
4	19	0.073372047434	-	3.08e-01	GO:0033280	response to vitamin D	BP
4	19	0.073372047434	-	3.08e-01	GO:0007141	male meiosis I	BP
4	19	0.073372047434	-	5.00e-01	GO:0048148	behavioral response to cocaine	BP
4	19	0.073372047434	-	5.19e-01	GO:0048663	neuron fate commitment	BP
4	19	0.073372047434	-	5.19e-01	GO:0048545	response to steroid hormone	BP
4	19	0.073372047434	-	5.43e-01	GO:0032502	developmental process	BP
4	19	0.073372047434	-	5.43e-01	GO:0048026	positive regulation of mRNA splicing, via spliceosome	BP
4	19	0.073372047434	-	5.43e-01	GO:0032332	positive regulation of chondrocyte differentiation	BP
4	19	0.073372047434	-	5.43e-01	GO:0045879	negative regulation of smoothened signaling pathway	BP
4	19	0.073372047434	-	7.61e-01	GO:0008589	regulation of smoothened signaling pathway	BP
4	19	0.073372047434	-	7.61e-01	GO:0050770	regulation of axonogenesis	BP
4	19	0.073372047434	-	7.70e-01	GO:0045022	early endosome to late endosome transport	BP
4	19	0.073372047434	-	7.70e-01	GO:0098586	cellular response to virus	BP
4	19	0.073372047434	-	7.70e-01	GO:0042311	vasodilation	BP
4	19	0.073372047434	-	1.00e+00	GO:0042098	T cell proliferation	BP
4	19	0.073372047434	-	1.00e+00	GO:0051170	nuclear import	BP
8	38	0.073372047434	-	3.77e-01	GO:0001786	phosphatidylserine binding	MF
4	19	0.073372047434	-	7.70e-01	GO:0017075	syntaxin-1 binding	MF
8	38	0.073372047434	-	8.37e-01	GO:0005484	SNAP receptor activity	MF
18	86	0.0649598076178	-	1.12e-01	GO:0036459	thiol-dependent ubiquitinyl hydrolase activity	MF
15	72	0.0582651550438	-	3.40e-01	GO:0007018	microtubule-based movement	BP
5	24	0.0582651550438	-	5.63e-01	GO:0032967	positive regulation of collagen biosynthetic process	BP
5	24	0.0582651550438	-	5.76e-01	GO:0032733	positive regulation of interleukin-10 production	BP
5	24	0.0582651550438	-	7.89e-01	GO:0034341	response to interferon-gamma	BP
5	24	0.0582651550438	-	7.96e-01	GO:0043325	phosphatidylinositol-3,4-bisphosphate binding	MF
105	505	0.0554055009046	-	2.42e-05	GO:0030154	cell differentiation	BP
16	77	0.0545130201827	-	4.44e-01	GO:0009952	anterior/posterior pattern specification	BP
6	29	0.0482810664712	-	4.38e-01	GO:0044344	cellular response to fibroblast growth factor stimulus	BP
12	58	0.0482810664712	-	7.33e-01	GO:0036498	IRE1-mediated unfolded protein response	BP
13	63	0.0444593555188	-	7.44e-01	GO:0048208	COPII vesicle coating	BP
7	34	0.0411916416849	-	1.81e-01	GO:0045747	positive regulation of Notch signaling pathway	BP
7	34	0.0411916416849	-	3.03e-01	GO:0030282	bone mineralization	BP
7	34	0.0411916416849	-	3.37e-01	GO:0008016	regulation of heart contraction	BP
7	34	0.0411916416849	-	6.41e-01	GO:0042130	negative regulation of T cell proliferation	BP
16	78	0.0358973420154	-	1.91e-01	GO:0008544	epidermis development	BP
17	83	0.033722970781	-	3.76e-01	GO:0001822	kidney development	BP
9	44	0.0317929436826	-	2.67e-01	GO:0061337	cardiac conduction	BP
18	88	0.0317929436826	-	3.07e-01	GO:0007517	muscle organ development	BP
9	44	0.0317929436826	-	5.36e-01	GO:0015631	tubulin binding	MF
38	186	0.0300682632132	-	1.90e-01	GO:0007420	brain development	BP
10	49	0.0285178116498	-	4.21e-01	GO:0035176	social behavior	BP
33	162	0.0258436773514	-	7.10e-02	GO:0008083	growth factor activity	MF
34	167	0.0250581096539	-	3.51e-01	GO:0006457	protein folding	BP
16	79	0.0175188127005	-	5.45e-01	GO:0007005	mitochondrion organization	BP
76	376	0.0146382226436	-	4.00e-03	GO:0043565	sequence-specific DNA binding	MF
26	129	0.0105120235955	-	1.33e-01	GO:0008289	lipid binding	MF
